data_2e5i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2e5i _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 217' ' ' VAL . 4.1 p-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.88 0.371 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -30.99 69.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.499 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 95.7 t -86.86 140.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.45 ' N ' HG11 ' A' ' 217' ' ' VAL . 14.0 mt -134.38 132.34 39.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 49.1 tp -81.89 103.82 11.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.9 mp -90.96 128.61 36.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.17 112.49 17.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 3.5 mp -75.42 130.62 36.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.139 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -99.47 120.52 39.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 19.0 m-20 63.61 52.28 1.41 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 0.0 110.91 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 60.2 Cg_endo -74.41 47.09 1.53 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.654 2.236 . . . . 0.0 112.352 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.3 mt -39.86 -41.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -97.78 141.49 23.08 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.68 0.752 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.31 124.38 9.11 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.734 2.289 . . . . 0.0 112.282 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.6 mm -107.11 109.04 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.12 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.1 p -102.98 159.05 15.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.437 ' N ' HD11 ' A' ' 249' ' ' ILE . 21.8 m -44.37 -39.88 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -54.19 -55.84 24.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.1 t -45.12 -39.11 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 25.7 mt -78.49 -64.06 1.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.414 ' CZ ' ' ND2' ' A' ' 239' ' ' ASN . 55.6 t80 -46.9 -27.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.477 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 63.6 m -64.34 -47.69 78.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.419 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 65.1 t -87.37 -11.2 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.115 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 64.4 m -87.39 -49.06 7.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.579 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.0 t-20 -48.65 -46.36 71.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.657 0.741 . . . . 0.0 110.896 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.2 Cg_exo -47.97 -17.4 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 96.2 t -102.59 -41.34 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -174.2 177.26 46.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 142.87 56.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.1 t -110.57 134.64 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -80.77 -60.84 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -161.74 155.07 21.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 74.9 mt -134.93 119.13 26.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 49.1 t -110.76 115.03 48.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.437 HD11 ' N ' ' A' ' 231' ' ' VAL . 64.5 mt -97.35 114.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.173 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 7.5 p90 -116.3 162.38 17.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -117.87 90.92 3.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -133.04 94.45 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 59.51 38.95 22.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 131.06 131.17 3.25 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.47 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 33.1 mm -48.1 102.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.518 ' HB3' ' CE1' ' A' ' 250' ' ' PHE . 27.7 mt-30 -118.15 166.14 12.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -168.17 130.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.065 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 33.8 mtt -97.1 132.82 42.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.7 t -122.73 125.31 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.154 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -101.85 150.52 23.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -122.36 159.36 27.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -41.19 -65.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.7 t -130.71 176.23 8.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 85.7 t -60.24 -51.43 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.111 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 20.9 tp -39.07 -62.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 65.7 m -47.44 -41.82 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -55.87 -42.75 76.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -54.88 -58.56 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -62.25 -56.67 16.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.866 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -47.18 -47.96 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.122 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 275' ' ' ASN . 22.7 tttt -50.27 -48.8 54.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -64.48 -67.71 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -39.78 -33.76 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.39 -28.13 17.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 272' ' ' ALA . 6.0 t30 -55.27 100.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.3 21.95 61.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -84.35 92.41 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.33 129.21 39.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 74.4 mt -100.36 -41.64 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.177 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -117.38 171.56 7.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -55.11 108.62 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.115 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.7 53.75 0.82 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 25.5 p -174.51 172.01 3.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 69.5 m 56.08 41.12 29.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 54.4 m -68.98 143.94 54.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.171 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.14 127.33 35.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -118.89 80.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.4 HG21 ' N ' ' A' ' 289' ' ' GLU . 17.0 mt -71.28 144.32 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 290' ' ' TYR . 19.7 mt-10 -157.31 107.79 2.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 289' ' ' GLU . 41.9 m-85 -34.4 101.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -56.19 165.24 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.498 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 0.4 OUTLIER -71.82 -57.8 3.86 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.647 0.736 . . . . 0.0 110.856 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 59.5 Cg_endo -73.14 160.47 45.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.67 2.247 . . . . 0.0 112.345 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.401 ' O ' ' CG2' ' A' ' 217' ' ' VAL . 33.2 p -102.95 -27.58 12.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -111.81 144.9 40.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 80.5 mt -109.45 175.9 5.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -135.87 139.05 43.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 95.2 t -134.97 97.29 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.141 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.3 mp -51.5 -57.3 3.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -139.69 175.95 9.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.76 116.67 33.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -159.29 171.32 20.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -44.47 -39.93 5.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.16 -61.11 2.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 53.4 p -131.05 133.46 45.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -124.18 141.17 52.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -115.04 100.88 8.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.36 -47.95 38.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.5 t30 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.866 0.365 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 217' ' ' VAL . 0.0 OUTLIER -50.47 -35.21 27.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.408 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 95.0 t -89.59 141.85 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.461 ' HB3' ' CG2' ' A' ' 288' ' ' ILE . 52.6 mt -142.19 128.35 19.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.2 tp -87.0 105.24 17.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.82 140.43 29.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -134.8 115.71 13.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -81.49 130.31 36.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -98.46 130.93 45.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.474 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 59.8 t30 48.34 52.74 13.16 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.6 Cg_exo -44.84 123.59 5.02 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.663 2.242 . . . . 0.0 112.381 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.438 ' CD2' ' HB2' ' A' ' 283' ' ' CYS . 4.0 mm? -91.81 -63.04 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -107.52 153.97 41.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.663 0.744 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.37 112.37 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.7 mm -90.83 116.59 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 29.8 p -127.11 159.84 32.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.163 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.9 m -37.7 -33.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -65.41 -60.45 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 90.4 t -45.63 -44.71 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.174 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 36.7 mt -70.45 -61.4 1.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -49.93 -27.35 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.483 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 98.3 m -65.62 -47.28 76.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.444 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 80.1 t -86.73 -16.98 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 85.1 m -83.87 -47.78 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.538 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -47.36 -48.78 55.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.594 0.711 . . . . 0.0 110.846 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.6 Cg_exo -48.0 -17.57 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 0.0 112.356 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.404 ' CG1' ' HA ' ' A' ' 270' ' ' ALA . 87.7 t -97.59 -43.93 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.56 -155.61 9.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 244' ' ' VAL . 0.6 OUTLIER -101.28 130.22 47.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 245' ' ' GLN . 66.2 t -100.35 143.67 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.425 ' N ' HG11 ' A' ' 244' ' ' VAL . 21.7 mm-40 -94.62 -58.75 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.408 ' CB ' ' HA ' ' A' ' 307' ' ' ASP . 14.8 ptt-85 -155.23 163.93 39.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 63.8 mt -145.3 140.79 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.66 121.28 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 304' ' ' ASP . 46.1 mt -102.52 118.2 49.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -130.88 154.69 47.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -111.48 93.22 4.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -129.55 102.83 6.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 47.7 39.35 10.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 133.54 121.45 2.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.5 mm -41.12 106.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -126.48 151.03 48.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -152.31 117.82 5.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 10.5 mtt -77.8 146.47 35.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.3 t -137.81 118.77 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 23.3 tt0 -97.83 152.24 19.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.434 ' N ' ' HG2' ' A' ' 260' ' ' GLU . 55.6 m-85 -126.5 154.91 43.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -41.13 -63.25 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.8 m -131.19 172.33 12.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 265' ' ' LEU . 94.8 t -59.27 -51.96 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 264' ' ' VAL . 23.4 tp -37.43 -65.59 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 54.6 m -45.72 -42.77 12.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -57.76 -41.47 82.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -52.92 -61.6 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -62.36 -53.37 55.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . 0.404 ' HA ' ' CG1' ' A' ' 241' ' ' VAL . . . -46.76 -49.22 20.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 275' ' ' ASN . 61.5 tttm -52.19 -47.34 65.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.83 -62.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.101 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -46.17 -36.4 5.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.9 mp -89.54 -24.22 21.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 271' ' ' LYS . 5.3 t30 -57.43 99.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.83 19.97 69.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -91.99 94.41 9.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.102 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.36 171.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 44.5 mt -119.74 -35.23 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . 0.402 ' O ' ' C ' ' A' ' 281' ' ' ALA . 60.2 m-85 -131.72 174.02 10.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -37.64 102.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.094 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.525 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 26.29 76.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.473 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . 0.438 ' HB2' ' CD2' ' A' ' 226' ' ' LEU . 20.2 p -176.13 -175.13 0.68 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.769 0.319 . . . . 0.0 110.897 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 283' ' ' CYS . 3.0 p 36.36 41.42 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 15.5 m -57.32 145.9 30.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 69.0 mt -97.44 139.24 33.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -130.11 105.66 8.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.879 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' A' ' 218' ' ' LEU . 23.5 mt -91.96 139.21 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 290' ' ' TYR . 16.5 mm-40 -146.17 110.24 4.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.873 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 289' ' ' GLU . 28.5 m-85 -35.99 100.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.949 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.1 159.13 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.105 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 4.4 mtp-105 -73.16 -58.02 2.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.596 0.712 . . . . 0.0 110.891 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 60.3 Cg_endo -74.24 156.96 46.36 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.227 . . . . 0.0 112.337 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 28.9 p -96.55 -32.45 12.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.162 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.19 143.8 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 35.7 mt -118.46 143.59 46.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -120.41 114.56 21.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 71.9 t -85.01 114.45 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.2 mp -67.13 -55.0 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -130.73 150.58 51.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -97.98 97.06 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 303' ' ' ASN . 2.7 p-10 -148.99 172.14 15.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 302' ' ' ASP . 4.7 m-20 -34.52 -44.67 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . 0.415 ' O ' ' CG1' ' A' ' 249' ' ' ILE . 73.2 m-20 -55.5 -55.71 28.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 88.8 p -130.45 135.69 48.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -140.1 116.81 10.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.408 ' HA ' ' CB ' ' A' ' 246' ' ' ARG . 0.8 OUTLIER -105.48 91.93 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -53.98 -44.97 71.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 65.4 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 217' ' ' VAL . 22.2 p-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -64.67 -50.15 68.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.503 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 89.3 t -77.55 150.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.154 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 14.1 mt -139.65 125.66 19.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 23.0 tp -84.12 103.34 13.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.408 HD12 ' CG2' ' A' ' 259' ' ' VAL . 6.9 mp -87.4 129.66 34.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.6 m -122.83 114.8 20.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 4.9 mp -81.17 150.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.105 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -115.82 120.16 38.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.508 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 52.3 t30 59.37 50.49 2.96 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.619 0.723 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 57.7 Cg_endo -71.12 106.53 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.252 . . . . 0.0 112.371 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.1 mt -87.77 -47.65 8.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -91.65 133.55 30.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.662 0.744 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.08 117.4 2.49 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.699 2.266 . . . . 0.0 112.314 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 49.1 mm -85.18 109.23 17.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.166 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 82.8 p -105.24 151.78 23.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.453 ' N ' HD11 ' A' ' 249' ' ' ILE . 33.7 m -38.55 -38.56 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -60.64 -59.61 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.5 t -41.52 -48.28 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 49.5 mt -69.29 -62.7 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.445 ' CE1' ' HB ' ' A' ' 244' ' ' VAL . 43.9 t80 -48.06 -25.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.503 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 94.0 m -65.08 -48.29 74.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.432 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 89.0 t -84.43 -18.65 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.443 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 85.1 m -81.75 -53.52 6.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -41.69 -49.6 10.04 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 0.0 110.898 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.1 Cg_exo -47.94 -39.05 32.15 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 76.0 t -72.86 -42.46 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.95 -126.09 0.81 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm -116.47 165.97 12.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.445 ' HB ' ' CE1' ' A' ' 235' ' ' TYR . 99.2 t -143.02 114.44 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -73.08 -64.31 1.0 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -143.92 164.33 30.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 248' ' ' VAL . 62.5 mt -142.14 141.54 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.402 ' N ' HG23 ' A' ' 247' ' ' ILE . 58.0 t -128.55 134.46 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 231' ' ' VAL . 67.1 mt -119.29 131.59 71.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.519 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 6.4 p90 -142.41 173.31 11.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -129.64 42.62 3.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -80.8 97.68 7.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 62.51 42.8 8.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 121.52 142.98 6.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.458 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 27.6 mm -56.43 116.16 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 0.0 111.096 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.519 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 47.4 mt-30 -142.19 168.75 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -162.43 126.05 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 15.4 mtt -91.06 120.61 32.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.408 ' CG2' HD12 ' A' ' 220' ' ' LEU . 86.2 t -110.29 133.16 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -108.22 137.96 45.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -109.57 160.27 16.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -47.28 -62.66 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.7 m -127.74 170.37 12.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.33 -52.36 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 14.6 tp -38.59 -62.2 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.941 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 60.8 m -43.39 -40.05 3.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.65 80.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -54.62 -60.4 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -63.97 -53.92 42.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -47.07 -48.8 22.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 275' ' ' ASN . 19.2 tttt -56.3 -45.29 80.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -65.35 -59.33 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.87 -37.35 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 6.0 mp -91.62 -22.25 20.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 271' ' ' LYS . 4.8 t30 -55.36 101.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.75 22.59 61.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.468 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -78.49 178.53 7.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.762 0.315 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -145.6 126.53 14.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 33.9 mt -91.83 -31.77 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -126.69 172.68 10.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.3 107.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.25 75.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 1.7 t -174.98 -177.57 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 286' ' ' LEU . 27.3 p 39.36 38.58 0.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 14.1 m -47.57 93.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 284' ' ' CYS . 32.7 mt -45.97 127.25 8.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -127.12 83.74 2.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 29.2 mt -72.99 145.95 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -151.08 115.53 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -38.55 105.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -56.55 139.99 47.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.157 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 4.9 ttp180 -62.61 -44.9 88.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.893 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.7 Cg_endo -80.36 150.87 19.94 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.698 2.266 . . . . 0.0 112.354 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 41.2 p -92.28 -24.45 18.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -125.59 158.89 33.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 48.7 mt -115.78 178.25 4.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.18 116.7 14.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.3 t -114.95 102.89 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.2 mp -66.17 -57.46 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -130.31 176.81 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -107.5 100.83 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -144.63 171.26 14.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -39.6 -44.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.945 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.88 -57.24 10.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.841 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 26.0 p -133.94 138.66 45.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.847 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -135.68 122.62 21.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -106.74 133.26 51.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -99.81 -47.1 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.168 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.889 0.376 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -47.06 -47.2 22.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.45 123.73 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.076 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 288' ' ' ILE . 26.2 mt -116.69 130.91 57.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.88 112.22 20.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.33 141.95 30.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.6 t -130.66 137.76 49.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.63 117.48 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.132 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -79.34 140.53 37.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.475 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 35.8 t30 38.33 54.0 4.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.607 0.718 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.2 Cg_exo -44.67 100.37 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.674 2.249 . . . . 0.0 112.386 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 46.0 mt -91.75 -51.06 5.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -109.52 132.57 21.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.663 0.744 . . . . 0.0 110.892 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.23 111.86 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.268 . . . . 0.0 112.31 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 48.7 mm -90.65 112.46 25.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.125 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 20.7 p -105.98 160.93 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 19.3 m -38.41 -37.56 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 235' ' ' TYR . 7.8 m-20 -58.12 -65.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 232' ' ' ASP . 73.9 t -37.63 -43.66 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 50.2 mt -76.64 -37.1 56.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 65.8 t80 -81.72 16.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 92.2 m -120.46 -37.11 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.156 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.426 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 86.6 t -98.66 -19.74 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 59.2 m -89.12 -44.4 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.2 t-20 -51.97 -45.73 92.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 110.861 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.3 Cg_exo -47.94 -22.81 3.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.335 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.4 t -96.64 -45.26 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -155.21 152.57 24.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.525 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.89 131.84 51.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.848 0.356 . . . . 0.0 110.888 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 245' ' ' GLN . 89.0 t -100.62 136.93 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.152 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.458 ' N ' HG13 ' A' ' 244' ' ' VAL . 9.0 mm-40 -93.62 -65.35 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.938 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 296' ' ' LEU . 4.0 tmm_? -143.69 152.36 41.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.403 ' N ' ' HD2' ' A' ' 246' ' ' ARG . 74.0 mt -129.35 147.79 33.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.425 HG23 ' CD ' ' A' ' 246' ' ' ARG . 54.4 t -139.85 133.84 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 43.7 mt -120.84 129.99 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -144.21 138.02 27.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -99.67 40.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -78.14 101.05 6.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 60.96 42.74 12.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.5 137.82 5.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.2 mm -56.14 112.66 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.128 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -141.89 173.42 11.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -164.63 126.36 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 36.2 mtt -94.66 120.32 34.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 94.2 t -110.54 135.38 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.083 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -105.67 153.46 21.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -126.85 163.61 23.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.895 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -47.48 -65.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 t -135.88 174.93 10.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 82.0 t -56.37 -55.3 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.1 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 18.5 tp -40.3 -50.27 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 61.4 m -55.94 -46.12 78.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 271' ' ' LYS . . . -53.84 -35.63 61.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -57.56 -65.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.914 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -59.49 -55.82 29.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -49.22 -53.2 22.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.07 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 275' ' ' ASN . 38.6 tttm -53.13 -43.96 67.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.74 -63.45 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.085 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -53.8 -46.98 71.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.407 ' C ' HD11 ' A' ' 288' ' ' ILE . 4.6 mp -67.0 -28.98 68.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.47 ' N ' HD11 ' A' ' 288' ' ' ILE . 8.9 t30 -65.33 102.87 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.61 19.72 65.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -83.33 92.26 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.32 135.19 57.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 60.9 mt -104.65 -42.7 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -117.85 172.84 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -51.97 103.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 35.46 51.52 1.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.447 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.5 m -162.55 164.88 26.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.884 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.7 m 62.5 41.31 9.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 23.6 m -58.21 134.29 56.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 83.6 mt -88.13 124.92 34.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -119.54 106.79 12.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.47 HD11 ' N ' ' A' ' 275' ' ' ASN . 18.9 mt -92.54 144.13 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.193 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . 0.426 ' N ' HG23 ' A' ' 288' ' ' ILE . 19.8 mt-10 -155.17 117.44 4.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -41.53 105.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.07 161.89 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.129 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.501 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 30.1 mtt180 -73.86 -56.69 2.72 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.67 0.748 . . . . 0.0 110.89 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 61.1 Cg_endo -74.67 150.42 39.87 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.631 2.221 . . . . 0.0 112.346 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 39.9 p -78.85 -30.14 45.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 296' ' ' LEU . 8.7 ttm180 -134.03 148.32 51.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 246' ' ' ARG . 23.6 mt -100.08 -178.14 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -137.42 117.86 13.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 73.8 t -104.37 112.96 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.123 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.0 -51.73 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -127.26 151.96 48.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -92.34 46.94 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.3 172.52 8.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -41.55 -47.16 3.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.13 -62.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.9 p -133.45 147.17 51.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -139.72 140.87 36.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -119.88 115.34 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 309' ' ' THR . 52.9 m-85 -88.62 -48.27 7.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' TYR . 32.4 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.193 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.8 t30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.92 0.391 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -76.19 -45.85 31.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 51.1 t -67.83 146.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.116 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.8 mt -147.72 123.51 10.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 50.8 tp -71.67 112.98 8.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.97 129.03 45.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -120.56 117.28 27.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.825 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 4.9 mp -81.84 123.32 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -89.3 138.77 31.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 226' ' ' LEU . 74.5 m-20 44.87 53.8 12.05 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.683 0.754 . . . . 0.0 110.927 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 77.0 Cg_exo -47.64 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.723 2.282 . . . . 0.0 112.329 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 224' ' ' ASN . 3.6 mm? -85.45 -56.96 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.447 ' CD2' ' CE2' ' A' ' 280' ' ' TYR . 2.2 m-85 -93.76 143.16 26.09 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.707 0.765 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.24 127.3 12.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 0.0 112.317 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 49.9 mm -114.75 102.11 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 232' ' ' ASP . 19.9 p -117.43 159.06 23.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.192 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.2 m -38.96 -26.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.4 m-20 -67.28 -61.01 2.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.8 t -47.39 -56.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 34.4 mt -56.72 -61.95 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.549 ' CD1' ' HB ' ' A' ' 244' ' ' VAL . 63.4 t80 -49.76 -33.41 16.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.486 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 98.7 m -64.14 -45.93 86.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.1 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.88 -5.89 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.454 ' HB3' ' CG2' ' A' ' 244' ' ' VAL . 90.8 m -93.29 -47.23 7.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 8.2 t-20 -51.06 -45.61 88.41 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 0.0 110.886 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -47.97 -41.2 33.13 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.62 -44.32 76.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.27 -105.48 0.21 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.502 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.8 115.84 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 110.916 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.549 ' HB ' ' CD1' ' A' ' 235' ' ' TYR . 96.3 t -84.04 143.71 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.468 ' HB3' ' CG2' ' A' ' 309' ' ' THR . 21.5 mm-40 -104.2 -68.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -125.03 152.36 44.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.829 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 48.6 mt -140.75 128.35 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.63 121.47 56.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.464 HG12 ' CB ' ' A' ' 257' ' ' ALA . 67.9 mt -110.86 119.06 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -126.32 146.11 50.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -102.42 44.71 1.0 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -70.29 86.16 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 55.2 49.22 17.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 135.33 129.67 2.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.3 mm -50.59 103.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.744 0.307 . . . . 0.0 111.158 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -135.47 164.37 27.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.464 ' CB ' HG12 ' A' ' 249' ' ' ILE . . . -166.49 130.75 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' MET . . . . . 0.433 ' CB ' HD23 ' A' ' 296' ' ' LEU . 32.8 mtt -94.76 123.31 38.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.885 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 88.4 t -114.92 130.19 69.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -109.1 160.36 16.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -130.26 167.85 17.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -40.64 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.5 t -126.1 -176.01 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 267' ' ' ALA . 63.3 t -63.62 -56.96 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 264' ' ' VAL . 25.1 tp -35.47 -59.73 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.4 -37.98 57.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 264' ' ' VAL . . . -61.42 -36.86 81.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.117 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -58.7 -57.85 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -66.72 -47.98 70.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.87 -52.47 49.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 275' ' ' ASN . 25.8 tttp -48.81 -48.46 41.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -61.41 -69.08 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.088 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -40.96 -36.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.443 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.1 mp -88.65 -25.31 22.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 272' ' ' ALA . 19.5 t30 -60.08 104.22 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 75.1 24.25 72.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -85.87 93.64 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 0.0 111.084 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.73 137.5 57.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 46.9 mt -106.45 -34.42 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . 0.447 ' CE2' ' CD2' ' A' ' 227' ' ' TYR . 50.7 m-85 -129.54 172.37 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -45.11 102.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.08 61.34 0.52 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.537 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . 0.435 ' C ' ' SG ' ' A' ' 284' ' ' CYS . 92.6 m -156.81 179.01 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 110.91 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 283' ' ' CYS . 0.8 OUTLIER 40.15 43.98 1.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 40.5 m -59.21 85.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 47.6 mt -38.59 120.01 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -120.1 85.44 2.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.443 HD11 ' CB ' ' A' ' 274' ' ' LEU . 50.5 mt -75.19 148.68 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.116 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -159.82 121.85 3.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -45.37 103.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -57.3 153.66 11.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.105 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.604 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 5.6 ttt180 -65.94 -44.87 63.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.9 Cg_endo -80.5 153.02 20.52 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.328 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 37.9 p -96.91 -22.29 16.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -126.24 151.35 47.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.433 HD23 ' CB ' ' A' ' 258' ' ' MET . 74.2 mt -109.93 179.11 4.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -146.85 133.41 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 93.4 t -122.45 133.35 68.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.064 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.35 -51.2 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.141 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.97 166.35 16.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -114.53 109.97 19.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 303' ' ' ASN . 7.5 t70 -164.19 173.09 12.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 302' ' ' ASP . 39.4 m-20 -33.95 -50.49 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.55 -63.43 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 24.8 m -142.45 147.99 37.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -142.08 137.35 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -122.02 91.11 3.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . 0.451 ' O ' ' C ' ' A' ' 309' ' ' THR . 86.9 m-85 -62.99 -49.17 75.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 245' ' ' GLN . 29.0 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 50.1 t30 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.919 0.39 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -52.55 -43.31 65.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.6 134.51 29.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.2 mt -134.96 125.07 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.2 tp -82.46 112.8 19.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -94.25 124.2 38.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.4 m -118.89 104.13 10.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 4.4 mp -69.29 144.72 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.476 ' C ' ' CG ' ' A' ' 224' ' ' ASN . 8.9 mm100 -109.85 126.31 53.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.476 ' CG ' ' C ' ' A' ' 223' ' ' GLN . 0.5 OUTLIER 49.88 54.75 16.27 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.668 0.747 . . . . 0.0 110.894 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 59.2 Cg_endo -72.62 101.6 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.341 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.55 -62.55 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -83.79 137.66 40.95 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.662 0.744 . . . . 0.0 110.919 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.49 115.0 1.38 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.741 2.294 . . . . 0.0 112.324 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 29.7 mm -83.72 127.14 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.143 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 24.3 p -121.33 152.04 39.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.409 HG13 ' CD1' ' A' ' 249' ' ' ILE . 32.0 m -37.65 -37.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.92 -61.67 2.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 96.6 t -42.46 -52.42 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 26.2 mt -62.04 -59.24 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.559 ' CD2' ' HB ' ' A' ' 244' ' ' VAL . 3.6 t80 -54.28 -24.11 17.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 92.9 m -69.87 -46.07 66.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.117 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.42 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 99.0 t -85.79 -17.38 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.44 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 81.9 m -84.23 -51.3 7.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.543 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -44.0 -48.61 22.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.688 0.756 . . . . 0.0 110.911 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.4 Cg_exo -47.9 -32.77 18.36 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 87.1 t -80.59 -42.91 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.94 -106.85 0.22 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.466 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 26.4 tttt -145.94 163.64 34.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.559 ' HB ' ' CD2' ' A' ' 235' ' ' TYR . 86.9 t -133.71 133.88 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.45 ' OE1' ' CG2' ' A' ' 309' ' ' THR . 32.0 mm-40 -92.83 -62.69 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 4.2 ptt-85 -143.36 155.11 44.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 57.7 mt -137.67 139.09 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.184 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 82.7 t -127.51 124.82 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.409 ' CD1' HG13 ' A' ' 231' ' ' VAL . 53.8 mt -110.24 128.81 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 18.9 p90 -136.61 148.92 47.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -100.12 40.05 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -78.05 109.4 12.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 53.3 t30 55.25 43.45 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.08 -150.07 16.97 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.504 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 11.8 mm -114.4 106.46 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 111.101 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.508 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 21.3 mp0 -132.21 168.01 18.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -168.25 120.47 0.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.092 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 14.1 mtt -87.78 130.87 34.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.63 137.88 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.442 ' CG ' HD11 ' A' ' 296' ' ' LEU . 25.6 mt-10 -101.28 162.77 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.914 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -135.48 158.31 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -46.67 -69.85 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.947 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 16.4 m -121.43 169.59 10.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 86.4 t -54.93 -52.35 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.129 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 15.8 tp -42.58 -64.26 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.84 -41.92 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.67 82.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -63.52 -57.65 9.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -56.82 -37.03 70.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -71.56 -42.62 67.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 275' ' ' ASN . 46.0 tttm -53.07 -48.9 67.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -59.64 -68.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.59 -38.17 1.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.05 -23.36 26.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 272' ' ' ALA . 34.8 t30 -56.92 101.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.55 19.41 73.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -80.06 93.03 5.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 111.118 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.87 133.11 55.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 66.8 mt -101.28 -41.22 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -116.17 174.44 6.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.63 104.44 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 37.92 54.78 1.9 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . 0.473 ' HA ' ' ND2' ' A' ' 224' ' ' ASN . 24.9 p -175.14 155.01 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.866 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 61.4 m 65.51 46.1 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 20.7 m -73.75 142.1 46.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 91.4 mt -86.2 123.8 31.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.939 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.24 81.85 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 31.7 mt -62.53 154.28 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -159.56 114.65 2.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.471 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 45.0 m-85 -39.55 107.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.51 127.58 32.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.104 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.9 OUTLIER -60.68 -45.06 96.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.58 0.705 . . . . 0.0 110.853 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.8 Cg_endo -80.31 148.76 18.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.641 2.227 . . . . 0.0 112.37 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 78.8 p -93.0 -25.79 17.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.165 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -120.36 144.89 47.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.442 HD11 ' CG ' ' A' ' 260' ' ' GLU . 55.0 mt -111.92 -178.98 3.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -139.11 129.99 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.83 110.81 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.8 mp -62.72 -57.27 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -144.03 176.33 9.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -99.61 87.17 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 303' ' ' ASN . 28.2 t70 -140.99 170.54 15.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 302' ' ' ASP . 86.1 m-20 -36.3 -47.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.852 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -50.12 -56.87 9.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.6 p -138.26 142.78 39.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.81 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -138.94 134.78 33.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -115.38 128.43 56.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -100.8 -59.01 1.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.895 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.45 ' CG2' ' OE1' ' A' ' 245' ' ' GLN . 39.8 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 216' ' ' LYS . 13.0 t30 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 215' ' ' ASN . 0.0 OUTLIER -33.27 -52.72 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 63.3 t -80.47 150.59 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.4 mt -141.48 126.7 18.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.8 tp -85.08 104.02 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.47 ' N ' HD13 ' A' ' 220' ' ' LEU . 9.3 mp -87.87 134.56 33.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.0 m -124.32 111.4 15.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -71.99 140.88 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 224' ' ' ASN . 7.0 tp60 -95.38 143.99 26.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.492 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 53.7 t30 34.96 54.49 1.84 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.591 0.71 . . . . 0.0 110.869 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.1 Cg_exo -47.37 102.19 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.704 2.269 . . . . 0.0 112.3 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 42.7 mt -103.88 -54.03 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -89.88 154.17 47.59 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.705 0.764 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.43 113.69 3.7 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.671 2.247 . . . . 0.0 112.323 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 230' ' ' THR . 47.4 mm -93.73 142.28 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.436 ' N ' HG22 ' A' ' 229' ' ' ILE . 16.5 p -139.4 163.26 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' A' ' 303' ' ' ASN . 31.4 m -46.76 -27.81 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.28 -36.27 82.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.9 t -71.12 -47.53 60.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.093 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 18.9 mt -83.74 20.84 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -129.95 -39.28 1.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.966 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.453 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 22.9 m -72.33 -37.43 68.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.19 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.448 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 44.7 t -85.02 -25.67 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.117 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.447 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 78.9 m -83.67 -47.82 10.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.53 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -41.37 -49.29 9.08 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.636 0.732 . . . . 0.0 110.862 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.9 Cg_exo -47.91 -62.17 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.728 2.285 . . . . 0.0 112.36 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 48.4 t -47.05 -50.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.24 -103.39 0.26 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -163.75 120.26 1.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 90.2 t -85.43 142.46 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.453 ' NE2' ' OE1' ' A' ' 262' ' ' GLU . 11.0 mm-40 -95.83 -57.79 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -141.24 152.44 44.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 58.0 mt -137.38 119.37 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 95.1 t -117.96 115.96 50.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.126 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 62.0 mt -103.53 122.18 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 36.8 p90 -131.45 148.81 52.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -124.8 40.95 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . 0.425 ' HB2' ' NH1' ' A' ' 252' ' ' ARG . 0.2 OUTLIER -72.9 -60.42 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -129.66 80.01 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 255' ' ' ILE . . . 88.04 116.34 1.26 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.506 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 254' ' ' GLY . 28.1 mm -33.42 104.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 111.141 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.456 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 34.7 mt-30 -136.19 166.42 23.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -165.13 121.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' MET . . . . . 0.42 ' CB ' HD23 ' A' ' 296' ' ' LEU . 13.9 mtt -86.06 137.36 32.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 94.8 t -126.84 129.48 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.468 ' HG3' ' N ' ' A' ' 261' ' ' PHE . 3.3 tp10 -102.1 148.23 25.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.468 ' N ' ' HG3' ' A' ' 260' ' ' GLU . 41.1 m-85 -122.71 157.64 31.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.453 ' OE1' ' NE2' ' A' ' 245' ' ' GLN . 3.8 mm-40 -36.37 -63.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -143.13 176.19 9.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 87.0 t -52.75 -56.9 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 16.1 tp -39.26 -64.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 83.3 m -49.17 -43.45 42.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.89 -40.35 69.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -55.24 -59.09 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -63.3 -51.17 67.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . 0.438 ' CB ' ' CZ ' ' A' ' 261' ' ' PHE . . . -48.69 -49.99 35.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 275' ' ' ASN . 55.0 tttm -54.07 -53.47 52.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -54.11 -70.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -42.43 -41.35 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.1 mp -79.64 -23.46 42.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 271' ' ' LYS . 18.4 t-20 -60.0 104.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 76.97 24.02 67.71 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.24 7.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.775 0.321 . . . . 0.0 111.077 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.44 117.02 2.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.98 -39.82 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -117.73 173.44 6.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -52.86 103.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.071 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.23 59.59 0.62 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.473 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 20.0 p -175.08 163.84 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 82.0 m 60.19 44.41 12.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 30.2 m -59.52 150.0 28.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 40.5 mt -92.51 105.87 17.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -104.78 82.14 1.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 19.3 mt -70.56 142.63 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.09 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -149.04 122.01 8.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -49.15 101.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.45 135.08 57.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.051 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.605 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.4 OUTLIER -59.3 -44.65 98.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 0.0 110.918 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.4 Cg_endo -80.41 144.06 15.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.723 2.282 . . . . 0.0 112.318 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 65.3 p -111.35 34.65 3.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.163 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 296' ' ' LEU . 3.7 tpt180 -144.3 143.59 31.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.431 ' N ' ' HG3' ' A' ' 295' ' ' ARG . 49.2 mt -132.3 114.4 14.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -88.4 135.36 33.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 75.0 t -137.57 115.49 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.3 mp -83.37 -59.01 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -115.86 166.52 11.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -102.55 44.06 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.05 169.75 17.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.401 ' O ' ' CG1' ' A' ' 231' ' ' VAL . 1.1 p30 -45.41 -47.24 13.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -44.31 -60.06 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.5 p -133.01 142.55 48.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -140.97 142.09 34.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.75 89.36 3.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.886 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -78.86 45.83 0.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.163 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.8 t30 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.884 0.374 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 15.8 mtmm -52.51 -40.75 62.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.12 148.25 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 13.9 mt -144.89 127.79 16.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.0 tp -84.88 117.9 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.432 HD12 ' CG2' ' A' ' 259' ' ' VAL . 6.0 mp -101.1 128.77 47.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.5 m -123.22 111.46 16.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.448 HG21 ' N ' ' A' ' 223' ' ' GLN . 5.2 mp -75.94 143.09 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.448 ' N ' HG21 ' A' ' 222' ' ' ILE . 59.9 mt-30 -103.23 137.69 41.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.487 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 46.0 t30 42.18 52.82 7.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.609 0.719 . . . . 0.0 110.911 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.0 Cg_exo -45.31 119.84 2.8 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.371 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.02 -56.73 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.557 ' CD1' ' CE2' ' A' ' 280' ' ' TYR . 16.5 m-85 -119.45 144.02 35.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.731 0.777 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.91 112.67 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.666 2.244 . . . . 0.0 112.343 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 48.2 mm -81.95 121.28 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.4 p -107.72 157.11 18.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.15 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.5 m -40.42 -38.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 235' ' ' TYR . 48.8 m-20 -56.45 -61.24 2.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' ASP . 97.0 t -36.94 -44.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.15 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.54 -38.12 41.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 71.8 t80 -83.87 19.85 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.487 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 96.2 m -125.0 -36.69 2.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.431 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 98.8 t -97.21 -24.58 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.125 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 85.7 m -85.11 -45.48 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.548 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.1 m120 -49.86 -48.31 78.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.674 0.749 . . . . 0.0 110.903 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 67.0 Cg_exo -48.03 -22.03 3.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.315 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.6 t -89.63 -50.28 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.083 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -145.97 -127.48 1.88 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.433 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.491 ' CB ' ' OE2' ' A' ' 262' ' ' GLU . 32.5 tptt -130.24 131.9 45.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.848 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.2 t -108.29 125.26 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -79.94 -70.22 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -134.68 160.27 38.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 235' ' ' TYR . 54.6 mt -137.84 136.61 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.449 ' HA ' ' CB ' ' A' ' 305' ' ' SER . 62.0 t -135.97 109.53 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 49.2 mt -99.92 100.88 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -105.79 134.61 48.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 78.51 2.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 113.74 18.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 47.12 43.9 14.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.13 119.03 2.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mm -42.38 107.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.329 . . . . 0.0 111.158 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -128.32 143.82 51.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.31 117.7 9.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 29.6 mtt -90.16 127.37 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.432 ' CG2' HD12 ' A' ' 220' ' ' LEU . 57.4 t -119.34 143.06 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -108.37 163.13 13.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.618 ' CZ ' ' CB ' ' A' ' 270' ' ' ALA . 42.0 m-85 -134.07 158.05 44.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.491 ' OE2' ' CB ' ' A' ' 243' ' ' LYS . 31.2 mt-10 -40.65 -63.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.5 m -140.93 178.52 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.94 -51.06 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 17.5 tp -47.66 -58.83 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 62.8 m -49.86 -43.95 49.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -55.72 -38.01 69.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.084 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -56.69 -65.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -57.58 -53.16 61.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . 0.618 ' CB ' ' CZ ' ' A' ' 261' ' ' PHE . . . -50.03 -53.27 27.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 275' ' ' ASN . 23.4 tttt -53.09 -44.19 67.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.7 -66.01 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -51.82 -47.27 64.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.402 ' CB ' HD13 ' A' ' 288' ' ' ILE . 2.8 mp -67.59 -28.19 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 271' ' ' LYS . 0.8 OUTLIER -66.85 104.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.07 20.8 75.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -82.15 91.87 6.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 111.126 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.64 128.38 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 73.2 mt -102.57 -41.92 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . 0.557 ' CE2' ' CD1' ' A' ' 227' ' ' TYR . 6.3 m-85 -118.3 173.54 6.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.93 105.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.59 59.99 0.65 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.522 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 31.8 p -175.16 167.11 3.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 2.2 m 62.57 44.11 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 57.3 m -61.55 136.74 58.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 61.4 mt -87.38 115.85 25.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -111.12 90.21 3.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.889 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.402 HD13 ' CB ' ' A' ' 274' ' ' LEU . 35.1 mt -76.3 145.59 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 290' ' ' TYR . 18.8 mt-10 -153.71 111.19 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' A' ' 289' ' ' GLU . 26.4 m-85 -37.52 102.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.78 144.03 6.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.069 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.599 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 4.6 ttp180 -60.42 -45.04 97.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 0.0 110.801 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.8 Cg_endo -80.3 150.81 20.08 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.6 p -85.6 -24.28 27.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -128.59 175.04 8.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 80.1 mt -132.47 175.51 9.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -152.6 118.62 5.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 63.2 t -102.07 104.71 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.9 mp -62.69 -59.82 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -115.36 154.96 28.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -105.77 105.46 15.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 303' ' ' ASN . 3.3 m-20 -149.02 167.71 25.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.452 ' C ' ' O ' ' A' ' 302' ' ' ASP . 65.2 m-20 -34.37 -47.49 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -50.72 -60.77 2.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' SER . . . . . 0.449 ' CB ' ' HA ' ' A' ' 248' ' ' VAL . 78.7 p -129.28 133.41 47.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -131.43 137.36 48.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.24 113.55 21.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -89.61 -59.85 2.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 72.1 p . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.173 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 64.5 t30 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.919 0.39 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -68.91 -44.15 73.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 218' ' ' LEU . 84.1 t -81.11 142.76 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.468 ' N ' HG12 ' A' ' 217' ' ' VAL . 20.5 mt -132.2 126.32 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 24.1 tp -82.5 111.92 18.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.7 mp -103.82 130.26 51.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 t -116.1 132.39 56.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 223' ' ' GLN . 4.7 mp -92.42 69.02 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.164 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 222' ' ' ILE . 8.2 mm100 -35.73 141.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.481 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 34.4 m-20 44.76 54.22 12.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.646 0.736 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.8 Cg_exo -46.92 93.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.661 2.24 . . . . 0.0 112.331 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.43 -44.62 5.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -107.6 130.27 23.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.734 0.778 . . . . 0.0 110.92 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.47 126.27 15.64 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.7 2.267 . . . . 0.0 112.336 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 49.6 mm -117.92 118.86 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 233' ' ' VAL . 21.5 p -121.75 167.36 13.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.174 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 35.3 m -40.08 -34.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.54 -43.89 96.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 230' ' ' THR . 61.2 t -66.17 -44.39 91.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 25.4 mt -83.19 20.15 1.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -124.81 -26.33 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 86.5 m -85.72 -36.35 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.442 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 13.3 t -89.15 -21.86 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.154 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.402 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 83.7 m -84.79 -47.66 10.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.541 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -46.86 -48.1 51.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.708 . . . . 0.0 110.917 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -48.03 -21.05 2.46 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.649 2.232 . . . . 0.0 112.323 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.432 ' CG1' ' HA ' ' A' ' 270' ' ' ALA . 77.7 t -96.98 -43.06 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.109 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.73 -158.52 9.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.98 120.55 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.829 0.347 . . . . 0.0 110.87 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.4 t -85.67 133.06 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -95.38 -60.55 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -150.58 153.32 35.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 68.5 mt -132.19 127.33 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.17 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.92 112.12 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.4 ' CD1' ' HA ' ' A' ' 230' ' ' THR . 58.2 mt -100.04 129.91 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.149 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -138.27 163.56 31.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -120.86 86.03 2.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -120.52 88.58 2.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.5 m120 56.14 42.82 27.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 138.25 108.06 0.81 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.497 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 31.7 mm -39.79 114.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 111.097 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -139.69 173.58 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -165.11 120.76 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.09 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.5 mtt -83.93 123.21 29.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 67.8 t -117.08 127.74 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -97.3 154.29 17.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -127.32 164.33 22.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -43.85 -65.11 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 25.1 p -138.47 169.61 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 265' ' ' LEU . 75.5 t -49.62 -53.83 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.141 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 264' ' ' VAL . 19.5 tp -38.3 -57.88 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 84.8 m -50.43 -44.84 55.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.11 -38.8 65.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.091 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -57.02 -60.84 2.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -63.71 -54.1 40.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . 0.432 ' HA ' ' CG1' ' A' ' 241' ' ' VAL . . . -47.63 -48.8 28.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 275' ' ' ASN . 49.4 tttm -51.19 -52.19 46.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -57.16 -67.32 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.79 -40.0 1.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.4 mp -84.98 -22.39 29.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 271' ' ' LYS . 41.1 t30 -60.16 100.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.05 19.95 68.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.513 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -78.32 91.68 4.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.737 0.303 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.21 123.37 14.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.873 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 84.9 mt -95.87 -41.55 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -116.17 173.04 6.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -51.09 102.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.33 61.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 28.2 p -175.06 168.83 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.807 0.337 . . . . 0.0 110.883 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 53.5 m 58.99 47.78 11.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 286' ' ' LEU . 19.7 m -61.81 145.81 51.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.143 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.429 ' N ' HG22 ' A' ' 285' ' ' THR . 50.0 mt -93.71 95.65 9.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -91.22 97.32 11.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 21.6 mt -83.86 138.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -143.97 124.87 14.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -51.61 97.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.59 156.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.086 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 1.1 mpt_? -71.45 -60.27 2.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.631 0.729 . . . . 0.0 110.882 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 58.8 Cg_endo -71.78 161.59 44.63 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.7 2.267 . . . . 0.0 112.341 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.6 p -97.31 -34.23 11.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -106.85 163.37 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 40.8 mt -124.04 -177.24 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -144.39 132.62 21.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 75.5 t -122.29 103.01 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.3 mp -55.42 -62.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.3 154.47 49.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -84.21 81.38 8.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -124.57 171.76 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -43.0 -47.63 5.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -47.39 -56.74 6.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.2 p -137.6 142.12 41.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -136.43 136.85 39.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.84 110.92 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.97 -49.34 8.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.964 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 31.3 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.174 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 41.5 t30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.855 0.36 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -38.73 -43.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.6 t -82.07 147.8 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 15.4 mt -145.3 123.68 12.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.2 tp -78.91 104.52 9.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.29 126.06 34.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 54.0 m -117.34 112.79 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.427 HD12 ' CG2' ' A' ' 255' ' ' ILE . 2.4 mp -80.85 118.0 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.471 ' C ' ' CG ' ' A' ' 224' ' ' ASN . 17.8 mm100 -85.28 133.28 34.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.932 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.471 ' CG ' ' C ' ' A' ' 223' ' ' GLN . 0.7 OUTLIER 49.39 54.97 16.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.64 0.733 . . . . 0.0 110.897 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 59.9 Cg_endo -73.36 99.69 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.328 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.87 -40.31 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -88.74 153.47 49.96 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.657 0.742 . . . . 0.0 110.941 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.39 115.93 4.52 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.7 2.266 . . . . 0.0 112.316 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 22.3 mm -97.24 148.17 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 232' ' ' ASP . 16.1 p -148.23 156.13 42.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 230' ' ' THR . 34.7 m -35.16 -35.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 230' ' ' THR . 6.4 t0 -65.48 -61.58 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 71.6 t -42.02 -46.32 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 34.8 mt -66.7 -65.6 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.525 ' CD2' ' HB ' ' A' ' 244' ' ' VAL . 5.9 t80 -48.0 -27.44 2.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.428 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 83.6 m -66.01 -47.58 73.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.145 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.441 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 63.5 t -87.42 -15.14 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 77.3 m -86.13 -46.75 10.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.56 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -47.36 -47.52 57.8 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.626 0.727 . . . . 0.0 110.902 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.8 Cg_exo -47.98 -18.6 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 78.6 t -98.6 -42.4 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.185 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -162.72 -145.25 4.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -116.53 119.21 34.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.525 ' HB ' ' CD2' ' A' ' 235' ' ' TYR . 89.1 t -82.49 141.1 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.416 ' N ' HG13 ' A' ' 244' ' ' VAL . 4.5 mm-40 -96.03 -51.85 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.411 ' NE ' ' OE1' ' A' ' 260' ' ' GLU . 22.9 ptt180 -159.89 153.1 21.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 248' ' ' VAL . 53.6 mt -131.82 139.26 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.433 ' N ' HG23 ' A' ' 247' ' ' ILE . 38.1 t -130.45 110.53 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.138 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.443 HG23 ' N ' ' A' ' 250' ' ' PHE . 52.9 mt -98.55 140.69 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 8.2 p90 -146.68 139.98 25.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -98.25 43.19 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -79.55 95.46 5.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 62.76 45.79 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 131.28 -155.56 21.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.427 ' CG2' HD12 ' A' ' 222' ' ' ILE . 32.2 mm -116.04 103.38 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 0.0 111.116 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.55 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 19.0 mp0 -131.56 157.31 43.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -162.12 118.63 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.116 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.8 mtt -82.2 128.81 34.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 65.4 t -119.33 127.73 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 24.6 tt0 -104.34 149.43 25.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.439 ' N ' ' HG2' ' A' ' 260' ' ' GLU . 60.1 m-85 -118.93 166.51 12.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.839 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -45.67 -64.58 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.4 t -130.87 177.81 7.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.54 -54.54 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.16 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 24.4 tp -40.89 -54.49 2.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.919 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 68.6 m -53.57 -43.05 68.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -56.33 -40.21 74.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.085 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -62.49 -63.55 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -55.48 -44.43 76.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.28 96.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 275' ' ' ASN . 42.6 tttm -55.27 -47.65 75.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.62 -62.12 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.102 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.13 -37.17 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.097 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.7 mp -88.38 -22.77 23.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 271' ' ' LYS . 2.0 t30 -60.52 101.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.46 21.44 69.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.506 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -84.55 93.41 8.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.329 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -49.53 143.53 6.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.559 HG23 ' CD1' ' A' ' 280' ' ' TYR . 68.2 mt -102.17 -36.59 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.157 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . 0.559 ' CD1' HG23 ' A' ' 279' ' ' ILE . 62.3 m-85 -139.02 175.88 9.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -39.82 101.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.045 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 29.3 73.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.472 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . 0.453 ' HA ' ' ND2' ' A' ' 224' ' ' ASN . 23.5 p -175.96 173.46 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 110.881 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 283' ' ' CYS . 2.0 p 40.25 43.85 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 90.2 m -60.76 139.3 57.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.167 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 31.5 mt -82.42 123.48 29.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.42 ' C ' ' HE3' ' A' ' 287' ' ' LYS . 0.1 OUTLIER -124.35 87.14 2.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.925 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.407 ' O ' ' CE ' ' A' ' 287' ' ' LYS . 17.9 mt -71.38 142.58 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . 0.401 ' N ' HG22 ' A' ' 288' ' ' ILE . 9.3 mt-10 -142.51 115.89 9.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -39.71 100.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -52.24 151.85 3.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.138 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.488 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 13.0 mmt180 -73.27 -58.05 2.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.594 0.712 . . . . 0.0 110.869 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 60.0 Cg_endo -73.74 159.09 46.12 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.724 2.282 . . . . 0.0 112.344 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 69.5 p -95.65 -34.84 11.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.467 ' HD2' ' N ' ' A' ' 296' ' ' LEU . 1.4 tmm_? -105.78 152.8 22.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.467 ' N ' ' HD2' ' A' ' 295' ' ' ARG . 74.9 mt -118.54 154.79 31.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.962 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -116.29 127.33 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 89.3 t -106.27 105.65 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.158 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.4 mp -59.2 -62.01 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -131.8 170.42 14.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.43 ' ND2' ' OD1' ' A' ' 307' ' ' ASP . 1.8 m-20 -106.56 100.01 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 303' ' ' ASN . 29.3 t70 -165.58 172.52 11.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 302' ' ' ASP . 1.9 m-80 -34.34 -46.09 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.99 -53.17 28.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 2.9 m -153.48 143.51 22.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.898 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -136.88 149.85 47.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.43 ' OD1' ' ND2' ' A' ' 301' ' ' ASN . 17.0 p-10 -129.44 95.62 4.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -71.35 -40.46 70.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.41 ' ND2' ' HB ' ' A' ' 217' ' ' VAL . 13.4 t30 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.919 0.39 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -59.65 -42.77 93.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.41 ' HB ' ' ND2' ' A' ' 215' ' ' ASN . 91.5 t -76.06 138.29 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.4 mt -136.44 128.58 29.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 54.5 tp -83.18 113.47 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -99.56 125.71 45.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.3 t -115.38 115.37 26.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.4 mp -77.03 122.24 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -80.05 139.09 37.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.488 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 31.6 m-20 43.44 53.82 10.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.666 0.746 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.6 Cg_exo -47.08 94.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.379 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 13.8 mt -109.91 -44.46 3.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.448 ' CG ' ' CE2' ' A' ' 280' ' ' TYR . 91.6 m-85 -94.66 137.8 22.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.674 0.75 . . . . 0.0 110.912 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.2 132.4 23.41 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.716 2.277 . . . . 0.0 112.341 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.9 mm -122.61 129.9 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.415 ' HA ' ' CD1' ' A' ' 249' ' ' ILE . 21.7 p -144.46 168.58 19.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 33.5 m -42.76 -36.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.2 -44.44 88.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.05 -47.9 88.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.106 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 26.1 mt -84.83 23.68 1.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -130.89 -36.14 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.502 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 26.5 m -79.45 -35.71 39.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.133 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.417 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 87.6 t -90.62 -14.65 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 76.2 m -87.99 -48.07 8.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.908 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.574 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.8 t-20 -49.78 -46.01 80.01 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.67 0.748 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.0 Cg_exo -47.92 -21.68 2.81 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.68 2.253 . . . . 0.0 112.358 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 21.9 t -99.8 -40.84 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.092 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -152.18 -132.64 1.85 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.46 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -131.8 115.45 15.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.7 t -87.82 137.2 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -109.84 -66.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -120.95 150.2 41.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 47.7 mt -141.98 121.77 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 66.6 t -119.27 129.45 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 230' ' ' THR . 56.8 mt -120.73 115.39 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -124.32 171.84 9.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -124.78 44.23 2.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.942 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -71.35 96.42 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 47.4 43.1 15.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 140.95 137.85 3.49 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.5 mm -58.33 101.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.328 . . . . 0.0 111.104 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -131.91 158.34 41.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -155.89 117.87 4.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 25.9 mtt -83.11 125.09 31.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.4 t -115.59 124.33 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -98.43 145.4 26.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.437 ' O ' ' C ' ' A' ' 262' ' ' GLU . 40.3 m-85 -118.93 158.0 26.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 261' ' ' PHE . 4.4 mm-40 -34.64 -65.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 11.1 t -139.44 166.23 25.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 265' ' ' LEU . 87.0 t -42.43 -59.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.124 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 264' ' ' VAL . 22.8 tp -35.82 -63.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 81.2 m -42.89 -45.06 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -52.87 -38.14 61.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -55.98 -59.87 4.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -65.49 -55.79 15.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . 0.427 ' CB ' ' CZ ' ' A' ' 261' ' ' PHE . . . -47.41 -48.21 26.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.073 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . 17.5 tttt -56.51 -45.23 81.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -60.34 -71.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.093 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.38 -39.53 1.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.5 mp -81.68 -27.35 34.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 272' ' ' ALA . 18.9 t-20 -59.84 100.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.2 20.71 69.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.457 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -84.23 94.5 8.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.736 0.303 . . . . 0.0 111.093 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.74 128.42 26.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.457 HD12 ' CG ' ' A' ' 286' ' ' LEU . 77.4 mt -104.42 -44.05 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . 0.448 ' CE2' ' CG ' ' A' ' 227' ' ' TYR . 33.8 m-85 -112.37 174.35 5.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.73 103.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 33.91 56.86 0.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.467 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 27.7 p -175.18 168.19 3.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.338 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 87.0 m 62.63 41.41 9.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' THR . . . . . 0.454 HG21 ' N ' ' A' ' 286' ' ' LEU . 15.3 m -59.54 149.94 28.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.21 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.457 ' CG ' HD12 ' A' ' 279' ' ' ILE . 57.5 mt -94.77 105.8 17.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -101.59 80.2 2.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 44.4 mt -69.45 141.54 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.133 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -149.24 109.84 4.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -38.3 106.43 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.75 157.23 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.086 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.471 ' CB ' ' CD ' ' A' ' 293' ' ' PRO . 11.9 mmt180 -73.69 -61.41 1.36 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 292' ' ' ARG . 59.0 Cg_endo -71.88 161.21 45.65 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 40.2 p -93.01 -28.14 16.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.144 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.16 160.01 15.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 66.9 mt -120.95 172.67 7.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -119.51 119.71 34.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.27 93.36 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.447 HD11 ' N ' ' A' ' 299' ' ' ILE . 4.7 mm -46.0 -66.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.36 160.54 43.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -64.88 101.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.83 171.77 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.833 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -46.3 -52.8 11.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.32 -53.87 10.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.7 p -143.39 140.93 30.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -126.77 145.49 50.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -126.71 92.45 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 309' ' ' THR . 58.6 m-85 -69.44 -50.7 43.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.899 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 308' ' ' TYR . 76.3 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.16 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 65.0 t30 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.908 0.385 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -74.79 -41.3 60.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.6 t -79.24 142.79 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.117 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 19.3 mt -139.81 132.35 28.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.86 111.96 18.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.33 127.3 49.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.3 t -115.33 138.72 50.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.85 131.03 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.136 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -94.7 133.46 38.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 226' ' ' LEU . 0.3 OUTLIER 46.17 53.34 12.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.884 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.0 Cg_exo -45.09 84.63 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.657 2.238 . . . . 0.0 112.351 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 224' ' ' ASN . 4.0 mm? -58.65 -59.79 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -117.57 146.38 38.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.666 0.746 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.78 114.86 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 0.0 112.336 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 27.6 mm -87.12 120.13 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.185 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 21.4 p -104.81 161.46 14.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 30.4 m -42.37 -40.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 235' ' ' TYR . 7.8 m-20 -55.42 -60.72 3.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 95.5 t -38.03 -37.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 41.6 mt -88.54 -31.85 18.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.774 ' CD1' ' CE2' ' A' ' 308' ' ' TYR . 37.6 t80 -84.75 23.37 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.502 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 88.3 m -125.21 -38.74 2.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.14 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.411 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 59.1 t -94.21 -15.4 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 97.1 m -88.72 -47.46 8.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.571 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 8.6 t-20 -50.58 -45.63 85.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.661 0.743 . . . . 0.0 110.928 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.2 Cg_exo -47.98 -22.97 3.87 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.27 . . . . 0.0 112.354 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 91.4 t -96.97 -45.58 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.111 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -146.6 -145.18 4.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.508 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.53 112.17 17.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.815 0.341 . . . . 0.0 110.937 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.499 ' HB ' ' CE1' ' A' ' 235' ' ' TYR . 51.4 t -80.73 141.7 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.165 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.46 ' NE2' ' CG2' ' A' ' 309' ' ' THR . 5.1 mm-40 -101.7 -60.89 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.9 mtm-85 -140.78 156.91 46.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 74.9 mt -142.56 138.45 28.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.11 134.76 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 87.6 mt -116.07 108.11 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -115.72 164.23 14.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -121.89 43.83 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -94.65 106.99 18.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.6 t30 68.1 44.12 1.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 105.91 151.05 19.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 39.1 mm -56.38 113.4 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -141.24 165.2 28.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -156.76 124.63 5.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 29.6 mtt -88.87 124.04 33.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.457 HG11 ' N ' ' A' ' 260' ' ' GLU . 72.9 t -112.08 138.02 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.457 ' N ' HG11 ' A' ' 259' ' ' VAL . 8.9 tm-20 -114.69 140.96 48.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -114.55 162.67 16.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -41.28 -65.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.2 m -137.5 176.31 8.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 265' ' ' LEU . 98.2 t -56.43 -56.75 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.158 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 264' ' ' VAL . 20.4 tp -37.51 -54.02 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 6.7 m -52.2 -47.0 65.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.25 -37.47 64.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -55.62 -63.44 1.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -61.34 -58.64 7.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -46.96 -49.65 20.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.133 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.447 ' HE3' ' CE2' ' A' ' 290' ' ' TYR . 49.3 tttm -47.82 -54.59 11.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -53.17 -66.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -42.98 -43.81 4.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.459 ' CB ' HD13 ' A' ' 288' ' ' ILE . 4.9 mp -77.52 -22.33 51.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 272' ' ' ALA . 44.4 t-20 -55.94 99.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.99 19.72 72.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.498 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -86.31 95.82 9.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 111.103 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.56 155.23 39.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 44.4 mt -113.89 -53.9 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -95.7 172.47 8.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -52.68 107.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.139 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.37 48.18 0.62 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 23.0 m -161.1 177.4 10.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.7 m 49.42 44.26 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' THR . . . . . 0.452 HG23 ' N ' ' A' ' 286' ' ' LEU . 41.1 m -63.51 143.93 57.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.124 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.452 ' N ' HG23 ' A' ' 285' ' ' THR . 90.3 mt -94.19 122.99 37.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -116.35 98.74 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.459 HD13 ' CB ' ' A' ' 274' ' ' LEU . 28.3 mt -79.27 139.11 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.178 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -150.23 114.36 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.447 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 77.6 m-85 -41.32 103.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.958 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -55.08 159.67 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.121 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.491 ' CB ' ' CD ' ' A' ' 293' ' ' PRO . 47.6 mtt180 -73.94 -62.17 1.14 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.583 0.706 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 292' ' ' ARG . 58.3 Cg_endo -71.8 156.96 56.24 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.673 2.249 . . . . 0.0 112.34 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 64.3 p -93.01 -36.33 12.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -107.28 148.7 28.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 31.3 mt -117.72 150.28 39.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . 0.406 HD22 ' CD1' ' A' ' 299' ' ' ILE . 16.3 t30 -98.56 120.4 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.63 102.02 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 299' ' ' ILE . 4.6 mm -46.71 -61.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -175.05 162.53 3.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -52.71 94.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 305' ' ' SER . 2.3 m-20 -141.69 172.85 12.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -54.64 -41.83 70.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -56.73 -59.92 4.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 302' ' ' ASP . 3.3 t -130.3 152.52 49.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -134.03 138.54 45.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -122.5 98.86 6.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.844 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . 0.774 ' CE2' ' CD1' ' A' ' 235' ' ' TYR . 99.4 m-85 -76.21 -50.84 13.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.46 ' CG2' ' NE2' ' A' ' 245' ' ' GLN . 46.1 p . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.178 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -33.67 43.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 62.0 t -77.77 137.73 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 15.2 mt -134.91 134.37 40.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 22.1 tp -89.94 110.29 21.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.982 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.441 ' N ' HD13 ' A' ' 220' ' ' LEU . 7.2 mp -97.51 139.76 32.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -128.81 131.61 47.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.437 HD11 ' CG2' ' A' ' 255' ' ' ILE . 4.9 mp -91.56 122.02 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.158 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -82.22 143.64 31.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.485 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 15.6 m-20 39.8 54.42 5.83 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.615 0.721 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 74.4 Cg_exo -47.21 92.55 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.738 2.292 . . . . 0.0 112.31 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 11.6 mt -100.78 -48.83 4.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -100.47 137.11 19.86 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.67 0.748 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.51 113.54 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.671 2.248 . . . . 0.0 112.328 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.6 mm -101.11 104.04 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.7 p -104.5 159.44 15.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.17 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.417 ' N ' HD11 ' A' ' 249' ' ' ILE . 26.8 m -42.77 -35.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.25 -58.72 7.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 95.2 t -45.15 -45.17 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.093 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 40.1 mt -68.66 -61.89 1.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.46 ' C ' ' CD1' ' A' ' 235' ' ' TYR . 4.8 t80 -49.58 -29.21 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 98.1 m -64.71 -46.98 80.0 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.126 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.424 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 61.1 t -87.49 -10.07 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.43 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 82.1 m -88.94 -45.17 9.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.909 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.577 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 1.9 t-20 -49.59 -46.11 78.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -47.96 -19.92 1.8 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.694 2.262 . . . . 0.0 112.336 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.444 ' CG1' ' HA ' ' A' ' 270' ' ' ALA . 87.4 t -99.1 -46.92 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.42 -170.18 30.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 244' ' ' VAL . 6.6 tmtm? -82.59 151.14 26.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.368 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.454 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 91.0 t -121.52 128.99 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -80.69 -62.63 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -151.07 155.4 38.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 248' ' ' VAL . 77.0 mt -136.85 150.95 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.46 ' N ' HG22 ' A' ' 247' ' ' ILE . 94.0 t -136.52 139.91 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.424 ' N ' HG11 ' A' ' 248' ' ' VAL . 88.9 mt -125.38 116.63 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -129.05 158.39 39.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.87 41.84 2.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . 0.401 ' HD3' ' C ' ' A' ' 252' ' ' ARG . 0.0 OUTLIER -67.54 86.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.854 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.2 t30 59.79 42.62 16.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.841 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 137.09 127.89 2.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.53 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.437 ' CG2' HD11 ' A' ' 222' ' ' ILE . 50.9 mm -48.4 113.11 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.766 0.317 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -137.67 165.46 26.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.32 127.07 4.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 11.0 mtt -95.67 126.25 40.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.83 127.02 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -105.85 172.74 6.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -142.24 169.78 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -54.27 -68.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 13.8 m -119.35 173.32 7.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 64.6 t -60.43 -52.39 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.139 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 55.2 tp -38.58 -63.48 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 80.7 m -48.03 -46.37 33.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -53.32 -45.57 69.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -63.74 -55.53 22.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -55.26 -58.27 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . 0.444 ' HA ' ' CG1' ' A' ' 241' ' ' VAL . . . -51.24 -46.2 62.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . 56.8 tttm -49.03 -52.0 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -56.82 -67.03 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.93 -41.12 2.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.9 mp -83.6 -22.15 32.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 271' ' ' LYS . 1.2 t30 -57.36 104.7 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.0 22.69 77.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -83.24 90.52 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 0.0 111.134 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.76 129.28 19.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.463 HD11 ' CD2' ' A' ' 286' ' ' LEU . 79.8 mt -99.4 -41.8 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -117.3 173.15 6.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -50.28 103.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.132 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.44 48.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.499 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.2 m -161.42 174.44 13.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.319 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 34.0 m 52.94 42.36 32.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' THR . . . . . 0.461 HG21 ' N ' ' A' ' 286' ' ' LEU . 11.3 m -57.58 152.13 15.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.155 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.463 ' CD2' HD11 ' A' ' 279' ' ' ILE . 50.9 mt -97.85 125.93 42.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 94.88 4.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 34.0 mt -85.62 145.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 290' ' ' TYR . 25.7 mt-10 -155.28 113.82 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 289' ' ' GLU . 68.9 m-85 -34.74 107.27 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -50.51 135.95 21.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.084 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.576 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 5.9 ttt180 -64.14 -46.67 79.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.587 0.708 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.5 Cg_endo -79.37 149.81 21.93 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.667 2.245 . . . . 0.0 112.38 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.5 p -87.1 -27.52 23.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.11 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -121.22 154.47 36.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 48.1 mt -114.62 179.67 3.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -145.1 133.84 22.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 96.8 t -131.23 105.69 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.2 mp -63.41 -60.57 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.122 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -124.82 166.97 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 302' ' ' ASP . 2.1 m-20 -106.67 95.19 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 303' ' ' ASN . 0.9 OUTLIER -141.19 172.38 12.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 302' ' ' ASP . 0.8 OUTLIER -34.23 -41.69 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -57.4 -63.35 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.4 p -129.57 149.47 51.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -150.9 120.94 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.81 100.66 12.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -84.1 38.51 0.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 291' ' ' ALA . 7.1 p-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 264' ' ' VAL . 17.3 mtmm -42.99 -45.85 5.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.0 137.64 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 19.7 mt -131.99 120.64 22.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 17.0 tp -76.8 114.52 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.417 HD13 ' CG2' ' A' ' 259' ' ' VAL . 7.0 mp -102.34 147.95 26.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.0 120.82 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.405 HD12 ' CG2' ' A' ' 229' ' ' ILE . 5.2 mp -80.62 123.93 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -81.54 137.57 35.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.495 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 50.4 t30 44.18 53.57 10.83 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.7 Cg_exo -47.3 103.98 0.06 OUTLIER 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.67 2.247 . . . . 0.0 112.38 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.455 HD13 ' ND2' ' A' ' 224' ' ' ASN . 37.8 mt -107.46 -47.65 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.543 ' CD2' ' CD2' ' A' ' 280' ' ' TYR . 94.8 m-85 -97.37 141.11 22.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.689 0.757 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.55 117.33 2.29 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.707 2.271 . . . . 0.0 112.371 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.405 ' CG2' HD12 ' A' ' 222' ' ' ILE . 30.5 mm -99.61 106.3 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 28.7 p -111.53 165.82 11.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 28.9 m -47.38 -40.44 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.147 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 235' ' ' TYR . 9.7 t0 -57.22 -63.89 1.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 232' ' ' ASP . 90.8 t -35.67 -36.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.17 -37.6 18.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 49.2 t80 -84.11 25.85 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.497 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 89.8 m -130.78 -36.22 1.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.124 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.435 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 25.4 t -98.12 -23.58 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.12 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.432 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 98.1 m -86.18 -48.78 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.568 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 11.9 t30 -47.43 -47.04 59.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.592 0.71 . . . . 0.0 110.85 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.8 Cg_exo -48.02 -21.5 2.8 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.643 2.229 . . . . 0.0 112.333 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.2 t -93.12 -48.64 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.097 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -138.12 -128.02 2.58 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -138.11 114.72 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.84 139.95 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.42 ' NE2' ' OE1' ' A' ' 262' ' ' GLU . 3.3 mm100 -108.09 -67.32 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -116.84 158.19 24.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 79.6 mt -149.72 108.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.62 143.25 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.42 HG12 ' CB ' ' A' ' 257' ' ' ALA . 73.1 mt -126.61 114.89 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -125.69 146.2 49.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -91.95 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -67.17 89.76 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 12.5 m120 50.58 42.02 26.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 137.32 136.2 3.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.506 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 32.7 mm -51.12 97.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.767 0.318 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -127.38 152.74 47.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.42 ' CB ' HG12 ' A' ' 249' ' ' ILE . . . -146.51 124.58 12.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.091 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 25.9 mtt -86.68 118.62 26.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.417 ' CG2' HD13 ' A' ' 220' ' ' LEU . 57.8 t -102.97 138.06 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -111.26 143.05 42.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -119.07 174.47 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.856 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.42 ' OE1' ' NE2' ' A' ' 245' ' ' GLN . 3.9 mm-40 -56.71 -66.82 0.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.411 ' C ' ' HG2' ' A' ' 216' ' ' LYS . 93.0 p -139.02 165.64 26.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.83 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.471 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 90.7 t -43.15 -54.38 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.116 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 34.7 tp -45.11 -60.8 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 81.7 m -47.91 -39.27 18.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.29 83.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -57.43 -59.82 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -56.79 -58.75 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -49.06 -57.45 6.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 275' ' ' ASN . 55.6 tttm -42.94 -50.26 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -47.5 -71.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.133 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.76 -48.61 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.083 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.401 ' N ' HD11 ' A' ' 274' ' ' LEU . 6.5 mp -64.58 -24.75 67.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 271' ' ' LYS . 50.4 t30 -62.16 102.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 76.27 20.77 76.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.505 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -86.36 94.8 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.0 111.12 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.03 162.99 6.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.425 HG21 ' CE1' ' A' ' 280' ' ' TYR . 53.5 mt -121.5 -42.95 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . 0.543 ' CD2' ' CD2' ' A' ' 227' ' ' TYR . 52.4 m-85 -112.74 173.43 6.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -50.77 104.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.101 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.63 58.53 0.71 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.495 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 26.1 p -175.1 160.48 2.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 110.872 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.6 m 63.47 46.67 4.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 18.0 m -67.9 155.93 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 80.3 mt -98.82 125.84 44.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -115.23 98.22 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 74.5 mt -84.05 146.77 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.15 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -159.67 113.32 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -40.83 102.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.491 ' O ' ' ND2' ' A' ' 215' ' ' ASN . . . -54.95 145.77 19.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.558 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 8.9 ttm180 -61.97 -47.26 91.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.601 0.715 . . . . 0.0 110.826 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.3 Cg_endo -78.9 148.89 22.53 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.682 2.255 . . . . 0.0 112.276 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.9 p -90.55 -26.36 19.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -123.81 149.85 45.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 78.9 mt -105.37 178.85 4.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -138.39 110.37 7.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 85.5 t -120.99 110.7 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.8 mp -73.23 -54.03 16.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.18 151.62 51.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.36 97.15 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 303' ' ' ASN . 7.7 p-10 -130.9 166.11 21.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 302' ' ' ASP . 1.1 t30 -36.5 -45.54 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -60.66 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 55.7 p -134.31 128.42 33.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 17.0 t-105 -114.14 149.48 35.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -129.29 106.24 8.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -82.62 -43.37 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 -179.975 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 23.5 t30 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.922 0.391 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -52.54 -46.06 66.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 90.1 t -81.59 131.11 34.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.128 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 288' ' ' ILE . 14.9 mt -123.09 128.17 49.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.473 HD21 ' NE2' ' A' ' 256' ' ' GLN . 29.4 tp -81.97 102.73 11.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 8.4 mp -89.54 132.78 34.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m -123.64 118.12 26.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 223' ' ' GLN . 5.2 mp -81.2 138.76 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.12 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.429 ' N ' HG22 ' A' ' 222' ' ' ILE . 2.1 tp-100 -96.68 141.45 29.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.487 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 48.7 t30 35.5 53.76 1.97 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.62 0.724 . . . . 0.0 110.843 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 77.6 Cg_exo -45.98 106.69 0.1 OUTLIER 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.367 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 66.7 mt -101.97 -48.4 4.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -112.49 126.1 28.92 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.675 0.75 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.55 112.25 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 29.5 mm -88.09 92.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.133 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.3 m -70.85 170.3 12.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 24.5 m -55.63 -41.31 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -58.05 -53.33 59.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.9 t -44.72 -37.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 52.6 mt -85.07 -35.65 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 81.8 t80 -82.55 19.95 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.412 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 93.0 m -122.78 -36.92 2.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.118 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.425 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 90.0 t -99.75 -18.84 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.431 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 58.5 m -89.07 -46.06 9.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.588 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.7 OUTLIER -50.58 -45.59 85.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.583 0.706 . . . . 0.0 110.896 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.4 Cg_exo -47.97 -28.19 9.93 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.681 2.254 . . . . 0.0 112.337 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 29.8 t -86.56 -49.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.097 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.92 -132.55 3.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -133.31 107.53 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 96.4 t -88.92 119.84 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.457 ' NE2' ' CD ' ' A' ' 262' ' ' GLU . 1.4 mm100 -81.13 -68.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.454 ' NH1' ' O ' ' A' ' 296' ' ' LEU . 7.5 ptp180 -132.97 154.9 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 70.4 mt -133.43 135.28 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.98 132.05 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.16 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 23.4 mt -120.61 118.68 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.492 ' CE2' ' HB3' ' A' ' 256' ' ' GLN . 20.2 p90 -126.75 155.18 43.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -110.22 45.22 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -90.05 109.91 20.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 61.51 41.41 12.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 109.04 149.82 13.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.457 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.9 mm -51.37 123.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 111.113 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.492 ' HB3' ' CE2' ' A' ' 250' ' ' PHE . 17.2 tt0 -153.15 163.79 39.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.24 146.18 16.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 35.3 mtt -111.38 124.92 53.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 65.7 t -111.89 121.64 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -98.36 140.81 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -116.35 158.21 23.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.457 ' CD ' ' NE2' ' A' ' 245' ' ' GLN . 3.9 mm-40 -41.48 -67.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 10.0 m -130.52 173.84 10.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.856 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 265' ' ' LEU . 92.1 t -57.02 -56.72 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 264' ' ' VAL . 17.4 tp -38.27 -64.06 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 61.6 m -45.59 -42.15 10.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -55.91 -40.35 72.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -52.04 -62.95 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -59.77 -59.99 4.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -42.78 -48.8 5.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.553 ' HE2' ' CE2' ' A' ' 290' ' ' TYR . 27.2 tttp -56.15 -44.29 79.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.04 -60.39 3.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.078 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -49.72 -40.45 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.99 -22.61 31.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 271' ' ' LYS . 2.7 t30 -62.17 100.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.56 18.0 61.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.451 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -80.56 154.3 27.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.331 . . . . 0.0 111.135 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -118.24 134.85 54.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 65.7 mt -101.53 -40.33 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.148 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.2 172.73 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -54.2 105.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.063 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.84 56.89 0.8 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.1 m -167.54 161.1 13.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.8 m 62.3 39.27 12.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.9 m -55.48 143.47 29.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.186 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 67.8 mt -93.41 126.74 38.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -124.92 84.92 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.423 HG21 ' NZ ' ' A' ' 271' ' ' LYS . 27.0 mt -71.27 144.95 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -147.68 120.07 8.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.553 ' CE2' ' HE2' ' A' ' 271' ' ' LYS . 59.0 m-85 -45.84 96.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.8 147.07 15.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.052 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 56.8 mtt-85 -65.41 -61.07 6.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.584 0.707 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 58.9 Cg_endo -71.37 154.55 60.95 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.654 2.236 . . . . 0.0 112.34 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 37.0 p -116.14 38.54 3.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 296' ' ' LEU . 37.4 ttt180 -149.88 151.21 33.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.466 ' N ' ' HG2' ' A' ' 295' ' ' ARG . 85.9 mt -141.58 120.91 13.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -106.96 135.05 49.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 92.0 t -120.25 98.34 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.163 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.8 mp -55.49 -62.55 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -119.88 169.65 9.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.424 ' ND2' ' OD1' ' A' ' 307' ' ' ASP . 3.2 m120 -107.49 114.83 29.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.414 ' CG ' ' C ' ' A' ' 301' ' ' ASN . 0.9 OUTLIER -162.56 172.15 15.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -42.34 -40.28 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.62 -46.31 70.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.6 m -158.03 143.89 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -134.88 145.19 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.424 ' OD1' ' ND2' ' A' ' 301' ' ' ASN . 2.2 p-10 -119.34 106.65 12.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.836 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.44 -39.67 24.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 37.9 p . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.16 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.0 t30 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.89 0.376 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -51.24 -41.26 60.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 50.4 t -78.64 147.38 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 10.1 mt -138.52 139.59 38.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.66 109.54 21.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.87 129.33 44.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -119.77 115.72 24.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.85 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -82.46 134.98 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.161 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 224' ' ' ASN . 2.2 tp-100 -100.4 139.06 36.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.495 ' O ' ' CD2' ' A' ' 226' ' ' LEU . 55.8 t30 35.61 54.0 2.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.5 Cg_exo -47.18 113.9 0.84 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.358 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 224' ' ' ASN . 3.3 mm? -89.25 -58.82 2.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.24 143.63 26.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.74 0.781 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.16 112.68 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.714 2.276 . . . . 0.0 112.354 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.7 mm -89.32 116.54 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 18.6 p -126.73 169.29 13.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 33.0 m -48.81 -20.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.97 -40.96 68.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.7 t -70.29 -31.8 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.17 10.48 35.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -121.94 -5.87 9.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.475 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 40.0 m -108.5 -32.51 7.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.134 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.2 -7.56 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.406 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 61.2 m -100.73 -45.36 5.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.588 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.6 t-20 -52.04 -45.39 93.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.644 0.735 . . . . 0.0 110.878 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.6 Cg_exo -48.04 -23.78 4.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 34.1 t -92.18 -53.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.45 -134.89 3.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.525 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.479 ' HE2' ' N ' ' A' ' 244' ' ' VAL . 0.0 OUTLIER -128.49 94.93 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.87 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.479 ' N ' ' HE2' ' A' ' 243' ' ' LYS . 72.9 t -53.11 132.94 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -110.53 -66.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.491 ' NE ' ' OD2' ' A' ' 307' ' ' ASP . 16.3 ttm105 -128.76 143.15 50.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 43.3 mt -128.63 132.51 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.093 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.55 132.45 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.2 mt -124.06 113.71 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.142 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -120.29 143.6 48.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -113.35 43.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -60.18 -70.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -107.15 48.16 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.58 -120.89 4.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.7 mm -133.81 93.92 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 111.172 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -125.99 167.9 14.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -161.89 124.98 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 10.7 mtt -93.59 119.23 32.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.78 130.42 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.092 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -104.65 153.92 20.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.409 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 58.3 m-85 -125.27 169.43 12.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -37.91 -73.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.9 m -137.57 -175.27 4.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.15 -50.9 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.085 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 15.9 tp -46.28 -59.41 2.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 3.5 t -55.29 -30.84 60.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -70.26 -36.13 74.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -58.14 -54.4 47.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -68.52 -44.02 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . 0.409 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -55.14 -49.57 71.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.542 ' HE3' ' CE2' ' A' ' 290' ' ' TYR . 27.0 tttm -50.97 -56.55 11.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.23 -59.45 5.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.13 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.61 -30.69 3.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.035 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.425 ' CB ' ' CD1' ' A' ' 288' ' ' ILE . 3.4 mp -98.07 -14.84 20.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 271' ' ' LYS . 8.9 t-20 -58.43 108.18 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 68.74 18.93 72.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.488 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -72.48 99.33 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.28 113.24 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.824 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 87.0 mt -72.36 -32.76 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . 0.424 ' O ' ' C ' ' A' ' 281' ' ' ALA . 63.2 m-85 -136.53 150.76 48.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 280' ' ' TYR . . . -35.85 105.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.1 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 39.86 70.87 0.31 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -174.84 150.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 0.0 110.919 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 3.3 m 57.36 51.56 9.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 28.1 m -60.59 109.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 35.5 mt -68.48 107.29 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -102.23 91.71 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.425 ' CD1' ' CB ' ' A' ' 274' ' ' LEU . 97.6 mt -79.59 139.58 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.1 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -149.1 125.97 11.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.542 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 32.4 m-85 -48.69 100.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.987 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.93 142.05 25.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.082 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.597 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.6 OUTLIER -64.55 -44.79 75.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.9 Cg_endo -80.46 147.53 17.92 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.709 2.272 . . . . 0.0 112.339 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 36.8 p -88.57 -14.32 37.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -127.59 164.95 20.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 42.9 mt -122.0 171.61 8.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -129.26 98.66 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 85.9 t -81.09 101.76 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.123 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 299' ' ' ILE . 3.2 mm -38.03 -63.24 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -170.17 142.29 2.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -39.49 100.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -167.63 172.52 9.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -47.68 -57.0 6.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.7 -41.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.5 m -162.39 136.94 6.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -126.77 129.06 47.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.491 ' OD2' ' NE ' ' A' ' 246' ' ' ARG . 19.8 t0 -121.8 81.02 1.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.859 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . 0.464 ' CE2' HG22 ' A' ' 309' ' ' THR . 1.6 p90 -70.72 -37.66 73.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.464 HG22 ' CE2' ' A' ' 308' ' ' TYR . 30.5 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 55.1 t30 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.905 0.384 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -43.72 79.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.8 t -88.13 146.78 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.101 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.3 mt -135.43 124.99 25.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 36.0 tp -81.62 109.03 15.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.3 mp -95.84 129.47 43.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 63.1 m -112.73 127.07 56.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 4.8 mp -89.61 121.74 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.74 138.77 39.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.477 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 1.8 m-20 43.43 53.92 10.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.73 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.5 Cg_exo -45.87 90.24 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.337 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.7 mt -97.04 -42.45 7.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -111.45 153.54 44.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.732 0.777 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.75 115.81 4.28 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.44 ' CG2' HD22 ' A' ' 234' ' ' LEU . 30.3 mm -99.23 92.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.6 m -71.81 167.22 20.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.093 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 21.2 m -54.44 -39.53 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.34 -52.05 67.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 96.0 t -46.05 -40.14 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.44 HD22 ' CG2' ' A' ' 229' ' ' ILE . 33.7 mt -76.05 -60.5 2.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.964 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -47.31 -34.06 6.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.481 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 87.2 m -63.35 -47.8 80.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.149 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.413 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 59.6 t -86.94 -10.77 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.128 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.427 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 72.9 m -87.39 -49.2 7.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.571 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 14.3 t30 -48.53 -46.48 70.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.649 0.738 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.3 Cg_exo -47.96 -18.63 1.2 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.667 2.245 . . . . 0.0 112.399 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 37.0 t -104.4 -41.62 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.79 -144.71 4.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -123.16 126.4 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 85.4 t -96.19 147.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -108.22 -61.89 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.451 ' HG2' ' N ' ' A' ' 247' ' ' ILE . 21.3 ttm180 -134.6 147.82 50.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.451 ' N ' ' HG2' ' A' ' 246' ' ' ARG . 61.3 mt -140.54 131.0 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.67 135.87 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 58.5 mt -120.94 120.82 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -136.1 155.13 50.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -131.76 40.59 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -68.78 -57.26 5.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -119.77 45.77 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 116.69 128.49 4.17 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.443 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.431 HG13 ' CB ' ' A' ' 225' ' ' PRO . 42.9 mm -43.92 104.41 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -146.3 170.76 16.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.54 130.22 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' MET . . . . . 0.467 ' SD ' ' CD2' ' A' ' 296' ' ' LEU . 22.4 mtt -87.89 118.0 27.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 87.7 t -107.87 123.43 63.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -103.08 150.3 23.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 262' ' ' GLU . 56.4 m-85 -126.0 161.12 28.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 261' ' ' PHE . 23.4 mt-10 -34.15 -70.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 t -140.39 167.71 21.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 265' ' ' LEU . 94.8 t -41.04 -57.14 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 264' ' ' VAL . 19.6 tp -37.22 -63.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 30.7 m -47.36 -42.2 21.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -56.33 -38.31 71.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -56.14 -59.44 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -66.32 -50.9 62.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.954 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -49.42 -49.92 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 275' ' ' ASN . 58.9 tttm -52.57 -46.96 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -60.05 -70.52 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -42.29 -36.8 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.7 mp -85.94 -23.97 26.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 271' ' ' LYS . 14.3 t-20 -58.75 102.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.9 23.07 60.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -93.24 93.71 8.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.1 148.63 50.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 41.0 mt -104.5 -40.34 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.89 172.93 6.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -57.16 107.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.4 55.68 0.75 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.514 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 6.5 m -164.47 153.67 13.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 4.9 m 62.82 44.53 6.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 39.2 m -59.92 129.22 40.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.439 ' O ' ' NZ ' ' A' ' 287' ' ' LYS . 35.5 mt -78.28 123.31 26.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 286' ' ' LEU . 0.9 OUTLIER -121.83 84.96 2.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 28.6 mt -65.26 144.02 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.174 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -153.98 111.09 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -38.07 106.26 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.62 160.76 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.097 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 14.8 mtt-85 -73.04 -59.37 2.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 59.7 Cg_endo -73.23 159.09 47.89 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.711 2.274 . . . . 0.0 112.342 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 34.4 p -88.22 -25.1 23.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -173.88 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.467 ' CD2' ' SD ' ' A' ' 258' ' ' MET . 17.8 mt -142.24 168.34 19.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -125.56 114.97 19.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 84.5 t -106.02 102.86 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.4 mp -57.25 -51.31 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.03 155.42 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -90.09 85.38 6.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.4 173.16 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -39.39 -51.12 2.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -45.46 -59.87 2.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 63.8 p -135.13 138.46 43.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -139.56 127.44 22.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -104.02 98.22 8.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -83.72 40.21 0.73 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.138 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.6 t30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.859 0.362 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -58.1 -42.95 86.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.84 139.27 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.123 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 29.5 mt -138.6 126.82 22.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.46 113.48 21.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -100.53 132.68 45.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -119.33 137.92 53.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.2 mp -105.28 125.31 60.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -82.57 142.43 31.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.475 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 42.0 t30 40.12 53.49 5.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.3 Cg_exo -44.7 103.61 0.05 OUTLIER 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.697 2.265 . . . . 0.0 112.343 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 55.2 mt -105.08 -46.93 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -100.5 153.61 37.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.709 0.766 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.75 116.34 4.64 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.711 2.274 . . . . 0.0 112.35 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.7 mm -100.22 119.98 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 232' ' ' ASP . 18.2 p -122.57 156.16 34.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 230' ' ' THR . 34.4 m -33.62 -35.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.2 m-20 -60.96 -65.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 87.3 t -43.62 -51.02 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.16 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 46.1 mt -60.93 -58.33 8.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.539 ' CE2' ' HB ' ' A' ' 244' ' ' VAL . 3.2 t80 -54.68 -25.86 29.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.422 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 66.6 m -70.19 -45.86 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.171 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.437 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 39.4 t -87.2 -15.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.413 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 71.0 m -86.27 -46.12 10.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.556 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -47.11 -47.76 54.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.866 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.0 Cg_exo -47.96 -21.07 2.41 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.723 2.282 . . . . 0.0 112.366 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 69.7 t -98.73 -39.09 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.13 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.53 -154.11 7.94 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.457 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.403 ' HB3' ' CD ' ' A' ' 262' ' ' GLU . 2.5 tmtm? -104.23 144.39 31.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.539 ' HB ' ' CE2' ' A' ' 235' ' ' TYR . 63.0 t -108.69 141.3 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.412 ' NE2' ' HG3' ' A' ' 262' ' ' GLU . 20.2 mt-30 -110.66 -65.11 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.474 ' NE ' HG21 ' A' ' 298' ' ' VAL . 17.4 ttm180 -130.9 145.08 51.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.489 HG22 ' N ' ' A' ' 248' ' ' VAL . 71.3 mt -138.34 140.17 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.489 ' N ' HG22 ' A' ' 247' ' ' ILE . 17.1 t -131.37 139.98 49.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 77.2 mt -129.02 109.45 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -118.96 151.29 38.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 40.88 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -58.48 -63.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -109.19 43.6 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.31 -121.96 4.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.495 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.418 HG13 ' CB ' ' A' ' 225' ' ' PRO . 28.7 mm -129.61 91.21 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 111.102 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -124.83 159.68 30.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -155.91 122.93 5.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 19.3 mtt -86.07 125.07 33.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.6 t -111.85 118.86 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -94.31 156.44 16.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -130.67 169.04 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.892 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.412 ' HG3' ' NE2' ' A' ' 245' ' ' GLN . 10.9 mp0 -54.26 -64.2 0.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 73.7 m -128.49 172.53 11.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 91.2 t -61.12 -51.43 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 24.9 tp -40.74 -63.49 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 33.5 m -46.03 -40.59 10.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.21 77.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.115 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -56.75 -57.09 13.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -63.51 -60.35 3.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -47.62 -50.01 25.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.113 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 275' ' ' ASN . 49.2 tttm -48.55 -51.67 26.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -59.36 -66.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.67 -37.75 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.4 mp -87.8 -22.1 24.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 272' ' ' ALA . 7.3 t30 -57.86 104.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.03 23.01 70.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -79.59 118.37 21.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 111.096 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.25 125.29 28.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.41 HD11 ' CG ' ' A' ' 286' ' ' LEU . 78.4 mt -97.8 -41.04 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.146 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -117.77 172.58 7.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -54.38 105.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.12 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 35.63 54.26 1.07 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.497 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 4.3 m -165.45 163.77 19.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.01 41.89 7.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 54.0 m -55.8 118.49 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.41 ' CG ' HD11 ' A' ' 279' ' ' ILE . 36.3 mt -71.39 127.08 31.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -127.02 95.03 4.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.416 ' CD1' ' O ' ' A' ' 271' ' ' LYS . 38.7 mt -77.23 147.36 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -150.38 124.05 9.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -49.64 97.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -47.5 134.75 11.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.116 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.575 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 9.2 ttp180 -60.21 -46.61 97.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 0.0 110.817 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.2 Cg_endo -79.45 149.26 21.38 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.712 2.275 . . . . 0.0 112.349 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 60.6 p -92.66 -25.25 18.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -123.9 139.59 53.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 40.0 mt -100.43 176.57 5.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . 0.428 ' ND2' HD12 ' A' ' 299' ' ' ILE . 5.1 t30 -131.46 115.42 16.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.474 HG21 ' NE ' ' A' ' 246' ' ' ARG . 58.6 t -113.56 105.66 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.135 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.428 HD12 ' ND2' ' A' ' 297' ' ' ASN . 5.3 mp -65.92 -59.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.136 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -132.9 175.58 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -104.16 105.69 15.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 303' ' ' ASN . 0.9 OUTLIER -149.7 166.74 28.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 302' ' ' ASP . 5.0 p30 -33.71 -39.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.58 -58.24 9.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' SER . . . . . 0.416 ' HB2' ' HA ' ' A' ' 248' ' ' VAL . 9.8 t -134.35 153.62 51.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -144.13 134.24 24.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -112.91 108.74 17.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.811 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -79.51 -50.58 10.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.902 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 68.6 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 -179.937 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.403 ' ND2' ' HB ' ' A' ' 217' ' ' VAL . 51.5 t30 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.921 0.391 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.417 ' HG2' ' N ' ' A' ' 264' ' ' VAL . 40.2 mtmt -57.61 -41.91 82.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 218' ' ' LEU . 55.8 t -77.59 138.58 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.436 ' N ' HG13 ' A' ' 217' ' ' VAL . 14.0 mt -133.79 119.2 18.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.9 tp -76.25 106.58 7.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.98 123.76 36.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.0 m -114.27 118.96 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.0 mp -79.55 133.9 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.09 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 224' ' ' ASN . 43.8 mt-30 -91.15 141.91 28.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.488 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 62.7 t30 35.11 54.42 1.91 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.632 0.73 . . . . 0.0 110.874 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.8 Cg_exo -47.33 115.91 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.326 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 62.6 mt -108.17 -54.86 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -101.08 137.82 19.82 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.67 0.748 . . . . 0.0 110.867 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.77 125.94 13.76 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.673 2.248 . . . . 0.0 112.365 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 49.9 mm -104.55 126.4 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.107 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.0 p -125.77 163.84 21.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.131 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 235' ' ' TYR . 35.8 m -40.22 -35.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.166 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -55.99 -45.54 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.7 t -61.9 -52.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 31.4 mt -84.11 24.38 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.455 ' CB ' ' O ' ' A' ' 231' ' ' VAL . 85.2 t80 -130.58 -37.25 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.971 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.499 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 85.2 m -80.58 -34.27 35.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.446 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 11.6 t -87.88 -19.4 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.448 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 73.0 m -84.63 -50.64 7.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.545 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 1.5 t-20 -45.31 -47.39 34.3 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.631 0.729 . . . . 0.0 110.904 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.6 Cg_exo -47.98 -30.93 14.76 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.259 . . . . 0.0 112.336 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.01 -39.86 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.168 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.47 -133.24 1.46 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.52 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -121.34 143.7 49.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.896 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.66 128.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.423 ' CD ' ' HA ' ' A' ' 262' ' ' GLU . 30.6 mm-40 -92.46 -59.44 2.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -147.27 154.3 40.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 79.5 mt -133.4 134.54 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.47 116.06 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 231' ' ' VAL . 37.5 mt -108.08 106.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -118.93 149.19 42.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 251' ' ' LYS . 2.6 mppt? -118.16 41.45 2.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -54.25 -63.86 1.02 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -109.52 43.26 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.3 -118.82 3.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 41.8 mm -127.05 95.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -128.83 157.52 41.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -156.32 118.52 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 24.7 mtt -87.53 125.74 34.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.58 131.59 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.103 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 261' ' ' PHE . 5.0 tp10 -104.77 152.0 23.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 270' ' ' ALA . 55.1 m-85 -130.08 157.6 41.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 261' ' ' PHE . 67.3 mt-10 -34.99 -66.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.2 p -143.68 174.54 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 265' ' ' LEU . 74.5 t -47.82 -59.87 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 264' ' ' VAL . 18.1 tp -35.98 -60.12 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 85.9 m -53.22 -40.97 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 264' ' ' VAL . . . -57.27 -36.88 71.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -58.76 -58.27 9.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -66.13 -53.03 42.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . 0.548 ' HB2' ' CE2' ' A' ' 261' ' ' PHE . . . -49.38 -47.83 47.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 275' ' ' ASN . 24.6 tttt -53.38 -55.57 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.847 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -53.64 -67.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.109 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.96 -42.29 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.6 mp -81.82 -22.0 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 271' ' ' LYS . 65.4 t30 -61.61 101.76 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.89 21.46 71.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -82.1 93.79 7.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.118 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.36 117.08 2.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.463 HD13 ' CD2' ' A' ' 286' ' ' LEU . 80.3 mt -91.14 -37.43 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.134 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -120.35 173.86 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -56.87 104.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.128 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.49 59.12 0.67 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.423 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 31.2 p -175.12 162.45 3.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.908 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 77.2 m 62.48 43.08 8.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 5.9 m -57.24 146.78 27.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.463 ' CD2' HD13 ' A' ' 279' ' ' ILE . 73.6 mt -91.81 119.33 31.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -116.71 79.53 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.471 ' CD1' ' O ' ' A' ' 271' ' ' LYS . 47.6 mt -65.41 147.73 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -151.85 113.63 4.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -41.12 101.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -50.67 138.9 17.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 6.2 ttt180 -66.08 -45.7 62.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.62 0.724 . . . . 0.0 110.889 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.3 Cg_endo -80.21 148.37 18.98 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.315 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.8 p -82.11 -25.75 34.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.44 ' HD3' ' N ' ' A' ' 296' ' ' LEU . 0.4 OUTLIER -119.21 -174.66 2.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.44 ' N ' ' HD3' ' A' ' 295' ' ' ARG . 52.0 mt -139.17 173.35 11.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.928 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -124.83 117.9 25.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 77.9 t -122.35 91.73 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.057 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.3 mp -50.43 -56.55 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.44 177.23 8.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -99.19 96.47 7.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -136.16 171.55 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -42.11 -45.28 3.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -55.67 -62.3 1.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 97.4 p -129.05 137.15 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -140.98 132.16 26.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -116.21 92.47 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 309' ' ' THR . 53.3 m-85 -69.02 -43.58 74.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 308' ' ' TYR . 47.5 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.136 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 49.7 t30 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.862 0.363 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -46.2 -40.22 10.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.462 HG13 ' CB ' ' A' ' 291' ' ' ALA . 49.0 t -77.81 137.23 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.095 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 24.1 mt -136.93 129.98 30.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.03 118.88 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.401 ' N ' HD11 ' A' ' 220' ' ' LEU . 6.6 mp -108.52 134.7 50.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.8 t -119.63 137.6 53.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.2 mp -99.21 128.83 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -89.75 138.96 31.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 49.7 t30 39.52 52.7 4.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.624 0.726 . . . . 0.0 110.935 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 71.5 Cg_exo -43.7 94.33 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.641 2.228 . . . . 0.0 112.334 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 20.2 mt -95.86 -43.78 7.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -102.71 153.48 38.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.715 0.769 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.29 115.77 4.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.696 2.264 . . . . 0.0 112.274 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.8 mm -98.41 110.48 26.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 232' ' ' ASP . 49.6 p -105.99 158.46 16.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.13 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 18.3 m -41.49 -26.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.123 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.5 m-20 -68.22 -61.98 1.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . 0.425 ' CG1' HD12 ' A' ' 279' ' ' ILE . 78.5 t -39.45 -45.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 31.5 mt -77.74 -37.92 48.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.595 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 76.9 t80 -83.42 20.14 1.4 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 99.2 m -124.43 -37.19 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.142 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.415 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 89.1 t -98.21 -19.26 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.424 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 65.3 m -89.75 -45.55 9.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.589 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 4.8 t-20 -51.37 -45.35 89.96 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.728 . . . . 0.0 110.944 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.1 Cg_exo -47.97 -56.87 2.71 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.711 2.274 . . . . 0.0 112.318 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.3 -47.04 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -142.74 -108.08 0.65 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.507 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.535 ' O ' ' CD2' ' A' ' 261' ' ' PHE . 13.7 tptp -152.33 151.34 30.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.469 ' N ' ' HG3' ' A' ' 243' ' ' LYS . 95.1 t -127.94 122.36 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -82.64 -69.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -137.24 156.91 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 55.5 mt -137.06 133.47 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.444 ' HA ' ' CB ' ' A' ' 305' ' ' SER . 94.9 t -126.54 110.18 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.468 ' CG1' ' O ' ' A' ' 304' ' ' ASP . 60.4 mt -94.09 126.14 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.159 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -141.35 135.16 30.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -84.5 41.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -89.59 119.19 29.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.8 m120 51.49 40.95 28.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 109.56 135.71 7.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.463 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.0 mm -46.56 104.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.321 . . . . 0.0 111.152 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -134.1 164.42 27.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -152.51 122.03 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' MET . . . . . 0.403 ' SD ' ' CD2' ' A' ' 296' ' ' LEU . 26.4 mtt -83.42 114.68 21.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 88.7 t -106.8 119.44 56.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 11.0 tt0 -91.54 151.01 20.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 243' ' ' LYS . 30.3 m-85 -123.5 163.74 20.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -52.97 -72.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 66.8 m -114.8 -174.95 2.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.66 -44.54 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 268' ' ' GLN . 36.6 tp -51.61 -65.8 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.935 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 24.3 p -42.44 -38.22 1.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.04 -38.66 83.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 265' ' ' LEU . 62.2 mt-30 -58.68 -59.39 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -56.56 -53.7 54.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.57 -55.04 25.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.074 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.416 ' HE3' ' CZ ' ' A' ' 290' ' ' TYR . 41.5 tttm -43.09 -51.34 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -46.86 -73.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -45.49 -50.18 12.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.43 ' CB ' ' CD1' ' A' ' 288' ' ' ILE . 5.1 mp -61.47 -26.79 68.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 271' ' ' LYS . 33.6 t30 -60.62 105.05 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.15 25.66 70.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.459 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -86.02 93.36 8.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 0.0 111.131 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.69 131.92 45.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.425 HD12 ' CG1' ' A' ' 233' ' ' VAL . 72.6 mt -88.56 -34.34 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -121.61 173.13 7.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -55.32 112.55 1.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.17 73.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.536 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' CYS . . . . . 0.4 ' O ' ' SG ' ' A' ' 284' ' ' CYS . 2.6 t -175.31 177.78 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.313 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 283' ' ' CYS . 27.8 p 39.44 46.61 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 55.8 m -57.86 90.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -45.72 131.13 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -127.8 96.85 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 289' ' ' GLU . 66.3 mt -80.2 145.94 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . 0.447 ' N ' HG23 ' A' ' 288' ' ' ILE . 16.3 mt-10 -153.01 114.91 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.416 ' CZ ' ' HE3' ' A' ' 271' ' ' LYS . 44.6 m-85 -43.08 98.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.462 ' CB ' HG13 ' A' ' 217' ' ' VAL . . . -48.15 141.73 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.559 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.0 OUTLIER -69.86 -47.43 23.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.56 0.695 . . . . 0.0 110.859 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 62.5 Cg_endo -77.57 144.28 22.33 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.676 2.251 . . . . 0.0 112.34 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 81.1 p -83.7 -31.31 26.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -112.8 161.11 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.403 ' CD2' ' SD ' ' A' ' 258' ' ' MET . 74.6 mt -119.36 -178.28 3.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -143.02 113.53 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 87.9 t -116.16 106.07 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.104 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.2 mp -66.87 -55.88 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . 0.42 ' CG ' ' OD2' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -133.83 153.13 51.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -90.09 87.19 6.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.42 ' OD2' ' CG ' ' A' ' 300' ' ' ARG . 5.0 p30 -123.18 171.78 9.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -39.89 -45.9 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . 0.468 ' O ' ' CG1' ' A' ' 249' ' ' ILE . 25.7 m-20 -57.42 -61.52 2.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' SER . . . . . 0.444 ' CB ' ' HA ' ' A' ' 248' ' ' VAL . 97.0 p -123.33 131.79 53.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -144.16 119.11 9.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -97.69 117.65 32.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.88 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -98.61 44.18 1.04 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 76.7 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.139 -179.972 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 48.3 t -171.44 157.22 4.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.899 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.2 m -162.92 143.89 9.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -167.93 147.6 11.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 54.3 m -107.96 142.59 37.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.796 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 95.9 p -126.85 118.39 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.866 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -134.77 156.09 22.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.513 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -156.05 162.64 40.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -126.47 135.24 51.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.442 HG21 ' N ' ' A' ' 203' ' ' THR . 21.2 mt -41.28 137.59 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.442 ' N ' HG21 ' A' ' 202' ' ' ILE . 25.0 m -154.95 124.24 6.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.51 145.85 54.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.564 0.697 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.3 -25.61 6.89 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.699 2.266 . . . . 0.0 112.315 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -62.11 145.78 49.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.434 ' O ' ' C ' ' A' ' 208' ' ' THR . 47.2 t30 -120.06 151.17 39.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.901 0.381 . . . . 0.0 110.899 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 207' ' ' ASN . 97.0 m -34.35 125.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -93.52 164.36 13.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.418 ' CG ' ' HD2' ' A' ' 211' ' ' PRO . 11.5 t70 -151.09 140.94 14.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.608 0.718 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 210' ' ' ASP . 62.6 Cg_endo -77.66 14.2 1.5 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.714 2.276 . . . . 0.0 112.373 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 211' ' ' PRO . 2.0 m -37.25 115.28 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.821 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.26 147.83 16.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.509 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 120.53 110.86 2.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.537 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 217' ' ' VAL . 4.1 p-10 -151.33 153.01 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 110.9 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -30.99 69.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.499 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 95.7 t -86.86 140.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.45 ' N ' HG11 ' A' ' 217' ' ' VAL . 14.0 mt -134.38 132.34 39.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 49.1 tp -81.89 103.82 11.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.9 mp -90.96 128.61 36.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.17 112.49 17.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 3.5 mp -75.42 130.62 36.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.139 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -99.47 120.52 39.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 19.0 m-20 63.61 52.28 1.41 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 0.0 110.91 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 60.2 Cg_endo -74.41 47.09 1.53 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.654 2.236 . . . . 0.0 112.352 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.3 mt -39.86 -41.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -97.78 141.49 23.08 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.68 0.752 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.31 124.38 9.11 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.734 2.289 . . . . 0.0 112.282 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.6 mm -107.11 109.04 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.12 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.1 p -102.98 159.05 15.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.437 ' N ' HD11 ' A' ' 249' ' ' ILE . 21.8 m -44.37 -39.88 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -54.19 -55.84 24.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.1 t -45.12 -39.11 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 25.7 mt -78.49 -64.06 1.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.414 ' CZ ' ' ND2' ' A' ' 239' ' ' ASN . 55.6 t80 -46.9 -27.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.477 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 63.6 m -64.34 -47.69 78.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.419 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 65.1 t -87.37 -11.2 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.115 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 64.4 m -87.39 -49.06 7.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.579 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.0 t-20 -48.65 -46.36 71.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.657 0.741 . . . . 0.0 110.896 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.2 Cg_exo -47.97 -17.4 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 96.2 t -102.59 -41.34 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -174.2 177.26 46.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 142.87 56.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.1 t -110.57 134.64 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -80.77 -60.84 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -161.74 155.07 21.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 74.9 mt -134.93 119.13 26.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 49.1 t -110.76 115.03 48.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.437 HD11 ' N ' ' A' ' 231' ' ' VAL . 64.5 mt -97.35 114.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.173 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 7.5 p90 -116.3 162.38 17.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -117.87 90.92 3.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -133.04 94.45 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 59.51 38.95 22.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 131.06 131.17 3.25 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.47 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 33.1 mm -48.1 102.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.518 ' HB3' ' CE1' ' A' ' 250' ' ' PHE . 27.7 mt-30 -118.15 166.14 12.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -168.17 130.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.065 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 33.8 mtt -97.1 132.82 42.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.7 t -122.73 125.31 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.154 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -101.85 150.52 23.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -122.36 159.36 27.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -41.19 -65.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.7 t -130.71 176.23 8.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 85.7 t -60.24 -51.43 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.111 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 20.9 tp -39.07 -62.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 65.7 m -47.44 -41.82 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -55.87 -42.75 76.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -54.88 -58.56 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -62.25 -56.67 16.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.866 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -47.18 -47.96 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.122 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 275' ' ' ASN . 22.7 tttt -50.27 -48.8 54.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -64.48 -67.71 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -39.78 -33.76 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.39 -28.13 17.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 272' ' ' ALA . 6.0 t30 -55.27 100.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.3 21.95 61.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -84.35 92.41 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.33 129.21 39.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 74.4 mt -100.36 -41.64 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.177 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -117.38 171.56 7.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -55.11 108.62 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.115 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.7 53.75 0.82 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 25.5 p -174.51 172.01 3.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 69.5 m 56.08 41.12 29.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 54.4 m -68.98 143.94 54.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.171 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.14 127.33 35.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -118.89 80.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.4 HG21 ' N ' ' A' ' 289' ' ' GLU . 17.0 mt -71.28 144.32 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 290' ' ' TYR . 19.7 mt-10 -157.31 107.79 2.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 289' ' ' GLU . 41.9 m-85 -34.4 101.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -56.19 165.24 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.498 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 0.4 OUTLIER -71.82 -57.8 3.86 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.647 0.736 . . . . 0.0 110.856 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 59.5 Cg_endo -73.14 160.47 45.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.67 2.247 . . . . 0.0 112.345 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.401 ' O ' ' CG2' ' A' ' 217' ' ' VAL . 33.2 p -102.95 -27.58 12.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -111.81 144.9 40.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 80.5 mt -109.45 175.9 5.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -135.87 139.05 43.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 95.2 t -134.97 97.29 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.141 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.3 mp -51.5 -57.3 3.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -139.69 175.95 9.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.76 116.67 33.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -159.29 171.32 20.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -44.47 -39.93 5.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.16 -61.11 2.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 53.4 p -131.05 133.46 45.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -124.18 141.17 52.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -115.04 100.88 8.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.36 -47.95 38.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 25.6 p -37.88 -43.55 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.524 ' HG3' ' CE1' ' A' ' 312' ' ' TYR . 28.0 ttpt -126.84 89.12 52.87 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.568 0.699 . . . . 0.0 110.93 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.31 -4.91 14.04 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 0.0 112.36 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.524 ' CE1' ' HG3' ' A' ' 310' ' ' LYS . 15.9 p90 -101.8 103.76 14.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -130.4 -61.21 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -103.15 101.64 2.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.509 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -84.32 41.84 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.897 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.407 ' C ' ' HD2' ' A' ' 316' ' ' ARG . 1.9 ppt_? . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.9 m -162.85 147.09 11.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 110.891 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.8 m -167.94 164.69 13.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -152.58 161.57 29.55 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.527 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 47.5 t -173.19 132.54 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 0.0 110.831 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.2 t -174.21 127.84 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -174.36 136.4 3.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.49 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -170.7 150.92 3.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.722 0.296 . . . . 0.0 110.916 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 45.4 mtt85 -151.12 125.01 9.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 43.1 mt -120.01 108.79 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.137 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.5 p -147.63 130.5 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -148.94 131.63 7.94 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.732 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.82 157.85 31.36 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 176.68 110.79 0.27 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -155.23 142.22 19.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.3 p -150.66 136.41 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -93.91 172.44 8.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.826 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.52 135.66 20.0 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.64 0.733 . . . . 0.0 110.879 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.79 134.07 13.17 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.655 2.237 . . . . 0.0 112.378 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 58.3 m -130.84 118.54 20.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 143.78 -168.51 26.38 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.461 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 161.95 -150.12 19.2 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.531 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -159.59 127.24 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.866 0.365 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 217' ' ' VAL . 0.0 OUTLIER -50.47 -35.21 27.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.408 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 95.0 t -89.59 141.85 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.461 ' HB3' ' CG2' ' A' ' 288' ' ' ILE . 52.6 mt -142.19 128.35 19.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.2 tp -87.0 105.24 17.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.82 140.43 29.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -134.8 115.71 13.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -81.49 130.31 36.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -98.46 130.93 45.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.474 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 59.8 t30 48.34 52.74 13.16 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.6 Cg_exo -44.84 123.59 5.02 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.663 2.242 . . . . 0.0 112.381 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.438 ' CD2' ' HB2' ' A' ' 283' ' ' CYS . 4.0 mm? -91.81 -63.04 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -107.52 153.97 41.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.663 0.744 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.37 112.37 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.7 mm -90.83 116.59 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 29.8 p -127.11 159.84 32.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.163 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.9 m -37.7 -33.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -65.41 -60.45 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 90.4 t -45.63 -44.71 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.174 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 36.7 mt -70.45 -61.4 1.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -49.93 -27.35 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.483 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 98.3 m -65.62 -47.28 76.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.444 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 80.1 t -86.73 -16.98 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 85.1 m -83.87 -47.78 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.538 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -47.36 -48.78 55.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.594 0.711 . . . . 0.0 110.846 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.6 Cg_exo -48.0 -17.57 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 0.0 112.356 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.404 ' CG1' ' HA ' ' A' ' 270' ' ' ALA . 87.7 t -97.59 -43.93 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.56 -155.61 9.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 244' ' ' VAL . 0.6 OUTLIER -101.28 130.22 47.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 245' ' ' GLN . 66.2 t -100.35 143.67 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.425 ' N ' HG11 ' A' ' 244' ' ' VAL . 21.7 mm-40 -94.62 -58.75 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.408 ' CB ' ' HA ' ' A' ' 307' ' ' ASP . 14.8 ptt-85 -155.23 163.93 39.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 63.8 mt -145.3 140.79 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.66 121.28 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 304' ' ' ASP . 46.1 mt -102.52 118.2 49.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -130.88 154.69 47.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -111.48 93.22 4.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -129.55 102.83 6.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 47.7 39.35 10.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 133.54 121.45 2.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.5 mm -41.12 106.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -126.48 151.03 48.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -152.31 117.82 5.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 10.5 mtt -77.8 146.47 35.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.3 t -137.81 118.77 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 23.3 tt0 -97.83 152.24 19.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.434 ' N ' ' HG2' ' A' ' 260' ' ' GLU . 55.6 m-85 -126.5 154.91 43.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -41.13 -63.25 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.8 m -131.19 172.33 12.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 265' ' ' LEU . 94.8 t -59.27 -51.96 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 264' ' ' VAL . 23.4 tp -37.43 -65.59 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 54.6 m -45.72 -42.77 12.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -57.76 -41.47 82.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -52.92 -61.6 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -62.36 -53.37 55.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.404 ' HA ' ' CG1' ' A' ' 241' ' ' VAL . . . -46.76 -49.22 20.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 275' ' ' ASN . 61.5 tttm -52.19 -47.34 65.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.83 -62.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.101 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -46.17 -36.4 5.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.9 mp -89.54 -24.22 21.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 271' ' ' LYS . 5.3 t30 -57.43 99.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.83 19.97 69.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -91.99 94.41 9.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.102 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.36 171.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 44.5 mt -119.74 -35.23 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . 0.402 ' O ' ' C ' ' A' ' 281' ' ' ALA . 60.2 m-85 -131.72 174.02 10.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -37.64 102.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.094 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.525 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 26.29 76.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.473 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . 0.438 ' HB2' ' CD2' ' A' ' 226' ' ' LEU . 20.2 p -176.13 -175.13 0.68 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.769 0.319 . . . . 0.0 110.897 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 283' ' ' CYS . 3.0 p 36.36 41.42 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 15.5 m -57.32 145.9 30.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 69.0 mt -97.44 139.24 33.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -130.11 105.66 8.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.879 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' A' ' 218' ' ' LEU . 23.5 mt -91.96 139.21 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 290' ' ' TYR . 16.5 mm-40 -146.17 110.24 4.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.873 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 289' ' ' GLU . 28.5 m-85 -35.99 100.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.949 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.1 159.13 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.105 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 4.4 mtp-105 -73.16 -58.02 2.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.596 0.712 . . . . 0.0 110.891 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 60.3 Cg_endo -74.24 156.96 46.36 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.227 . . . . 0.0 112.337 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 28.9 p -96.55 -32.45 12.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.162 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.19 143.8 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 35.7 mt -118.46 143.59 46.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -120.41 114.56 21.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 71.9 t -85.01 114.45 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.2 mp -67.13 -55.0 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -130.73 150.58 51.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -97.98 97.06 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 303' ' ' ASN . 2.7 p-10 -148.99 172.14 15.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 302' ' ' ASP . 4.7 m-20 -34.52 -44.67 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . 0.415 ' O ' ' CG1' ' A' ' 249' ' ' ILE . 73.2 m-20 -55.5 -55.71 28.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 88.8 p -130.45 135.69 48.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -140.1 116.81 10.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.408 ' HA ' ' CB ' ' A' ' 246' ' ' ARG . 0.8 OUTLIER -105.48 91.93 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -53.98 -44.97 71.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 65.4 p -40.55 -48.6 2.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -117.66 92.12 40.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.594 0.711 . . . . 0.0 110.928 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.24 -6.17 16.28 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.26 . . . . 0.0 112.327 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -96.95 -48.79 5.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.933 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 10.4 tp -42.83 146.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 157.55 -142.6 8.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.514 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -106.25 -50.25 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.772 0.32 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.905 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.6 m -102.02 -44.94 5.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.873 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.7 m 56.38 42.34 27.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -125.07 119.42 3.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 67.0 m -130.04 160.64 33.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.876 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 82.6 p -164.63 160.76 20.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 42.48 46.51 5.66 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -46.03 -49.1 16.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 110.948 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -123.74 111.48 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.4 mm -123.14 95.58 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.199 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 12.6 t -169.44 147.78 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -174.63 143.6 0.84 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.68 175.25 11.22 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.665 2.244 . . . . 0.0 112.343 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -166.27 57.07 0.24 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -146.08 159.42 43.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.871 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 37.0 p -138.95 107.53 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.65 158.22 43.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.2 p30 -154.35 145.25 16.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.84 -21.81 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 0.0 112.378 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 3.4 m -164.74 129.24 2.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 173.21 61.15 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.511 ' HA2' ' CE1' ' A' ' 290' ' ' TYR . . . -117.67 163.22 12.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.447 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 217' ' ' VAL . 22.2 p-10 -149.61 157.66 43.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -64.67 -50.15 68.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.503 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 89.3 t -77.55 150.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.154 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 14.1 mt -139.65 125.66 19.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 23.0 tp -84.12 103.34 13.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.408 HD12 ' CG2' ' A' ' 259' ' ' VAL . 6.9 mp -87.4 129.66 34.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.6 m -122.83 114.8 20.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 4.9 mp -81.17 150.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.105 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -115.82 120.16 38.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.508 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 52.3 t30 59.37 50.49 2.96 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.619 0.723 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 57.7 Cg_endo -71.12 106.53 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.252 . . . . 0.0 112.371 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.1 mt -87.77 -47.65 8.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -91.65 133.55 30.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.662 0.744 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.08 117.4 2.49 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.699 2.266 . . . . 0.0 112.314 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 49.1 mm -85.18 109.23 17.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.166 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 82.8 p -105.24 151.78 23.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.453 ' N ' HD11 ' A' ' 249' ' ' ILE . 33.7 m -38.55 -38.56 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -60.64 -59.61 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.5 t -41.52 -48.28 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 49.5 mt -69.29 -62.7 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.445 ' CE1' ' HB ' ' A' ' 244' ' ' VAL . 43.9 t80 -48.06 -25.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.503 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 94.0 m -65.08 -48.29 74.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.432 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 89.0 t -84.43 -18.65 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.443 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 85.1 m -81.75 -53.52 6.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -41.69 -49.6 10.04 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 0.0 110.898 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.1 Cg_exo -47.94 -39.05 32.15 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 76.0 t -72.86 -42.46 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.95 -126.09 0.81 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm -116.47 165.97 12.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.445 ' HB ' ' CE1' ' A' ' 235' ' ' TYR . 99.2 t -143.02 114.44 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -73.08 -64.31 1.0 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -143.92 164.33 30.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 248' ' ' VAL . 62.5 mt -142.14 141.54 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.402 ' N ' HG23 ' A' ' 247' ' ' ILE . 58.0 t -128.55 134.46 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 231' ' ' VAL . 67.1 mt -119.29 131.59 71.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.519 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 6.4 p90 -142.41 173.31 11.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -129.64 42.62 3.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -80.8 97.68 7.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 62.51 42.8 8.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 121.52 142.98 6.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.458 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 27.6 mm -56.43 116.16 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 0.0 111.096 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.519 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 47.4 mt-30 -142.19 168.75 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -162.43 126.05 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 15.4 mtt -91.06 120.61 32.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.408 ' CG2' HD12 ' A' ' 220' ' ' LEU . 86.2 t -110.29 133.16 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -108.22 137.96 45.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -109.57 160.27 16.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -47.28 -62.66 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.7 m -127.74 170.37 12.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.33 -52.36 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 14.6 tp -38.59 -62.2 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.941 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 60.8 m -43.39 -40.05 3.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.65 80.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -54.62 -60.4 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -63.97 -53.92 42.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -47.07 -48.8 22.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 275' ' ' ASN . 19.2 tttt -56.3 -45.29 80.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -65.35 -59.33 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.87 -37.35 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 6.0 mp -91.62 -22.25 20.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 271' ' ' LYS . 4.8 t30 -55.36 101.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.75 22.59 61.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.468 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -78.49 178.53 7.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.762 0.315 . . . . 0.0 111.126 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -145.6 126.53 14.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 33.9 mt -91.83 -31.77 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -126.69 172.68 10.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.3 107.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.25 75.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 1.7 t -174.98 -177.57 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 286' ' ' LEU . 27.3 p 39.36 38.58 0.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 14.1 m -47.57 93.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 284' ' ' CYS . 32.7 mt -45.97 127.25 8.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -127.12 83.74 2.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 29.2 mt -72.99 145.95 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -151.08 115.53 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.511 ' CE1' ' HA2' ' A' ' 214' ' ' GLY . 38.6 m-85 -38.55 105.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -56.55 139.99 47.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.157 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 4.9 ttp180 -62.61 -44.9 88.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.893 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.7 Cg_endo -80.36 150.87 19.94 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.698 2.266 . . . . 0.0 112.354 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 41.2 p -92.28 -24.45 18.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -125.59 158.89 33.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 48.7 mt -115.78 178.25 4.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.18 116.7 14.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.3 t -114.95 102.89 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.2 mp -66.17 -57.46 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -130.31 176.81 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -107.5 100.83 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -144.63 171.26 14.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -39.6 -44.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.945 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.88 -57.24 10.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.841 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 26.0 p -133.94 138.66 45.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.847 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -135.68 122.62 21.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -106.74 133.26 51.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -99.81 -47.1 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 73.3 p -44.34 -46.21 9.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.168 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -110.07 94.26 17.42 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.901 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.16 -50.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.701 2.267 . . . . 0.0 112.352 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 312' ' ' TYR . 0.2 OUTLIER -81.37 39.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 12.3 tp -89.99 84.6 6.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.949 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 102.78 138.72 10.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -57.62 4.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.813 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.882 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.516 -0.233 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 63.1 p -38.41 -35.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.853 0.358 . . . . 0.0 110.869 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.5 p -132.94 167.27 20.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.847 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -140.69 160.76 26.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.5 m -141.27 165.13 28.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.872 0.368 . . . . 0.0 110.87 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 77.1 p -169.46 155.0 5.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -169.08 174.17 43.57 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.514 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.03 138.52 30.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -107.91 123.09 48.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 34.4 mt -96.94 84.28 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 66.6 p -53.18 110.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -53.07 130.67 50.07 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.664 0.745 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.51 140.61 19.24 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.255 . . . . 0.0 112.354 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -63.96 167.93 25.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.509 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -86.04 99.58 11.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 110.899 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.0 p -113.92 98.03 6.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -166.91 115.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -134.95 143.69 47.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.567 0.698 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.11 152.1 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.709 2.273 . . . . 0.0 112.35 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 91.0 p -102.5 40.9 1.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 49.08 -104.16 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 177.08 168.24 36.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -156.6 124.41 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.892 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -47.06 -47.2 22.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.45 123.73 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.076 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 288' ' ' ILE . 26.2 mt -116.69 130.91 57.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.88 112.22 20.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.33 141.95 30.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.6 t -130.66 137.76 49.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.63 117.48 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.132 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -79.34 140.53 37.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.475 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 35.8 t30 38.33 54.0 4.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.607 0.718 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.2 Cg_exo -44.67 100.37 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.674 2.249 . . . . 0.0 112.386 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 46.0 mt -91.75 -51.06 5.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -109.52 132.57 21.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.663 0.744 . . . . 0.0 110.892 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.23 111.86 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.268 . . . . 0.0 112.31 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 48.7 mm -90.65 112.46 25.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.125 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 20.7 p -105.98 160.93 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 19.3 m -38.41 -37.56 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 235' ' ' TYR . 7.8 m-20 -58.12 -65.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 232' ' ' ASP . 73.9 t -37.63 -43.66 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 50.2 mt -76.64 -37.1 56.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 65.8 t80 -81.72 16.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 92.2 m -120.46 -37.11 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.156 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.426 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 86.6 t -98.66 -19.74 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 59.2 m -89.12 -44.4 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.2 t-20 -51.97 -45.73 92.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 110.861 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.3 Cg_exo -47.94 -22.81 3.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.335 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.4 t -96.64 -45.26 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -155.21 152.57 24.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.525 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.89 131.84 51.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.848 0.356 . . . . 0.0 110.888 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 245' ' ' GLN . 89.0 t -100.62 136.93 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.152 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.458 ' N ' HG13 ' A' ' 244' ' ' VAL . 9.0 mm-40 -93.62 -65.35 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.938 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 296' ' ' LEU . 4.0 tmm_? -143.69 152.36 41.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.403 ' N ' ' HD2' ' A' ' 246' ' ' ARG . 74.0 mt -129.35 147.79 33.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.425 HG23 ' CD ' ' A' ' 246' ' ' ARG . 54.4 t -139.85 133.84 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 43.7 mt -120.84 129.99 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -144.21 138.02 27.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -99.67 40.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -78.14 101.05 6.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 60.96 42.74 12.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.5 137.82 5.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.2 mm -56.14 112.66 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.128 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -141.89 173.42 11.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -164.63 126.36 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 36.2 mtt -94.66 120.32 34.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 94.2 t -110.54 135.38 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.083 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -105.67 153.46 21.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -126.85 163.61 23.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.895 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -47.48 -65.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 t -135.88 174.93 10.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 82.0 t -56.37 -55.3 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.1 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 18.5 tp -40.3 -50.27 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 61.4 m -55.94 -46.12 78.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 271' ' ' LYS . . . -53.84 -35.63 61.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -57.56 -65.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.914 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -59.49 -55.82 29.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -49.22 -53.2 22.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.07 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 275' ' ' ASN . 38.6 tttm -53.13 -43.96 67.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.74 -63.45 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.085 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -53.8 -46.98 71.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.407 ' C ' HD11 ' A' ' 288' ' ' ILE . 4.6 mp -67.0 -28.98 68.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.47 ' N ' HD11 ' A' ' 288' ' ' ILE . 8.9 t30 -65.33 102.87 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.61 19.72 65.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -83.33 92.26 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.32 135.19 57.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 60.9 mt -104.65 -42.7 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -117.85 172.84 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -51.97 103.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 35.46 51.52 1.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.447 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.5 m -162.55 164.88 26.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.884 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.7 m 62.5 41.31 9.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 23.6 m -58.21 134.29 56.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 83.6 mt -88.13 124.92 34.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -119.54 106.79 12.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.47 HD11 ' N ' ' A' ' 275' ' ' ASN . 18.9 mt -92.54 144.13 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.193 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . 0.426 ' N ' HG23 ' A' ' 288' ' ' ILE . 19.8 mt-10 -155.17 117.44 4.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -41.53 105.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.07 161.89 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.129 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.501 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 30.1 mtt180 -73.86 -56.69 2.72 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.67 0.748 . . . . 0.0 110.89 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 61.1 Cg_endo -74.67 150.42 39.87 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.631 2.221 . . . . 0.0 112.346 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 39.9 p -78.85 -30.14 45.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 296' ' ' LEU . 8.7 ttm180 -134.03 148.32 51.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 246' ' ' ARG . 23.6 mt -100.08 -178.14 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -137.42 117.86 13.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 73.8 t -104.37 112.96 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.123 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.0 -51.73 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -127.26 151.96 48.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -92.34 46.94 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.3 172.52 8.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -41.55 -47.16 3.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.13 -62.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.9 p -133.45 147.17 51.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -139.72 140.87 36.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -119.88 115.34 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 309' ' ' THR . 52.9 m-85 -88.62 -48.27 7.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' TYR . 32.4 p -35.88 -40.9 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.193 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -139.59 106.3 7.04 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.573 0.701 . . . . 0.0 110.902 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.86 -13.94 17.45 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.636 2.224 . . . . 0.0 112.387 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.436 ' O ' ' CD2' ' A' ' 312' ' ' TYR . 32.4 p90 -113.61 106.27 14.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -132.32 99.76 4.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.9 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -129.34 -139.67 4.7 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.467 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.38 -59.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 -179.863 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 195' ' ' SER . 12.6 m 49.45 42.36 22.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.368 . . . . 0.0 110.856 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 194' ' ' SER . 33.5 p -37.91 -58.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 159.69 -179.22 35.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 61.9 m -158.97 171.23 20.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.836 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.4 t -117.71 149.28 41.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.81 94.27 1.64 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.507 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -129.36 88.84 2.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.725 0.298 . . . . 0.0 110.859 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -117.72 158.88 23.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.33 136.17 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 96.7 m -147.56 108.31 4.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -127.96 94.11 37.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.596 0.713 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.49 10.56 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.66 2.24 . . . . 0.0 112.35 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -127.79 130.7 6.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.485 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -109.22 124.32 50.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 0.0 110.916 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 209' ' ' ASP . 28.6 m -49.52 134.25 19.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 208' ' ' THR . 1.1 p30 -36.54 149.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -86.86 112.61 48.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.4 115.08 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.72 2.28 . . . . 0.0 112.33 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 62.8 m -42.28 157.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.98 -149.46 50.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.452 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.45 -126.84 2.45 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.47 158.73 39.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.391 . . . . 0.0 110.867 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -76.19 -45.85 31.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 51.1 t -67.83 146.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.116 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.8 mt -147.72 123.51 10.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 50.8 tp -71.67 112.98 8.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.97 129.03 45.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -120.56 117.28 27.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.825 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 4.9 mp -81.84 123.32 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -89.3 138.77 31.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 226' ' ' LEU . 74.5 m-20 44.87 53.8 12.05 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.683 0.754 . . . . 0.0 110.927 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 77.0 Cg_exo -47.64 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.723 2.282 . . . . 0.0 112.329 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 224' ' ' ASN . 3.6 mm? -85.45 -56.96 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.447 ' CD2' ' CE2' ' A' ' 280' ' ' TYR . 2.2 m-85 -93.76 143.16 26.09 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.707 0.765 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.24 127.3 12.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 0.0 112.317 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 49.9 mm -114.75 102.11 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 232' ' ' ASP . 19.9 p -117.43 159.06 23.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.192 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.2 m -38.96 -26.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.4 m-20 -67.28 -61.01 2.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.8 t -47.39 -56.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 34.4 mt -56.72 -61.95 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.549 ' CD1' ' HB ' ' A' ' 244' ' ' VAL . 63.4 t80 -49.76 -33.41 16.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.486 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 98.7 m -64.14 -45.93 86.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.1 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.88 -5.89 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.454 ' HB3' ' CG2' ' A' ' 244' ' ' VAL . 90.8 m -93.29 -47.23 7.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 8.2 t-20 -51.06 -45.61 88.41 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 0.0 110.886 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -47.97 -41.2 33.13 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.62 -44.32 76.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.27 -105.48 0.21 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.502 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.8 115.84 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 110.916 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.549 ' HB ' ' CD1' ' A' ' 235' ' ' TYR . 96.3 t -84.04 143.71 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.468 ' HB3' ' CG2' ' A' ' 309' ' ' THR . 21.5 mm-40 -104.2 -68.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -125.03 152.36 44.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.829 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 48.6 mt -140.75 128.35 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.63 121.47 56.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.464 HG12 ' CB ' ' A' ' 257' ' ' ALA . 67.9 mt -110.86 119.06 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -126.32 146.11 50.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -102.42 44.71 1.0 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -70.29 86.16 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 55.2 49.22 17.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 135.33 129.67 2.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.3 mm -50.59 103.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.744 0.307 . . . . 0.0 111.158 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -135.47 164.37 27.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.464 ' CB ' HG12 ' A' ' 249' ' ' ILE . . . -166.49 130.75 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.433 ' CB ' HD23 ' A' ' 296' ' ' LEU . 32.8 mtt -94.76 123.31 38.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.885 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 88.4 t -114.92 130.19 69.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -109.1 160.36 16.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -130.26 167.85 17.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -40.64 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.5 t -126.1 -176.01 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 267' ' ' ALA . 63.3 t -63.62 -56.96 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 264' ' ' VAL . 25.1 tp -35.47 -59.73 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.4 -37.98 57.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 264' ' ' VAL . . . -61.42 -36.86 81.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.117 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -58.7 -57.85 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -66.72 -47.98 70.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -51.87 -52.47 49.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 275' ' ' ASN . 25.8 tttp -48.81 -48.46 41.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -61.41 -69.08 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.088 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -40.96 -36.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.443 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.1 mp -88.65 -25.31 22.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 272' ' ' ALA . 19.5 t30 -60.08 104.22 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 75.1 24.25 72.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -85.87 93.64 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 0.0 111.084 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.73 137.5 57.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 46.9 mt -106.45 -34.42 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . 0.447 ' CE2' ' CD2' ' A' ' 227' ' ' TYR . 50.7 m-85 -129.54 172.37 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -45.11 102.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.08 61.34 0.52 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.537 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . 0.435 ' C ' ' SG ' ' A' ' 284' ' ' CYS . 92.6 m -156.81 179.01 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 110.91 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 283' ' ' CYS . 0.8 OUTLIER 40.15 43.98 1.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 40.5 m -59.21 85.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 47.6 mt -38.59 120.01 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -120.1 85.44 2.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.443 HD11 ' CB ' ' A' ' 274' ' ' LEU . 50.5 mt -75.19 148.68 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.116 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -159.82 121.85 3.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -45.37 103.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -57.3 153.66 11.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.105 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.604 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 5.6 ttt180 -65.94 -44.87 63.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.9 Cg_endo -80.5 153.02 20.52 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.328 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 37.9 p -96.91 -22.29 16.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -126.24 151.35 47.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.433 HD23 ' CB ' ' A' ' 258' ' ' MET . 74.2 mt -109.93 179.11 4.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -146.85 133.41 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 93.4 t -122.45 133.35 68.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.064 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.35 -51.2 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.141 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.97 166.35 16.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -114.53 109.97 19.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 303' ' ' ASN . 7.5 t70 -164.19 173.09 12.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 302' ' ' ASP . 39.4 m-20 -33.95 -50.49 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.55 -63.43 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 24.8 m -142.45 147.99 37.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -142.08 137.35 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -122.02 91.11 3.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . 0.451 ' O ' ' C ' ' A' ' 309' ' ' THR . 86.9 m-85 -62.99 -49.17 75.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 245' ' ' GLN . 29.0 p -33.95 -43.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.51 ' CD ' ' CZ ' ' A' ' 312' ' ' TYR . 0.0 OUTLIER -114.92 83.99 10.09 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 0.0 110.897 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.14 -11.33 16.3 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.712 2.274 . . . . 0.0 112.301 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.51 ' CZ ' ' CD ' ' A' ' 310' ' ' LYS . 43.5 p90 -105.21 50.02 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.983 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 9.4 tp -117.46 42.92 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 315' ' ' ARG . . . -112.01 162.48 12.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.431 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.495 ' O ' ' CD ' ' A' ' 315' ' ' ARG . 0.0 OUTLIER 33.63 50.96 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.843 0.354 . . . . 0.0 110.907 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.7 t -75.7 -44.24 43.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.881 0.372 . . . . 0.0 110.843 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 35.2 p 39.63 42.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.861 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -111.11 128.8 8.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.459 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.7 t -160.44 146.82 15.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.348 . . . . 0.0 110.833 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.1 t -142.1 163.41 32.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 141.94 67.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.67 170.84 15.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -134.4 126.53 29.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 26.3 pt -83.89 128.69 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 40.1 p -148.01 142.45 26.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -98.66 127.44 35.69 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.626 0.727 . . . . 0.0 110.828 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.36 89.89 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.692 2.261 . . . . 0.0 112.361 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 137.55 60.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -129.37 111.7 13.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.904 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 30.9 m -143.8 133.7 23.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -108.35 111.68 23.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.03 94.47 10.87 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.626 0.726 . . . . 0.0 110.871 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.94 89.56 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.276 . . . . 0.0 112.323 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 3.8 m -128.43 159.76 34.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.66 148.38 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.476 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.15 -100.19 0.14 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.468 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -169.16 123.87 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -52.55 -43.31 65.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.6 134.51 29.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.2 mt -134.96 125.07 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.2 tp -82.46 112.8 19.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -94.25 124.2 38.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.4 m -118.89 104.13 10.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 4.4 mp -69.29 144.72 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.476 ' C ' ' CG ' ' A' ' 224' ' ' ASN . 8.9 mm100 -109.85 126.31 53.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.476 ' CG ' ' C ' ' A' ' 223' ' ' GLN . 0.5 OUTLIER 49.88 54.75 16.27 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.668 0.747 . . . . 0.0 110.894 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 59.2 Cg_endo -72.62 101.6 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.341 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.55 -62.55 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -83.79 137.66 40.95 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.662 0.744 . . . . 0.0 110.919 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.49 115.0 1.38 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.741 2.294 . . . . 0.0 112.324 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 29.7 mm -83.72 127.14 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.143 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 24.3 p -121.33 152.04 39.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.409 HG13 ' CD1' ' A' ' 249' ' ' ILE . 32.0 m -37.65 -37.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.92 -61.67 2.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 96.6 t -42.46 -52.42 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 26.2 mt -62.04 -59.24 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.559 ' CD2' ' HB ' ' A' ' 244' ' ' VAL . 3.6 t80 -54.28 -24.11 17.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 92.9 m -69.87 -46.07 66.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.117 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.42 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 99.0 t -85.79 -17.38 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.44 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 81.9 m -84.23 -51.3 7.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.543 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -44.0 -48.61 22.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.688 0.756 . . . . 0.0 110.911 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.4 Cg_exo -47.9 -32.77 18.36 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 87.1 t -80.59 -42.91 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.94 -106.85 0.22 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.466 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 26.4 tttt -145.94 163.64 34.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.559 ' HB ' ' CD2' ' A' ' 235' ' ' TYR . 86.9 t -133.71 133.88 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.45 ' OE1' ' CG2' ' A' ' 309' ' ' THR . 32.0 mm-40 -92.83 -62.69 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 4.2 ptt-85 -143.36 155.11 44.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 57.7 mt -137.67 139.09 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.184 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 82.7 t -127.51 124.82 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.409 ' CD1' HG13 ' A' ' 231' ' ' VAL . 53.8 mt -110.24 128.81 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 18.9 p90 -136.61 148.92 47.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -100.12 40.05 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -78.05 109.4 12.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 53.3 t30 55.25 43.45 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.08 -150.07 16.97 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.504 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 11.8 mm -114.4 106.46 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 111.101 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.508 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 21.3 mp0 -132.21 168.01 18.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -168.25 120.47 0.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.092 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 14.1 mtt -87.78 130.87 34.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.63 137.88 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.442 ' CG ' HD11 ' A' ' 296' ' ' LEU . 25.6 mt-10 -101.28 162.77 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.914 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -135.48 158.31 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -46.67 -69.85 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.947 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 16.4 m -121.43 169.59 10.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 86.4 t -54.93 -52.35 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.129 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 15.8 tp -42.58 -64.26 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.84 -41.92 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.67 82.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -63.52 -57.65 9.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -56.82 -37.03 70.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -71.56 -42.62 67.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 275' ' ' ASN . 46.0 tttm -53.07 -48.9 67.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -59.64 -68.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.59 -38.17 1.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.05 -23.36 26.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 272' ' ' ALA . 34.8 t30 -56.92 101.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.55 19.41 73.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -80.06 93.03 5.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 111.118 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.87 133.11 55.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 66.8 mt -101.28 -41.22 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -116.17 174.44 6.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.63 104.44 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 37.92 54.78 1.9 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . 0.473 ' HA ' ' ND2' ' A' ' 224' ' ' ASN . 24.9 p -175.14 155.01 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.866 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 61.4 m 65.51 46.1 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 20.7 m -73.75 142.1 46.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 91.4 mt -86.2 123.8 31.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.939 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.24 81.85 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 31.7 mt -62.53 154.28 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -159.56 114.65 2.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.471 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 45.0 m-85 -39.55 107.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.51 127.58 32.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.104 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.9 OUTLIER -60.68 -45.06 96.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.58 0.705 . . . . 0.0 110.853 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.8 Cg_endo -80.31 148.76 18.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.641 2.227 . . . . 0.0 112.37 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 78.8 p -93.0 -25.79 17.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.165 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -120.36 144.89 47.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.442 HD11 ' CG ' ' A' ' 260' ' ' GLU . 55.0 mt -111.92 -178.98 3.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -139.11 129.99 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.83 110.81 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.8 mp -62.72 -57.27 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -144.03 176.33 9.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -99.61 87.17 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 303' ' ' ASN . 28.2 t70 -140.99 170.54 15.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 302' ' ' ASP . 86.1 m-20 -36.3 -47.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.852 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -50.12 -56.87 9.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.6 p -138.26 142.78 39.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.81 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -138.94 134.78 33.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -115.38 128.43 56.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -100.8 -59.01 1.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.895 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.45 ' CG2' ' OE1' ' A' ' 245' ' ' GLN . 39.8 p -38.02 -47.87 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -123.2 93.91 47.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.66 -12.42 18.34 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.676 2.251 . . . . 0.0 112.353 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -104.85 83.21 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 74.8 mt -131.17 109.57 10.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -119.42 -144.37 7.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.502 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 52.8 mtt-85 -63.56 -44.41 94.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.811 0.339 . . . . 0.0 110.919 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.939 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.6 m -153.74 170.49 20.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.853 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 2.0 m -170.1 167.11 8.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.845 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 125.07 116.85 2.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.479 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.4 m -172.39 144.18 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 110.854 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 t -152.19 159.5 43.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.818 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -164.27 127.92 1.73 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.455 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -162.76 156.87 20.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -142.54 111.16 6.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.0 pt -67.37 134.11 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.163 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.9 p -138.98 131.9 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.38 143.1 43.56 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.54 0.686 . . . . 0.0 110.866 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.74 113.14 3.59 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.682 2.255 . . . . 0.0 112.369 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -127.63 48.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -112.75 80.75 1.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.939 0.4 . . . . 0.0 110.917 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 21.3 m -48.58 102.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.218 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -98.83 87.48 3.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -162.91 146.0 8.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.579 0.704 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 212' ' ' SER . 62.5 Cg_endo -76.92 152.07 31.72 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.699 2.266 . . . . 0.0 112.379 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 211' ' ' PRO . 3.4 m -36.91 138.47 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -70.42 -74.13 0.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 63.23 147.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.473 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 216' ' ' LYS . 13.0 t30 -169.47 128.49 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 215' ' ' ASN . 0.0 OUTLIER -33.27 -52.72 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 63.3 t -80.47 150.59 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.4 mt -141.48 126.7 18.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.8 tp -85.08 104.02 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.47 ' N ' HD13 ' A' ' 220' ' ' LEU . 9.3 mp -87.87 134.56 33.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.0 m -124.32 111.4 15.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -71.99 140.88 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 224' ' ' ASN . 7.0 tp60 -95.38 143.99 26.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.492 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 53.7 t30 34.96 54.49 1.84 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.591 0.71 . . . . 0.0 110.869 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.1 Cg_exo -47.37 102.19 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.704 2.269 . . . . 0.0 112.3 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 42.7 mt -103.88 -54.03 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -89.88 154.17 47.59 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.705 0.764 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.43 113.69 3.7 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.671 2.247 . . . . 0.0 112.323 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 230' ' ' THR . 47.4 mm -93.73 142.28 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.436 ' N ' HG22 ' A' ' 229' ' ' ILE . 16.5 p -139.4 163.26 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' A' ' 303' ' ' ASN . 31.4 m -46.76 -27.81 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.28 -36.27 82.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.9 t -71.12 -47.53 60.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.093 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 18.9 mt -83.74 20.84 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -129.95 -39.28 1.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.966 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.453 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 22.9 m -72.33 -37.43 68.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.19 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.448 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 44.7 t -85.02 -25.67 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.117 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.447 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 78.9 m -83.67 -47.82 10.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.53 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -41.37 -49.29 9.08 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.636 0.732 . . . . 0.0 110.862 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.9 Cg_exo -47.91 -62.17 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.728 2.285 . . . . 0.0 112.36 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 48.4 t -47.05 -50.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.24 -103.39 0.26 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -163.75 120.26 1.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 90.2 t -85.43 142.46 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.453 ' NE2' ' OE1' ' A' ' 262' ' ' GLU . 11.0 mm-40 -95.83 -57.79 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -141.24 152.44 44.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 58.0 mt -137.38 119.37 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 95.1 t -117.96 115.96 50.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.126 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 62.0 mt -103.53 122.18 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 36.8 p90 -131.45 148.81 52.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -124.8 40.95 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.425 ' HB2' ' NH1' ' A' ' 252' ' ' ARG . 0.2 OUTLIER -72.9 -60.42 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -129.66 80.01 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 255' ' ' ILE . . . 88.04 116.34 1.26 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.506 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 254' ' ' GLY . 28.1 mm -33.42 104.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 111.141 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.456 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 34.7 mt-30 -136.19 166.42 23.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -165.13 121.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.42 ' CB ' HD23 ' A' ' 296' ' ' LEU . 13.9 mtt -86.06 137.36 32.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 94.8 t -126.84 129.48 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.468 ' HG3' ' N ' ' A' ' 261' ' ' PHE . 3.3 tp10 -102.1 148.23 25.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.468 ' N ' ' HG3' ' A' ' 260' ' ' GLU . 41.1 m-85 -122.71 157.64 31.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.453 ' OE1' ' NE2' ' A' ' 245' ' ' GLN . 3.8 mm-40 -36.37 -63.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -143.13 176.19 9.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 87.0 t -52.75 -56.9 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 16.1 tp -39.26 -64.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 83.3 m -49.17 -43.45 42.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.89 -40.35 69.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -55.24 -59.09 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -63.3 -51.17 67.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.438 ' CB ' ' CZ ' ' A' ' 261' ' ' PHE . . . -48.69 -49.99 35.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 275' ' ' ASN . 55.0 tttm -54.07 -53.47 52.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -54.11 -70.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -42.43 -41.35 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.1 mp -79.64 -23.46 42.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 271' ' ' LYS . 18.4 t-20 -60.0 104.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 76.97 24.02 67.71 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.24 7.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.775 0.321 . . . . 0.0 111.077 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.44 117.02 2.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.98 -39.82 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -117.73 173.44 6.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -52.86 103.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.071 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.23 59.59 0.62 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.473 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 20.0 p -175.08 163.84 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 82.0 m 60.19 44.41 12.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 30.2 m -59.52 150.0 28.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 40.5 mt -92.51 105.87 17.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -104.78 82.14 1.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 19.3 mt -70.56 142.63 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.09 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -149.04 122.01 8.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -49.15 101.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -60.45 135.08 57.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.051 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.605 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.4 OUTLIER -59.3 -44.65 98.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 0.0 110.918 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.4 Cg_endo -80.41 144.06 15.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.723 2.282 . . . . 0.0 112.318 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 65.3 p -111.35 34.65 3.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.163 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 296' ' ' LEU . 3.7 tpt180 -144.3 143.59 31.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.431 ' N ' ' HG3' ' A' ' 295' ' ' ARG . 49.2 mt -132.3 114.4 14.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -88.4 135.36 33.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 75.0 t -137.57 115.49 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.3 mp -83.37 -59.01 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -115.86 166.52 11.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -102.55 44.06 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.05 169.75 17.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.401 ' O ' ' CG1' ' A' ' 231' ' ' VAL . 1.1 p30 -45.41 -47.24 13.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -44.31 -60.06 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.5 p -133.01 142.55 48.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -140.97 142.09 34.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.75 89.36 3.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.886 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -78.86 45.83 0.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 67.4 p -124.98 -42.61 2.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.163 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.412 ' CD ' HD12 ' A' ' 313' ' ' LEU . 7.1 ttmm -126.14 94.18 41.92 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.547 0.689 . . . . 0.0 110.899 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.59 -19.05 14.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -103.81 41.69 1.26 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.88 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.412 HD12 ' CD ' ' A' ' 310' ' ' LYS . 24.5 tp -117.46 127.54 54.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.894 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -145.85 -144.7 4.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.491 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -74.01 -44.77 53.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.865 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.8 mmm-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 -179.928 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.1 m 63.8 42.42 6.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 0.0 110.891 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 97.0 p -108.85 174.01 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.811 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 162.05 136.87 2.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.534 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 5.2 m -165.95 166.84 17.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.857 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 24.4 p -157.53 174.37 15.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.83 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 165.19 137.51 2.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -132.09 120.25 22.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.707 0.289 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.87 162.82 40.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 67.1 mt -134.58 109.59 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 81.9 p -50.41 165.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.149 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -91.91 109.8 39.54 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 110.876 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.02 162.77 31.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.269 . . . . 0.0 112.372 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -178.72 -130.14 1.39 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.488 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -155.35 166.72 32.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 85.9 m -127.34 131.85 50.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -130.85 171.78 12.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.425 ' CG ' ' HD2' ' A' ' 211' ' ' PRO . 4.7 t70 -141.68 141.67 23.28 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.58 0.705 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 210' ' ' ASP . 62.2 Cg_endo -77.53 86.38 1.65 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.697 2.265 . . . . 0.0 112.377 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 79.3 p -113.81 116.75 29.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 55.15 -143.16 34.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 151.79 -120.73 1.11 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.45 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -144.65 129.83 18.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.884 0.374 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 15.8 mtmm -52.51 -40.75 62.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.12 148.25 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 13.9 mt -144.89 127.79 16.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.0 tp -84.88 117.9 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.432 HD12 ' CG2' ' A' ' 259' ' ' VAL . 6.0 mp -101.1 128.77 47.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.5 m -123.22 111.46 16.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.448 HG21 ' N ' ' A' ' 223' ' ' GLN . 5.2 mp -75.94 143.09 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.448 ' N ' HG21 ' A' ' 222' ' ' ILE . 59.9 mt-30 -103.23 137.69 41.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.487 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 46.0 t30 42.18 52.82 7.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.609 0.719 . . . . 0.0 110.911 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.0 Cg_exo -45.31 119.84 2.8 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.371 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.02 -56.73 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.557 ' CD1' ' CE2' ' A' ' 280' ' ' TYR . 16.5 m-85 -119.45 144.02 35.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.731 0.777 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.91 112.67 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.666 2.244 . . . . 0.0 112.343 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 48.2 mm -81.95 121.28 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.4 p -107.72 157.11 18.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.15 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.5 m -40.42 -38.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 235' ' ' TYR . 48.8 m-20 -56.45 -61.24 2.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 232' ' ' ASP . 97.0 t -36.94 -44.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.15 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.54 -38.12 41.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 71.8 t80 -83.87 19.85 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.487 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 96.2 m -125.0 -36.69 2.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.431 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 98.8 t -97.21 -24.58 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.125 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 85.7 m -85.11 -45.48 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.548 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.1 m120 -49.86 -48.31 78.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.674 0.749 . . . . 0.0 110.903 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 67.0 Cg_exo -48.03 -22.03 3.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.315 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.6 t -89.63 -50.28 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.083 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -145.97 -127.48 1.88 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.433 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.491 ' CB ' ' OE2' ' A' ' 262' ' ' GLU . 32.5 tptt -130.24 131.9 45.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.848 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.2 t -108.29 125.26 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -79.94 -70.22 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -134.68 160.27 38.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 235' ' ' TYR . 54.6 mt -137.84 136.61 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.449 ' HA ' ' CB ' ' A' ' 305' ' ' SER . 62.0 t -135.97 109.53 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 49.2 mt -99.92 100.88 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -105.79 134.61 48.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 78.51 2.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 113.74 18.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 47.12 43.9 14.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.13 119.03 2.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mm -42.38 107.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.329 . . . . 0.0 111.158 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -128.32 143.82 51.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.31 117.7 9.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 29.6 mtt -90.16 127.37 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.432 ' CG2' HD12 ' A' ' 220' ' ' LEU . 57.4 t -119.34 143.06 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -108.37 163.13 13.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.618 ' CZ ' ' CB ' ' A' ' 270' ' ' ALA . 42.0 m-85 -134.07 158.05 44.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.491 ' OE2' ' CB ' ' A' ' 243' ' ' LYS . 31.2 mt-10 -40.65 -63.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.5 m -140.93 178.52 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.94 -51.06 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 17.5 tp -47.66 -58.83 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 62.8 m -49.86 -43.95 49.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -55.72 -38.01 69.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.084 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -56.69 -65.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -57.58 -53.16 61.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.618 ' CB ' ' CZ ' ' A' ' 261' ' ' PHE . . . -50.03 -53.27 27.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 275' ' ' ASN . 23.4 tttt -53.09 -44.19 67.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.7 -66.01 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -51.82 -47.27 64.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.402 ' CB ' HD13 ' A' ' 288' ' ' ILE . 2.8 mp -67.59 -28.19 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 271' ' ' LYS . 0.8 OUTLIER -66.85 104.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.07 20.8 75.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -82.15 91.87 6.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 111.126 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.64 128.38 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 73.2 mt -102.57 -41.92 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . 0.557 ' CE2' ' CD1' ' A' ' 227' ' ' TYR . 6.3 m-85 -118.3 173.54 6.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.93 105.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.59 59.99 0.65 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.522 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 31.8 p -175.16 167.11 3.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 2.2 m 62.57 44.11 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 57.3 m -61.55 136.74 58.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 61.4 mt -87.38 115.85 25.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -111.12 90.21 3.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.889 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.402 HD13 ' CB ' ' A' ' 274' ' ' LEU . 35.1 mt -76.3 145.59 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 290' ' ' TYR . 18.8 mt-10 -153.71 111.19 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' A' ' 289' ' ' GLU . 26.4 m-85 -37.52 102.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.78 144.03 6.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.069 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.599 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 4.6 ttp180 -60.42 -45.04 97.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 0.0 110.801 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.8 Cg_endo -80.3 150.81 20.08 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.6 p -85.6 -24.28 27.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -128.59 175.04 8.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 80.1 mt -132.47 175.51 9.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -152.6 118.62 5.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 63.2 t -102.07 104.71 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.9 mp -62.69 -59.82 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -115.36 154.96 28.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -105.77 105.46 15.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 303' ' ' ASN . 3.3 m-20 -149.02 167.71 25.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.452 ' C ' ' O ' ' A' ' 302' ' ' ASP . 65.2 m-20 -34.37 -47.49 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -50.72 -60.77 2.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.449 ' CB ' ' HA ' ' A' ' 248' ' ' VAL . 78.7 p -129.28 133.41 47.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -131.43 137.36 48.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.24 113.55 21.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -89.61 -59.85 2.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 72.1 p -43.18 -40.14 3.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.173 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.564 ' HD2' ' CE2' ' A' ' 312' ' ' TYR . 4.3 tppp? -113.27 80.53 4.45 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.581 0.705 . . . . 0.0 110.87 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.96 -10.94 15.23 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.351 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.564 ' CE2' ' HD2' ' A' ' 310' ' ' LYS . 48.4 p90 -101.14 46.32 0.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.908 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.454 ' HB2' ' CG ' ' A' ' 310' ' ' LYS . 18.8 tp -124.9 130.53 52.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -174.16 -89.52 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.504 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -80.4 45.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.519 ' CD ' ' C ' ' A' ' 316' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 52.9 p -161.52 172.29 16.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 93.7 p -164.27 133.55 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -165.2 55.18 0.26 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.485 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 198' ' ' SER . 12.8 t -84.38 101.5 12.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.87 0.367 . . . . 0.0 110.83 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 197' ' ' SER . 3.3 m -35.42 149.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -152.92 81.53 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.468 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -78.26 120.93 23.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 202' ' ' ILE . 1.6 mpt_? -72.03 83.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.473 ' C ' ' O ' ' A' ' 201' ' ' ARG . 11.2 mt 32.07 53.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.3 p -100.96 39.16 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.52 155.05 56.98 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.624 0.726 . . . . 0.0 110.899 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -78.31 158.73 29.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.708 2.272 . . . . 0.0 112.302 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -160.86 153.06 23.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.498 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -102.52 131.51 49.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.929 0.395 . . . . 0.0 110.846 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 14.8 t -147.52 152.9 38.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.99 133.98 45.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.828 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.55 143.28 14.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 0.0 110.823 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.45 ' CG ' ' HB2' ' A' ' 215' ' ' ASN . 62.7 Cg_endo -77.78 139.77 17.97 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.62 2.213 . . . . 0.0 112.336 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 211' ' ' PRO . 55.8 p -37.32 120.91 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 39.93 75.28 0.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 55.88 -155.55 11.85 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.45 ' HB2' ' CG ' ' A' ' 211' ' ' PRO . 64.5 t30 -160.19 147.79 16.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.861 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -68.91 -44.15 73.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 218' ' ' LEU . 84.1 t -81.11 142.76 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.468 ' N ' HG12 ' A' ' 217' ' ' VAL . 20.5 mt -132.2 126.32 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 24.1 tp -82.5 111.92 18.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.7 mp -103.82 130.26 51.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 t -116.1 132.39 56.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.423 ' O ' ' C ' ' A' ' 223' ' ' GLN . 4.7 mp -92.42 69.02 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.164 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 222' ' ' ILE . 8.2 mm100 -35.73 141.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.481 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 34.4 m-20 44.76 54.22 12.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.646 0.736 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.8 Cg_exo -46.92 93.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.661 2.24 . . . . 0.0 112.331 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.3 mt -102.43 -44.62 5.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -107.6 130.27 23.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.734 0.778 . . . . 0.0 110.92 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.47 126.27 15.64 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.7 2.267 . . . . 0.0 112.336 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 49.6 mm -117.92 118.86 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 233' ' ' VAL . 21.5 p -121.75 167.36 13.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.174 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 35.3 m -40.08 -34.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.54 -43.89 96.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 230' ' ' THR . 61.2 t -66.17 -44.39 91.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 25.4 mt -83.19 20.15 1.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -124.81 -26.33 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 86.5 m -85.72 -36.35 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.442 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 13.3 t -89.15 -21.86 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.154 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.402 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 83.7 m -84.79 -47.66 10.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.541 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -46.86 -48.1 51.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.708 . . . . 0.0 110.917 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -48.03 -21.05 2.46 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.649 2.232 . . . . 0.0 112.323 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.432 ' CG1' ' HA ' ' A' ' 270' ' ' ALA . 77.7 t -96.98 -43.06 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.109 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.73 -158.52 9.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.98 120.55 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.829 0.347 . . . . 0.0 110.87 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.4 t -85.67 133.06 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -95.38 -60.55 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -150.58 153.32 35.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 68.5 mt -132.19 127.33 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.17 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.92 112.12 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.4 ' CD1' ' HA ' ' A' ' 230' ' ' THR . 58.2 mt -100.04 129.91 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.149 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -138.27 163.56 31.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -120.86 86.03 2.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -120.52 88.58 2.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.5 m120 56.14 42.82 27.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 138.25 108.06 0.81 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.497 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 31.7 mm -39.79 114.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 111.097 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -139.69 173.58 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -165.11 120.76 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.09 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.5 mtt -83.93 123.21 29.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 67.8 t -117.08 127.74 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -97.3 154.29 17.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -127.32 164.33 22.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -43.85 -65.11 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 25.1 p -138.47 169.61 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 265' ' ' LEU . 75.5 t -49.62 -53.83 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.141 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 264' ' ' VAL . 19.5 tp -38.3 -57.88 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 84.8 m -50.43 -44.84 55.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.11 -38.8 65.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.091 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -57.02 -60.84 2.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -63.71 -54.1 40.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.432 ' HA ' ' CG1' ' A' ' 241' ' ' VAL . . . -47.63 -48.8 28.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 275' ' ' ASN . 49.4 tttm -51.19 -52.19 46.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -57.16 -67.32 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.79 -40.0 1.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.4 mp -84.98 -22.39 29.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 271' ' ' LYS . 41.1 t30 -60.16 100.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.05 19.95 68.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.513 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -78.32 91.68 4.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.737 0.303 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.21 123.37 14.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.873 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 84.9 mt -95.87 -41.55 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -116.17 173.04 6.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -51.09 102.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.33 61.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 28.2 p -175.06 168.83 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.807 0.337 . . . . 0.0 110.883 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 53.5 m 58.99 47.78 11.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 286' ' ' LEU . 19.7 m -61.81 145.81 51.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.143 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.429 ' N ' HG22 ' A' ' 285' ' ' THR . 50.0 mt -93.71 95.65 9.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -91.22 97.32 11.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 21.6 mt -83.86 138.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -143.97 124.87 14.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -51.61 97.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.59 156.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.086 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 1.1 mpt_? -71.45 -60.27 2.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.631 0.729 . . . . 0.0 110.882 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 58.8 Cg_endo -71.78 161.59 44.63 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.7 2.267 . . . . 0.0 112.341 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.6 p -97.31 -34.23 11.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -106.85 163.37 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 40.8 mt -124.04 -177.24 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -144.39 132.62 21.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 75.5 t -122.29 103.01 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.3 mp -55.42 -62.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.3 154.47 49.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -84.21 81.38 8.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -124.57 171.76 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -43.0 -47.63 5.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -47.39 -56.74 6.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.2 p -137.6 142.12 41.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -136.43 136.85 39.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.84 110.92 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.97 -49.34 8.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.964 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 31.3 p -38.0 -50.18 1.31 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.174 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -122.29 93.71 48.35 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.576 0.703 . . . . 0.0 110.83 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.86 -11.18 16.75 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.358 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 312' ' ' TYR . 11.0 p90 -105.67 94.63 5.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -128.4 131.63 48.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 169.95 -101.62 0.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -76.78 -35.42 57.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.776 0.322 . . . . 0.0 110.839 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 25.5 mtt85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.6 t -157.87 139.71 14.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 110.866 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.3 t -152.13 155.1 37.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 122.16 89.88 1.01 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.505 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 30.1 t -148.98 140.77 23.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.916 0.389 . . . . 0.0 110.833 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.3 m -147.74 166.81 26.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 159.09 84.93 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -161.27 150.2 16.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -140.2 106.41 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.29 140.5 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 58.4 p -155.75 127.88 7.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -145.74 142.96 18.57 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.61 0.719 . . . . 0.0 110.858 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.28 153.42 31.47 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.676 2.251 . . . . 0.0 112.316 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -159.65 -89.06 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -67.62 91.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.953 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 32.2 m -135.8 115.93 13.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -145.48 120.19 9.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -128.29 153.71 78.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.7 . . . . 0.0 110.846 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.08 103.28 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.683 2.255 . . . . 0.0 112.341 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 4.8 t -121.03 142.06 50.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.98 96.53 0.88 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -55.25 -164.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -141.06 121.55 14.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 0.0 110.921 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -38.73 -43.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.6 t -82.07 147.8 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 15.4 mt -145.3 123.68 12.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.2 tp -78.91 104.52 9.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.29 126.06 34.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 54.0 m -117.34 112.79 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.427 HD12 ' CG2' ' A' ' 255' ' ' ILE . 2.4 mp -80.85 118.0 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.471 ' C ' ' CG ' ' A' ' 224' ' ' ASN . 17.8 mm100 -85.28 133.28 34.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.932 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.471 ' CG ' ' C ' ' A' ' 223' ' ' GLN . 0.7 OUTLIER 49.39 54.97 16.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.64 0.733 . . . . 0.0 110.897 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 59.9 Cg_endo -73.36 99.69 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.328 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.87 -40.31 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -88.74 153.47 49.96 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.657 0.742 . . . . 0.0 110.941 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.39 115.93 4.52 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.7 2.266 . . . . 0.0 112.316 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 22.3 mm -97.24 148.17 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 232' ' ' ASP . 16.1 p -148.23 156.13 42.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 230' ' ' THR . 34.7 m -35.16 -35.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 230' ' ' THR . 6.4 t0 -65.48 -61.58 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 71.6 t -42.02 -46.32 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 34.8 mt -66.7 -65.6 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.525 ' CD2' ' HB ' ' A' ' 244' ' ' VAL . 5.9 t80 -48.0 -27.44 2.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.428 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 83.6 m -66.01 -47.58 73.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.145 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.441 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 63.5 t -87.42 -15.14 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 77.3 m -86.13 -46.75 10.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.56 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -47.36 -47.52 57.8 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.626 0.727 . . . . 0.0 110.902 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.8 Cg_exo -47.98 -18.6 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 78.6 t -98.6 -42.4 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.185 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -162.72 -145.25 4.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -116.53 119.21 34.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.525 ' HB ' ' CD2' ' A' ' 235' ' ' TYR . 89.1 t -82.49 141.1 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.416 ' N ' HG13 ' A' ' 244' ' ' VAL . 4.5 mm-40 -96.03 -51.85 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.411 ' NE ' ' OE1' ' A' ' 260' ' ' GLU . 22.9 ptt180 -159.89 153.1 21.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 248' ' ' VAL . 53.6 mt -131.82 139.26 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.433 ' N ' HG23 ' A' ' 247' ' ' ILE . 38.1 t -130.45 110.53 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.138 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.443 HG23 ' N ' ' A' ' 250' ' ' PHE . 52.9 mt -98.55 140.69 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 8.2 p90 -146.68 139.98 25.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -98.25 43.19 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -79.55 95.46 5.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 62.76 45.79 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 131.28 -155.56 21.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.427 ' CG2' HD12 ' A' ' 222' ' ' ILE . 32.2 mm -116.04 103.38 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 0.0 111.116 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.55 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 19.0 mp0 -131.56 157.31 43.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -162.12 118.63 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.116 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.8 mtt -82.2 128.81 34.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 65.4 t -119.33 127.73 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 24.6 tt0 -104.34 149.43 25.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.439 ' N ' ' HG2' ' A' ' 260' ' ' GLU . 60.1 m-85 -118.93 166.51 12.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.839 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -45.67 -64.58 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.4 t -130.87 177.81 7.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.54 -54.54 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.16 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 24.4 tp -40.89 -54.49 2.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.919 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 68.6 m -53.57 -43.05 68.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -56.33 -40.21 74.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.085 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -62.49 -63.55 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -55.48 -44.43 76.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.28 96.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 275' ' ' ASN . 42.6 tttm -55.27 -47.65 75.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.62 -62.12 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.102 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.13 -37.17 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.097 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.7 mp -88.38 -22.77 23.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 271' ' ' LYS . 2.0 t30 -60.52 101.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.46 21.44 69.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.506 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -84.55 93.41 8.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.329 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -49.53 143.53 6.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.559 HG23 ' CD1' ' A' ' 280' ' ' TYR . 68.2 mt -102.17 -36.59 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.157 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . 0.559 ' CD1' HG23 ' A' ' 279' ' ' ILE . 62.3 m-85 -139.02 175.88 9.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -39.82 101.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.045 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 29.3 73.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.472 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . 0.453 ' HA ' ' ND2' ' A' ' 224' ' ' ASN . 23.5 p -175.96 173.46 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 110.881 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 283' ' ' CYS . 2.0 p 40.25 43.85 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 90.2 m -60.76 139.3 57.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.167 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 31.5 mt -82.42 123.48 29.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.42 ' C ' ' HE3' ' A' ' 287' ' ' LYS . 0.1 OUTLIER -124.35 87.14 2.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.925 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.407 ' O ' ' CE ' ' A' ' 287' ' ' LYS . 17.9 mt -71.38 142.58 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . 0.401 ' N ' HG22 ' A' ' 288' ' ' ILE . 9.3 mt-10 -142.51 115.89 9.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -39.71 100.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -52.24 151.85 3.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.138 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.488 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 13.0 mmt180 -73.27 -58.05 2.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.594 0.712 . . . . 0.0 110.869 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 60.0 Cg_endo -73.74 159.09 46.12 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.724 2.282 . . . . 0.0 112.344 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 69.5 p -95.65 -34.84 11.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.467 ' HD2' ' N ' ' A' ' 296' ' ' LEU . 1.4 tmm_? -105.78 152.8 22.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.467 ' N ' ' HD2' ' A' ' 295' ' ' ARG . 74.9 mt -118.54 154.79 31.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.962 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -116.29 127.33 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 89.3 t -106.27 105.65 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.158 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.4 mp -59.2 -62.01 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -131.8 170.42 14.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.43 ' ND2' ' OD1' ' A' ' 307' ' ' ASP . 1.8 m-20 -106.56 100.01 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 303' ' ' ASN . 29.3 t70 -165.58 172.52 11.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 302' ' ' ASP . 1.9 m-80 -34.34 -46.09 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.99 -53.17 28.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 2.9 m -153.48 143.51 22.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.898 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -136.88 149.85 47.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.43 ' OD1' ' ND2' ' A' ' 301' ' ' ASN . 17.0 p-10 -129.44 95.62 4.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -71.35 -40.46 70.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 21.9 p -40.76 -33.19 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -132.95 88.56 36.79 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.54 0.686 . . . . 0.0 110.868 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.31 -7.84 17.17 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.647 2.232 . . . . 0.0 112.341 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -108.93 40.09 1.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 10.0 tp -109.71 148.97 30.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 132.34 127.37 2.81 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.452 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -39.52 -58.12 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.417 ' C ' ' HD3' ' A' ' 316' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 93.8 p -161.47 135.18 6.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 0.0 110.868 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.9 t -89.36 171.9 9.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.884 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 127.2 178.46 15.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.5 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 51.4 p -160.4 152.54 20.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 110.848 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 20.9 t -63.1 -48.31 79.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.882 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.05 157.73 9.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -165.49 130.78 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . 0.424 ' HG3' ' N ' ' A' ' 202' ' ' ILE . 17.3 tpt180 -162.27 149.01 13.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.424 ' N ' ' HG3' ' A' ' 201' ' ' ARG . 32.4 pt -78.33 129.51 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.9 t -174.9 133.18 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -174.59 113.79 0.3 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.601 0.715 . . . . 0.0 110.864 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.72 161.18 33.94 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.638 2.226 . . . . 0.0 112.375 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 133.87 64.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -116.61 132.75 56.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 110.862 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 21.5 p -122.93 90.21 3.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -146.83 130.05 16.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -156.71 154.51 26.88 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.55 12.4 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.288 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 213' ' ' GLY . 48.1 t -132.37 150.2 52.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 212' ' ' SER . . . -37.25 155.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.501 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -49.45 -100.53 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.527 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.41 ' ND2' ' HB ' ' A' ' 217' ' ' VAL . 13.4 t30 -160.02 136.75 9.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -59.65 -42.77 93.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.41 ' HB ' ' ND2' ' A' ' 215' ' ' ASN . 91.5 t -76.06 138.29 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.4 mt -136.44 128.58 29.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 54.5 tp -83.18 113.47 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -99.56 125.71 45.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.3 t -115.38 115.37 26.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.4 mp -77.03 122.24 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -80.05 139.09 37.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.488 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 31.6 m-20 43.44 53.82 10.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.666 0.746 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.6 Cg_exo -47.08 94.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.379 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 13.8 mt -109.91 -44.46 3.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.448 ' CG ' ' CE2' ' A' ' 280' ' ' TYR . 91.6 m-85 -94.66 137.8 22.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.674 0.75 . . . . 0.0 110.912 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.2 132.4 23.41 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.716 2.277 . . . . 0.0 112.341 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.9 mm -122.61 129.9 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.415 ' HA ' ' CD1' ' A' ' 249' ' ' ILE . 21.7 p -144.46 168.58 19.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 33.5 m -42.76 -36.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.2 -44.44 88.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.05 -47.9 88.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.106 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 26.1 mt -84.83 23.68 1.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -130.89 -36.14 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.502 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 26.5 m -79.45 -35.71 39.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.133 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.417 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 87.6 t -90.62 -14.65 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 76.2 m -87.99 -48.07 8.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.908 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.574 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.8 t-20 -49.78 -46.01 80.01 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.67 0.748 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.0 Cg_exo -47.92 -21.68 2.81 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.68 2.253 . . . . 0.0 112.358 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 21.9 t -99.8 -40.84 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.092 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -152.18 -132.64 1.85 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.46 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -131.8 115.45 15.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.7 t -87.82 137.2 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -109.84 -66.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -120.95 150.2 41.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 47.7 mt -141.98 121.77 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 66.6 t -119.27 129.45 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 230' ' ' THR . 56.8 mt -120.73 115.39 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -124.32 171.84 9.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -124.78 44.23 2.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.942 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -71.35 96.42 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 47.4 43.1 15.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 140.95 137.85 3.49 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.5 mm -58.33 101.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.328 . . . . 0.0 111.104 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -131.91 158.34 41.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -155.89 117.87 4.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 25.9 mtt -83.11 125.09 31.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.4 t -115.59 124.33 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -98.43 145.4 26.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.437 ' O ' ' C ' ' A' ' 262' ' ' GLU . 40.3 m-85 -118.93 158.0 26.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 261' ' ' PHE . 4.4 mm-40 -34.64 -65.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 11.1 t -139.44 166.23 25.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 265' ' ' LEU . 87.0 t -42.43 -59.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.124 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 264' ' ' VAL . 22.8 tp -35.82 -63.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 81.2 m -42.89 -45.06 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -52.87 -38.14 61.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -55.98 -59.87 4.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -65.49 -55.79 15.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.427 ' CB ' ' CZ ' ' A' ' 261' ' ' PHE . . . -47.41 -48.21 26.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.073 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . 17.5 tttt -56.51 -45.23 81.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -60.34 -71.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.093 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.38 -39.53 1.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.5 mp -81.68 -27.35 34.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 272' ' ' ALA . 18.9 t-20 -59.84 100.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.2 20.71 69.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.457 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -84.23 94.5 8.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.736 0.303 . . . . 0.0 111.093 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.74 128.42 26.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.457 HD12 ' CG ' ' A' ' 286' ' ' LEU . 77.4 mt -104.42 -44.05 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . 0.448 ' CE2' ' CG ' ' A' ' 227' ' ' TYR . 33.8 m-85 -112.37 174.35 5.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.73 103.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 33.91 56.86 0.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.467 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 27.7 p -175.18 168.19 3.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.338 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 87.0 m 62.63 41.41 9.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' THR . . . . . 0.454 HG21 ' N ' ' A' ' 286' ' ' LEU . 15.3 m -59.54 149.94 28.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.21 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.457 ' CG ' HD12 ' A' ' 279' ' ' ILE . 57.5 mt -94.77 105.8 17.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -101.59 80.2 2.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 44.4 mt -69.45 141.54 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.133 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -149.24 109.84 4.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -38.3 106.43 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.75 157.23 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.086 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.471 ' CB ' ' CD ' ' A' ' 293' ' ' PRO . 11.9 mmt180 -73.69 -61.41 1.36 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 292' ' ' ARG . 59.0 Cg_endo -71.88 161.21 45.65 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 40.2 p -93.01 -28.14 16.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.144 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.16 160.01 15.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 66.9 mt -120.95 172.67 7.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -119.51 119.71 34.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.27 93.36 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.447 HD11 ' N ' ' A' ' 299' ' ' ILE . 4.7 mm -46.0 -66.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.36 160.54 43.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -64.88 101.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.83 171.77 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.833 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -46.3 -52.8 11.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.32 -53.87 10.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.7 p -143.39 140.93 30.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -126.77 145.49 50.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -126.71 92.45 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 309' ' ' THR . 58.6 m-85 -69.44 -50.7 43.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.899 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 308' ' ' TYR . 76.3 p -34.99 -49.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.16 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -112.75 87.08 9.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.551 0.691 . . . . 0.0 110.897 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.54 -1.8 11.92 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.675 2.25 . . . . 0.0 112.301 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -105.79 46.11 0.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 34.4 mt -106.42 41.88 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.93 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -75.07 160.6 52.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.446 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -72.22 78.5 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 110.889 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.422 ' C ' ' HD3' ' A' ' 316' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 22.0 m -152.17 131.48 12.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 110.867 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 95.6 p -142.48 162.47 35.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.828 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 162.08 95.38 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.484 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 48.4 p -124.29 98.89 5.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 110.852 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 6.0 t -124.44 155.04 39.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.882 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 119.11 45.77 0.44 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.502 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -73.29 86.1 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.733 0.302 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 19.2 ttm105 -134.93 98.28 3.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.0 pt -41.18 124.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.1 m -147.01 105.21 3.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -62.19 155.2 66.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.606 0.717 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.74 -23.97 16.17 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.716 2.277 . . . . 0.0 112.331 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 178.61 81.78 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.45 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -89.12 139.07 30.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.872 0.368 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.1 p -71.14 116.34 11.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.06 108.03 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.28 112.76 46.21 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.624 0.726 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.5 167.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.71 2.273 . . . . 0.0 112.321 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 4.0 m -97.11 42.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 75.16 118.11 0.1 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.455 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -112.13 -177.88 19.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -149.86 158.98 44.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.908 0.385 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -74.79 -41.3 60.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.6 t -79.24 142.79 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.117 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 19.3 mt -139.81 132.35 28.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.86 111.96 18.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.33 127.3 49.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.3 t -115.33 138.72 50.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.85 131.03 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.136 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -94.7 133.46 38.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 226' ' ' LEU . 0.3 OUTLIER 46.17 53.34 12.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.884 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.0 Cg_exo -45.09 84.63 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.657 2.238 . . . . 0.0 112.351 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 224' ' ' ASN . 4.0 mm? -58.65 -59.79 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -117.57 146.38 38.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.666 0.746 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.78 114.86 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 0.0 112.336 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 27.6 mm -87.12 120.13 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.185 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 21.4 p -104.81 161.46 14.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 30.4 m -42.37 -40.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 235' ' ' TYR . 7.8 m-20 -55.42 -60.72 3.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 95.5 t -38.03 -37.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 41.6 mt -88.54 -31.85 18.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.774 ' CD1' ' CE2' ' A' ' 308' ' ' TYR . 37.6 t80 -84.75 23.37 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.502 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 88.3 m -125.21 -38.74 2.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.14 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.411 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 59.1 t -94.21 -15.4 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 97.1 m -88.72 -47.46 8.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.571 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 8.6 t-20 -50.58 -45.63 85.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.661 0.743 . . . . 0.0 110.928 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.2 Cg_exo -47.98 -22.97 3.87 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.27 . . . . 0.0 112.354 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 91.4 t -96.97 -45.58 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.111 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -146.6 -145.18 4.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.508 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.53 112.17 17.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.815 0.341 . . . . 0.0 110.937 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.499 ' HB ' ' CE1' ' A' ' 235' ' ' TYR . 51.4 t -80.73 141.7 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.165 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.46 ' NE2' ' CG2' ' A' ' 309' ' ' THR . 5.1 mm-40 -101.7 -60.89 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.9 mtm-85 -140.78 156.91 46.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 74.9 mt -142.56 138.45 28.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.11 134.76 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 87.6 mt -116.07 108.11 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -115.72 164.23 14.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -121.89 43.83 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -94.65 106.99 18.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.6 t30 68.1 44.12 1.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 105.91 151.05 19.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 39.1 mm -56.38 113.4 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -141.24 165.2 28.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -156.76 124.63 5.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 29.6 mtt -88.87 124.04 33.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.457 HG11 ' N ' ' A' ' 260' ' ' GLU . 72.9 t -112.08 138.02 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.457 ' N ' HG11 ' A' ' 259' ' ' VAL . 8.9 tm-20 -114.69 140.96 48.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -114.55 162.67 16.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -41.28 -65.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.2 m -137.5 176.31 8.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 265' ' ' LEU . 98.2 t -56.43 -56.75 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.158 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 264' ' ' VAL . 20.4 tp -37.51 -54.02 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 6.7 m -52.2 -47.0 65.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.25 -37.47 64.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -55.62 -63.44 1.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -61.34 -58.64 7.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -46.96 -49.65 20.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.133 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.447 ' HE3' ' CE2' ' A' ' 290' ' ' TYR . 49.3 tttm -47.82 -54.59 11.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -53.17 -66.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -42.98 -43.81 4.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.459 ' CB ' HD13 ' A' ' 288' ' ' ILE . 4.9 mp -77.52 -22.33 51.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 272' ' ' ALA . 44.4 t-20 -55.94 99.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.99 19.72 72.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.498 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -86.31 95.82 9.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 111.103 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.56 155.23 39.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 44.4 mt -113.89 -53.9 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -95.7 172.47 8.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -52.68 107.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.139 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.37 48.18 0.62 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 23.0 m -161.1 177.4 10.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.7 m 49.42 44.26 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' THR . . . . . 0.452 HG23 ' N ' ' A' ' 286' ' ' LEU . 41.1 m -63.51 143.93 57.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.124 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.452 ' N ' HG23 ' A' ' 285' ' ' THR . 90.3 mt -94.19 122.99 37.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -116.35 98.74 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.459 HD13 ' CB ' ' A' ' 274' ' ' LEU . 28.3 mt -79.27 139.11 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.178 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -150.23 114.36 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.447 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 77.6 m-85 -41.32 103.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.958 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -55.08 159.67 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.121 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.491 ' CB ' ' CD ' ' A' ' 293' ' ' PRO . 47.6 mtt180 -73.94 -62.17 1.14 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.583 0.706 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 292' ' ' ARG . 58.3 Cg_endo -71.8 156.96 56.24 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.673 2.249 . . . . 0.0 112.34 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 64.3 p -93.01 -36.33 12.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -107.28 148.7 28.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 31.3 mt -117.72 150.28 39.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . 0.406 HD22 ' CD1' ' A' ' 299' ' ' ILE . 16.3 t30 -98.56 120.4 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.63 102.02 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 299' ' ' ILE . 4.6 mm -46.71 -61.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -175.05 162.53 3.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -52.71 94.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 305' ' ' SER . 2.3 m-20 -141.69 172.85 12.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -54.64 -41.83 70.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -56.73 -59.92 4.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 302' ' ' ASP . 3.3 t -130.3 152.52 49.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -134.03 138.54 45.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -122.5 98.86 6.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.844 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . 0.774 ' CE2' ' CD1' ' A' ' 235' ' ' TYR . 99.4 m-85 -76.21 -50.84 13.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.46 ' CG2' ' NE2' ' A' ' 245' ' ' GLN . 46.1 p -36.72 -43.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.178 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.524 ' HG3' ' CE1' ' A' ' 312' ' ' TYR . 64.4 tttt -111.56 82.07 3.54 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.535 0.683 . . . . 0.0 110.906 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.72 -4.93 15.02 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.681 2.254 . . . . 0.0 112.367 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.524 ' CE1' ' HG3' ' A' ' 310' ' ' LYS . 5.0 p90 -104.73 80.45 1.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 56.8 mt -136.65 118.84 15.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.956 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 124.01 110.01 1.89 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.5 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -99.83 81.65 2.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.793 0.33 . . . . 0.0 110.891 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 75.9 p -163.66 168.85 19.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.371 . . . . 0.0 110.864 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.6 t -156.29 152.01 27.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.833 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -147.9 167.97 28.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.472 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 47.8 t -161.19 138.85 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 110.835 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 56.4 p -138.75 172.08 13.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 148.43 122.78 1.27 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.441 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -134.33 130.53 37.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -145.77 118.97 8.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.8 mt -123.82 110.88 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.9 m -116.46 86.21 2.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -69.75 140.98 89.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 0.0 110.835 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.96 84.74 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.302 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -114.24 87.17 0.44 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -81.66 110.93 17.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.936 0.398 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 41.6 p -97.82 84.42 3.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -127.05 142.05 51.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -40.47 133.49 1.62 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.604 0.716 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.88 -18.77 12.97 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.718 2.279 . . . . 0.0 112.347 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.2 m -97.31 104.61 16.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 107.41 130.0 6.27 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.44 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.84 -109.96 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -154.63 122.87 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -33.67 43.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 62.0 t -77.77 137.73 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 15.2 mt -134.91 134.37 40.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 22.1 tp -89.94 110.29 21.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.982 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.441 ' N ' HD13 ' A' ' 220' ' ' LEU . 7.2 mp -97.51 139.76 32.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -128.81 131.61 47.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.437 HD11 ' CG2' ' A' ' 255' ' ' ILE . 4.9 mp -91.56 122.02 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.158 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -82.22 143.64 31.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.485 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 15.6 m-20 39.8 54.42 5.83 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.615 0.721 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 74.4 Cg_exo -47.21 92.55 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.738 2.292 . . . . 0.0 112.31 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 11.6 mt -100.78 -48.83 4.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -100.47 137.11 19.86 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.67 0.748 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.51 113.54 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.671 2.248 . . . . 0.0 112.328 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.6 mm -101.11 104.04 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.7 p -104.5 159.44 15.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.17 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.417 ' N ' HD11 ' A' ' 249' ' ' ILE . 26.8 m -42.77 -35.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.25 -58.72 7.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 95.2 t -45.15 -45.17 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.093 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 40.1 mt -68.66 -61.89 1.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.46 ' C ' ' CD1' ' A' ' 235' ' ' TYR . 4.8 t80 -49.58 -29.21 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 98.1 m -64.71 -46.98 80.0 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.126 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.424 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 61.1 t -87.49 -10.07 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.43 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 82.1 m -88.94 -45.17 9.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.909 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.577 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 1.9 t-20 -49.59 -46.11 78.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -47.96 -19.92 1.8 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.694 2.262 . . . . 0.0 112.336 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.444 ' CG1' ' HA ' ' A' ' 270' ' ' ALA . 87.4 t -99.1 -46.92 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.42 -170.18 30.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 244' ' ' VAL . 6.6 tmtm? -82.59 151.14 26.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.368 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.454 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 91.0 t -121.52 128.99 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -80.69 -62.63 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -151.07 155.4 38.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 248' ' ' VAL . 77.0 mt -136.85 150.95 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.46 ' N ' HG22 ' A' ' 247' ' ' ILE . 94.0 t -136.52 139.91 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.424 ' N ' HG11 ' A' ' 248' ' ' VAL . 88.9 mt -125.38 116.63 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -129.05 158.39 39.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.87 41.84 2.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.401 ' HD3' ' C ' ' A' ' 252' ' ' ARG . 0.0 OUTLIER -67.54 86.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.854 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.2 t30 59.79 42.62 16.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.841 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 137.09 127.89 2.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.53 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.437 ' CG2' HD11 ' A' ' 222' ' ' ILE . 50.9 mm -48.4 113.11 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.766 0.317 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -137.67 165.46 26.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.32 127.07 4.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 11.0 mtt -95.67 126.25 40.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.83 127.02 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -105.85 172.74 6.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -142.24 169.78 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -54.27 -68.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 13.8 m -119.35 173.32 7.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 64.6 t -60.43 -52.39 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.139 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 55.2 tp -38.58 -63.48 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 80.7 m -48.03 -46.37 33.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -53.32 -45.57 69.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -63.74 -55.53 22.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -55.26 -58.27 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.444 ' HA ' ' CG1' ' A' ' 241' ' ' VAL . . . -51.24 -46.2 62.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . 56.8 tttm -49.03 -52.0 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -56.82 -67.03 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.93 -41.12 2.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.9 mp -83.6 -22.15 32.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 271' ' ' LYS . 1.2 t30 -57.36 104.7 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.0 22.69 77.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -83.24 90.52 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 0.0 111.134 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.76 129.28 19.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.463 HD11 ' CD2' ' A' ' 286' ' ' LEU . 79.8 mt -99.4 -41.8 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -117.3 173.15 6.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -50.28 103.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.132 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.44 48.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.499 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.2 m -161.42 174.44 13.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.319 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 34.0 m 52.94 42.36 32.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' THR . . . . . 0.461 HG21 ' N ' ' A' ' 286' ' ' LEU . 11.3 m -57.58 152.13 15.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.155 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.463 ' CD2' HD11 ' A' ' 279' ' ' ILE . 50.9 mt -97.85 125.93 42.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 94.88 4.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 34.0 mt -85.62 145.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 290' ' ' TYR . 25.7 mt-10 -155.28 113.82 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 289' ' ' GLU . 68.9 m-85 -34.74 107.27 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -50.51 135.95 21.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.084 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.576 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 5.9 ttt180 -64.14 -46.67 79.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.587 0.708 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.5 Cg_endo -79.37 149.81 21.93 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.667 2.245 . . . . 0.0 112.38 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.5 p -87.1 -27.52 23.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.11 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -121.22 154.47 36.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 48.1 mt -114.62 179.67 3.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -145.1 133.84 22.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 96.8 t -131.23 105.69 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.2 mp -63.41 -60.57 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.122 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -124.82 166.97 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 302' ' ' ASP . 2.1 m-20 -106.67 95.19 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 303' ' ' ASN . 0.9 OUTLIER -141.19 172.38 12.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 302' ' ' ASP . 0.8 OUTLIER -34.23 -41.69 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -57.4 -63.35 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.4 p -129.57 149.47 51.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -150.9 120.94 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.81 100.66 12.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -84.1 38.51 0.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 67.6 p -119.36 -40.62 2.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -129.6 101.31 18.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.561 0.696 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.52 -50.33 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.687 2.258 . . . . 0.0 112.3 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.566 ' CG ' ' O ' ' A' ' 312' ' ' TYR . 0.2 OUTLIER -81.0 39.83 0.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 11.6 tp -96.21 123.24 39.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -95.36 -125.5 4.62 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.471 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 316' ' ' ARG . 0.2 OUTLIER -75.27 -38.69 60.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.334 . . . . 0.0 110.865 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 315' ' ' ARG . 11.6 mmm180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.3 m -167.28 148.53 5.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 0.0 110.848 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 4.0 m -160.57 159.37 30.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 155.27 134.76 1.92 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 57.4 p -136.79 128.03 28.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.369 . . . . 0.0 110.821 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 8.0 t -112.16 103.22 11.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.64 113.63 0.54 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.536 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -168.8 120.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.791 0.329 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -141.25 128.06 20.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.402 ' C ' HG21 ' A' ' 203' ' ' THR . 74.1 mt -92.98 95.31 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.402 HG21 ' C ' ' A' ' 202' ' ' ILE . 81.4 p -154.76 119.34 4.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.095 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 36.6 ttt85 -38.34 133.94 0.95 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.82 35.8 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.249 . . . . 0.0 112.344 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 178.4 63.42 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.58 83.07 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.865 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 44.5 p -132.63 100.22 4.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -88.42 95.12 10.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -88.06 111.06 40.4 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.54 160.61 34.96 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.672 2.248 . . . . 0.0 112.336 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.8 m -56.31 98.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -107.96 -176.8 22.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.418 ' HA2' ' CE1' ' A' ' 290' ' ' TYR . . . -165.52 108.53 0.33 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.535 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 291' ' ' ALA . 7.1 p-10 -157.57 139.42 14.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 264' ' ' VAL . 17.3 mtmm -42.99 -45.85 5.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.0 137.64 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 19.7 mt -131.99 120.64 22.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 17.0 tp -76.8 114.52 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.417 HD13 ' CG2' ' A' ' 259' ' ' VAL . 7.0 mp -102.34 147.95 26.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.0 120.82 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.405 HD12 ' CG2' ' A' ' 229' ' ' ILE . 5.2 mp -80.62 123.93 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -81.54 137.57 35.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.495 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 50.4 t30 44.18 53.57 10.83 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.7 Cg_exo -47.3 103.98 0.06 OUTLIER 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.67 2.247 . . . . 0.0 112.38 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.455 HD13 ' ND2' ' A' ' 224' ' ' ASN . 37.8 mt -107.46 -47.65 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.543 ' CD2' ' CD2' ' A' ' 280' ' ' TYR . 94.8 m-85 -97.37 141.11 22.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.689 0.757 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.55 117.33 2.29 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.707 2.271 . . . . 0.0 112.371 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.405 ' CG2' HD12 ' A' ' 222' ' ' ILE . 30.5 mm -99.61 106.3 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 28.7 p -111.53 165.82 11.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 28.9 m -47.38 -40.44 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.147 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 235' ' ' TYR . 9.7 t0 -57.22 -63.89 1.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 232' ' ' ASP . 90.8 t -35.67 -36.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.17 -37.6 18.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 49.2 t80 -84.11 25.85 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.497 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 89.8 m -130.78 -36.22 1.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.124 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.435 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 25.4 t -98.12 -23.58 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.12 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.432 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 98.1 m -86.18 -48.78 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.568 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 11.9 t30 -47.43 -47.04 59.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.592 0.71 . . . . 0.0 110.85 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.8 Cg_exo -48.02 -21.5 2.8 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.643 2.229 . . . . 0.0 112.333 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.2 t -93.12 -48.64 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.097 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -138.12 -128.02 2.58 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -138.11 114.72 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.84 139.95 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.42 ' NE2' ' OE1' ' A' ' 262' ' ' GLU . 3.3 mm100 -108.09 -67.32 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -116.84 158.19 24.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 79.6 mt -149.72 108.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.62 143.25 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.42 HG12 ' CB ' ' A' ' 257' ' ' ALA . 73.1 mt -126.61 114.89 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -125.69 146.2 49.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -91.95 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -67.17 89.76 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 12.5 m120 50.58 42.02 26.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 137.32 136.2 3.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.506 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 32.7 mm -51.12 97.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.767 0.318 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -127.38 152.74 47.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.42 ' CB ' HG12 ' A' ' 249' ' ' ILE . . . -146.51 124.58 12.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.091 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 25.9 mtt -86.68 118.62 26.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.417 ' CG2' HD13 ' A' ' 220' ' ' LEU . 57.8 t -102.97 138.06 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -111.26 143.05 42.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -119.07 174.47 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.856 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.42 ' OE1' ' NE2' ' A' ' 245' ' ' GLN . 3.9 mm-40 -56.71 -66.82 0.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.411 ' C ' ' HG2' ' A' ' 216' ' ' LYS . 93.0 p -139.02 165.64 26.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.83 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.471 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 90.7 t -43.15 -54.38 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.116 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 34.7 tp -45.11 -60.8 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 81.7 m -47.91 -39.27 18.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.29 83.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -57.43 -59.82 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -56.79 -58.75 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -49.06 -57.45 6.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 275' ' ' ASN . 55.6 tttm -42.94 -50.26 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -47.5 -71.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.133 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.76 -48.61 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.083 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.401 ' N ' HD11 ' A' ' 274' ' ' LEU . 6.5 mp -64.58 -24.75 67.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 271' ' ' LYS . 50.4 t30 -62.16 102.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 76.27 20.77 76.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.505 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -86.36 94.8 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.0 111.12 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.03 162.99 6.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.425 HG21 ' CE1' ' A' ' 280' ' ' TYR . 53.5 mt -121.5 -42.95 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . 0.543 ' CD2' ' CD2' ' A' ' 227' ' ' TYR . 52.4 m-85 -112.74 173.43 6.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -50.77 104.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.101 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.63 58.53 0.71 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.495 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 26.1 p -175.1 160.48 2.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 110.872 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.6 m 63.47 46.67 4.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 18.0 m -67.9 155.93 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 80.3 mt -98.82 125.84 44.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -115.23 98.22 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 74.5 mt -84.05 146.77 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.15 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -159.67 113.32 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.418 ' CE1' ' HA2' ' A' ' 214' ' ' GLY . 62.8 m-85 -40.83 102.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.491 ' O ' ' ND2' ' A' ' 215' ' ' ASN . . . -54.95 145.77 19.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.558 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 8.9 ttm180 -61.97 -47.26 91.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.601 0.715 . . . . 0.0 110.826 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.3 Cg_endo -78.9 148.89 22.53 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.682 2.255 . . . . 0.0 112.276 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.9 p -90.55 -26.36 19.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -123.81 149.85 45.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 78.9 mt -105.37 178.85 4.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -138.39 110.37 7.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 85.5 t -120.99 110.7 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.8 mp -73.23 -54.03 16.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.18 151.62 51.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.36 97.15 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 303' ' ' ASN . 7.7 p-10 -130.9 166.11 21.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 302' ' ' ASP . 1.1 t30 -36.5 -45.54 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -60.66 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 55.7 p -134.31 128.42 33.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 17.0 t-105 -114.14 149.48 35.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -129.29 106.24 8.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -82.62 -43.37 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 58.8 p -44.44 -45.46 9.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -110.59 86.21 5.39 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.544 0.687 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.68 -11.51 18.48 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.649 2.232 . . . . 0.0 112.34 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -101.04 44.01 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 20.7 mt -94.96 -51.26 4.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 100.02 129.4 6.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.468 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -59.98 -44.41 94.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.918 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 52.4 p -112.88 156.31 23.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 110.86 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 9.5 t -106.49 -45.6 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 97.63 52.92 1.37 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 33.1 t -122.35 160.15 25.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.3 t -77.79 -42.83 32.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.865 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.33 165.44 12.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -174.72 116.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.716 0.294 . . . . 0.0 110.856 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.21 155.58 28.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 29.8 pt -77.57 129.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 14.7 t -145.58 146.24 31.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.31 143.57 49.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.584 0.707 . . . . 0.0 110.919 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.06 145.57 24.81 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.708 2.272 . . . . 0.0 112.364 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -113.72 168.53 12.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -142.66 156.71 45.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 110.84 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 209' ' ' ASP . 87.8 m -134.32 142.2 47.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.432 ' N ' HG22 ' A' ' 208' ' ' THR . 28.4 p30 -164.24 170.5 16.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -151.44 121.7 3.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.674 0.749 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -45.94 123.89 6.65 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.709 2.273 . . . . 0.0 112.325 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 92.7 p -44.13 135.22 4.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 81.92 123.55 0.7 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.488 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -56.32 -161.35 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.473 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -166.77 131.46 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 110.886 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -52.54 -46.06 66.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 90.1 t -81.59 131.11 34.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.128 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 288' ' ' ILE . 14.9 mt -123.09 128.17 49.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.473 HD21 ' NE2' ' A' ' 256' ' ' GLN . 29.4 tp -81.97 102.73 11.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 8.4 mp -89.54 132.78 34.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m -123.64 118.12 26.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 223' ' ' GLN . 5.2 mp -81.2 138.76 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.12 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.429 ' N ' HG22 ' A' ' 222' ' ' ILE . 2.1 tp-100 -96.68 141.45 29.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.487 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 48.7 t30 35.5 53.76 1.97 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.62 0.724 . . . . 0.0 110.843 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 77.6 Cg_exo -45.98 106.69 0.1 OUTLIER 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.367 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 66.7 mt -101.97 -48.4 4.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -112.49 126.1 28.92 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.675 0.75 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.55 112.25 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 29.5 mm -88.09 92.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.133 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.3 m -70.85 170.3 12.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 24.5 m -55.63 -41.31 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -58.05 -53.33 59.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.9 t -44.72 -37.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 52.6 mt -85.07 -35.65 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 81.8 t80 -82.55 19.95 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.412 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 93.0 m -122.78 -36.92 2.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.118 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.425 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 90.0 t -99.75 -18.84 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.431 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 58.5 m -89.07 -46.06 9.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.588 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.7 OUTLIER -50.58 -45.59 85.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.583 0.706 . . . . 0.0 110.896 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.4 Cg_exo -47.97 -28.19 9.93 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.681 2.254 . . . . 0.0 112.337 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 29.8 t -86.56 -49.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.097 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.92 -132.55 3.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -133.31 107.53 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 96.4 t -88.92 119.84 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.457 ' NE2' ' CD ' ' A' ' 262' ' ' GLU . 1.4 mm100 -81.13 -68.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.454 ' NH1' ' O ' ' A' ' 296' ' ' LEU . 7.5 ptp180 -132.97 154.9 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 70.4 mt -133.43 135.28 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.98 132.05 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.16 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 23.4 mt -120.61 118.68 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.492 ' CE2' ' HB3' ' A' ' 256' ' ' GLN . 20.2 p90 -126.75 155.18 43.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -110.22 45.22 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -90.05 109.91 20.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 61.51 41.41 12.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 109.04 149.82 13.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.457 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.9 mm -51.37 123.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 111.113 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.492 ' HB3' ' CE2' ' A' ' 250' ' ' PHE . 17.2 tt0 -153.15 163.79 39.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.24 146.18 16.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 35.3 mtt -111.38 124.92 53.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 65.7 t -111.89 121.64 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -98.36 140.81 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -116.35 158.21 23.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.457 ' CD ' ' NE2' ' A' ' 245' ' ' GLN . 3.9 mm-40 -41.48 -67.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 10.0 m -130.52 173.84 10.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.856 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 265' ' ' LEU . 92.1 t -57.02 -56.72 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 264' ' ' VAL . 17.4 tp -38.27 -64.06 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 61.6 m -45.59 -42.15 10.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -55.91 -40.35 72.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -52.04 -62.95 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -59.77 -59.99 4.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -42.78 -48.8 5.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.553 ' HE2' ' CE2' ' A' ' 290' ' ' TYR . 27.2 tttp -56.15 -44.29 79.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.04 -60.39 3.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.078 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -49.72 -40.45 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.99 -22.61 31.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 271' ' ' LYS . 2.7 t30 -62.17 100.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.56 18.0 61.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.451 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -80.56 154.3 27.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.331 . . . . 0.0 111.135 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -118.24 134.85 54.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 65.7 mt -101.53 -40.33 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.148 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.2 172.73 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -54.2 105.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.063 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.84 56.89 0.8 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.1 m -167.54 161.1 13.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.8 m 62.3 39.27 12.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.9 m -55.48 143.47 29.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.186 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 67.8 mt -93.41 126.74 38.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -124.92 84.92 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.423 HG21 ' NZ ' ' A' ' 271' ' ' LYS . 27.0 mt -71.27 144.95 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -147.68 120.07 8.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.553 ' CE2' ' HE2' ' A' ' 271' ' ' LYS . 59.0 m-85 -45.84 96.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.8 147.07 15.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.052 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 56.8 mtt-85 -65.41 -61.07 6.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.584 0.707 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 58.9 Cg_endo -71.37 154.55 60.95 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.654 2.236 . . . . 0.0 112.34 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 37.0 p -116.14 38.54 3.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 296' ' ' LEU . 37.4 ttt180 -149.88 151.21 33.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.466 ' N ' ' HG2' ' A' ' 295' ' ' ARG . 85.9 mt -141.58 120.91 13.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -106.96 135.05 49.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 92.0 t -120.25 98.34 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.163 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.8 mp -55.49 -62.55 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -119.88 169.65 9.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.424 ' ND2' ' OD1' ' A' ' 307' ' ' ASP . 3.2 m120 -107.49 114.83 29.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.414 ' CG ' ' C ' ' A' ' 301' ' ' ASN . 0.9 OUTLIER -162.56 172.15 15.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -42.34 -40.28 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.62 -46.31 70.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.6 m -158.03 143.89 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -134.88 145.19 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.424 ' OD1' ' ND2' ' A' ' 301' ' ' ASN . 2.2 p-10 -119.34 106.65 12.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.836 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.44 -39.67 24.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 37.9 p -48.4 -47.4 37.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -131.18 88.64 44.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.517 0.675 . . . . 0.0 110.885 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.06 -48.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 312' ' ' TYR . 0.1 OUTLIER -75.87 52.67 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.949 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 28.0 mt -89.78 112.35 23.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.93 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 95.25 79.17 1.45 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -87.11 39.58 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.801 0.334 . . . . 0.0 110.855 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 -179.906 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 82.7 p -172.52 136.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 1.1 t -167.88 175.25 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -148.13 73.71 0.29 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 83.7 p -82.53 92.29 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.878 0.371 . . . . 0.0 110.826 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.3 t -165.14 171.11 14.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.866 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 129.91 99.8 0.89 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.472 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -174.2 146.42 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 110.847 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -135.29 120.95 19.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 7.4 pt -48.86 161.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.163 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.1 t -162.05 160.75 27.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.153 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . 0.429 ' CD ' ' HD2' ' A' ' 205' ' ' PRO . 23.9 tpt180 -95.97 136.98 21.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.55 0.691 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.429 ' HD2' ' CD ' ' A' ' 204' ' ' ARG . 72.4 Cg_exo -46.8 165.0 0.09 OUTLIER 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.673 2.249 . . . . 0.0 112.367 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -70.08 71.26 0.59 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.451 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -52.49 147.07 8.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.398 . . . . 0.0 110.873 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 61.8 p -73.04 164.08 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -67.36 145.61 54.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.905 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -71.63 129.91 87.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.34 142.74 12.13 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.667 2.245 . . . . 0.0 112.364 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.4 t -153.92 149.31 27.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -109.47 137.73 14.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.511 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -54.38 168.7 1.66 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.521 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -146.19 127.72 15.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 0.0 110.906 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -51.24 -41.26 60.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 50.4 t -78.64 147.38 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 10.1 mt -138.52 139.59 38.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.66 109.54 21.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.87 129.33 44.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -119.77 115.72 24.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.85 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -82.46 134.98 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.161 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 224' ' ' ASN . 2.2 tp-100 -100.4 139.06 36.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.495 ' O ' ' CD2' ' A' ' 226' ' ' LEU . 55.8 t30 35.61 54.0 2.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.5 Cg_exo -47.18 113.9 0.84 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.358 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 224' ' ' ASN . 3.3 mm? -89.25 -58.82 2.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.24 143.63 26.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.74 0.781 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.16 112.68 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.714 2.276 . . . . 0.0 112.354 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.7 mm -89.32 116.54 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 18.6 p -126.73 169.29 13.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 33.0 m -48.81 -20.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.97 -40.96 68.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.7 t -70.29 -31.8 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.17 10.48 35.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -121.94 -5.87 9.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.475 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 40.0 m -108.5 -32.51 7.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.134 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.2 -7.56 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.406 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 61.2 m -100.73 -45.36 5.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.588 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.6 t-20 -52.04 -45.39 93.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.644 0.735 . . . . 0.0 110.878 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.6 Cg_exo -48.04 -23.78 4.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 34.1 t -92.18 -53.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.45 -134.89 3.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.525 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.479 ' HE2' ' N ' ' A' ' 244' ' ' VAL . 0.0 OUTLIER -128.49 94.93 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.87 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.479 ' N ' ' HE2' ' A' ' 243' ' ' LYS . 72.9 t -53.11 132.94 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -110.53 -66.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.491 ' NE ' ' OD2' ' A' ' 307' ' ' ASP . 16.3 ttm105 -128.76 143.15 50.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 43.3 mt -128.63 132.51 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.093 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.55 132.45 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.2 mt -124.06 113.71 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.142 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -120.29 143.6 48.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -113.35 43.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -60.18 -70.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -107.15 48.16 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.58 -120.89 4.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.7 mm -133.81 93.92 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 111.172 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -125.99 167.9 14.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -161.89 124.98 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 10.7 mtt -93.59 119.23 32.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.78 130.42 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.092 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -104.65 153.92 20.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.409 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 58.3 m-85 -125.27 169.43 12.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -37.91 -73.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.9 m -137.57 -175.27 4.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.15 -50.9 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.085 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 15.9 tp -46.28 -59.41 2.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 3.5 t -55.29 -30.84 60.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -70.26 -36.13 74.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -58.14 -54.4 47.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -68.52 -44.02 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.409 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -55.14 -49.57 71.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.542 ' HE3' ' CE2' ' A' ' 290' ' ' TYR . 27.0 tttm -50.97 -56.55 11.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.23 -59.45 5.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.13 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.61 -30.69 3.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.035 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.425 ' CB ' ' CD1' ' A' ' 288' ' ' ILE . 3.4 mp -98.07 -14.84 20.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 271' ' ' LYS . 8.9 t-20 -58.43 108.18 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 68.74 18.93 72.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.488 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -72.48 99.33 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.28 113.24 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.824 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 87.0 mt -72.36 -32.76 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . 0.424 ' O ' ' C ' ' A' ' 281' ' ' ALA . 63.2 m-85 -136.53 150.76 48.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 280' ' ' TYR . . . -35.85 105.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.1 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 39.86 70.87 0.31 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -174.84 150.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 0.0 110.919 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 3.3 m 57.36 51.56 9.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 28.1 m -60.59 109.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 35.5 mt -68.48 107.29 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -102.23 91.71 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.425 ' CD1' ' CB ' ' A' ' 274' ' ' LEU . 97.6 mt -79.59 139.58 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.1 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -149.1 125.97 11.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.542 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 32.4 m-85 -48.69 100.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.987 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.93 142.05 25.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.082 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.597 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.6 OUTLIER -64.55 -44.79 75.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.9 Cg_endo -80.46 147.53 17.92 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.709 2.272 . . . . 0.0 112.339 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 36.8 p -88.57 -14.32 37.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -127.59 164.95 20.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 42.9 mt -122.0 171.61 8.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -129.26 98.66 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 85.9 t -81.09 101.76 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.123 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 299' ' ' ILE . 3.2 mm -38.03 -63.24 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -170.17 142.29 2.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -39.49 100.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -167.63 172.52 9.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -47.68 -57.0 6.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.7 -41.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.5 m -162.39 136.94 6.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -126.77 129.06 47.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.491 ' OD2' ' NE ' ' A' ' 246' ' ' ARG . 19.8 t0 -121.8 81.02 1.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.859 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . 0.464 ' CE2' HG22 ' A' ' 309' ' ' THR . 1.6 p90 -70.72 -37.66 73.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.464 HG22 ' CE2' ' A' ' 308' ' ' TYR . 30.5 p -62.13 -21.31 64.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 312' ' ' TYR . 32.5 ttpt -127.09 90.16 50.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.57 0.7 . . . . 0.0 110.894 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.98 -3.1 12.95 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.702 2.268 . . . . 0.0 112.332 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.553 ' O ' ' CD2' ' A' ' 312' ' ' TYR . 36.5 p90 -107.44 93.7 4.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -119.78 120.06 35.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 51.66 71.61 0.63 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -71.25 85.4 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 0.0 110.868 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 62.7 m -108.76 160.27 16.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.887 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.3 t -69.25 167.45 16.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 98.71 97.2 2.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.526 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 51.3 p -128.6 -45.67 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.839 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 4.7 t -110.98 98.13 7.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -91.29 73.9 1.66 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 201' ' ' ARG . 0.0 OUTLIER -43.7 -26.42 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 110.899 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . 0.41 ' N ' ' HG2' ' A' ' 200' ' ' LYS . 23.5 mtt180 -124.73 162.79 23.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.4 mt -122.87 141.15 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.6 m -41.32 -52.95 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -153.23 143.24 15.29 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.32 154.24 31.9 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.38 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -41.87 114.65 0.71 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.494 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -59.73 108.94 0.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.1 m -125.44 89.03 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -112.09 122.42 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.9 143.75 54.19 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.655 0.74 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.01 159.48 34.02 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.74 2.293 . . . . 0.0 112.345 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 6.0 t -122.01 42.7 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.9 -68.27 0.76 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 81.23 156.53 15.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -170.92 144.95 2.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.384 . . . . 0.0 110.856 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -43.72 79.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.8 t -88.13 146.78 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.101 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.3 mt -135.43 124.99 25.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 36.0 tp -81.62 109.03 15.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.3 mp -95.84 129.47 43.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 63.1 m -112.73 127.07 56.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 4.8 mp -89.61 121.74 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.74 138.77 39.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.477 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 1.8 m-20 43.43 53.92 10.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.73 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.5 Cg_exo -45.87 90.24 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.337 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.7 mt -97.04 -42.45 7.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -111.45 153.54 44.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.732 0.777 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.75 115.81 4.28 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.44 ' CG2' HD22 ' A' ' 234' ' ' LEU . 30.3 mm -99.23 92.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.6 m -71.81 167.22 20.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.093 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 21.2 m -54.44 -39.53 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.34 -52.05 67.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 96.0 t -46.05 -40.14 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.44 HD22 ' CG2' ' A' ' 229' ' ' ILE . 33.7 mt -76.05 -60.5 2.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.964 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -47.31 -34.06 6.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.481 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 87.2 m -63.35 -47.8 80.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.149 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.413 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 59.6 t -86.94 -10.77 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.128 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.427 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 72.9 m -87.39 -49.2 7.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.571 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 14.3 t30 -48.53 -46.48 70.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.649 0.738 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.3 Cg_exo -47.96 -18.63 1.2 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.667 2.245 . . . . 0.0 112.399 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 37.0 t -104.4 -41.62 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.79 -144.71 4.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -123.16 126.4 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 85.4 t -96.19 147.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -108.22 -61.89 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.451 ' HG2' ' N ' ' A' ' 247' ' ' ILE . 21.3 ttm180 -134.6 147.82 50.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.451 ' N ' ' HG2' ' A' ' 246' ' ' ARG . 61.3 mt -140.54 131.0 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.67 135.87 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 58.5 mt -120.94 120.82 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -136.1 155.13 50.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -131.76 40.59 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -68.78 -57.26 5.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -119.77 45.77 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 116.69 128.49 4.17 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.443 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.431 HG13 ' CB ' ' A' ' 225' ' ' PRO . 42.9 mm -43.92 104.41 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -146.3 170.76 16.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.54 130.22 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.467 ' SD ' ' CD2' ' A' ' 296' ' ' LEU . 22.4 mtt -87.89 118.0 27.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 87.7 t -107.87 123.43 63.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -103.08 150.3 23.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 262' ' ' GLU . 56.4 m-85 -126.0 161.12 28.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 261' ' ' PHE . 23.4 mt-10 -34.15 -70.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 t -140.39 167.71 21.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 265' ' ' LEU . 94.8 t -41.04 -57.14 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 264' ' ' VAL . 19.6 tp -37.22 -63.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 30.7 m -47.36 -42.2 21.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -56.33 -38.31 71.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -56.14 -59.44 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -66.32 -50.9 62.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.954 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -49.42 -49.92 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 275' ' ' ASN . 58.9 tttm -52.57 -46.96 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -60.05 -70.52 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -42.29 -36.8 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 4.7 mp -85.94 -23.97 26.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 271' ' ' LYS . 14.3 t-20 -58.75 102.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.9 23.07 60.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -93.24 93.71 8.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.1 148.63 50.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 41.0 mt -104.5 -40.34 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.89 172.93 6.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -57.16 107.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.4 55.68 0.75 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.514 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 6.5 m -164.47 153.67 13.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 4.9 m 62.82 44.53 6.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 39.2 m -59.92 129.22 40.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.439 ' O ' ' NZ ' ' A' ' 287' ' ' LYS . 35.5 mt -78.28 123.31 26.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 286' ' ' LEU . 0.9 OUTLIER -121.83 84.96 2.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 28.6 mt -65.26 144.02 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.174 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -153.98 111.09 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -38.07 106.26 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.62 160.76 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.097 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 14.8 mtt-85 -73.04 -59.37 2.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 59.7 Cg_endo -73.23 159.09 47.89 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.711 2.274 . . . . 0.0 112.342 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 34.4 p -88.22 -25.1 23.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -173.88 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.467 ' CD2' ' SD ' ' A' ' 258' ' ' MET . 17.8 mt -142.24 168.34 19.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -125.56 114.97 19.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 84.5 t -106.02 102.86 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.4 mp -57.25 -51.31 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.03 155.42 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -90.09 85.38 6.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.4 173.16 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -39.39 -51.12 2.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -45.46 -59.87 2.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 63.8 p -135.13 138.46 43.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -139.56 127.44 22.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -104.02 98.22 8.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -83.72 40.21 0.73 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 77.3 p -114.68 -39.34 3.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.138 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.448 ' HG2' ' CZ ' ' A' ' 312' ' ' TYR . 24.7 mttp -126.72 89.01 53.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.534 0.683 . . . . 0.0 110.877 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.72 -5.36 15.93 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.707 2.271 . . . . 0.0 112.36 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.448 ' CZ ' ' HG2' ' A' ' 310' ' ' LYS . 8.8 p90 -102.9 45.78 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 20.1 mt -121.61 106.21 11.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.939 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 161.99 46.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.511 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.34 80.27 1.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.813 0.339 . . . . 0.0 110.888 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -179.905 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.8 t -153.95 115.64 4.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.351 . . . . 0.0 110.866 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.3 m -75.21 122.03 23.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 159.19 87.05 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.491 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 66.7 m -119.43 123.62 44.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.888 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 83.8 p -171.32 146.56 2.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.43 -171.26 17.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -82.28 -44.77 15.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -117.56 95.45 4.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 4.5 pt -70.48 70.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.119 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.1 p -140.77 152.78 45.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.175 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -122.71 122.49 27.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.605 0.717 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.87 106.16 2.21 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.743 2.295 . . . . 0.0 112.327 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -129.2 51.12 0.87 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -170.35 157.47 6.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 110.899 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 209' ' ' ASP . 23.7 m -116.78 154.26 30.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 208' ' ' THR . 8.5 p-10 -96.87 121.82 39.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -107.98 151.75 41.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.576 0.703 . . . . 0.0 110.912 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.87 122.67 6.42 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.737 2.291 . . . . 0.0 112.371 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 8.4 t 49.96 41.51 23.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -110.13 -149.01 12.26 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.462 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 114.85 -172.1 14.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -156.25 142.31 18.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.859 0.362 . . . . 0.0 110.893 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -58.1 -42.95 86.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.84 139.27 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.123 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 29.5 mt -138.6 126.82 22.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.46 113.48 21.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -100.53 132.68 45.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -119.33 137.92 53.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.2 mp -105.28 125.31 60.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -82.57 142.43 31.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.475 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 42.0 t30 40.12 53.49 5.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.3 Cg_exo -44.7 103.61 0.05 OUTLIER 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.697 2.265 . . . . 0.0 112.343 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 55.2 mt -105.08 -46.93 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -100.5 153.61 37.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.709 0.766 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.75 116.34 4.64 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.711 2.274 . . . . 0.0 112.35 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.7 mm -100.22 119.98 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 232' ' ' ASP . 18.2 p -122.57 156.16 34.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 230' ' ' THR . 34.4 m -33.62 -35.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.2 m-20 -60.96 -65.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 87.3 t -43.62 -51.02 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.16 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 46.1 mt -60.93 -58.33 8.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.539 ' CE2' ' HB ' ' A' ' 244' ' ' VAL . 3.2 t80 -54.68 -25.86 29.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.422 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 66.6 m -70.19 -45.86 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.171 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.437 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 39.4 t -87.2 -15.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.413 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 71.0 m -86.27 -46.12 10.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.556 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -47.11 -47.76 54.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.866 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.0 Cg_exo -47.96 -21.07 2.41 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.723 2.282 . . . . 0.0 112.366 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 69.7 t -98.73 -39.09 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.13 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.53 -154.11 7.94 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.457 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.403 ' HB3' ' CD ' ' A' ' 262' ' ' GLU . 2.5 tmtm? -104.23 144.39 31.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.539 ' HB ' ' CE2' ' A' ' 235' ' ' TYR . 63.0 t -108.69 141.3 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.412 ' NE2' ' HG3' ' A' ' 262' ' ' GLU . 20.2 mt-30 -110.66 -65.11 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.474 ' NE ' HG21 ' A' ' 298' ' ' VAL . 17.4 ttm180 -130.9 145.08 51.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.489 HG22 ' N ' ' A' ' 248' ' ' VAL . 71.3 mt -138.34 140.17 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.489 ' N ' HG22 ' A' ' 247' ' ' ILE . 17.1 t -131.37 139.98 49.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 77.2 mt -129.02 109.45 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -118.96 151.29 38.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 40.88 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -58.48 -63.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -109.19 43.6 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.31 -121.96 4.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.495 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.418 HG13 ' CB ' ' A' ' 225' ' ' PRO . 28.7 mm -129.61 91.21 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 111.102 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -124.83 159.68 30.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -155.91 122.93 5.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 19.3 mtt -86.07 125.07 33.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.6 t -111.85 118.86 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -94.31 156.44 16.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -130.67 169.04 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.892 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.412 ' HG3' ' NE2' ' A' ' 245' ' ' GLN . 10.9 mp0 -54.26 -64.2 0.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 73.7 m -128.49 172.53 11.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 91.2 t -61.12 -51.43 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 24.9 tp -40.74 -63.49 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 33.5 m -46.03 -40.59 10.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.21 77.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.115 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -56.75 -57.09 13.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -63.51 -60.35 3.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -47.62 -50.01 25.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.113 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 275' ' ' ASN . 49.2 tttm -48.55 -51.67 26.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -59.36 -66.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.67 -37.75 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 5.4 mp -87.8 -22.1 24.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 272' ' ' ALA . 7.3 t30 -57.86 104.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.03 23.01 70.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -79.59 118.37 21.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 111.096 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.25 125.29 28.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.41 HD11 ' CG ' ' A' ' 286' ' ' LEU . 78.4 mt -97.8 -41.04 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.146 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -117.77 172.58 7.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -54.38 105.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.12 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 35.63 54.26 1.07 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.497 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 4.3 m -165.45 163.77 19.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.01 41.89 7.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 54.0 m -55.8 118.49 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.41 ' CG ' HD11 ' A' ' 279' ' ' ILE . 36.3 mt -71.39 127.08 31.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -127.02 95.03 4.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.416 ' CD1' ' O ' ' A' ' 271' ' ' LYS . 38.7 mt -77.23 147.36 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -150.38 124.05 9.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -49.64 97.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -47.5 134.75 11.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.116 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.575 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 9.2 ttp180 -60.21 -46.61 97.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 0.0 110.817 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.2 Cg_endo -79.45 149.26 21.38 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.712 2.275 . . . . 0.0 112.349 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 60.6 p -92.66 -25.25 18.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -123.9 139.59 53.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 40.0 mt -100.43 176.57 5.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . 0.428 ' ND2' HD12 ' A' ' 299' ' ' ILE . 5.1 t30 -131.46 115.42 16.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.474 HG21 ' NE ' ' A' ' 246' ' ' ARG . 58.6 t -113.56 105.66 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.135 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.428 HD12 ' ND2' ' A' ' 297' ' ' ASN . 5.3 mp -65.92 -59.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.136 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -132.9 175.58 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -104.16 105.69 15.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 303' ' ' ASN . 0.9 OUTLIER -149.7 166.74 28.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 302' ' ' ASP . 5.0 p30 -33.71 -39.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.58 -58.24 9.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.416 ' HB2' ' HA ' ' A' ' 248' ' ' VAL . 9.8 t -134.35 153.62 51.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -144.13 134.24 24.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -112.91 108.74 17.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.811 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -79.51 -50.58 10.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.902 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 68.6 p -41.9 -32.56 0.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.451 ' CB ' HD11 ' A' ' 313' ' ' LEU . 31.8 mmtt -135.02 90.42 21.67 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.586 0.708 . . . . 0.0 110.86 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -79.26 -16.63 12.1 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.676 2.25 . . . . 0.0 112.365 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -104.14 69.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.451 HD11 ' CB ' ' A' ' 310' ' ' LYS . 31.4 mt -130.39 112.39 13.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 315' ' ' ARG . . . 99.78 156.24 28.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 314' ' ' GLY . 22.3 ttp180 -35.09 -53.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.845 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.883 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.8 m -155.73 176.07 13.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.902 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 74.3 m -152.32 170.5 19.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -150.09 176.46 28.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.501 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 70.2 m -153.79 116.08 4.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.878 0.371 . . . . 0.0 110.865 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.6 m -77.08 174.83 10.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -140.79 129.23 4.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.48 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -147.41 154.97 41.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -144.87 150.91 37.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.3 pt -70.21 166.8 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.158 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.2 t -136.27 151.67 49.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -98.61 154.73 37.36 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.606 0.717 . . . . 0.0 110.93 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.63 149.43 34.19 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.712 2.275 . . . . 0.0 112.312 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -114.39 127.41 7.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.464 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -71.01 165.67 22.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.892 0.377 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 31.4 m -118.29 139.4 51.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.0 168.78 19.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -119.46 133.19 23.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.627 0.727 . . . . 0.0 110.874 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -80.03 27.8 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.707 2.271 . . . . 0.0 112.361 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.7 m -44.45 98.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.839 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 79.62 -163.78 48.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.436 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.463 ' HA2' ' CE1' ' A' ' 290' ' ' TYR . . . 163.22 139.89 2.74 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.485 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.403 ' ND2' ' HB ' ' A' ' 217' ' ' VAL . 51.5 t30 -143.29 147.53 34.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.899 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.417 ' HG2' ' N ' ' A' ' 264' ' ' VAL . 40.2 mtmt -57.61 -41.91 82.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 218' ' ' LEU . 55.8 t -77.59 138.58 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.436 ' N ' HG13 ' A' ' 217' ' ' VAL . 14.0 mt -133.79 119.2 18.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.9 tp -76.25 106.58 7.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.98 123.76 36.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.0 m -114.27 118.96 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.0 mp -79.55 133.9 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.09 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 224' ' ' ASN . 43.8 mt-30 -91.15 141.91 28.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.488 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 62.7 t30 35.11 54.42 1.91 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.632 0.73 . . . . 0.0 110.874 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.8 Cg_exo -47.33 115.91 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.326 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 62.6 mt -108.17 -54.86 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -101.08 137.82 19.82 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.67 0.748 . . . . 0.0 110.867 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.77 125.94 13.76 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.673 2.248 . . . . 0.0 112.365 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 49.9 mm -104.55 126.4 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.107 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.0 p -125.77 163.84 21.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.131 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 235' ' ' TYR . 35.8 m -40.22 -35.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.166 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -55.99 -45.54 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.7 t -61.9 -52.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 31.4 mt -84.11 24.38 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.455 ' CB ' ' O ' ' A' ' 231' ' ' VAL . 85.2 t80 -130.58 -37.25 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.971 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.499 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 85.2 m -80.58 -34.27 35.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.446 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 11.6 t -87.88 -19.4 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.448 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 73.0 m -84.63 -50.64 7.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.545 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 1.5 t-20 -45.31 -47.39 34.3 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.631 0.729 . . . . 0.0 110.904 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.6 Cg_exo -47.98 -30.93 14.76 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.259 . . . . 0.0 112.336 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.01 -39.86 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.168 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.47 -133.24 1.46 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.52 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -121.34 143.7 49.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.896 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.66 128.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.423 ' CD ' ' HA ' ' A' ' 262' ' ' GLU . 30.6 mm-40 -92.46 -59.44 2.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -147.27 154.3 40.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 79.5 mt -133.4 134.54 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.47 116.06 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 231' ' ' VAL . 37.5 mt -108.08 106.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -118.93 149.19 42.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 251' ' ' LYS . 2.6 mppt? -118.16 41.45 2.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -54.25 -63.86 1.02 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -109.52 43.26 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.3 -118.82 3.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 41.8 mm -127.05 95.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -128.83 157.52 41.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -156.32 118.52 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 24.7 mtt -87.53 125.74 34.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.58 131.59 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.103 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 261' ' ' PHE . 5.0 tp10 -104.77 152.0 23.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 270' ' ' ALA . 55.1 m-85 -130.08 157.6 41.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 261' ' ' PHE . 67.3 mt-10 -34.99 -66.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.2 p -143.68 174.54 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 265' ' ' LEU . 74.5 t -47.82 -59.87 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 264' ' ' VAL . 18.1 tp -35.98 -60.12 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 85.9 m -53.22 -40.97 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 264' ' ' VAL . . . -57.27 -36.88 71.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -58.76 -58.27 9.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -66.13 -53.03 42.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.548 ' HB2' ' CE2' ' A' ' 261' ' ' PHE . . . -49.38 -47.83 47.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 275' ' ' ASN . 24.6 tttt -53.38 -55.57 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.847 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -53.64 -67.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.109 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.96 -42.29 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 3.6 mp -81.82 -22.0 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 271' ' ' LYS . 65.4 t30 -61.61 101.76 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.89 21.46 71.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -82.1 93.79 7.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.118 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.36 117.08 2.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.463 HD13 ' CD2' ' A' ' 286' ' ' LEU . 80.3 mt -91.14 -37.43 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.134 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -120.35 173.86 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -56.87 104.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.128 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.49 59.12 0.67 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.423 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 31.2 p -175.12 162.45 3.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.908 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 77.2 m 62.48 43.08 8.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 5.9 m -57.24 146.78 27.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.463 ' CD2' HD13 ' A' ' 279' ' ' ILE . 73.6 mt -91.81 119.33 31.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -116.71 79.53 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.471 ' CD1' ' O ' ' A' ' 271' ' ' LYS . 47.6 mt -65.41 147.73 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -151.85 113.63 4.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.463 ' CE1' ' HA2' ' A' ' 214' ' ' GLY . 39.1 m-85 -41.12 101.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -50.67 138.9 17.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 6.2 ttt180 -66.08 -45.7 62.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.62 0.724 . . . . 0.0 110.889 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.3 Cg_endo -80.21 148.37 18.98 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.315 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.8 p -82.11 -25.75 34.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.44 ' HD3' ' N ' ' A' ' 296' ' ' LEU . 0.4 OUTLIER -119.21 -174.66 2.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.44 ' N ' ' HD3' ' A' ' 295' ' ' ARG . 52.0 mt -139.17 173.35 11.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.928 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -124.83 117.9 25.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 77.9 t -122.35 91.73 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.057 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.3 mp -50.43 -56.55 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.44 177.23 8.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -99.19 96.47 7.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -136.16 171.55 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -42.11 -45.28 3.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -55.67 -62.3 1.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 97.4 p -129.05 137.15 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -140.98 132.16 26.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -116.21 92.47 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 309' ' ' THR . 53.3 m-85 -69.02 -43.58 74.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 308' ' ' TYR . 47.5 p -37.43 -49.89 1.04 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.136 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.8 102.34 44.77 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.55 0.691 . . . . 0.0 110.884 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.668 ' O ' ' CD1' ' A' ' 312' ' ' TYR . 43.4 Cg_endo -70.71 -159.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 0.0 112.295 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.668 ' CD1' ' O ' ' A' ' 311' ' ' PRO . 0.9 OUTLIER 34.08 55.01 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 10.5 mt -123.92 149.28 46.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 315' ' ' ARG . . . 120.38 -60.28 0.53 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.479 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 314' ' ' GLY . 10.4 ttm180 -37.02 -45.35 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.925 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.6 p -152.47 153.08 32.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.858 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 50.0 m -114.62 167.77 10.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -78.79 119.5 5.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.446 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.6 t -118.33 -60.6 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 110.862 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 6.6 t -71.1 -50.88 28.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.821 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 160.48 90.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.464 ' HG3' ' N ' ' A' ' 201' ' ' ARG . 14.6 pttp -70.5 -44.17 68.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.308 . . . . 0.0 110.893 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . 0.464 ' N ' ' HG3' ' A' ' 200' ' ' LYS . 13.1 tpp85 -146.31 120.02 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 2.3 pp -47.56 150.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 86.6 m -147.01 125.1 12.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.172 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -129.43 113.25 18.1 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.591 0.71 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.53 134.29 13.71 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.67 2.247 . . . . 0.0 112.351 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -169.71 43.06 0.21 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.452 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -141.95 159.18 42.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.913 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 14.8 t -152.98 142.45 21.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.105 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -162.68 134.15 5.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.819 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.48 143.88 98.41 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.563 0.697 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.35 -12.54 17.12 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.315 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 58.6 m 49.77 42.29 23.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.94 88.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -61.63 -144.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.515 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -165.85 125.38 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 110.901 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -46.2 -40.22 10.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.462 HG13 ' CB ' ' A' ' 291' ' ' ALA . 49.0 t -77.81 137.23 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.095 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 24.1 mt -136.93 129.98 30.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.03 118.88 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.401 ' N ' HD11 ' A' ' 220' ' ' LEU . 6.6 mp -108.52 134.7 50.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.8 t -119.63 137.6 53.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.2 mp -99.21 128.83 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -89.75 138.96 31.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 49.7 t30 39.52 52.7 4.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.624 0.726 . . . . 0.0 110.935 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 71.5 Cg_exo -43.7 94.33 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.641 2.228 . . . . 0.0 112.334 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 20.2 mt -95.86 -43.78 7.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -102.71 153.48 38.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.715 0.769 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.29 115.77 4.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.696 2.264 . . . . 0.0 112.274 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.8 mm -98.41 110.48 26.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 232' ' ' ASP . 49.6 p -105.99 158.46 16.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.13 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 18.3 m -41.49 -26.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.123 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.5 m-20 -68.22 -61.98 1.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.425 ' CG1' HD12 ' A' ' 279' ' ' ILE . 78.5 t -39.45 -45.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 31.5 mt -77.74 -37.92 48.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.595 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 76.9 t80 -83.42 20.14 1.4 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 99.2 m -124.43 -37.19 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.142 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.415 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 89.1 t -98.21 -19.26 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.424 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 65.3 m -89.75 -45.55 9.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.589 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 4.8 t-20 -51.37 -45.35 89.96 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.728 . . . . 0.0 110.944 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.1 Cg_exo -47.97 -56.87 2.71 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.711 2.274 . . . . 0.0 112.318 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.3 -47.04 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -142.74 -108.08 0.65 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.507 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.535 ' O ' ' CD2' ' A' ' 261' ' ' PHE . 13.7 tptp -152.33 151.34 30.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.469 ' N ' ' HG3' ' A' ' 243' ' ' LYS . 95.1 t -127.94 122.36 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -82.64 -69.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -137.24 156.91 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 55.5 mt -137.06 133.47 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.444 ' HA ' ' CB ' ' A' ' 305' ' ' SER . 94.9 t -126.54 110.18 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.468 ' CG1' ' O ' ' A' ' 304' ' ' ASP . 60.4 mt -94.09 126.14 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.159 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -141.35 135.16 30.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -84.5 41.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -89.59 119.19 29.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.8 m120 51.49 40.95 28.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 109.56 135.71 7.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.463 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.0 mm -46.56 104.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.321 . . . . 0.0 111.152 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -134.1 164.42 27.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -152.51 122.03 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.403 ' SD ' ' CD2' ' A' ' 296' ' ' LEU . 26.4 mtt -83.42 114.68 21.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 88.7 t -106.8 119.44 56.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 11.0 tt0 -91.54 151.01 20.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 243' ' ' LYS . 30.3 m-85 -123.5 163.74 20.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -52.97 -72.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 66.8 m -114.8 -174.95 2.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.66 -44.54 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 268' ' ' GLN . 36.6 tp -51.61 -65.8 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.935 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 24.3 p -42.44 -38.22 1.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.04 -38.66 83.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 265' ' ' LEU . 62.2 mt-30 -58.68 -59.39 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -56.56 -53.7 54.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -52.57 -55.04 25.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.074 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.416 ' HE3' ' CZ ' ' A' ' 290' ' ' TYR . 41.5 tttm -43.09 -51.34 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -46.86 -73.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -45.49 -50.18 12.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.43 ' CB ' ' CD1' ' A' ' 288' ' ' ILE . 5.1 mp -61.47 -26.79 68.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 271' ' ' LYS . 33.6 t30 -60.62 105.05 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.15 25.66 70.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.459 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -86.02 93.36 8.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 0.0 111.131 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.69 131.92 45.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.425 HD12 ' CG1' ' A' ' 233' ' ' VAL . 72.6 mt -88.56 -34.34 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -121.61 173.13 7.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -55.32 112.55 1.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.17 73.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.536 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' CYS . . . . . 0.4 ' O ' ' SG ' ' A' ' 284' ' ' CYS . 2.6 t -175.31 177.78 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.313 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 283' ' ' CYS . 27.8 p 39.44 46.61 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 55.8 m -57.86 90.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -45.72 131.13 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -127.8 96.85 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 289' ' ' GLU . 66.3 mt -80.2 145.94 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . 0.447 ' N ' HG23 ' A' ' 288' ' ' ILE . 16.3 mt-10 -153.01 114.91 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.416 ' CZ ' ' HE3' ' A' ' 271' ' ' LYS . 44.6 m-85 -43.08 98.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.462 ' CB ' HG13 ' A' ' 217' ' ' VAL . . . -48.15 141.73 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.559 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.0 OUTLIER -69.86 -47.43 23.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.56 0.695 . . . . 0.0 110.859 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 62.5 Cg_endo -77.57 144.28 22.33 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.676 2.251 . . . . 0.0 112.34 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 81.1 p -83.7 -31.31 26.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -112.8 161.11 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.403 ' CD2' ' SD ' ' A' ' 258' ' ' MET . 74.6 mt -119.36 -178.28 3.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -143.02 113.53 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 87.9 t -116.16 106.07 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.104 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.2 mp -66.87 -55.88 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . 0.42 ' CG ' ' OD2' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -133.83 153.13 51.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -90.09 87.19 6.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.42 ' OD2' ' CG ' ' A' ' 300' ' ' ARG . 5.0 p30 -123.18 171.78 9.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -39.89 -45.9 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . 0.468 ' O ' ' CG1' ' A' ' 249' ' ' ILE . 25.7 m-20 -57.42 -61.52 2.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.444 ' CB ' ' HA ' ' A' ' 248' ' ' VAL . 97.0 p -123.33 131.79 53.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -144.16 119.11 9.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -97.69 117.65 32.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.88 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -98.61 44.18 1.04 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 76.7 p -116.05 -41.3 3.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.139 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 312' ' ' TYR . 19.3 ttpt -131.29 98.08 19.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.534 0.683 . . . . 0.0 110.875 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.64 -10.15 21.67 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.697 2.265 . . . . 0.0 112.386 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.576 ' CE1' ' HG3' ' A' ' 310' ' ' LYS . 3.1 p90 -110.38 108.65 18.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.949 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.424 HD22 ' C ' ' A' ' 312' ' ' TYR . 4.4 mm? -134.97 44.6 2.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.937 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -83.45 177.08 52.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.504 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.24 -30.36 43.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 0.0 110.871 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.523 ' CD ' ' C ' ' A' ' 316' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.91 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 217' ' ' VAL . 4.1 p-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.88 0.371 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -30.99 69.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.499 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 95.7 t -86.86 140.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 14.0 mt -134.38 132.34 39.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 49.1 tp -81.89 103.82 11.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.9 mp -90.96 128.61 36.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.17 112.49 17.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.772 HD12 ' H ' ' A' ' 222' ' ' ILE . 3.5 mp -75.42 130.62 36.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.139 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -99.47 120.52 39.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 19.0 m-20 63.61 52.28 1.41 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 0.0 110.91 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 60.2 Cg_endo -74.41 47.09 1.53 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.654 2.236 . . . . 0.0 112.352 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.3 mt -39.86 -41.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -97.78 141.49 23.08 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.68 0.752 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.31 124.38 9.11 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.734 2.289 . . . . 0.0 112.282 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.6 mm -107.11 109.04 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.12 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.1 p -102.98 159.05 15.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.461 ' N ' HD11 ' A' ' 249' ' ' ILE . 21.8 m -44.37 -39.88 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -54.19 -55.84 24.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.1 t -45.12 -39.11 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 25.7 mt -78.49 -64.06 1.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -46.9 -27.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.477 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 63.6 m -64.34 -47.69 78.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 237' ' ' VAL . 65.1 t -87.37 -11.2 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.115 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 64.4 m -87.39 -49.06 7.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.579 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 6.0 t30 -48.65 -46.36 71.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.657 0.741 . . . . 0.0 110.896 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.2 Cg_exo -47.97 -17.4 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.8 HG11 ' HA ' ' A' ' 270' ' ' ALA . 96.2 t -102.59 -41.34 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -174.2 177.26 46.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 142.87 56.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.1 t -110.57 134.64 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -80.77 -60.84 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -161.74 155.07 21.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.791 HG12 HG22 ' A' ' 259' ' ' VAL . 74.9 mt -134.93 119.13 26.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 298' ' ' VAL . 49.1 t -110.76 115.03 48.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 231' ' ' VAL . 64.5 mt -97.35 114.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.173 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 7.5 p90 -116.3 162.38 17.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -117.87 90.92 3.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -133.04 94.45 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 59.51 38.95 22.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 131.06 131.17 3.25 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.47 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.569 HG22 HD13 ' A' ' 222' ' ' ILE . 33.1 mm -48.1 102.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.539 ' HB3' ' CE1' ' A' ' 250' ' ' PHE . 27.7 mt-30 -118.15 166.14 12.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -168.17 130.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.065 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 33.8 mtt -97.1 132.82 42.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.791 HG22 HG12 ' A' ' 247' ' ' ILE . 97.7 t -122.73 125.31 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.154 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -101.85 150.52 23.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -122.36 159.36 27.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -41.19 -65.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.7 t -130.71 176.23 8.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 85.7 t -60.24 -51.43 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.111 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 20.9 tp -39.07 -62.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 65.7 m -47.44 -41.82 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -55.87 -42.75 76.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -54.88 -58.56 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -62.25 -56.67 16.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.866 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.8 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.18 -47.96 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.122 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.484 ' HA ' HD13 ' A' ' 288' ' ' ILE . 22.7 tttt -50.27 -48.8 54.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -64.48 -67.71 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -39.78 -33.76 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.776 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.5 mp -92.39 -28.13 17.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 272' ' ' ALA . 6.0 t30 -55.27 100.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.3 21.95 61.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -84.35 92.41 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.33 129.21 39.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.566 HG22 ' CD1' ' A' ' 280' ' ' TYR . 74.4 mt -100.36 -41.64 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.177 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' TYR . . . . . 0.566 ' CD1' HG22 ' A' ' 279' ' ' ILE . 8.1 m-85 -117.38 171.56 7.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -55.11 108.62 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.115 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.7 53.75 0.82 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 25.5 p -174.51 172.01 3.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 69.5 m 56.08 41.12 29.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 54.4 m -68.98 143.94 54.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.171 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.466 HD11 HD11 ' A' ' 279' ' ' ILE . 88.5 mt -89.14 127.33 35.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -118.89 80.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.776 HD11 ' CB ' ' A' ' 274' ' ' LEU . 17.0 mt -71.28 144.32 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 290' ' ' TYR . 19.7 mt-10 -157.31 107.79 2.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 289' ' ' GLU . 41.9 m-85 -34.4 101.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -56.19 165.24 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 0.4 OUTLIER -71.82 -57.8 3.86 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.647 0.736 . . . . 0.0 110.856 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 59.5 Cg_endo -73.14 160.47 45.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.67 2.247 . . . . 0.0 112.345 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 217' ' ' VAL . 33.2 p -102.95 -27.58 12.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -111.81 144.9 40.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 80.5 mt -109.45 175.9 5.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -135.87 139.05 43.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 248' ' ' VAL . 95.2 t -134.97 97.29 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.141 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.733 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -51.5 -57.3 3.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -139.69 175.95 9.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.76 116.67 33.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -159.29 171.32 20.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -44.47 -39.93 5.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.16 -61.11 2.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 53.4 p -131.05 133.46 45.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -124.18 141.17 52.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -115.04 100.88 8.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.36 -47.95 38.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.5 t30 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.866 0.365 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 217' ' ' VAL . 0.0 OUTLIER -50.47 -35.21 27.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.408 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 95.0 t -89.59 141.85 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.548 ' HB3' HG23 ' A' ' 288' ' ' ILE . 52.6 mt -142.19 128.35 19.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.2 tp -87.0 105.24 17.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.468 HD13 ' CG2' ' A' ' 259' ' ' VAL . 7.1 mp -88.82 140.43 29.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -134.8 115.71 13.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -81.49 130.31 36.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -98.46 130.93 45.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.527 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 59.8 t30 48.34 52.74 13.16 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.6 Cg_exo -44.84 123.59 5.02 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.663 2.242 . . . . 0.0 112.381 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.442 ' CD2' ' HB2' ' A' ' 283' ' ' CYS . 4.0 mm? -91.81 -63.04 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -107.52 153.97 41.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.663 0.744 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.37 112.37 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.7 mm -90.83 116.59 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 29.8 p -127.11 159.84 32.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.163 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.9 m -37.7 -33.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -65.41 -60.45 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 90.4 t -45.63 -44.71 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.174 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 36.7 mt -70.45 -61.4 1.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -49.93 -27.35 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.483 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 98.3 m -65.62 -47.28 76.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.444 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 80.1 t -86.73 -16.98 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 85.1 m -83.87 -47.78 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.538 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -47.36 -48.78 55.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.594 0.711 . . . . 0.0 110.846 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.6 Cg_exo -48.0 -17.57 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 0.0 112.356 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.933 HG11 ' HA ' ' A' ' 270' ' ' ALA . 87.7 t -97.59 -43.93 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.56 -155.61 9.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.42 ' HD3' ' N ' ' A' ' 244' ' ' VAL . 0.6 OUTLIER -101.28 130.22 47.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.42 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 66.2 t -100.35 143.67 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -94.62 -58.75 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.415 ' CB ' ' HA ' ' A' ' 307' ' ' ASP . 14.8 ptt-85 -155.23 163.93 39.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.405 HG13 ' C ' ' A' ' 246' ' ' ARG . 63.8 mt -145.3 140.79 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.66 121.28 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 304' ' ' ASP . 46.1 mt -102.52 118.2 49.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -130.88 154.69 47.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -111.48 93.22 4.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -129.55 102.83 6.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 47.7 39.35 10.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 133.54 121.45 2.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.5 mm -41.12 106.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -126.48 151.03 48.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -152.31 117.82 5.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' MET . . . . . 0.427 ' SD ' HD21 ' A' ' 296' ' ' LEU . 10.5 mtt -77.8 146.47 35.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.468 ' CG2' HD13 ' A' ' 220' ' ' LEU . 95.3 t -137.81 118.77 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.443 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 23.3 tt0 -97.83 152.24 19.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.443 ' N ' ' HG2' ' A' ' 260' ' ' GLU . 55.6 m-85 -126.5 154.91 43.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -41.13 -63.25 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.8 m -131.19 172.33 12.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 94.8 t -59.27 -51.96 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 264' ' ' VAL . 23.4 tp -37.43 -65.59 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 54.6 m -45.72 -42.77 12.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -57.76 -41.47 82.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -52.92 -61.6 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -62.36 -53.37 55.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.933 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -46.76 -49.22 20.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.553 ' HA ' HD13 ' A' ' 288' ' ' ILE . 61.5 tttm -52.19 -47.34 65.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.83 -62.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.101 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -46.17 -36.4 5.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.639 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.9 mp -89.54 -24.22 21.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 271' ' ' LYS . 5.3 t30 -57.43 99.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.83 19.97 69.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -91.99 94.41 9.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.102 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.36 171.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 286' ' ' LEU . 44.5 mt -119.74 -35.23 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' TYR . . . . . 0.408 ' HB2' ' SG ' ' A' ' 283' ' ' CYS . 60.2 m-85 -131.72 174.02 10.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -37.64 102.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.094 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.525 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 26.29 76.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.473 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' CYS . . . . . 0.442 ' HB2' ' CD2' ' A' ' 226' ' ' LEU . 20.2 p -176.13 -175.13 0.68 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.769 0.319 . . . . 0.0 110.897 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 283' ' ' CYS . 3.0 p 36.36 41.42 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 15.5 m -57.32 145.9 30.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 279' ' ' ILE . 69.0 mt -97.44 139.24 33.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -130.11 105.66 8.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.879 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.639 HD11 ' CB ' ' A' ' 274' ' ' LEU . 23.5 mt -91.96 139.21 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 290' ' ' TYR . 16.5 mm-40 -146.17 110.24 4.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.873 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 289' ' ' GLU . 28.5 m-85 -35.99 100.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.949 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.1 159.13 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.105 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.485 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 4.4 mtp-105 -73.16 -58.02 2.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.596 0.712 . . . . 0.0 110.891 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 60.3 Cg_endo -74.24 156.96 46.36 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.227 . . . . 0.0 112.337 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 28.9 p -96.55 -32.45 12.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.162 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.19 143.8 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.427 HD21 ' SD ' ' A' ' 258' ' ' MET . 35.7 mt -118.46 143.59 46.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -120.41 114.56 21.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 71.9 t -85.01 114.45 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.2 mp -67.13 -55.0 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -130.73 150.58 51.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -97.98 97.06 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 303' ' ' ASN . 2.7 p-10 -148.99 172.14 15.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 302' ' ' ASP . 4.7 m-20 -34.52 -44.67 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.415 ' O ' ' CG1' ' A' ' 249' ' ' ILE . 73.2 m-20 -55.5 -55.71 28.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 88.8 p -130.45 135.69 48.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -140.1 116.81 10.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.415 ' HA ' ' CB ' ' A' ' 246' ' ' ARG . 0.8 OUTLIER -105.48 91.93 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -53.98 -44.97 71.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 65.4 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 217' ' ' VAL . 22.2 p-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -64.67 -50.15 68.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.503 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 89.3 t -77.55 150.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.154 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 220' ' ' LEU . 14.1 mt -139.65 125.66 19.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 23.0 tp -84.12 103.34 13.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.503 HD13 HG23 ' A' ' 259' ' ' VAL . 6.9 mp -87.4 129.66 34.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.6 m -122.83 114.8 20.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.499 HD12 ' H ' ' A' ' 222' ' ' ILE . 4.9 mp -81.17 150.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.105 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -115.82 120.16 38.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.508 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 52.3 t30 59.37 50.49 2.96 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.619 0.723 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 57.7 Cg_endo -71.12 106.53 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.252 . . . . 0.0 112.371 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.1 mt -87.77 -47.65 8.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -91.65 133.55 30.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.662 0.744 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.08 117.4 2.49 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.699 2.266 . . . . 0.0 112.314 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.423 HG21 HD21 ' A' ' 234' ' ' LEU . 49.1 mm -85.18 109.23 17.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.166 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 82.8 p -105.24 151.78 23.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 303' ' ' ASN . 33.7 m -38.55 -38.56 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -60.64 -59.61 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.5 t -41.52 -48.28 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.423 HD21 HG21 ' A' ' 229' ' ' ILE . 49.5 mt -69.29 -62.7 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.455 ' CE1' ' HB ' ' A' ' 244' ' ' VAL . 43.9 t80 -48.06 -25.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.503 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 94.0 m -65.08 -48.29 74.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.431 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 89.0 t -84.43 -18.65 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.453 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 85.1 m -81.75 -53.52 6.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -41.69 -49.6 10.04 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 0.0 110.898 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.1 Cg_exo -47.94 -39.05 32.15 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.934 HG11 ' HA ' ' A' ' 270' ' ' ALA . 76.0 t -72.86 -42.46 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.95 -126.09 0.81 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm -116.47 165.97 12.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.677 HG11 HD11 ' A' ' 247' ' ' ILE . 99.2 t -143.02 114.44 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.08 -64.31 1.0 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.403 ' HE ' HG21 ' A' ' 298' ' ' VAL . 6.9 ptm180 -143.92 164.33 30.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.677 HD11 HG11 ' A' ' 244' ' ' VAL . 62.5 mt -142.14 141.54 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.55 134.46 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.449 HD11 ' N ' ' A' ' 231' ' ' VAL . 67.1 mt -119.29 131.59 71.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.539 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 6.4 p90 -142.41 173.31 11.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -129.64 42.62 3.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -80.8 97.68 7.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 62.51 42.8 8.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 121.52 142.98 6.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.458 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 27.6 mm -56.43 116.16 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 0.0 111.096 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.539 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 47.4 mt-30 -142.19 168.75 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -162.43 126.05 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' MET . . . . . 0.481 ' SD ' HD21 ' A' ' 296' ' ' LEU . 15.4 mtt -91.06 120.61 32.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.53 HG22 HG23 ' A' ' 247' ' ' ILE . 86.2 t -110.29 133.16 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -108.22 137.96 45.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -109.57 160.27 16.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -47.28 -62.66 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.7 m -127.74 170.37 12.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 99.4 t -58.33 -52.36 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 14.6 tp -38.59 -62.2 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.941 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 60.8 m -43.39 -40.05 3.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -57.91 -40.65 80.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -54.62 -60.4 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -63.97 -53.92 42.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.934 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.07 -48.8 22.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.544 ' HA ' HD13 ' A' ' 288' ' ' ILE . 19.2 tttt -56.3 -45.29 80.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -65.35 -59.33 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.87 -37.35 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.79 ' CB ' HD11 ' A' ' 288' ' ' ILE . 6.0 mp -91.62 -22.25 20.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 271' ' ' LYS . 4.8 t30 -55.36 101.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.75 22.59 61.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.468 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.627 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -78.49 178.53 7.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.762 0.315 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -145.6 126.53 14.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 33.9 mt -91.83 -31.77 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -126.69 172.68 10.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.3 107.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.25 75.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 1.7 t -174.98 -177.57 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 286' ' ' LEU . 27.3 p 39.36 38.58 0.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 14.1 m -47.57 93.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.627 HD12 ' HB3' ' A' ' 277' ' ' ALA . 32.7 mt -45.97 127.25 8.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -127.12 83.74 2.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.79 HD11 ' CB ' ' A' ' 274' ' ' LEU . 29.2 mt -72.99 145.95 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -151.08 115.53 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -38.55 105.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -56.55 139.99 47.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.157 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 4.9 ttp180 -62.61 -44.9 88.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.893 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.7 Cg_endo -80.36 150.87 19.94 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.698 2.266 . . . . 0.0 112.354 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 41.2 p -92.28 -24.45 18.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -125.59 158.89 33.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.481 HD21 ' SD ' ' A' ' 258' ' ' MET . 48.7 mt -115.78 178.25 4.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.18 116.7 14.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.403 HG21 ' HE ' ' A' ' 246' ' ' ARG . 61.3 t -114.95 102.89 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.77 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.2 mp -66.17 -57.46 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -130.31 176.81 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -107.5 100.83 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -144.63 171.26 14.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.539 ' O ' HG13 ' A' ' 231' ' ' VAL . 2.7 m120 -39.6 -44.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.945 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.88 -57.24 10.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.841 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 26.0 p -133.94 138.66 45.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.847 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -135.68 122.62 21.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -106.74 133.26 51.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -99.81 -47.1 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.168 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.889 0.376 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -47.06 -47.2 22.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.405 HG12 ' CB ' ' A' ' 291' ' ' ALA . 92.2 t -74.45 123.73 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.076 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' A' ' 288' ' ' ILE . 26.2 mt -116.69 130.91 57.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.572 HD13 ' HE2' ' A' ' 258' ' ' MET . 33.5 tp -84.88 112.22 20.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.33 141.95 30.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.6 t -130.66 137.76 49.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.63 117.48 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.132 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -79.34 140.53 37.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.511 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 35.8 t30 38.33 54.0 4.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.607 0.718 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.2 Cg_exo -44.67 100.37 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.674 2.249 . . . . 0.0 112.386 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 46.0 mt -91.75 -51.06 5.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -109.52 132.57 21.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.663 0.744 . . . . 0.0 110.892 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.23 111.86 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.268 . . . . 0.0 112.31 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.598 HD12 HG11 ' A' ' 233' ' ' VAL . 48.7 mm -90.65 112.46 25.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.125 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 20.7 p -105.98 160.93 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 19.3 m -38.41 -37.56 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 235' ' ' TYR . 7.8 m-20 -58.12 -65.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.598 HG11 HD12 ' A' ' 229' ' ' ILE . 73.9 t -37.63 -43.66 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 50.2 mt -76.64 -37.1 56.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 65.8 t80 -81.72 16.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 92.2 m -120.46 -37.11 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.156 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.428 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 86.6 t -98.66 -19.74 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.413 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 59.2 m -89.12 -44.4 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -51.97 -45.73 92.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 110.861 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.3 Cg_exo -47.94 -22.81 3.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.335 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.4 t -96.64 -45.26 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -155.21 152.57 24.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.525 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.89 131.84 51.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.848 0.356 . . . . 0.0 110.888 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.0 t -100.62 136.93 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.152 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -93.62 -65.35 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.545 HH11 HG23 ' A' ' 298' ' ' VAL . 4.0 tmm_? -143.69 152.36 41.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.597 HG23 HG22 ' A' ' 259' ' ' VAL . 74.0 mt -129.35 147.79 33.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.426 HG23 ' CD ' ' A' ' 246' ' ' ARG . 54.4 t -139.85 133.84 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 304' ' ' ASP . 43.7 mt -120.84 129.99 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -144.21 138.02 27.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -99.67 40.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -78.14 101.05 6.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 60.96 42.74 12.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.5 137.82 5.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.2 mm -56.14 112.66 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.128 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -141.89 173.42 11.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -164.63 126.36 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' MET . . . . . 0.572 ' HE2' HD13 ' A' ' 219' ' ' LEU . 36.2 mtt -94.66 120.32 34.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.597 HG22 HG23 ' A' ' 247' ' ' ILE . 94.2 t -110.54 135.38 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.083 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -105.67 153.46 21.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -126.85 163.61 23.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.895 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -47.48 -65.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 t -135.88 174.93 10.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 82.0 t -56.37 -55.3 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.1 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 18.5 tp -40.3 -50.27 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 61.4 m -55.94 -46.12 78.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 271' ' ' LYS . . . -53.84 -35.63 61.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -57.56 -65.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.914 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -59.49 -55.82 29.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.433 ' O ' HD13 ' A' ' 274' ' ' LEU . . . -49.22 -53.2 22.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.07 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.461 ' HA ' HD13 ' A' ' 288' ' ' ILE . 38.6 tttm -53.13 -43.96 67.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 275' ' ' ASN . . . -54.74 -63.45 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.085 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.672 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -53.8 -46.98 71.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.751 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.6 mp -67.0 -28.98 68.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 271' ' ' LYS . 8.9 t30 -65.33 102.87 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.61 19.72 65.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -83.33 92.26 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.32 135.19 57.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 286' ' ' LEU . 60.9 mt -104.65 -42.7 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -117.85 172.84 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -51.97 103.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 35.46 51.52 1.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.447 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.5 m -162.55 164.88 26.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.884 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.7 m 62.5 41.31 9.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 23.6 m -58.21 134.29 56.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.494 HD11 HD11 ' A' ' 279' ' ' ILE . 83.6 mt -88.13 124.92 34.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -119.54 106.79 12.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.751 HD11 ' CB ' ' A' ' 274' ' ' LEU . 18.9 mt -92.54 144.13 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.193 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -155.17 117.44 4.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -41.53 105.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.405 ' CB ' HG12 ' A' ' 217' ' ' VAL . . . -53.07 161.89 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.129 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 30.1 mtt180 -73.86 -56.69 2.72 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.67 0.748 . . . . 0.0 110.89 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 61.1 Cg_endo -74.67 150.42 39.87 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.631 2.221 . . . . 0.0 112.346 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 39.9 p -78.85 -30.14 45.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.456 ' HG2' ' N ' ' A' ' 296' ' ' LEU . 8.7 ttm180 -134.03 148.32 51.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.516 HD21 ' SD ' ' A' ' 258' ' ' MET . 23.6 mt -100.08 -178.14 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -137.42 117.86 13.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.545 HG23 HH11 ' A' ' 246' ' ' ARG . 73.8 t -104.37 112.96 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.123 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.527 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.8 mp -78.0 -51.73 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -127.26 151.96 48.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -92.34 46.94 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.3 172.52 8.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -41.55 -47.16 3.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.467 ' O ' HD12 ' A' ' 249' ' ' ILE . 0.1 OUTLIER -43.13 -62.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.9 p -133.45 147.17 51.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -139.72 140.87 36.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -119.88 115.34 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 309' ' ' THR . 52.9 m-85 -88.62 -48.27 7.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' TYR . 32.4 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.193 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.8 t30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.92 0.391 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 267' ' ' ALA . 6.2 pttt -76.19 -45.85 31.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.512 ' O ' HD23 ' A' ' 218' ' ' LEU . 51.1 t -67.83 146.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.116 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 220' ' ' LEU . 6.8 mt -147.72 123.51 10.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 50.8 tp -71.67 112.98 8.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 218' ' ' LEU . 7.4 mp -99.97 129.03 45.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -120.56 117.28 27.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.825 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.587 HD13 HG22 ' A' ' 255' ' ' ILE . 4.9 mp -81.84 123.32 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -89.3 138.77 31.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.706 ' O ' HD23 ' A' ' 226' ' ' LEU . 74.5 m-20 44.87 53.8 12.05 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.683 0.754 . . . . 0.0 110.927 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 77.0 Cg_exo -47.64 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.723 2.282 . . . . 0.0 112.329 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 224' ' ' ASN . 3.6 mm? -85.45 -56.96 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.447 ' CD2' ' CE2' ' A' ' 280' ' ' TYR . 2.2 m-85 -93.76 143.16 26.09 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.707 0.765 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.24 127.3 12.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 0.0 112.317 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.401 HG13 HG21 ' A' ' 222' ' ' ILE . 49.9 mm -114.75 102.11 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 232' ' ' ASP . 19.9 p -117.43 159.06 23.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.192 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.2 m -38.96 -26.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.4 m-20 -67.28 -61.01 2.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.8 t -47.39 -56.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 34.4 mt -56.72 -61.95 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.559 ' CD1' ' HB ' ' A' ' 244' ' ' VAL . 63.4 t80 -49.76 -33.41 16.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.486 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 98.7 m -64.14 -45.93 86.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.1 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 237' ' ' VAL . 62.0 t -87.88 -5.89 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.473 ' HB3' ' CG2' ' A' ' 244' ' ' VAL . 90.8 m -93.29 -47.23 7.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 8.2 t-20 -51.06 -45.61 88.41 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 0.0 110.886 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -47.97 -41.2 33.13 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 270' ' ' ALA . 40.4 t -70.62 -44.32 76.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.27 -105.48 0.21 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.502 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.8 115.84 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 110.916 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 247' ' ' ILE . 96.3 t -84.04 143.71 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.468 ' HB3' ' CG2' ' A' ' 309' ' ' THR . 21.5 mm-40 -104.2 -68.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -125.03 152.36 44.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.829 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 244' ' ' VAL . 48.6 mt -140.75 128.35 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.63 121.47 56.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.487 HG12 ' CB ' ' A' ' 257' ' ' ALA . 67.9 mt -110.86 119.06 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -126.32 146.11 50.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -102.42 44.71 1.0 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -70.29 86.16 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 55.2 49.22 17.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 135.33 129.67 2.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.587 HG22 HD13 ' A' ' 222' ' ' ILE . 21.3 mm -50.59 103.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.744 0.307 . . . . 0.0 111.158 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -135.47 164.37 27.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.487 ' CB ' HG12 ' A' ' 249' ' ' ILE . . . -166.49 130.75 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 32.8 mtt -94.76 123.31 38.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 247' ' ' ILE . 88.4 t -114.92 130.19 69.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.132 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -109.1 160.36 16.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -130.26 167.85 17.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -40.64 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.5 t -126.1 -176.01 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 267' ' ' ALA . 63.3 t -63.62 -56.96 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 264' ' ' VAL . 25.1 tp -35.47 -59.73 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.4 -37.98 57.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 264' ' ' VAL . . . -61.42 -36.86 81.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.117 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -58.7 -57.85 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -66.72 -47.98 70.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.819 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -51.87 -52.47 49.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.656 ' HG3' HG21 ' A' ' 288' ' ' ILE . 25.8 tttp -48.81 -48.46 41.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -61.41 -69.08 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.088 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -40.96 -36.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.846 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.1 mp -88.65 -25.31 22.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 272' ' ' ALA . 19.5 t30 -60.08 104.22 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 75.1 24.25 72.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -85.87 93.64 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 0.0 111.084 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.73 137.5 57.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.42 HG22 ' CD1' ' A' ' 280' ' ' TYR . 46.9 mt -106.45 -34.42 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' TYR . . . . . 0.447 ' CE2' ' CD2' ' A' ' 227' ' ' TYR . 50.7 m-85 -129.54 172.37 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -45.11 102.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.08 61.34 0.52 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.537 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' CYS . . . . . 0.435 ' C ' ' SG ' ' A' ' 284' ' ' CYS . 92.6 m -156.81 179.01 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 110.91 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 283' ' ' CYS . 0.8 OUTLIER 40.15 43.98 1.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 40.5 m -59.21 85.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 277' ' ' ALA . 47.6 mt -38.59 120.01 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -120.1 85.44 2.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.846 HD11 ' CB ' ' A' ' 274' ' ' LEU . 50.5 mt -75.19 148.68 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.116 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -159.82 121.85 3.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -45.37 103.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -57.3 153.66 11.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.105 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.604 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 5.6 ttt180 -65.94 -44.87 63.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 291' ' ' ALA . 60.9 Cg_endo -80.5 153.02 20.52 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.328 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 37.9 p -96.91 -22.29 16.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -126.24 151.35 47.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.93 179.11 4.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -146.85 133.41 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 93.4 t -122.45 133.35 68.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.064 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.35 -51.2 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.141 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.97 166.35 16.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -114.53 109.97 19.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 303' ' ' ASN . 7.5 t70 -164.19 173.09 12.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 302' ' ' ASP . 39.4 m-20 -33.95 -50.49 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.55 -63.43 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 24.8 m -142.45 147.99 37.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -142.08 137.35 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -122.02 91.11 3.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' TYR . . . . . 0.451 ' O ' ' C ' ' A' ' 309' ' ' THR . 86.9 m-85 -62.99 -49.17 75.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 245' ' ' GLN . 29.0 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 50.1 t30 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.919 0.39 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 267' ' ' ALA . 3.8 pttm -52.55 -43.31 65.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.6 134.51 29.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.2 mt -134.96 125.07 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.2 tp -82.46 112.8 19.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.411 HD23 HD22 ' A' ' 286' ' ' LEU . 6.9 mp -94.25 124.2 38.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.4 m -118.89 104.13 10.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.683 HD12 ' H ' ' A' ' 222' ' ' ILE . 4.4 mp -69.29 144.72 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.476 ' C ' ' CG ' ' A' ' 224' ' ' ASN . 8.9 mm100 -109.85 126.31 53.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 283' ' ' CYS . 0.5 OUTLIER 49.88 54.75 16.27 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.668 0.747 . . . . 0.0 110.894 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 59.2 Cg_endo -72.62 101.6 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.341 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 224' ' ' ASN . 10.1 mp -73.55 -62.55 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -83.79 137.66 40.95 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.662 0.744 . . . . 0.0 110.919 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.49 115.0 1.38 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.741 2.294 . . . . 0.0 112.324 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 29.7 mm -83.72 127.14 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.143 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 24.3 p -121.33 152.04 39.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.484 ' N ' HD11 ' A' ' 249' ' ' ILE . 32.0 m -37.65 -37.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.92 -61.67 2.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 96.6 t -42.46 -52.42 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 26.2 mt -62.04 -59.24 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.569 ' CD2' ' HB ' ' A' ' 244' ' ' VAL . 3.6 t80 -54.28 -24.11 17.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 92.9 m -69.87 -46.07 66.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.117 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.422 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 99.0 t -85.79 -17.38 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.448 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 81.9 m -84.23 -51.3 7.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.543 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -44.0 -48.61 22.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.688 0.756 . . . . 0.0 110.911 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.4 Cg_exo -47.9 -32.77 18.36 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.734 HG11 ' HA ' ' A' ' 270' ' ' ALA . 87.1 t -80.59 -42.91 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.94 -106.85 0.22 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.466 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 26.4 tttt -145.94 163.64 34.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.631 HG11 HD11 ' A' ' 247' ' ' ILE . 86.9 t -133.71 133.88 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.45 ' OE1' ' CG2' ' A' ' 309' ' ' THR . 32.0 mm-40 -92.83 -62.69 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 4.2 ptt-85 -143.36 155.11 44.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.631 HD11 HG11 ' A' ' 244' ' ' VAL . 57.7 mt -137.67 139.09 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.184 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 82.7 t -127.51 124.82 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.484 HD11 ' N ' ' A' ' 231' ' ' VAL . 53.8 mt -110.24 128.81 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.528 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 18.9 p90 -136.61 148.92 47.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -100.12 40.05 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -78.05 109.4 12.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 53.3 t30 55.25 43.45 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.08 -150.07 16.97 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.504 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 11.8 mm -114.4 106.46 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 111.101 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.528 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 21.3 mp0 -132.21 168.01 18.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -168.25 120.47 0.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.092 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 14.1 mtt -87.78 130.87 34.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 247' ' ' ILE . 58.7 t -120.63 137.88 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -101.28 162.77 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.914 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -135.48 158.31 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -46.67 -69.85 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.947 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 16.4 m -121.43 169.59 10.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 86.4 t -54.93 -52.35 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 15.8 tp -42.58 -64.26 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.84 -41.92 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -56.82 -45.67 82.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -63.52 -57.65 9.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -56.82 -37.03 70.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.734 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -71.56 -42.62 67.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.806 ' HA ' HD13 ' A' ' 288' ' ' ILE . 46.0 tttm -53.07 -48.9 67.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -59.64 -68.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.59 -38.17 1.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.706 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.4 mp -86.05 -23.36 26.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 272' ' ' ALA . 34.8 t30 -56.92 101.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.55 19.41 73.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -80.06 93.03 5.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 111.118 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.87 133.11 55.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.46 HD11 HD11 ' A' ' 286' ' ' LEU . 66.8 mt -101.28 -41.22 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' TYR . . . . . 0.404 ' CD1' HG22 ' A' ' 279' ' ' ILE . 13.3 m-85 -116.17 174.44 6.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.63 104.44 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 37.92 54.78 1.9 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' CYS . . . . . 0.485 ' HA ' ' ND2' ' A' ' 224' ' ' ASN . 24.9 p -175.14 155.01 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.866 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 225' ' ' PRO . 61.4 m 65.51 46.1 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 20.7 m -73.75 142.1 46.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.46 HD11 HD11 ' A' ' 279' ' ' ILE . 91.4 mt -86.2 123.8 31.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.939 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.24 81.85 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.806 HD13 ' HA ' ' A' ' 271' ' ' LYS . 31.7 mt -62.53 154.28 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.43 ' N ' HG22 ' A' ' 288' ' ' ILE . 17.1 mt-10 -159.56 114.65 2.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.477 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 45.0 m-85 -39.55 107.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.51 127.58 32.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.104 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.9 OUTLIER -60.68 -45.06 96.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.58 0.705 . . . . 0.0 110.853 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.8 Cg_endo -80.31 148.76 18.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.641 2.227 . . . . 0.0 112.37 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 78.8 p -93.0 -25.79 17.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.165 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -120.36 144.89 47.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 55.0 mt -111.92 -178.98 3.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -139.11 129.99 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.83 110.81 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.786 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.8 mp -62.72 -57.27 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -144.03 176.33 9.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -99.61 87.17 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 303' ' ' ASN . 28.2 t70 -140.99 170.54 15.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 302' ' ' ASP . 86.1 m-20 -36.3 -47.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.852 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -50.12 -56.87 9.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.6 p -138.26 142.78 39.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.81 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -138.94 134.78 33.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -115.38 128.43 56.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -100.8 -59.01 1.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.895 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.45 ' CG2' ' OE1' ' A' ' 245' ' ' GLN . 39.8 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 216' ' ' LYS . 13.0 t30 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 215' ' ' ASN . 0.0 OUTLIER -33.27 -52.72 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 63.3 t -80.47 150.59 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.4 mt -141.48 126.7 18.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.447 HD11 ' OE1' ' A' ' 256' ' ' GLN . 7.8 tp -85.08 104.02 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 9.3 mp -87.87 134.56 33.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.0 m -124.32 111.4 15.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.501 HD12 ' H ' ' A' ' 222' ' ' ILE . 5.3 mp -71.99 140.88 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 224' ' ' ASN . 7.0 tp60 -95.38 143.99 26.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.543 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 53.7 t30 34.96 54.49 1.84 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.591 0.71 . . . . 0.0 110.869 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.1 Cg_exo -47.37 102.19 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.704 2.269 . . . . 0.0 112.3 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 42.7 mt -103.88 -54.03 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -89.88 154.17 47.59 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.705 0.764 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.43 113.69 3.7 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.671 2.247 . . . . 0.0 112.323 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.4 mm -93.73 142.28 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 16.5 p -139.4 163.26 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 303' ' ' ASN . 31.4 m -46.76 -27.81 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.28 -36.27 82.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.9 t -71.12 -47.53 60.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.093 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 18.9 mt -83.74 20.84 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.419 ' O ' ' HB3' ' A' ' 239' ' ' ASN . 75.7 t80 -129.95 -39.28 1.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.966 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.453 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 22.9 m -72.33 -37.43 68.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.19 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.449 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 44.7 t -85.02 -25.67 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.117 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.456 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 78.9 m -83.67 -47.82 10.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.53 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -41.37 -49.29 9.08 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.636 0.732 . . . . 0.0 110.862 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.9 Cg_exo -47.91 -62.17 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.728 2.285 . . . . 0.0 112.36 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 48.4 t -47.05 -50.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.24 -103.39 0.26 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.403 ' C ' ' HD3' ' A' ' 243' ' ' LYS . 1.1 tmtp? -163.75 120.26 1.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 110.916 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.474 HG11 HD11 ' A' ' 247' ' ' ILE . 90.2 t -85.43 142.46 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.494 ' O ' HG23 ' A' ' 309' ' ' THR . 11.0 mm-40 -95.83 -57.79 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -141.24 152.44 44.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.474 HD11 HG11 ' A' ' 244' ' ' VAL . 58.0 mt -137.38 119.37 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 95.1 t -117.96 115.96 50.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.126 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 62.0 mt -103.53 122.18 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 36.8 p90 -131.45 148.81 52.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -124.8 40.95 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ARG . . . . . 0.418 ' HB2' ' NH1' ' A' ' 252' ' ' ARG . 0.2 OUTLIER -72.9 -60.42 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.45 ' O ' ' NE2' ' A' ' 256' ' ' GLN . 93.5 m-20 -129.66 80.01 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 255' ' ' ILE . . . 88.04 116.34 1.26 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.506 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 254' ' ' GLY . 28.1 mm -33.42 104.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 111.141 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.478 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 34.7 mt-30 -136.19 166.42 23.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -165.13 121.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' MET . . . . . 0.404 ' SD ' HD21 ' A' ' 296' ' ' LEU . 13.9 mtt -86.06 137.36 32.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 94.8 t -126.84 129.48 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 261' ' ' PHE . 3.3 tp10 -102.1 148.23 25.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.691 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 41.1 m-85 -122.71 157.64 31.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.453 ' OE1' ' NE2' ' A' ' 245' ' ' GLN . 3.8 mm-40 -36.37 -63.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -143.13 176.19 9.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 87.0 t -52.75 -56.9 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 16.1 tp -39.26 -64.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 83.3 m -49.17 -43.45 42.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -54.89 -40.35 69.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -55.24 -59.09 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -63.3 -51.17 67.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.691 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -48.69 -49.99 35.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.672 ' HA ' HD13 ' A' ' 288' ' ' ILE . 55.0 tttm -54.07 -53.47 52.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -54.11 -70.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -42.43 -41.35 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.608 ' CB ' HD11 ' A' ' 288' ' ' ILE . 3.1 mp -79.64 -23.46 42.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 271' ' ' LYS . 18.4 t-20 -60.0 104.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 76.97 24.02 67.71 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.733 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -82.8 93.24 7.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.775 0.321 . . . . 0.0 111.077 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.44 117.02 2.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.546 HG22 ' CD1' ' A' ' 280' ' ' TYR . 70.1 mt -89.98 -39.82 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.129 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' TYR . . . . . 0.546 ' CD1' HG22 ' A' ' 279' ' ' ILE . 5.5 m-85 -117.73 173.44 6.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -52.86 103.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.071 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.23 59.59 0.62 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.473 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 20.0 p -175.08 163.84 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 82.0 m 60.19 44.41 12.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 30.2 m -59.52 150.0 28.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.733 HD12 ' HB3' ' A' ' 277' ' ' ALA . 40.5 mt -92.51 105.87 17.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -104.78 82.14 1.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.672 HD13 ' HA ' ' A' ' 271' ' ' LYS . 19.3 mt -70.56 142.63 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.09 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -149.04 122.01 8.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -49.15 101.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.442 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -60.45 135.08 57.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.051 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.605 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.4 OUTLIER -59.3 -44.65 98.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 0.0 110.918 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.4 Cg_endo -80.41 144.06 15.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.723 2.282 . . . . 0.0 112.318 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 65.3 p -111.35 34.65 3.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.163 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 296' ' ' LEU . 3.7 tpt180 -144.3 143.59 31.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.423 ' N ' ' HG3' ' A' ' 295' ' ' ARG . 49.2 mt -132.3 114.4 14.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -88.4 135.36 33.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 75.0 t -137.57 115.49 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -83.37 -59.01 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -115.86 166.52 11.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -102.55 44.06 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.05 169.75 17.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.75 ' O ' HG13 ' A' ' 231' ' ' VAL . 1.1 p30 -45.41 -47.24 13.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -44.31 -60.06 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.5 p -133.01 142.55 48.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -140.97 142.09 34.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.75 89.36 3.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.886 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -78.86 45.83 0.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 245' ' ' GLN . 67.4 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.163 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.8 t30 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.884 0.374 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 15.8 mtmm -52.51 -40.75 62.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.841 HG22 ' HG2' ' A' ' 260' ' ' GLU . 42.9 t -84.12 148.25 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 220' ' ' LEU . 13.9 mt -144.89 127.79 16.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.0 tp -84.88 117.9 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.578 HD13 HG23 ' A' ' 259' ' ' VAL . 6.0 mp -101.1 128.77 47.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.5 m -123.22 111.46 16.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.422 HD12 ' H ' ' A' ' 222' ' ' ILE . 5.2 mp -75.94 143.09 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -103.23 137.69 41.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.541 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 17.5 t-20 42.18 52.82 7.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.609 0.719 . . . . 0.0 110.911 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.0 Cg_exo -45.31 119.84 2.8 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.371 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.481 HD22 ' O ' ' A' ' 224' ' ' ASN . 4.1 mm? -88.02 -56.73 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.557 ' CD1' ' CE2' ' A' ' 280' ' ' TYR . 16.5 m-85 -119.45 144.02 35.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.731 0.777 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.91 112.67 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.666 2.244 . . . . 0.0 112.343 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.442 HD12 HG11 ' A' ' 233' ' ' VAL . 48.2 mm -81.95 121.28 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.4 p -107.72 157.11 18.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.15 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 303' ' ' ASN . 27.5 m -40.42 -38.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.156 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 235' ' ' TYR . 48.8 m-20 -56.45 -61.24 2.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 229' ' ' ILE . 97.0 t -36.94 -44.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.15 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.54 -38.12 41.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 71.8 t80 -83.87 19.85 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.487 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 96.2 m -125.0 -36.69 2.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.432 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 98.8 t -97.21 -24.58 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.125 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 85.7 m -85.11 -45.48 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.548 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.1 m120 -49.86 -48.31 78.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.674 0.749 . . . . 0.0 110.903 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 67.0 Cg_exo -48.03 -22.03 3.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.315 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.6 t -89.63 -50.28 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.083 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -145.97 -127.48 1.88 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.433 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.491 ' CB ' ' OE2' ' A' ' 262' ' ' GLU . 32.5 tptt -130.24 131.9 45.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.848 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.501 HG11 HD11 ' A' ' 247' ' ' ILE . 84.2 t -108.29 125.26 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -79.94 -70.22 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -134.68 160.27 38.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.501 HD11 HG11 ' A' ' 244' ' ' VAL . 54.6 mt -137.84 136.61 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 298' ' ' VAL . 62.0 t -135.97 109.53 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 49.2 mt -99.92 100.88 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -105.79 134.61 48.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 78.51 2.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 113.74 18.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 47.12 43.9 14.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.13 119.03 2.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mm -42.38 107.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.329 . . . . 0.0 111.158 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -128.32 143.82 51.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.31 117.7 9.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' MET . . . . . 0.473 ' HB3' HD11 ' A' ' 296' ' ' LEU . 29.6 mtt -90.16 127.37 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.578 HG23 HD13 ' A' ' 220' ' ' LEU . 57.4 t -119.34 143.06 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.841 ' HG2' HG22 ' A' ' 217' ' ' VAL . 17.5 mt-10 -108.37 163.13 13.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.819 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 42.0 m-85 -134.07 158.05 44.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.491 ' OE2' ' CB ' ' A' ' 243' ' ' LYS . 31.2 mt-10 -40.65 -63.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.5 m -140.93 178.52 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.94 -51.06 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 17.5 tp -47.66 -58.83 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 62.8 m -49.86 -43.95 49.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -55.72 -38.01 69.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.084 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -56.69 -65.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -57.58 -53.16 61.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.819 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -50.03 -53.27 27.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.729 ' HG3' HG21 ' A' ' 288' ' ' ILE . 23.4 tttt -53.09 -44.19 67.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.7 -66.01 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.877 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -51.82 -47.27 64.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.504 ' CB ' HD11 ' A' ' 288' ' ' ILE . 2.8 mp -67.59 -28.19 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 271' ' ' LYS . 0.8 OUTLIER -66.85 104.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.07 20.8 75.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -82.15 91.87 6.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.64 128.38 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.654 HG22 ' CD1' ' A' ' 280' ' ' TYR . 73.2 mt -102.57 -41.92 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' TYR . . . . . 0.654 ' CD1' HG22 ' A' ' 279' ' ' ILE . 6.3 m-85 -118.3 173.54 6.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.93 105.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.59 59.99 0.65 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.522 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 31.8 p -175.16 167.11 3.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 2.2 m 62.57 44.11 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 57.3 m -61.55 136.74 58.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 277' ' ' ALA . 61.4 mt -87.38 115.85 25.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -111.12 90.21 3.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.889 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.729 HG21 ' HG3' ' A' ' 271' ' ' LYS . 35.1 mt -76.3 145.59 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 290' ' ' TYR . 18.8 mt-10 -153.71 111.19 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' A' ' 289' ' ' GLU . 26.4 m-85 -37.52 102.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -49.78 144.03 6.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.069 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.599 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 4.6 ttp180 -60.42 -45.04 97.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 0.0 110.801 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.8 Cg_endo -80.3 150.81 20.08 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.6 p -85.6 -24.28 27.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -128.59 175.04 8.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 258' ' ' MET . 80.1 mt -132.47 175.51 9.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -152.6 118.62 5.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 248' ' ' VAL . 63.2 t -102.07 104.71 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.685 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.9 mp -62.69 -59.82 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ARG . . . . . 0.424 ' HG3' HG22 ' A' ' 299' ' ' ILE . 37.6 mtm180 -115.36 154.96 28.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -105.77 105.46 15.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 303' ' ' ASN . 3.3 m-20 -149.02 167.71 25.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.674 ' O ' HG13 ' A' ' 231' ' ' VAL . 65.2 m-20 -34.37 -47.49 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -50.72 -60.77 2.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 248' ' ' VAL . 78.7 p -129.28 133.41 47.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -131.43 137.36 48.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.24 113.55 21.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -89.61 -59.85 2.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 72.1 p . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.173 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 64.5 t30 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.919 0.39 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -68.91 -44.15 73.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.541 HG11 HD21 ' A' ' 296' ' ' LEU . 84.1 t -81.11 142.76 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.415 HD21 ' HB1' ' A' ' 267' ' ' ALA . 20.5 mt -132.2 126.32 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.44 HD11 ' OE1' ' A' ' 256' ' ' GLN . 24.1 tp -82.5 111.92 18.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.568 HD23 HD22 ' A' ' 286' ' ' LEU . 7.7 mp -103.82 130.26 51.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 t -116.1 132.39 56.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.824 HD13 HG22 ' A' ' 255' ' ' ILE . 4.7 mp -92.42 69.02 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.164 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 222' ' ' ILE . 8.2 mm100 -35.73 141.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.53 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 34.4 m-20 44.76 54.22 12.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.646 0.736 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.8 Cg_exo -46.92 93.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.661 2.24 . . . . 0.0 112.331 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.507 HD12 ' HB2' ' A' ' 283' ' ' CYS . 12.3 mt -102.43 -44.62 5.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . 63.8 m-85 -107.6 130.27 23.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.734 0.778 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 227' ' ' TYR . 77.5 Cg_exo -49.47 126.27 15.64 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.7 2.267 . . . . 0.0 112.336 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.806 HD12 HG11 ' A' ' 233' ' ' VAL . 49.6 mm -117.92 118.86 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.407 ' HA ' ' CD1' ' A' ' 249' ' ' ILE . 21.5 p -121.75 167.36 13.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.174 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 35.3 m -40.08 -34.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.54 -43.89 96.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.806 HG11 HD12 ' A' ' 229' ' ' ILE . 61.2 t -66.17 -44.39 91.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 25.4 mt -83.19 20.15 1.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -124.81 -26.33 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 86.5 m -85.72 -36.35 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.444 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 13.3 t -89.15 -21.86 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.154 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 83.7 m -84.79 -47.66 10.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.541 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -46.86 -48.1 51.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.708 . . . . 0.0 110.917 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -48.03 -21.05 2.46 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.649 2.232 . . . . 0.0 112.323 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.937 HG11 ' HA ' ' A' ' 270' ' ' ALA . 77.7 t -96.98 -43.06 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.109 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.73 -158.52 9.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.98 120.55 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.829 0.347 . . . . 0.0 110.87 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.4 t -85.67 133.06 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -95.38 -60.55 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -150.58 153.32 35.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.509 HG23 HG22 ' A' ' 259' ' ' VAL . 68.5 mt -132.19 127.33 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.17 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 298' ' ' VAL . 57.3 t -119.92 112.12 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.432 HG12 ' HB2' ' A' ' 257' ' ' ALA . 58.2 mt -100.04 129.91 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.149 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -138.27 163.56 31.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.736 ' HG3' HD13 ' A' ' 255' ' ' ILE . 22.2 ttpt -120.86 86.03 2.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -120.52 88.58 2.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.5 m120 56.14 42.82 27.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 138.25 108.06 0.81 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.497 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.824 HG22 HD13 ' A' ' 222' ' ' ILE . 31.7 mm -39.79 114.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 111.097 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.44 ' OE1' HD11 ' A' ' 219' ' ' LEU . 13.0 mt-30 -139.69 173.58 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 249' ' ' ILE . . . -165.11 120.76 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.09 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.5 mtt -83.93 123.21 29.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.509 HG22 HG23 ' A' ' 247' ' ' ILE . 67.8 t -117.08 127.74 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -97.3 154.29 17.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -127.32 164.33 22.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -43.85 -65.11 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 25.1 p -138.47 169.61 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 265' ' ' LEU . 75.5 t -49.62 -53.83 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.141 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 264' ' ' VAL . 19.5 tp -38.3 -57.88 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 84.8 m -50.43 -44.84 55.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.415 ' HB1' HD21 ' A' ' 218' ' ' LEU . . . -54.11 -38.8 65.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.091 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -57.02 -60.84 2.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -63.71 -54.1 40.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.937 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.63 -48.8 28.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.643 ' HA ' HD13 ' A' ' 288' ' ' ILE . 49.4 tttm -51.19 -52.19 46.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -57.16 -67.32 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.79 -40.0 1.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.581 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.4 mp -84.98 -22.39 29.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 271' ' ' LYS . 41.1 t30 -60.16 100.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.05 19.95 68.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.513 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.477 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -78.32 91.68 4.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.737 0.303 . . . . 0.0 111.117 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.21 123.37 14.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.873 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.465 HD11 HD11 ' A' ' 286' ' ' LEU . 84.9 mt -95.87 -41.55 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -116.17 173.04 6.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -51.09 102.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.33 61.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' CYS . . . . . 0.507 ' HB2' HD12 ' A' ' 226' ' ' LEU . 28.2 p -175.06 168.83 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.807 0.337 . . . . 0.0 110.883 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 53.5 m 58.99 47.78 11.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 19.7 m -61.81 145.81 51.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.143 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.568 HD22 HD23 ' A' ' 220' ' ' LEU . 50.0 mt -93.71 95.65 9.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -91.22 97.32 11.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' A' ' 271' ' ' LYS . 21.6 mt -83.86 138.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -143.97 124.87 14.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -51.61 97.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.59 156.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.086 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 1.1 mpt_? -71.45 -60.27 2.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.631 0.729 . . . . 0.0 110.882 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 58.8 Cg_endo -71.78 161.59 44.63 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.7 2.267 . . . . 0.0 112.341 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.6 p -97.31 -34.23 11.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -106.85 163.37 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.541 HD21 HG11 ' A' ' 217' ' ' VAL . 40.8 mt -124.04 -177.24 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -144.39 132.62 21.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.546 HG11 ' OD1' ' A' ' 307' ' ' ASP . 75.5 t -122.29 103.01 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.742 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -55.42 -62.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.3 154.47 49.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -84.21 81.38 8.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -124.57 171.76 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -43.0 -47.63 5.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -47.39 -56.74 6.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.2 p -137.6 142.12 41.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -136.43 136.85 39.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.546 ' OD1' HG11 ' A' ' 298' ' ' VAL . 0.8 OUTLIER -114.84 110.92 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.97 -49.34 8.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.964 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 31.3 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.174 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 41.5 t30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.855 0.36 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -38.73 -43.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.508 HG13 HD11 ' A' ' 296' ' ' LEU . 76.6 t -82.07 147.8 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 220' ' ' LEU . 15.4 mt -145.3 123.68 12.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.2 tp -78.91 104.52 9.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.44 HD13 HG23 ' A' ' 259' ' ' VAL . 6.9 mp -87.29 126.06 34.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 54.0 m -117.34 112.79 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 1.021 HD13 HG22 ' A' ' 255' ' ' ILE . 2.4 mp -80.85 118.0 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.471 ' C ' ' CG ' ' A' ' 224' ' ' ASN . 17.8 mm100 -85.28 133.28 34.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.932 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.471 ' CG ' ' C ' ' A' ' 223' ' ' GLN . 0.7 OUTLIER 49.39 54.97 16.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.64 0.733 . . . . 0.0 110.897 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 59.9 Cg_endo -73.36 99.69 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.328 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.87 -40.31 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -88.74 153.47 49.96 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.657 0.742 . . . . 0.0 110.941 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.39 115.93 4.52 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.7 2.266 . . . . 0.0 112.316 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 22.3 mm -97.24 148.17 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 232' ' ' ASP . 16.1 p -148.23 156.13 42.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 303' ' ' ASN . 34.7 m -35.16 -35.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 230' ' ' THR . 6.4 t0 -65.48 -61.58 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 71.6 t -42.02 -46.32 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.437 HD12 HG21 ' A' ' 247' ' ' ILE . 34.8 mt -66.7 -65.6 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.535 ' CD2' ' HB ' ' A' ' 244' ' ' VAL . 5.9 t80 -48.0 -27.44 2.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.428 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 83.6 m -66.01 -47.58 73.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.145 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.441 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 63.5 t -87.42 -15.14 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.428 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 77.3 m -86.13 -46.75 10.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.56 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -47.36 -47.52 57.8 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.626 0.727 . . . . 0.0 110.902 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.8 Cg_exo -47.98 -18.6 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 270' ' ' ALA . 78.6 t -98.6 -42.4 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -162.72 -145.25 4.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.405 ' HD3' ' C ' ' A' ' 243' ' ' LYS . 8.9 tmtm? -116.53 119.21 34.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.535 ' HB ' ' CD2' ' A' ' 235' ' ' TYR . 89.1 t -82.49 141.1 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -96.03 -51.85 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.411 ' NE ' ' OE1' ' A' ' 260' ' ' GLU . 22.9 ptt180 -159.89 153.1 21.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.437 HG21 HD12 ' A' ' 234' ' ' LEU . 53.6 mt -131.82 139.26 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 38.1 t -130.45 110.53 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.138 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 52.9 mt -98.55 140.69 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 8.2 p90 -146.68 139.98 25.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -98.25 43.19 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -79.55 95.46 5.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 62.76 45.79 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 131.28 -155.56 21.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 1.021 HG22 HD13 ' A' ' 222' ' ' ILE . 32.2 mm -116.04 103.38 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 0.0 111.116 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.569 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 19.0 mp0 -131.56 157.31 43.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -162.12 118.63 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.116 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.8 mtt -82.2 128.81 34.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 220' ' ' LEU . 65.4 t -119.33 127.73 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 24.6 tt0 -104.34 149.43 25.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.45 ' N ' ' HG2' ' A' ' 260' ' ' GLU . 60.1 m-85 -118.93 166.51 12.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.839 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -45.67 -64.58 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.4 t -130.87 177.81 7.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.54 -54.54 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.16 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 24.4 tp -40.89 -54.49 2.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.919 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 68.6 m -53.57 -43.05 68.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -56.33 -40.21 74.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.085 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -62.49 -63.55 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -55.48 -44.43 76.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.821 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -64.15 -42.28 96.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.695 ' HA ' HD13 ' A' ' 288' ' ' ILE . 42.6 tttm -55.27 -47.65 75.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.62 -62.12 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.102 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -47.13 -37.17 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.097 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.785 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.7 mp -88.38 -22.77 23.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 271' ' ' LYS . 2.0 t30 -60.52 101.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.46 21.44 69.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.506 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -84.55 93.41 8.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.329 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -49.53 143.53 6.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.615 HG22 ' CD1' ' A' ' 280' ' ' TYR . 68.2 mt -102.17 -36.59 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.157 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' TYR . . . . . 0.615 ' CD1' HG22 ' A' ' 279' ' ' ILE . 62.3 m-85 -139.02 175.88 9.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -39.82 101.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.045 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 29.3 73.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.472 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' CYS . . . . . 0.464 ' HA ' ' ND2' ' A' ' 224' ' ' ASN . 23.5 p -175.96 173.46 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 110.881 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 283' ' ' CYS . 2.0 p 40.25 43.85 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 90.2 m -60.76 139.3 57.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.167 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.435 HD22 HD23 ' A' ' 220' ' ' LEU . 31.5 mt -82.42 123.48 29.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.431 ' C ' ' HE3' ' A' ' 287' ' ' LYS . 0.1 OUTLIER -124.35 87.14 2.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.925 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.785 HD11 ' CB ' ' A' ' 274' ' ' LEU . 17.9 mt -71.38 142.58 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -142.51 115.89 9.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -39.71 100.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -52.24 151.85 3.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.138 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 13.0 mmt180 -73.27 -58.05 2.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.594 0.712 . . . . 0.0 110.869 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 60.0 Cg_endo -73.74 159.09 46.12 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.724 2.282 . . . . 0.0 112.344 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 69.5 p -95.65 -34.84 11.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 296' ' ' LEU . 1.4 tmm_? -105.78 152.8 22.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.508 HD11 HG13 ' A' ' 217' ' ' VAL . 74.9 mt -118.54 154.79 31.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.962 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -116.29 127.33 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' A' ' 307' ' ' ASP . 89.3 t -106.27 105.65 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.158 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.703 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.4 mp -59.2 -62.01 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -131.8 170.42 14.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.43 ' ND2' ' OD1' ' A' ' 307' ' ' ASP . 1.8 m-20 -106.56 100.01 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 303' ' ' ASN . 29.3 t70 -165.58 172.52 11.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.728 ' O ' HG13 ' A' ' 231' ' ' VAL . 1.9 m-80 -34.34 -46.09 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.99 -53.17 28.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 2.9 m -153.48 143.51 22.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.898 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -136.88 149.85 47.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.718 ' HB3' HG21 ' A' ' 298' ' ' VAL . 17.0 p-10 -129.44 95.62 4.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -71.35 -40.46 70.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.416 ' ND2' ' HB ' ' A' ' 217' ' ' VAL . 13.4 t30 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.919 0.39 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -59.65 -42.77 93.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.547 HG11 HD21 ' A' ' 296' ' ' LEU . 91.5 t -76.06 138.29 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.402 ' HB3' HG23 ' A' ' 288' ' ' ILE . 12.4 mt -136.44 128.58 29.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 54.5 tp -83.18 113.47 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.514 HD23 HD22 ' A' ' 286' ' ' LEU . 6.9 mp -99.56 125.71 45.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.3 t -115.38 115.37 26.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.573 HD13 HG22 ' A' ' 255' ' ' ILE . 5.4 mp -77.03 122.24 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -80.05 139.09 37.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.543 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 31.6 m-20 43.44 53.82 10.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.666 0.746 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.6 Cg_exo -47.08 94.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.379 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 13.8 mt -109.91 -44.46 3.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.448 ' CG ' ' CE2' ' A' ' 280' ' ' TYR . 91.6 m-85 -94.66 137.8 22.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.674 0.75 . . . . 0.0 110.912 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.2 132.4 23.41 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.716 2.277 . . . . 0.0 112.341 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.9 mm -122.61 129.9 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.42 ' HA ' ' CD1' ' A' ' 249' ' ' ILE . 21.7 p -144.46 168.58 19.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 33.5 m -42.76 -36.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.2 -44.44 88.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.05 -47.9 88.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.106 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 26.1 mt -84.83 23.68 1.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -130.89 -36.14 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.502 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 26.5 m -79.45 -35.71 39.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.133 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 237' ' ' VAL . 87.6 t -90.62 -14.65 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 76.2 m -87.99 -48.07 8.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.908 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.574 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.8 t-20 -49.78 -46.01 80.01 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.67 0.748 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.0 Cg_exo -47.92 -21.68 2.81 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.68 2.253 . . . . 0.0 112.358 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.482 HG11 ' HB3' ' A' ' 273' ' ' ALA . 21.9 t -99.8 -40.84 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.092 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -152.18 -132.64 1.85 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.46 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -131.8 115.45 15.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.879 HG11 HD11 ' A' ' 247' ' ' ILE . 84.7 t -87.82 137.2 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -109.84 -66.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -120.95 150.2 41.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.879 HD11 HG11 ' A' ' 244' ' ' VAL . 47.7 mt -141.98 121.77 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 66.6 t -119.27 129.45 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 230' ' ' THR . 56.8 mt -120.73 115.39 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -124.32 171.84 9.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -124.78 44.23 2.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.942 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -71.35 96.42 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 47.4 43.1 15.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 140.95 137.85 3.49 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.573 HG22 HD13 ' A' ' 222' ' ' ILE . 44.5 mm -58.33 101.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.328 . . . . 0.0 111.104 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -131.91 158.34 41.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -155.89 117.87 4.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 25.9 mtt -83.11 125.09 31.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 247' ' ' ILE . 90.4 t -115.59 124.33 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.17 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -98.43 145.4 26.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.671 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 40.3 m-85 -118.93 158.0 26.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 261' ' ' PHE . 4.4 mm-40 -34.64 -65.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 11.1 t -139.44 166.23 25.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 87.0 t -42.43 -59.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.124 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 264' ' ' VAL . 22.8 tp -35.82 -63.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 81.2 m -42.89 -45.06 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -52.87 -38.14 61.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -55.98 -59.87 4.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -65.49 -55.79 15.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.671 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -47.41 -48.21 26.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.073 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.735 ' HA ' HD13 ' A' ' 288' ' ' ILE . 17.5 tttt -56.51 -45.23 81.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -60.34 -71.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.093 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.704 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -41.38 -39.53 1.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.768 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.5 mp -81.68 -27.35 34.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 272' ' ' ALA . 18.9 t-20 -59.84 100.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.2 20.71 69.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.457 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -84.23 94.5 8.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.736 0.303 . . . . 0.0 111.093 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.74 128.42 26.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.561 HD11 HD11 ' A' ' 286' ' ' LEU . 77.4 mt -104.42 -44.05 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' TYR . . . . . 0.448 ' CE2' ' CG ' ' A' ' 227' ' ' TYR . 33.8 m-85 -112.37 174.35 5.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.73 103.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 33.91 56.86 0.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.467 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 27.7 p -175.18 168.19 3.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.338 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 87.0 m 62.63 41.41 9.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 15.3 m -59.54 149.94 28.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.21 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 279' ' ' ILE . 57.5 mt -94.77 105.8 17.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -101.59 80.2 2.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.768 HD11 ' CB ' ' A' ' 274' ' ' LEU . 44.4 mt -69.45 141.54 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.133 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -149.24 109.84 4.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -38.3 106.43 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.75 157.23 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.086 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.471 ' CB ' ' CD ' ' A' ' 293' ' ' PRO . 11.9 mmt180 -73.69 -61.41 1.36 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 292' ' ' ARG . 59.0 Cg_endo -71.88 161.21 45.65 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 40.2 p -93.01 -28.14 16.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.144 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.16 160.01 15.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.547 HD21 HG11 ' A' ' 217' ' ' VAL . 66.9 mt -120.95 172.67 7.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -119.51 119.71 34.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.27 93.36 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.441 ' N ' HD13 ' A' ' 299' ' ' ILE . 4.7 mm -46.0 -66.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.36 160.54 43.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -64.88 101.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.83 171.77 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.833 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -46.3 -52.8 11.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.32 -53.87 10.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.7 p -143.39 140.93 30.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -126.77 145.49 50.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -126.71 92.45 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 309' ' ' THR . 58.6 m-85 -69.44 -50.7 43.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.899 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 308' ' ' TYR . 76.3 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.16 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 65.0 t30 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.908 0.385 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -74.79 -41.3 60.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' A' ' 260' ' ' GLU . 52.6 t -79.24 142.79 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.117 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.555 ' HB3' HG23 ' A' ' 288' ' ' ILE . 19.3 mt -139.81 132.35 28.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.86 111.96 18.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.33 127.3 49.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.3 t -115.33 138.72 50.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.85 131.03 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.136 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -94.7 133.46 38.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.581 ' O ' HD22 ' A' ' 226' ' ' LEU . 0.3 OUTLIER 46.17 53.34 12.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.884 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.0 Cg_exo -45.09 84.63 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.657 2.238 . . . . 0.0 112.351 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.581 HD22 ' O ' ' A' ' 224' ' ' ASN . 4.0 mm? -58.65 -59.79 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -117.57 146.38 38.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.666 0.746 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.78 114.86 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 0.0 112.336 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.554 HD12 HG11 ' A' ' 233' ' ' VAL . 27.6 mm -87.12 120.13 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.185 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 21.4 p -104.81 161.46 14.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 232' ' ' ASP . 30.4 m -42.37 -40.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 235' ' ' TYR . 7.8 m-20 -55.42 -60.72 3.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.554 HG11 HD12 ' A' ' 229' ' ' ILE . 95.5 t -38.03 -37.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 41.6 mt -88.54 -31.85 18.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.774 ' CD1' ' CE2' ' A' ' 308' ' ' TYR . 37.6 t80 -84.75 23.37 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.502 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 88.3 m -125.21 -38.74 2.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.14 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 237' ' ' VAL . 59.1 t -94.21 -15.4 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.428 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 97.1 m -88.72 -47.46 8.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.571 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 8.6 t-20 -50.58 -45.63 85.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.661 0.743 . . . . 0.0 110.928 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.2 Cg_exo -47.98 -22.97 3.87 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.27 . . . . 0.0 112.354 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' ' 270' ' ' ALA . 91.4 t -96.97 -45.58 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -146.6 -145.18 4.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.508 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.53 112.17 17.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.815 0.341 . . . . 0.0 110.937 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.509 ' HB ' ' CE1' ' A' ' 235' ' ' TYR . 51.4 t -80.73 141.7 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.165 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.493 ' NE2' ' OE1' ' A' ' 262' ' ' GLU . 13.0 mm100 -101.7 -60.89 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.9 mtm-85 -140.78 156.91 46.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.455 HD11 HG11 ' A' ' 244' ' ' VAL . 74.9 mt -142.56 138.45 28.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.11 134.76 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 87.6 mt -116.07 108.11 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -115.72 164.23 14.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -121.89 43.83 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -94.65 106.99 18.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.6 t30 68.1 44.12 1.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 105.91 151.05 19.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 39.1 mm -56.38 113.4 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -141.24 165.2 28.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -156.76 124.63 5.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 29.6 mtt -88.87 124.04 33.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.413 HG13 HG12 ' A' ' 247' ' ' ILE . 72.9 t -112.08 138.02 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.642 ' HG2' HG22 ' A' ' 217' ' ' VAL . 8.9 tm-20 -114.69 140.96 48.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -114.55 162.67 16.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.493 ' OE1' ' NE2' ' A' ' 245' ' ' GLN . 4.4 mm-40 -41.28 -65.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.2 m -137.5 176.31 8.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 265' ' ' LEU . 98.2 t -56.43 -56.75 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.158 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 264' ' ' VAL . 20.4 tp -37.51 -54.02 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 6.7 m -52.2 -47.0 65.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.25 -37.47 64.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -55.62 -63.44 1.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -61.34 -58.64 7.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.772 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -46.96 -49.65 20.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.133 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.612 ' HA ' HD13 ' A' ' 288' ' ' ILE . 49.3 tttm -47.82 -54.59 11.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -53.17 -66.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -42.98 -43.81 4.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.873 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.9 mp -77.52 -22.33 51.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 272' ' ' ALA . 44.4 t-20 -55.94 99.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.99 19.72 72.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.498 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -86.31 95.82 9.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 111.103 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.56 155.23 39.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 44.4 mt -113.89 -53.9 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -95.7 172.47 8.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -52.68 107.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.139 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.37 48.18 0.62 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 23.0 m -161.1 177.4 10.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.7 m 49.42 44.26 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 41.1 m -63.51 143.93 57.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.124 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 90.3 mt -94.19 122.99 37.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -116.35 98.74 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.873 HD11 ' CB ' ' A' ' 274' ' ' LEU . 28.3 mt -79.27 139.11 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.178 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -150.23 114.36 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.441 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 77.6 m-85 -41.32 103.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.958 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -55.08 159.67 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.121 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.491 ' CB ' ' CD ' ' A' ' 293' ' ' PRO . 47.6 mtt180 -73.94 -62.17 1.14 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.583 0.706 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 292' ' ' ARG . 58.3 Cg_endo -71.8 156.96 56.24 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.673 2.249 . . . . 0.0 112.34 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 64.3 p -93.01 -36.33 12.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -107.28 148.7 28.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.48 HD11 HG13 ' A' ' 217' ' ' VAL . 31.3 mt -117.72 150.28 39.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -98.56 120.4 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.63 102.02 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.472 ' N ' HD13 ' A' ' 299' ' ' ILE . 4.6 mm -46.71 -61.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -175.05 162.53 3.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -52.71 94.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 305' ' ' SER . 2.3 m-20 -141.69 172.85 12.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -54.64 -41.83 70.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -56.73 -59.92 4.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 302' ' ' ASP . 3.3 t -130.3 152.52 49.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -134.03 138.54 45.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -122.5 98.86 6.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.844 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' TYR . . . . . 0.774 ' CE2' ' CD1' ' A' ' 235' ' ' TYR . 99.4 m-85 -76.21 -50.84 13.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 308' ' ' TYR . 46.1 p . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.178 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 217' ' ' VAL . 0.1 OUTLIER -52.3 -33.67 43.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.579 HG12 ' CB ' ' A' ' 291' ' ' ALA . 62.0 t -77.77 137.73 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 15.2 mt -134.91 134.37 40.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.453 HD11 ' OE1' ' A' ' 256' ' ' GLN . 22.1 tp -89.94 110.29 21.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.982 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.2 mp -97.51 139.76 32.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -128.81 131.61 47.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.877 HD13 HG22 ' A' ' 255' ' ' ILE . 4.9 mp -91.56 122.02 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.158 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -82.22 143.64 31.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.536 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 15.6 m-20 39.8 54.42 5.83 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.615 0.721 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 74.4 Cg_exo -47.21 92.55 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.738 2.292 . . . . 0.0 112.31 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 11.6 mt -100.78 -48.83 4.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -100.47 137.11 19.86 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.67 0.748 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.51 113.54 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.671 2.248 . . . . 0.0 112.328 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.437 HG13 HG21 ' A' ' 222' ' ' ILE . 47.6 mm -101.11 104.04 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.7 p -104.5 159.44 15.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.17 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.462 ' N ' HD11 ' A' ' 249' ' ' ILE . 26.8 m -42.77 -35.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.25 -58.72 7.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 95.2 t -45.15 -45.17 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.093 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 40.1 mt -68.66 -61.89 1.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.46 ' C ' ' CD1' ' A' ' 235' ' ' TYR . 4.8 t80 -49.58 -29.21 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 98.1 m -64.71 -46.98 80.0 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.126 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 237' ' ' VAL . 61.1 t -87.49 -10.07 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.44 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 82.1 m -88.94 -45.17 9.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.909 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.577 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 4.8 t30 -49.59 -46.11 78.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -47.96 -19.92 1.8 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.694 2.262 . . . . 0.0 112.336 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.986 HG11 ' HA ' ' A' ' 270' ' ' ALA . 87.4 t -99.1 -46.92 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.42 -170.18 30.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 244' ' ' VAL . 6.6 tmtm? -82.59 151.14 26.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.368 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.564 HG11 HD11 ' A' ' 247' ' ' ILE . 91.0 t -121.52 128.99 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -80.69 -62.63 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -151.07 155.4 38.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.661 HG12 HG13 ' A' ' 259' ' ' VAL . 77.0 mt -136.85 150.95 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.638 HG22 HG22 ' A' ' 298' ' ' VAL . 94.0 t -136.52 139.91 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 231' ' ' VAL . 88.9 mt -125.38 116.63 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -129.05 158.39 39.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.87 41.84 2.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ARG . . . . . 0.402 ' HD3' ' C ' ' A' ' 252' ' ' ARG . 0.0 OUTLIER -67.54 86.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.854 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.2 t30 59.79 42.62 16.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.841 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 137.09 127.89 2.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.53 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.877 HG22 HD13 ' A' ' 222' ' ' ILE . 50.9 mm -48.4 113.11 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.766 0.317 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.453 ' OE1' HD11 ' A' ' 219' ' ' LEU . 37.1 mt-30 -137.67 165.46 26.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.32 127.07 4.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 11.0 mtt -95.67 126.25 40.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.661 HG13 HG12 ' A' ' 247' ' ' ILE . 61.2 t -123.83 127.02 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -105.85 172.74 6.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -142.24 169.78 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -54.27 -68.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 13.8 m -119.35 173.32 7.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 64.6 t -60.43 -52.39 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.139 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 55.2 tp -38.58 -63.48 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 80.7 m -48.03 -46.37 33.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -53.32 -45.57 69.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -63.74 -55.53 22.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -55.26 -58.27 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.986 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -51.24 -46.2 62.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.698 ' HA ' HD13 ' A' ' 288' ' ' ILE . 56.8 tttm -49.03 -52.0 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -56.82 -67.03 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.93 -41.12 2.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.547 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.9 mp -83.6 -22.15 32.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 271' ' ' LYS . 1.2 t30 -57.36 104.7 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.0 22.69 77.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -83.24 90.52 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 0.0 111.134 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.76 129.28 19.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.588 HD11 HD21 ' A' ' 286' ' ' LEU . 79.8 mt -99.4 -41.8 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -117.3 173.15 6.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -50.28 103.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.132 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.44 48.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.499 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.2 m -161.42 174.44 13.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.319 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 34.0 m 52.94 42.36 32.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 11.3 m -57.58 152.13 15.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.155 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.588 HD21 HD11 ' A' ' 279' ' ' ILE . 50.9 mt -97.85 125.93 42.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 94.88 4.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.698 HD13 ' HA ' ' A' ' 271' ' ' LYS . 34.0 mt -85.62 145.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 290' ' ' TYR . 25.7 mt-10 -155.28 113.82 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 289' ' ' GLU . 68.9 m-85 -34.74 107.27 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.579 ' CB ' HG12 ' A' ' 217' ' ' VAL . . . -50.51 135.95 21.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.084 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.576 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 5.9 ttt180 -64.14 -46.67 79.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.587 0.708 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.5 Cg_endo -79.37 149.81 21.93 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.667 2.245 . . . . 0.0 112.38 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.5 p -87.1 -27.52 23.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.11 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -121.22 154.47 36.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 48.1 mt -114.62 179.67 3.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -145.1 133.84 22.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.638 HG22 HG22 ' A' ' 248' ' ' VAL . 96.8 t -131.23 105.69 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.576 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.2 mp -63.41 -60.57 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.122 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ARG . . . . . 0.47 ' HG3' HG22 ' A' ' 299' ' ' ILE . 88.4 mtt-85 -124.82 166.97 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 302' ' ' ASP . 2.1 m-20 -106.67 95.19 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 303' ' ' ASN . 0.9 OUTLIER -141.19 172.38 12.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 302' ' ' ASP . 1.7 p-10 -34.23 -41.69 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -57.4 -63.35 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.4 p -129.57 149.47 51.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -150.9 120.94 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.81 100.66 12.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -84.1 38.51 0.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 291' ' ' ALA . 7.1 p-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.494 ' HG2' ' N ' ' A' ' 264' ' ' VAL . 17.3 mtmm -42.99 -45.85 5.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.0 137.64 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.614 ' O ' HD12 ' A' ' 220' ' ' LEU . 19.7 mt -131.99 120.64 22.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.4 HD13 ' HZ ' ' A' ' 250' ' ' PHE . 17.0 tp -76.8 114.52 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.776 HD13 HG23 ' A' ' 259' ' ' VAL . 7.0 mp -102.34 147.95 26.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.0 120.82 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 229' ' ' ILE . 5.2 mp -80.62 123.93 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -81.54 137.57 35.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.561 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 50.4 t30 44.18 53.57 10.83 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.7 Cg_exo -47.3 103.98 0.06 OUTLIER 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.67 2.247 . . . . 0.0 112.38 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 37.8 mt -107.46 -47.65 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.543 ' CD2' ' CD2' ' A' ' 280' ' ' TYR . 94.8 m-85 -97.37 141.11 22.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.689 0.757 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.55 117.33 2.29 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.707 2.271 . . . . 0.0 112.371 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.481 HG21 HD11 ' A' ' 222' ' ' ILE . 30.5 mm -99.61 106.3 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.627 HG22 ' OD1' ' A' ' 303' ' ' ASN . 28.7 p -111.53 165.82 11.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 306' ' ' TRP . 28.9 m -47.38 -40.44 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.147 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 235' ' ' TYR . 9.7 t0 -57.22 -63.89 1.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 232' ' ' ASP . 90.8 t -35.67 -36.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.17 -37.6 18.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 49.2 t80 -84.11 25.85 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.497 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 89.8 m -130.78 -36.22 1.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.124 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.435 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 25.4 t -98.12 -23.58 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.12 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.446 ' SG ' HD21 ' A' ' 274' ' ' LEU . 98.1 m -86.18 -48.78 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.568 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 11.9 t30 -47.43 -47.04 59.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.592 0.71 . . . . 0.0 110.85 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.8 Cg_exo -48.02 -21.5 2.8 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.643 2.229 . . . . 0.0 112.333 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 273' ' ' ALA . 20.2 t -93.12 -48.64 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.097 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -138.12 -128.02 2.58 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -138.11 114.72 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.759 HG11 HD11 ' A' ' 247' ' ' ILE . 58.9 t -94.84 139.95 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.42 ' NE2' ' OE1' ' A' ' 262' ' ' GLU . 3.3 mm100 -108.09 -67.32 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -116.84 158.19 24.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.759 HD11 HG11 ' A' ' 244' ' ' VAL . 79.6 mt -149.72 108.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' A' ' 305' ' ' SER . 48.2 t -107.62 143.25 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 257' ' ' ALA . 73.1 mt -126.61 114.89 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.4 ' HZ ' HD13 ' A' ' 219' ' ' LEU . 15.8 p90 -125.69 146.2 49.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -91.95 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -67.17 89.76 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 12.5 m120 50.58 42.02 26.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 137.32 136.2 3.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.506 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 32.7 mm -51.12 97.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.767 0.318 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -127.38 152.74 47.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.564 ' HB2' HG12 ' A' ' 249' ' ' ILE . . . -146.51 124.58 12.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.091 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' MET . . . . . 0.496 ' SD ' HD21 ' A' ' 296' ' ' LEU . 25.9 mtt -86.68 118.62 26.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.776 HG23 HD13 ' A' ' 220' ' ' LEU . 57.8 t -102.97 138.06 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -111.26 143.05 42.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -119.07 174.47 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.856 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.42 ' OE1' ' NE2' ' A' ' 245' ' ' GLN . 3.9 mm-40 -56.71 -66.82 0.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.425 ' C ' ' HG2' ' A' ' 216' ' ' LYS . 93.0 p -139.02 165.64 26.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.83 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.494 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 90.7 t -43.15 -54.38 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.116 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 34.7 tp -45.11 -60.8 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 81.7 m -47.91 -39.27 18.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -59.6 -39.29 83.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -57.43 -59.82 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -56.79 -58.75 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.43 ' O ' HD13 ' A' ' 274' ' ' LEU . . . -49.06 -57.45 6.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.692 ' HG3' HG21 ' A' ' 288' ' ' ILE . 55.6 tttm -42.94 -50.26 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -47.5 -71.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.133 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.644 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -47.76 -48.61 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.886 ' HB3' HD11 ' A' ' 288' ' ' ILE . 6.5 mp -64.58 -24.75 67.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 271' ' ' LYS . 50.4 t30 -62.16 102.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 76.27 20.77 76.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.505 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -86.36 94.8 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.0 111.12 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.03 162.99 6.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 53.5 mt -121.5 -42.95 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' TYR . . . . . 0.543 ' CD2' ' CD2' ' A' ' 227' ' ' TYR . 52.4 m-85 -112.74 173.43 6.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -50.77 104.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.101 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.63 58.53 0.71 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.495 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 26.1 p -175.1 160.48 2.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 110.872 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.6 m 63.47 46.67 4.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 286' ' ' LEU . 18.0 m -67.9 155.93 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.404 ' N ' HG22 ' A' ' 285' ' ' THR . 80.3 mt -98.82 125.84 44.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -115.23 98.22 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.886 HD11 ' HB3' ' A' ' 274' ' ' LEU . 74.5 mt -84.05 146.77 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.15 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -159.67 113.32 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -40.83 102.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -54.95 145.77 19.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.569 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 8.9 ttm180 -61.97 -47.26 91.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.601 0.715 . . . . 0.0 110.826 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 61.3 Cg_endo -78.9 148.89 22.53 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.682 2.255 . . . . 0.0 112.276 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.9 p -90.55 -26.36 19.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -123.81 149.85 45.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.496 HD21 ' SD ' ' A' ' 258' ' ' MET . 78.9 mt -105.37 178.85 4.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.924 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -138.39 110.37 7.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 85.5 t -120.99 110.7 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.8 mp -73.23 -54.03 16.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.18 151.62 51.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.36 97.15 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 303' ' ' ASN . 7.7 p-10 -130.9 166.11 21.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.627 ' OD1' HG22 ' A' ' 230' ' ' THR . 1.1 t30 -36.5 -45.54 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -60.66 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' SER . . . . . 0.544 ' HB2' HG22 ' A' ' 248' ' ' VAL . 55.7 p -134.31 128.42 33.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' TRP . . . . . 0.505 ' HB2' HG11 ' A' ' 231' ' ' VAL . 17.0 t-105 -114.14 149.48 35.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -129.29 106.24 8.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -82.62 -43.37 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 -179.975 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.774 ' OD1' HG22 ' A' ' 294' ' ' THR . 23.5 t30 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.922 0.391 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -52.54 -46.06 66.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 90.1 t -81.59 131.11 34.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.128 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.463 HD22 ' HZ2' ' A' ' 271' ' ' LYS . 14.9 mt -123.09 128.17 49.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.658 HD11 ' OE1' ' A' ' 256' ' ' GLN . 29.4 tp -81.97 102.73 11.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.491 HD13 HG23 ' A' ' 259' ' ' VAL . 8.4 mp -89.54 132.78 34.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m -123.64 118.12 26.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.2 mp -81.2 138.76 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.12 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.438 ' C ' ' HD3' ' A' ' 225' ' ' PRO . 2.1 tp-100 -96.68 141.45 29.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.542 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 48.7 t30 35.5 53.76 1.97 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.62 0.724 . . . . 0.0 110.843 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 77.6 Cg_exo -45.98 106.69 0.1 OUTLIER 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.367 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 66.7 mt -101.97 -48.4 4.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -112.49 126.1 28.92 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.675 0.75 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.55 112.25 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.63 HG21 HD21 ' A' ' 234' ' ' LEU . 29.5 mm -88.09 92.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.133 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.684 HG23 ' HB3' ' A' ' 303' ' ' ASN . 2.3 m -70.85 170.3 12.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.577 ' H ' HG22 ' A' ' 230' ' ' THR . 24.5 m -55.63 -41.31 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.408 ' N ' HG23 ' A' ' 231' ' ' VAL . 67.9 m-20 -58.05 -53.33 59.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.9 t -44.72 -37.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.63 HD21 HG21 ' A' ' 229' ' ' ILE . 52.6 mt -85.07 -35.65 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 81.8 t80 -82.55 19.95 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.412 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 93.0 m -122.78 -36.92 2.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.118 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.426 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 90.0 t -99.75 -18.84 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.441 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 58.5 m -89.07 -46.06 9.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.588 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.6 OUTLIER -50.58 -45.59 85.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.583 0.706 . . . . 0.0 110.896 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.4 Cg_exo -47.97 -28.19 9.93 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.681 2.254 . . . . 0.0 112.337 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 29.8 t -86.56 -49.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.097 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.92 -132.55 3.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -133.31 107.53 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.63 HG11 HD11 ' A' ' 247' ' ' ILE . 96.4 t -88.92 119.84 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.457 ' NE2' ' CD ' ' A' ' 262' ' ' GLU . 1.4 mm100 -81.13 -68.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.454 ' NH1' ' O ' ' A' ' 296' ' ' LEU . 7.5 ptp180 -132.97 154.9 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.63 HD11 HG11 ' A' ' 244' ' ' VAL . 70.4 mt -133.43 135.28 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.478 HG13 ' OG ' ' A' ' 305' ' ' SER . 58.7 t -126.98 132.05 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.16 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 23.4 mt -120.61 118.68 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.501 ' CE2' ' HB3' ' A' ' 256' ' ' GLN . 20.2 p90 -126.75 155.18 43.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -110.22 45.22 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -90.05 109.91 20.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 61.51 41.41 12.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 109.04 149.82 13.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.457 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.9 mm -51.37 123.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 111.113 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.658 ' OE1' HD11 ' A' ' 219' ' ' LEU . 17.2 tt0 -153.15 163.79 39.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.24 146.18 16.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 35.3 mtt -111.38 124.92 53.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.491 HG23 HD13 ' A' ' 220' ' ' LEU . 65.7 t -111.89 121.64 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.667 ' HB2' HD12 ' A' ' 296' ' ' LEU . 3.9 tp10 -98.36 140.81 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.527 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 42.0 m-85 -116.35 158.21 23.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.457 ' CD ' ' NE2' ' A' ' 245' ' ' GLN . 3.9 mm-40 -41.48 -67.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 10.0 m -130.52 173.84 10.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.856 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 92.1 t -57.02 -56.72 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 264' ' ' VAL . 17.4 tp -38.27 -64.06 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 61.6 m -45.59 -42.15 10.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -55.91 -40.35 72.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -52.04 -62.95 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -59.77 -59.99 4.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.527 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -42.78 -48.8 5.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.706 ' HG3' HG21 ' A' ' 288' ' ' ILE . 27.2 tttp -56.15 -44.29 79.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.04 -60.39 3.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.078 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -49.72 -40.45 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.732 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.7 mp -83.99 -22.61 31.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 271' ' ' LYS . 2.7 t30 -62.17 100.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.56 18.0 61.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.451 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.786 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -80.56 154.3 27.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.331 . . . . 0.0 111.135 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -118.24 134.85 54.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.576 HD11 HD21 ' A' ' 286' ' ' LEU . 65.7 mt -101.53 -40.33 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.148 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.2 172.73 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -54.2 105.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.063 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.84 56.89 0.8 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.1 m -167.54 161.1 13.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.8 m 62.3 39.27 12.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.9 m -55.48 143.47 29.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.186 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.786 HD12 ' HB3' ' A' ' 277' ' ' ALA . 67.8 mt -93.41 126.74 38.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.883 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -124.92 84.92 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.732 HD11 ' CB ' ' A' ' 274' ' ' LEU . 27.0 mt -71.27 144.95 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -147.68 120.07 8.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.549 ' CE2' ' HE2' ' A' ' 271' ' ' LYS . 59.0 m-85 -45.84 96.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.8 147.07 15.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.052 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.474 ' HB2' ' HD3' ' A' ' 293' ' ' PRO . 56.8 mtt-85 -65.41 -61.07 6.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.584 0.707 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 292' ' ' ARG . 58.9 Cg_endo -71.37 154.55 60.95 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.654 2.236 . . . . 0.0 112.34 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.774 HG22 ' OD1' ' A' ' 215' ' ' ASN . 37.0 p -116.14 38.54 3.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.475 ' HG2' ' N ' ' A' ' 296' ' ' LEU . 37.4 ttt180 -149.88 151.21 33.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.667 HD12 ' HB2' ' A' ' 260' ' ' GLU . 85.9 mt -141.58 120.91 13.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -106.96 135.05 49.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 92.0 t -120.25 98.34 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.163 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.8 mp -55.49 -62.55 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -119.88 169.65 9.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.424 ' ND2' ' OD1' ' A' ' 307' ' ' ASP . 3.2 m120 -107.49 114.83 29.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.414 ' CG ' ' C ' ' A' ' 301' ' ' ASN . 0.9 OUTLIER -162.56 172.15 15.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.684 ' HB3' HG23 ' A' ' 230' ' ' THR . 20.8 m120 -42.34 -40.28 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.62 -46.31 70.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' SER . . . . . 0.478 ' OG ' HG13 ' A' ' 248' ' ' VAL . 8.6 m -158.03 143.89 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -134.88 145.19 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.424 ' OD1' ' ND2' ' A' ' 301' ' ' ASN . 2.2 p-10 -119.34 106.65 12.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.836 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.44 -39.67 24.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 37.9 p . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.16 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.0 t30 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.89 0.376 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -51.24 -41.26 60.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.418 HG11 HD21 ' A' ' 296' ' ' LEU . 50.4 t -78.64 147.38 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 10.1 mt -138.52 139.59 38.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.66 109.54 21.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.859 HD23 HD22 ' A' ' 286' ' ' LEU . 7.6 mp -97.87 129.33 44.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -119.77 115.72 24.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.85 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -82.46 134.98 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.161 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.426 ' C ' ' HD3' ' A' ' 225' ' ' PRO . 2.2 tp-100 -100.4 139.06 36.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.552 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 12.9 t-20 35.61 54.0 2.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.5 Cg_exo -47.18 113.9 0.84 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.358 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 224' ' ' ASN . 3.3 mm? -89.25 -58.82 2.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.24 143.63 26.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.74 0.781 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.16 112.68 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.714 2.276 . . . . 0.0 112.354 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.7 mm -89.32 116.54 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 18.6 p -126.73 169.29 13.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 303' ' ' ASN . 33.0 m -48.81 -20.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.97 -40.96 68.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.7 t -70.29 -31.8 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.17 10.48 35.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -121.94 -5.87 9.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.475 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 40.0 m -108.5 -32.51 7.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.134 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 237' ' ' VAL . 59.7 t -97.2 -7.56 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 61.2 m -100.73 -45.36 5.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.588 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.6 t-20 -52.04 -45.39 93.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.644 0.735 . . . . 0.0 110.878 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.6 Cg_exo -48.04 -23.78 4.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 34.1 t -92.18 -53.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.45 -134.89 3.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.525 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.492 ' HE2' ' N ' ' A' ' 244' ' ' VAL . 0.0 OUTLIER -128.49 94.93 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.87 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.634 HG11 HD11 ' A' ' 247' ' ' ILE . 72.9 t -53.11 132.94 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -110.53 -66.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.491 ' NE ' ' OD2' ' A' ' 307' ' ' ASP . 16.3 ttm105 -128.76 143.15 50.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.634 HD11 HG11 ' A' ' 244' ' ' VAL . 43.3 mt -128.63 132.51 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.093 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.49 HG22 HG22 ' A' ' 298' ' ' VAL . 46.8 t -136.55 132.45 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.2 mt -124.06 113.71 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.142 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -120.29 143.6 48.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -113.35 43.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -60.18 -70.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -107.15 48.16 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.58 -120.89 4.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.7 mm -133.81 93.92 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 111.172 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -125.99 167.9 14.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -161.89 124.98 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' MET . . . . . 0.596 ' HB3' HD11 ' A' ' 296' ' ' LEU . 10.7 mtt -93.59 119.23 32.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.78 130.42 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.092 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -104.65 153.92 20.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -125.27 169.43 12.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -37.91 -73.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.9 m -137.57 -175.27 4.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 60.1 t -55.15 -50.9 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.085 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 15.9 tp -46.28 -59.41 2.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 3.5 t -55.29 -30.84 60.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -70.26 -36.13 74.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -58.14 -54.4 47.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -68.52 -44.02 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.14 -49.57 71.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.677 ' HG3' HG21 ' A' ' 288' ' ' ILE . 27.0 tttm -50.97 -56.55 11.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.23 -59.45 5.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.13 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.61 -30.69 3.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.035 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.801 ' CB ' HD11 ' A' ' 288' ' ' ILE . 3.4 mp -98.07 -14.84 20.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 271' ' ' LYS . 8.9 t-20 -58.43 108.18 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 68.74 18.93 72.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.488 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -72.48 99.33 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.28 113.24 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.824 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 87.0 mt -72.36 -32.76 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' TYR . . . . . 0.424 ' O ' ' C ' ' A' ' 281' ' ' ALA . 63.2 m-85 -136.53 150.76 48.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 280' ' ' TYR . . . -35.85 105.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.1 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 39.86 70.87 0.31 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -174.84 150.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 0.0 110.919 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 3.3 m 57.36 51.56 9.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 28.1 m -60.59 109.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.859 HD22 HD23 ' A' ' 220' ' ' LEU . 35.5 mt -68.48 107.29 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -102.23 91.71 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.801 HD11 ' CB ' ' A' ' 274' ' ' LEU . 97.6 mt -79.59 139.58 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.1 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -149.1 125.97 11.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.537 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 32.4 m-85 -48.69 100.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.987 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -53.93 142.05 25.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.597 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.6 OUTLIER -64.55 -44.79 75.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.9 Cg_endo -80.46 147.53 17.92 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.709 2.272 . . . . 0.0 112.339 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 36.8 p -88.57 -14.32 37.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -127.59 164.95 20.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 258' ' ' MET . 42.9 mt -122.0 171.61 8.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.94 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -129.26 98.66 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 307' ' ' ASP . 85.9 t -81.09 101.76 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.123 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.484 HG22 ' HE ' ' A' ' 300' ' ' ARG . 3.2 mm -38.03 -63.24 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' ARG . . . . . 0.484 ' HE ' HG22 ' A' ' 299' ' ' ILE . 16.1 ptp180 -170.17 142.29 2.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -39.49 100.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -167.63 172.52 9.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.712 ' O ' HG13 ' A' ' 231' ' ' VAL . 12.6 m-80 -47.68 -57.0 6.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.7 -41.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' SER . . . . . 0.43 ' OG ' HG13 ' A' ' 248' ' ' VAL . 8.5 m -162.39 136.94 6.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -126.77 129.06 47.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.587 ' HB2' HG21 ' A' ' 298' ' ' VAL . 19.8 t0 -121.8 81.02 1.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.859 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' TYR . . . . . 0.518 ' CZ ' HG22 ' A' ' 309' ' ' THR . 1.6 p90 -70.72 -37.66 73.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.518 HG22 ' CZ ' ' A' ' 308' ' ' TYR . 30.5 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 55.1 t30 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.905 0.384 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -43.72 79.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 296' ' ' LEU . 92.8 t -88.13 146.78 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.101 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.3 mt -135.43 124.99 25.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 36.0 tp -81.62 109.03 15.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.3 mp -95.84 129.47 43.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 63.1 m -112.73 127.07 56.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.575 HD13 HG22 ' A' ' 255' ' ' ILE . 4.8 mp -89.61 121.74 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.74 138.77 39.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.517 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 1.8 m-20 43.43 53.92 10.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.73 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.5 Cg_exo -45.87 90.24 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.337 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.7 mt -97.04 -42.45 7.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -111.45 153.54 44.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.732 0.777 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.75 115.81 4.28 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.537 HG21 HD21 ' A' ' 234' ' ' LEU . 30.3 mm -99.23 92.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 231' ' ' VAL . 1.6 m -71.81 167.22 20.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.093 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 230' ' ' THR . 21.2 m -54.44 -39.53 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.34 -52.05 67.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 96.0 t -46.05 -40.14 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.537 HD21 HG21 ' A' ' 229' ' ' ILE . 33.7 mt -76.05 -60.5 2.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.964 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -47.31 -34.06 6.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.481 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 87.2 m -63.35 -47.8 80.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.149 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 237' ' ' VAL . 59.6 t -86.94 -10.77 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.128 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.435 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 72.9 m -87.39 -49.2 7.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.571 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 14.3 t30 -48.53 -46.48 70.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.649 0.738 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.3 Cg_exo -47.96 -18.63 1.2 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.667 2.245 . . . . 0.0 112.399 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 37.0 t -104.4 -41.62 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.79 -144.71 4.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -123.16 126.4 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.914 HG11 HD11 ' A' ' 247' ' ' ILE . 85.4 t -96.19 147.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -108.22 -61.89 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 247' ' ' ILE . 21.3 ttm180 -134.6 147.82 50.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.914 HD11 HG11 ' A' ' 244' ' ' VAL . 61.3 mt -140.54 131.0 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.466 HG22 HG22 ' A' ' 298' ' ' VAL . 89.7 t -125.67 135.87 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 304' ' ' ASP . 58.5 mt -120.94 120.82 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -136.1 155.13 50.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -131.76 40.59 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -68.78 -57.26 5.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -119.77 45.77 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 116.69 128.49 4.17 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.443 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.575 HG22 HD13 ' A' ' 222' ' ' ILE . 42.9 mm -43.92 104.41 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -146.3 170.76 16.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.54 130.22 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' MET . . . . . 0.467 ' SD ' ' CD2' ' A' ' 296' ' ' LEU . 22.4 mtt -87.89 118.0 27.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 87.7 t -107.87 123.43 63.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -103.08 150.3 23.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 262' ' ' GLU . 56.4 m-85 -126.0 161.12 28.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 261' ' ' PHE . 23.4 mt-10 -34.15 -70.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 t -140.39 167.71 21.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 94.8 t -41.04 -57.14 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 264' ' ' VAL . 19.6 tp -37.22 -63.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 30.7 m -47.36 -42.2 21.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -56.33 -38.31 71.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -56.14 -59.44 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -66.32 -50.9 62.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.954 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -49.42 -49.92 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.68 ' HA ' HD13 ' A' ' 288' ' ' ILE . 58.9 tttm -52.57 -46.96 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -60.05 -70.52 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -42.29 -36.8 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.713 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.7 mp -85.94 -23.97 26.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 271' ' ' LYS . 14.3 t-20 -58.75 102.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.9 23.07 60.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -93.24 93.71 8.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.1 148.63 50.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 41.0 mt -104.5 -40.34 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.89 172.93 6.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -57.16 107.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.4 55.68 0.75 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.514 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 6.5 m -164.47 153.67 13.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 4.9 m 62.82 44.53 6.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 39.2 m -59.92 129.22 40.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.439 ' O ' ' NZ ' ' A' ' 287' ' ' LYS . 35.5 mt -78.28 123.31 26.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 286' ' ' LEU . 0.9 OUTLIER -121.83 84.96 2.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.713 HD11 ' CB ' ' A' ' 274' ' ' LEU . 28.6 mt -65.26 144.02 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.174 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -153.98 111.09 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -38.07 106.26 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.62 160.76 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.097 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 14.8 mtt-85 -73.04 -59.37 2.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 59.7 Cg_endo -73.23 159.09 47.89 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.711 2.274 . . . . 0.0 112.342 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 34.4 p -88.22 -25.1 23.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -173.88 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.606 HD21 HG11 ' A' ' 217' ' ' VAL . 17.8 mt -142.24 168.34 19.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -125.56 114.97 19.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.466 HG22 HG22 ' A' ' 248' ' ' VAL . 84.5 t -106.02 102.86 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.7 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.4 mp -57.25 -51.31 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.03 155.42 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -90.09 85.38 6.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.4 173.16 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -39.39 -51.12 2.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.402 ' O ' HD12 ' A' ' 249' ' ' ILE . 2.1 m-20 -45.46 -59.87 2.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 63.8 p -135.13 138.46 43.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -139.56 127.44 22.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -104.02 98.22 8.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -83.72 40.21 0.73 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.138 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.6 t30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.859 0.362 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -58.1 -42.95 86.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.438 ' O ' HD23 ' A' ' 218' ' ' LEU . 59.6 t -73.84 139.27 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.123 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 217' ' ' VAL . 29.5 mt -138.6 126.82 22.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.46 113.48 21.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.489 HD23 HD22 ' A' ' 286' ' ' LEU . 6.9 mp -100.53 132.68 45.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -119.33 137.92 53.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.599 HD13 HG22 ' A' ' 255' ' ' ILE . 5.2 mp -105.28 125.31 60.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -82.57 142.43 31.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.517 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 42.0 t30 40.12 53.49 5.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.3 Cg_exo -44.7 103.61 0.05 OUTLIER 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.697 2.265 . . . . 0.0 112.343 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 55.2 mt -105.08 -46.93 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -100.5 153.61 37.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.709 0.766 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.75 116.34 4.64 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.711 2.274 . . . . 0.0 112.35 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.534 HG21 HD21 ' A' ' 234' ' ' LEU . 43.7 mm -100.22 119.98 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 232' ' ' ASP . 18.2 p -122.57 156.16 34.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 303' ' ' ASN . 34.4 m -33.62 -35.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.2 m-20 -60.96 -65.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 87.3 t -43.62 -51.02 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.16 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.534 HD21 HG21 ' A' ' 229' ' ' ILE . 46.1 mt -60.93 -58.33 8.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.549 ' CE2' ' HB ' ' A' ' 244' ' ' VAL . 3.2 t80 -54.68 -25.86 29.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.422 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 66.6 m -70.19 -45.86 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.171 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.439 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 39.4 t -87.2 -15.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 71.0 m -86.27 -46.12 10.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.556 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -47.11 -47.76 54.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.866 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.0 Cg_exo -47.96 -21.07 2.41 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.723 2.282 . . . . 0.0 112.366 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.874 HG11 ' HA ' ' A' ' 270' ' ' ALA . 69.7 t -98.73 -39.09 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.13 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.53 -154.11 7.94 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.457 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.408 ' HB3' ' CD ' ' A' ' 262' ' ' GLU . 2.5 tmtm? -104.23 144.39 31.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.944 HG11 HD11 ' A' ' 247' ' ' ILE . 63.0 t -108.69 141.3 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -110.66 -65.11 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.446 ' HG2' ' N ' ' A' ' 247' ' ' ILE . 17.4 ttm180 -130.9 145.08 51.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.944 HD11 HG11 ' A' ' 244' ' ' VAL . 71.3 mt -138.34 140.17 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 305' ' ' SER . 17.1 t -131.37 139.98 49.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.418 HG12 ' CB ' ' A' ' 257' ' ' ALA . 77.2 mt -129.02 109.45 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -118.96 151.29 38.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 40.88 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -58.48 -63.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -109.19 43.6 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.31 -121.96 4.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.495 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.599 HG22 HD13 ' A' ' 222' ' ' ILE . 28.7 mm -129.61 91.21 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 111.102 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -124.83 159.68 30.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.418 ' CB ' HG12 ' A' ' 249' ' ' ILE . . . -155.91 122.93 5.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' MET . . . . . 0.464 ' SD ' HD21 ' A' ' 296' ' ' LEU . 19.3 mtt -86.07 125.07 33.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.447 HG23 HD13 ' A' ' 220' ' ' LEU . 95.6 t -111.85 118.86 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -94.31 156.44 16.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -130.67 169.04 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.892 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 262' ' ' GLU . 10.9 mp0 -54.26 -64.2 0.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 73.7 m -128.49 172.53 11.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 91.2 t -61.12 -51.43 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 24.9 tp -40.74 -63.49 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 33.5 m -46.03 -40.59 10.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -58.06 -39.21 77.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -56.75 -57.09 13.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -63.51 -60.35 3.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.874 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.62 -50.01 25.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.113 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.555 ' HG3' HG21 ' A' ' 288' ' ' ILE . 49.2 tttm -48.55 -51.67 26.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -59.36 -66.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.67 -37.75 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.473 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.4 mp -87.8 -22.1 24.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 272' ' ' ALA . 7.3 t30 -57.86 104.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.03 23.01 70.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.49 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -79.59 118.37 21.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.25 125.29 28.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 286' ' ' LEU . 78.4 mt -97.8 -41.04 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.146 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -117.77 172.58 7.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -54.38 105.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.12 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 35.63 54.26 1.07 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.497 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 4.3 m -165.45 163.77 19.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.01 41.89 7.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 54.0 m -55.8 118.49 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 279' ' ' ILE . 36.3 mt -71.39 127.08 31.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -127.02 95.03 4.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.555 HG21 ' HG3' ' A' ' 271' ' ' LYS . 38.7 mt -77.23 147.36 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -150.38 124.05 9.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -49.64 97.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -47.5 134.75 11.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.116 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.575 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 9.2 ttp180 -60.21 -46.61 97.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 0.0 110.817 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.2 Cg_endo -79.45 149.26 21.38 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.712 2.275 . . . . 0.0 112.349 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 60.6 p -92.66 -25.25 18.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -123.9 139.59 53.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.464 HD21 ' SD ' ' A' ' 258' ' ' MET . 40.0 mt -100.43 176.57 5.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -131.46 115.42 16.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.56 105.66 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.135 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.671 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -65.92 -59.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.136 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -132.9 175.58 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -104.16 105.69 15.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 303' ' ' ASN . 0.9 OUTLIER -149.7 166.74 28.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 231' ' ' VAL . 5.0 p30 -33.71 -39.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.58 -58.24 9.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' SER . . . . . 0.416 ' HB2' ' HA ' ' A' ' 248' ' ' VAL . 9.8 t -134.35 153.62 51.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -144.13 134.24 24.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -112.91 108.74 17.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.811 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -79.51 -50.58 10.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.902 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 68.6 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 -179.937 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.408 ' ND2' ' HB ' ' A' ' 217' ' ' VAL . 51.5 t30 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.921 0.391 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 264' ' ' VAL . 40.2 mtmt -57.61 -41.91 82.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.674 HG11 HD21 ' A' ' 296' ' ' LEU . 55.8 t -77.59 138.58 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 220' ' ' LEU . 14.0 mt -133.79 119.2 18.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.9 tp -76.25 106.58 7.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.695 HD13 ' CG2' ' A' ' 259' ' ' VAL . 6.9 mp -92.98 123.76 36.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.0 m -114.27 118.96 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.0 mp -79.55 133.9 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.09 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.43 ' C ' ' HD3' ' A' ' 225' ' ' PRO . 43.8 mt-30 -91.15 141.91 28.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.547 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 62.7 t30 35.11 54.42 1.91 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.632 0.73 . . . . 0.0 110.874 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.8 Cg_exo -47.33 115.91 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.326 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 62.6 mt -108.17 -54.86 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -101.08 137.82 19.82 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.67 0.748 . . . . 0.0 110.867 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.77 125.94 13.76 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.673 2.248 . . . . 0.0 112.365 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.442 HD12 HG11 ' A' ' 233' ' ' VAL . 49.9 mm -104.55 126.4 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.107 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.0 p -125.77 163.84 21.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.131 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 235' ' ' TYR . 35.8 m -40.22 -35.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.166 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -55.99 -45.54 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 229' ' ' ILE . 94.7 t -61.9 -52.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 31.4 mt -84.11 24.38 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.455 ' CB ' ' O ' ' A' ' 231' ' ' VAL . 85.2 t80 -130.58 -37.25 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.971 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.499 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 85.2 m -80.58 -34.27 35.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.447 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 11.6 t -87.88 -19.4 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.462 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 73.0 m -84.63 -50.64 7.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.545 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 1.5 t-20 -45.31 -47.39 34.3 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.631 0.729 . . . . 0.0 110.904 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.6 Cg_exo -47.98 -30.93 14.76 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.259 . . . . 0.0 112.336 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.01 -39.86 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.168 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.47 -133.24 1.46 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.52 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -121.34 143.7 49.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.896 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.66 128.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.708 ' O ' HG23 ' A' ' 309' ' ' THR . 30.6 mm-40 -92.46 -59.44 2.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -147.27 154.3 40.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 79.5 mt -133.4 134.54 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 298' ' ' VAL . 58.1 t -133.47 116.06 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.5 mt -108.08 106.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -118.93 149.19 42.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.512 ' HG3' HD13 ' A' ' 255' ' ' ILE . 2.6 mppt? -118.16 41.45 2.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -54.25 -63.86 1.02 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -109.52 43.26 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.3 -118.82 3.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.512 HD13 ' HG3' ' A' ' 251' ' ' LYS . 41.8 mm -127.05 95.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 111.132 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -128.83 157.52 41.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -156.32 118.52 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 24.7 mtt -87.53 125.74 34.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.695 ' CG2' HD13 ' A' ' 220' ' ' LEU . 91.7 t -111.58 131.59 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.103 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 261' ' ' PHE . 5.0 tp10 -104.77 152.0 23.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.583 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 55.1 m-85 -130.08 157.6 41.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 261' ' ' PHE . 67.3 mt-10 -34.99 -66.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.2 p -143.68 174.54 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.432 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 74.5 t -47.82 -59.87 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 264' ' ' VAL . 18.1 tp -35.98 -60.12 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 85.9 m -53.22 -40.97 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -57.27 -36.88 71.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -58.76 -58.27 9.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -66.13 -53.03 42.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.583 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -49.38 -47.83 47.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.804 ' HG3' HG21 ' A' ' 288' ' ' ILE . 24.6 tttt -53.38 -55.57 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.847 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -53.64 -67.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.109 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -41.96 -42.29 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.602 ' CB ' HD11 ' A' ' 288' ' ' ILE . 3.6 mp -81.82 -22.0 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 271' ' ' LYS . 65.4 t30 -61.61 101.76 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.89 21.46 71.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.629 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -82.1 93.79 7.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.118 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.36 117.08 2.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.587 HD11 HD21 ' A' ' 286' ' ' LEU . 80.3 mt -91.14 -37.43 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.134 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -120.35 173.86 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -56.87 104.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.128 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.49 59.12 0.67 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.423 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 31.2 p -175.12 162.45 3.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.908 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 77.2 m 62.48 43.08 8.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 5.9 m -57.24 146.78 27.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.629 HD12 ' HB3' ' A' ' 277' ' ' ALA . 73.6 mt -91.81 119.33 31.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -116.71 79.53 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.804 HG21 ' HG3' ' A' ' 271' ' ' LYS . 47.6 mt -65.41 147.73 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -151.85 113.63 4.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.435 ' HE2' ' HZ1' ' A' ' 271' ' ' LYS . 39.1 m-85 -41.12 101.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -50.67 138.9 17.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 6.2 ttt180 -66.08 -45.7 62.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.62 0.724 . . . . 0.0 110.889 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.3 Cg_endo -80.21 148.37 18.98 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.315 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.8 p -82.11 -25.75 34.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.438 ' HD3' ' N ' ' A' ' 296' ' ' LEU . 0.4 OUTLIER -119.21 -174.66 2.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.674 HD21 HG11 ' A' ' 217' ' ' VAL . 52.0 mt -139.17 173.35 11.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.928 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -124.83 117.9 25.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 248' ' ' VAL . 77.9 t -122.35 91.73 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.057 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.714 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -50.43 -56.55 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.44 177.23 8.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -99.19 96.47 7.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -136.16 171.55 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -42.11 -45.28 3.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -55.67 -62.3 1.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 97.4 p -129.05 137.15 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -140.98 132.16 26.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -116.21 92.47 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 309' ' ' THR . 53.3 m-85 -69.02 -43.58 74.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 245' ' ' GLN . 47.5 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.136 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 49.7 t30 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.862 0.363 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -46.2 -40.22 10.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 49.0 t -77.81 137.23 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.095 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 24.1 mt -136.93 129.98 30.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.03 118.88 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.52 134.7 50.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.8 t -119.63 137.6 53.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.76 HD13 HG22 ' A' ' 255' ' ' ILE . 5.2 mp -99.21 128.83 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -89.75 138.96 31.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.508 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 9.6 t-20 39.52 52.7 4.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.624 0.726 . . . . 0.0 110.935 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.5 Cg_exo -43.7 94.33 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.641 2.228 . . . . 0.0 112.334 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 20.2 mt -95.86 -43.78 7.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -102.71 153.48 38.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.715 0.769 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.29 115.77 4.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.696 2.264 . . . . 0.0 112.274 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.8 mm -98.41 110.48 26.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 232' ' ' ASP . 49.6 p -105.99 158.46 16.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.13 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 303' ' ' ASN . 18.3 m -41.49 -26.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.123 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.5 m-20 -68.22 -61.98 1.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' VAL . . . . . 0.477 ' CG1' HD13 ' A' ' 279' ' ' ILE . 78.5 t -39.45 -45.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 31.5 mt -77.74 -37.92 48.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.595 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 76.9 t80 -83.42 20.14 1.4 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 99.2 m -124.43 -37.19 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.142 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.413 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 89.1 t -98.21 -19.26 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 65.3 m -89.75 -45.55 9.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.589 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.1 OUTLIER -51.37 -45.35 89.96 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.728 . . . . 0.0 110.944 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.1 Cg_exo -47.97 -56.87 2.71 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.711 2.274 . . . . 0.0 112.318 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.3 -47.04 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -142.74 -108.08 0.65 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.507 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.535 ' O ' ' CD2' ' A' ' 261' ' ' PHE . 13.7 tptp -152.33 151.34 30.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.74 HG11 HD11 ' A' ' 247' ' ' ILE . 95.1 t -127.94 122.36 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -82.64 -69.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -137.24 156.91 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.74 HD11 HG11 ' A' ' 244' ' ' VAL . 55.5 mt -137.06 133.47 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.721 HG22 HG22 ' A' ' 298' ' ' VAL . 94.9 t -126.54 110.18 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 257' ' ' ALA . 60.4 mt -94.09 126.14 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.159 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -141.35 135.16 30.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -84.5 41.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -89.59 119.19 29.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.8 m120 51.49 40.95 28.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 109.56 135.71 7.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.463 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.76 HG22 HD13 ' A' ' 222' ' ' ILE . 38.0 mm -46.56 104.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.321 . . . . 0.0 111.152 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -134.1 164.42 27.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.468 ' HB2' HG12 ' A' ' 249' ' ' ILE . . . -152.51 122.03 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' MET . . . . . 0.431 ' SD ' HD21 ' A' ' 296' ' ' LEU . 26.4 mtt -83.42 114.68 21.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.517 HG22 HG12 ' A' ' 247' ' ' ILE . 88.7 t -106.8 119.44 56.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 11.0 tt0 -91.54 151.01 20.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 243' ' ' LYS . 30.3 m-85 -123.5 163.74 20.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -52.97 -72.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 66.8 m -114.8 -174.95 2.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 58.6 t -77.66 -44.54 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 36.6 tp -51.61 -65.8 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 24.3 p -42.44 -38.22 1.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -60.04 -38.66 83.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -58.68 -59.39 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -56.56 -53.7 54.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.448 ' O ' HD13 ' A' ' 274' ' ' LEU . . . -52.57 -55.04 25.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.074 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.416 ' HA ' HD13 ' A' ' 288' ' ' ILE . 41.5 tttm -43.09 -51.34 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -46.86 -73.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -45.49 -50.18 12.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.071 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.919 ' HB3' HD11 ' A' ' 288' ' ' ILE . 5.1 mp -61.47 -26.79 68.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 271' ' ' LYS . 33.6 t30 -60.62 105.05 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.15 25.66 70.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.459 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -86.02 93.36 8.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 0.0 111.131 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.69 131.92 45.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.477 HD13 ' CG1' ' A' ' 233' ' ' VAL . 72.6 mt -88.56 -34.34 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -121.61 173.13 7.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -55.32 112.55 1.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.17 73.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.536 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.6 t -175.31 177.78 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.313 . . . . 0.0 110.911 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 27.8 p 39.44 46.61 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 55.8 m -57.86 90.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -45.72 131.13 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -127.8 96.85 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' ILE . . . . . 0.919 HD11 ' HB3' ' A' ' 274' ' ' LEU . 66.3 mt -80.2 145.94 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -153.01 114.91 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -43.08 98.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -48.15 141.73 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.602 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 0.0 OUTLIER -69.86 -47.43 23.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.56 0.695 . . . . 0.0 110.859 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 62.5 Cg_endo -77.57 144.28 22.33 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.676 2.251 . . . . 0.0 112.34 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 81.1 p -83.7 -31.31 26.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -112.8 161.11 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.431 HD21 ' SD ' ' A' ' 258' ' ' MET . 74.6 mt -119.36 -178.28 3.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -143.02 113.53 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.721 HG22 HG22 ' A' ' 248' ' ' VAL . 87.9 t -116.16 106.07 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.515 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.2 mp -66.87 -55.88 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 300' ' ' ARG . . . . . 0.42 ' CG ' ' OD2' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -133.83 153.13 51.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -90.09 87.19 6.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.42 ' OD2' ' CG ' ' A' ' 300' ' ' ARG . 5.0 p30 -123.18 171.78 9.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.683 ' O ' HG13 ' A' ' 231' ' ' VAL . 6.5 m120 -39.89 -45.9 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.468 ' O ' ' CG1' ' A' ' 249' ' ' ILE . 25.7 m-20 -57.42 -61.52 2.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' SER . . . . . 0.444 ' CB ' ' HA ' ' A' ' 248' ' ' VAL . 97.0 p -123.33 131.79 53.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -144.16 119.11 9.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -97.69 117.65 32.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.88 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -98.61 44.18 1.04 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 76.7 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.139 -179.972 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 48.3 t -171.44 157.22 4.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.899 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.2 m -162.92 143.89 9.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -167.93 147.6 11.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 54.3 m -107.96 142.59 37.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.796 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 95.9 p -126.85 118.39 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.866 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -134.77 156.09 22.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.513 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -156.05 162.64 40.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -126.47 135.24 51.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.2 mt -41.28 137.59 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.0 m -154.95 124.24 6.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.51 145.85 54.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.564 0.697 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.3 -25.61 6.89 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.699 2.266 . . . . 0.0 112.315 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -62.11 145.78 49.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.434 ' O ' ' C ' ' A' ' 208' ' ' THR . 47.2 t30 -120.06 151.17 39.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.901 0.381 . . . . 0.0 110.899 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 207' ' ' ASN . 97.0 m -34.35 125.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -93.52 164.36 13.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.43 ' CG ' ' HD2' ' A' ' 211' ' ' PRO . 11.5 t70 -151.09 140.94 14.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.608 0.718 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 210' ' ' ASP . 62.6 Cg_endo -77.66 14.2 1.5 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.714 2.276 . . . . 0.0 112.373 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 211' ' ' PRO . 2.0 m -37.25 115.28 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.821 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.26 147.83 16.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.509 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 120.53 110.86 2.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.537 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 217' ' ' VAL . 4.1 p-10 -151.33 153.01 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 110.9 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -30.99 69.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.499 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 95.7 t -86.86 140.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 14.0 mt -134.38 132.34 39.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 49.1 tp -81.89 103.82 11.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.9 mp -90.96 128.61 36.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.17 112.49 17.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.772 HD12 ' H ' ' A' ' 222' ' ' ILE . 3.5 mp -75.42 130.62 36.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.139 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -99.47 120.52 39.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 19.0 m-20 63.61 52.28 1.41 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 0.0 110.91 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 60.2 Cg_endo -74.41 47.09 1.53 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.654 2.236 . . . . 0.0 112.352 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.3 mt -39.86 -41.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -97.78 141.49 23.08 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.68 0.752 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.31 124.38 9.11 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.734 2.289 . . . . 0.0 112.282 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.6 mm -107.11 109.04 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.12 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.1 p -102.98 159.05 15.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.461 ' N ' HD11 ' A' ' 249' ' ' ILE . 21.8 m -44.37 -39.88 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -54.19 -55.84 24.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.1 t -45.12 -39.11 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 25.7 mt -78.49 -64.06 1.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -46.9 -27.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.477 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 63.6 m -64.34 -47.69 78.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 237' ' ' VAL . 65.1 t -87.37 -11.2 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.115 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 64.4 m -87.39 -49.06 7.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.579 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 6.0 t30 -48.65 -46.36 71.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.657 0.741 . . . . 0.0 110.896 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.2 Cg_exo -47.97 -17.4 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.8 HG11 ' HA ' ' A' ' 270' ' ' ALA . 96.2 t -102.59 -41.34 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -174.2 177.26 46.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 142.87 56.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.1 t -110.57 134.64 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -80.77 -60.84 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -161.74 155.07 21.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.791 HG12 HG22 ' A' ' 259' ' ' VAL . 74.9 mt -134.93 119.13 26.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 298' ' ' VAL . 49.1 t -110.76 115.03 48.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 231' ' ' VAL . 64.5 mt -97.35 114.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.173 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 7.5 p90 -116.3 162.38 17.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -117.87 90.92 3.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -133.04 94.45 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 59.51 38.95 22.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 131.06 131.17 3.25 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.47 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.569 HG22 HD13 ' A' ' 222' ' ' ILE . 33.1 mm -48.1 102.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.539 ' HB3' ' CE1' ' A' ' 250' ' ' PHE . 27.7 mt-30 -118.15 166.14 12.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -168.17 130.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.065 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 33.8 mtt -97.1 132.82 42.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.791 HG22 HG12 ' A' ' 247' ' ' ILE . 97.7 t -122.73 125.31 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.154 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -101.85 150.52 23.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -122.36 159.36 27.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -41.19 -65.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.7 t -130.71 176.23 8.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 85.7 t -60.24 -51.43 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.111 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 20.9 tp -39.07 -62.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 65.7 m -47.44 -41.82 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -55.87 -42.75 76.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -54.88 -58.56 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -62.25 -56.67 16.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.866 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.8 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.18 -47.96 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.122 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.484 ' HA ' HD13 ' A' ' 288' ' ' ILE . 22.7 tttt -50.27 -48.8 54.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -64.48 -67.71 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -39.78 -33.76 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.776 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.5 mp -92.39 -28.13 17.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 272' ' ' ALA . 6.0 t30 -55.27 100.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.3 21.95 61.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -84.35 92.41 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.33 129.21 39.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.566 HG22 ' CD1' ' A' ' 280' ' ' TYR . 74.4 mt -100.36 -41.64 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.177 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' TYR . . . . . 0.566 ' CD1' HG22 ' A' ' 279' ' ' ILE . 8.1 m-85 -117.38 171.56 7.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -55.11 108.62 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.115 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.7 53.75 0.82 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 25.5 p -174.51 172.01 3.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 69.5 m 56.08 41.12 29.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 54.4 m -68.98 143.94 54.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.171 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.466 HD11 HD11 ' A' ' 279' ' ' ILE . 88.5 mt -89.14 127.33 35.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -118.89 80.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.776 HD11 ' CB ' ' A' ' 274' ' ' LEU . 17.0 mt -71.28 144.32 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 290' ' ' TYR . 19.7 mt-10 -157.31 107.79 2.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 289' ' ' GLU . 41.9 m-85 -34.4 101.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -56.19 165.24 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 0.4 OUTLIER -71.82 -57.8 3.86 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.647 0.736 . . . . 0.0 110.856 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 59.5 Cg_endo -73.14 160.47 45.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.67 2.247 . . . . 0.0 112.345 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 217' ' ' VAL . 33.2 p -102.95 -27.58 12.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -111.81 144.9 40.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 80.5 mt -109.45 175.9 5.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -135.87 139.05 43.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 248' ' ' VAL . 95.2 t -134.97 97.29 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.141 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.733 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -51.5 -57.3 3.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -139.69 175.95 9.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.76 116.67 33.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -159.29 171.32 20.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -44.47 -39.93 5.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.16 -61.11 2.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 53.4 p -131.05 133.46 45.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -124.18 141.17 52.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -115.04 100.88 8.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.36 -47.95 38.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 25.6 p -37.88 -43.55 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.526 ' HG3' ' CE1' ' A' ' 312' ' ' TYR . 28.0 ttpt -126.84 89.12 52.87 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.568 0.699 . . . . 0.0 110.93 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.31 -4.91 14.04 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 0.0 112.36 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.594 ' C ' HD22 ' A' ' 313' ' ' LEU . 15.9 p90 -101.8 103.76 14.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.594 HD22 ' C ' ' A' ' 312' ' ' TYR . 3.9 mm? -130.4 -61.21 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -103.15 101.64 2.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.509 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -84.32 41.84 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.897 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.409 ' C ' ' HD2' ' A' ' 316' ' ' ARG . 1.9 ppt_? . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.9 m -162.85 147.09 11.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 110.891 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.8 m -167.94 164.69 13.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -152.58 161.57 29.55 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.527 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 47.5 t -173.19 132.54 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 0.0 110.831 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.2 t -174.21 127.84 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -174.36 136.4 3.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.49 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -170.7 150.92 3.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.722 0.296 . . . . 0.0 110.916 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 45.4 mtt85 -151.12 125.01 9.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 43.1 mt -120.01 108.79 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.137 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.5 p -147.63 130.5 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -148.94 131.63 7.94 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.732 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.82 157.85 31.36 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 176.68 110.79 0.27 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -155.23 142.22 19.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.3 p -150.66 136.41 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -93.91 172.44 8.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.826 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.52 135.66 20.0 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.64 0.733 . . . . 0.0 110.879 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.79 134.07 13.17 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.655 2.237 . . . . 0.0 112.378 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 58.3 m -130.84 118.54 20.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 143.78 -168.51 26.38 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.461 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 161.95 -150.12 19.2 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.531 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -159.59 127.24 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.866 0.365 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 217' ' ' VAL . 0.0 OUTLIER -50.47 -35.21 27.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.408 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 95.0 t -89.59 141.85 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.548 ' HB3' HG23 ' A' ' 288' ' ' ILE . 52.6 mt -142.19 128.35 19.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.2 tp -87.0 105.24 17.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.468 HD13 ' CG2' ' A' ' 259' ' ' VAL . 7.1 mp -88.82 140.43 29.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -134.8 115.71 13.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -81.49 130.31 36.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -98.46 130.93 45.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.527 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 59.8 t30 48.34 52.74 13.16 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.6 Cg_exo -44.84 123.59 5.02 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.663 2.242 . . . . 0.0 112.381 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.442 ' CD2' ' HB2' ' A' ' 283' ' ' CYS . 4.0 mm? -91.81 -63.04 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -107.52 153.97 41.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.663 0.744 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.37 112.37 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.7 mm -90.83 116.59 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 29.8 p -127.11 159.84 32.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.163 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.9 m -37.7 -33.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -65.41 -60.45 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 90.4 t -45.63 -44.71 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.174 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 36.7 mt -70.45 -61.4 1.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -49.93 -27.35 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.483 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 98.3 m -65.62 -47.28 76.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.444 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 80.1 t -86.73 -16.98 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 85.1 m -83.87 -47.78 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.538 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -47.36 -48.78 55.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.594 0.711 . . . . 0.0 110.846 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.6 Cg_exo -48.0 -17.57 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 0.0 112.356 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.933 HG11 ' HA ' ' A' ' 270' ' ' ALA . 87.7 t -97.59 -43.93 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.56 -155.61 9.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.42 ' HD3' ' N ' ' A' ' 244' ' ' VAL . 0.6 OUTLIER -101.28 130.22 47.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.42 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 66.2 t -100.35 143.67 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -94.62 -58.75 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.415 ' CB ' ' HA ' ' A' ' 307' ' ' ASP . 14.8 ptt-85 -155.23 163.93 39.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.405 HG13 ' C ' ' A' ' 246' ' ' ARG . 63.8 mt -145.3 140.79 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.66 121.28 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 304' ' ' ASP . 46.1 mt -102.52 118.2 49.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -130.88 154.69 47.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -111.48 93.22 4.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -129.55 102.83 6.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 47.7 39.35 10.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 133.54 121.45 2.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.5 mm -41.12 106.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -126.48 151.03 48.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -152.31 117.82 5.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.427 ' SD ' HD21 ' A' ' 296' ' ' LEU . 10.5 mtt -77.8 146.47 35.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.468 ' CG2' HD13 ' A' ' 220' ' ' LEU . 95.3 t -137.81 118.77 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.443 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 23.3 tt0 -97.83 152.24 19.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.443 ' N ' ' HG2' ' A' ' 260' ' ' GLU . 55.6 m-85 -126.5 154.91 43.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -41.13 -63.25 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.8 m -131.19 172.33 12.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 94.8 t -59.27 -51.96 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 264' ' ' VAL . 23.4 tp -37.43 -65.59 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 54.6 m -45.72 -42.77 12.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -57.76 -41.47 82.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -52.92 -61.6 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -62.36 -53.37 55.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.933 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -46.76 -49.22 20.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.553 ' HA ' HD13 ' A' ' 288' ' ' ILE . 61.5 tttm -52.19 -47.34 65.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.83 -62.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.101 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -46.17 -36.4 5.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.639 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.9 mp -89.54 -24.22 21.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 271' ' ' LYS . 5.3 t30 -57.43 99.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.83 19.97 69.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -91.99 94.41 9.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.102 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.36 171.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 286' ' ' LEU . 44.5 mt -119.74 -35.23 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' TYR . . . . . 0.408 ' HB2' ' SG ' ' A' ' 283' ' ' CYS . 60.2 m-85 -131.72 174.02 10.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -37.64 102.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.094 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.525 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 26.29 76.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.473 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' CYS . . . . . 0.442 ' HB2' ' CD2' ' A' ' 226' ' ' LEU . 20.2 p -176.13 -175.13 0.68 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.769 0.319 . . . . 0.0 110.897 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 283' ' ' CYS . 3.0 p 36.36 41.42 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 15.5 m -57.32 145.9 30.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 279' ' ' ILE . 69.0 mt -97.44 139.24 33.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -130.11 105.66 8.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.879 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.639 HD11 ' CB ' ' A' ' 274' ' ' LEU . 23.5 mt -91.96 139.21 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 290' ' ' TYR . 16.5 mm-40 -146.17 110.24 4.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.873 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 289' ' ' GLU . 28.5 m-85 -35.99 100.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.949 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.1 159.13 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.105 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.485 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 4.4 mtp-105 -73.16 -58.02 2.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.596 0.712 . . . . 0.0 110.891 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 60.3 Cg_endo -74.24 156.96 46.36 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.227 . . . . 0.0 112.337 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 28.9 p -96.55 -32.45 12.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.162 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.19 143.8 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.427 HD21 ' SD ' ' A' ' 258' ' ' MET . 35.7 mt -118.46 143.59 46.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -120.41 114.56 21.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 71.9 t -85.01 114.45 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.2 mp -67.13 -55.0 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -130.73 150.58 51.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -97.98 97.06 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 303' ' ' ASN . 2.7 p-10 -148.99 172.14 15.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 302' ' ' ASP . 4.7 m-20 -34.52 -44.67 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.415 ' O ' ' CG1' ' A' ' 249' ' ' ILE . 73.2 m-20 -55.5 -55.71 28.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 88.8 p -130.45 135.69 48.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -140.1 116.81 10.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.415 ' HA ' ' CB ' ' A' ' 246' ' ' ARG . 0.8 OUTLIER -105.48 91.93 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -53.98 -44.97 71.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 65.4 p -40.55 -48.6 2.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -117.66 92.12 40.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.594 0.711 . . . . 0.0 110.928 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.24 -6.17 16.28 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.26 . . . . 0.0 112.327 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -96.95 -48.79 5.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.933 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 10.4 tp -42.83 146.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 157.55 -142.6 8.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.514 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -106.25 -50.25 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.772 0.32 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.905 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.6 m -102.02 -44.94 5.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.873 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.7 m 56.38 42.34 27.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -125.07 119.42 3.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 67.0 m -130.04 160.64 33.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.876 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 82.6 p -164.63 160.76 20.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 42.48 46.51 5.66 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -46.03 -49.1 16.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 110.948 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.567 ' HD3' HG22 ' A' ' 203' ' ' THR . 8.0 tmm_? -123.74 111.48 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.4 mm -123.14 95.58 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.199 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.567 HG22 ' HD3' ' A' ' 201' ' ' ARG . 12.6 t -169.44 147.78 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -174.63 143.6 0.84 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.68 175.25 11.22 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.665 2.244 . . . . 0.0 112.343 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -166.27 57.07 0.24 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -146.08 159.42 43.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.871 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 37.0 p -138.95 107.53 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.65 158.22 43.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.2 p30 -154.35 145.25 16.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.84 -21.81 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 0.0 112.378 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 3.4 m -164.74 129.24 2.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 173.21 61.15 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.527 ' HA2' ' CE1' ' A' ' 290' ' ' TYR . . . -117.67 163.22 12.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.447 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 217' ' ' VAL . 22.2 p-10 -149.61 157.66 43.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -64.67 -50.15 68.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.503 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 89.3 t -77.55 150.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.154 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 220' ' ' LEU . 14.1 mt -139.65 125.66 19.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 23.0 tp -84.12 103.34 13.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.503 HD13 HG23 ' A' ' 259' ' ' VAL . 6.9 mp -87.4 129.66 34.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.6 m -122.83 114.8 20.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.499 HD12 ' H ' ' A' ' 222' ' ' ILE . 4.9 mp -81.17 150.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.105 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -115.82 120.16 38.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.508 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 52.3 t30 59.37 50.49 2.96 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.619 0.723 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 57.7 Cg_endo -71.12 106.53 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.252 . . . . 0.0 112.371 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.1 mt -87.77 -47.65 8.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -91.65 133.55 30.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.662 0.744 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.08 117.4 2.49 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.699 2.266 . . . . 0.0 112.314 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.423 HG21 HD21 ' A' ' 234' ' ' LEU . 49.1 mm -85.18 109.23 17.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.166 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 82.8 p -105.24 151.78 23.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 303' ' ' ASN . 33.7 m -38.55 -38.56 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -60.64 -59.61 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.5 t -41.52 -48.28 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.423 HD21 HG21 ' A' ' 229' ' ' ILE . 49.5 mt -69.29 -62.7 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.455 ' CE1' ' HB ' ' A' ' 244' ' ' VAL . 43.9 t80 -48.06 -25.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.503 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 94.0 m -65.08 -48.29 74.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.431 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 89.0 t -84.43 -18.65 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.453 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 85.1 m -81.75 -53.52 6.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -41.69 -49.6 10.04 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 0.0 110.898 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.1 Cg_exo -47.94 -39.05 32.15 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.934 HG11 ' HA ' ' A' ' 270' ' ' ALA . 76.0 t -72.86 -42.46 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.95 -126.09 0.81 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm -116.47 165.97 12.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.677 HG11 HD11 ' A' ' 247' ' ' ILE . 99.2 t -143.02 114.44 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.08 -64.31 1.0 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.403 ' HE ' HG21 ' A' ' 298' ' ' VAL . 6.9 ptm180 -143.92 164.33 30.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.677 HD11 HG11 ' A' ' 244' ' ' VAL . 62.5 mt -142.14 141.54 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.55 134.46 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.449 HD11 ' N ' ' A' ' 231' ' ' VAL . 67.1 mt -119.29 131.59 71.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.539 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 6.4 p90 -142.41 173.31 11.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -129.64 42.62 3.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -80.8 97.68 7.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 62.51 42.8 8.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 121.52 142.98 6.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.458 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 27.6 mm -56.43 116.16 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 0.0 111.096 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.539 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 47.4 mt-30 -142.19 168.75 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -162.43 126.05 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.481 ' SD ' HD21 ' A' ' 296' ' ' LEU . 15.4 mtt -91.06 120.61 32.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.53 HG22 HG23 ' A' ' 247' ' ' ILE . 86.2 t -110.29 133.16 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -108.22 137.96 45.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -109.57 160.27 16.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -47.28 -62.66 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.7 m -127.74 170.37 12.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 99.4 t -58.33 -52.36 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 14.6 tp -38.59 -62.2 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.941 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 60.8 m -43.39 -40.05 3.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -57.91 -40.65 80.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -54.62 -60.4 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -63.97 -53.92 42.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.934 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.07 -48.8 22.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.544 ' HA ' HD13 ' A' ' 288' ' ' ILE . 19.2 tttt -56.3 -45.29 80.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -65.35 -59.33 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.87 -37.35 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.79 ' CB ' HD11 ' A' ' 288' ' ' ILE . 6.0 mp -91.62 -22.25 20.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 271' ' ' LYS . 4.8 t30 -55.36 101.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.75 22.59 61.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.468 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.627 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -78.49 178.53 7.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.762 0.315 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -145.6 126.53 14.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 33.9 mt -91.83 -31.77 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -126.69 172.68 10.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.3 107.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.25 75.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 1.7 t -174.98 -177.57 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 286' ' ' LEU . 27.3 p 39.36 38.58 0.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 14.1 m -47.57 93.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.627 HD12 ' HB3' ' A' ' 277' ' ' ALA . 32.7 mt -45.97 127.25 8.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -127.12 83.74 2.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.79 HD11 ' CB ' ' A' ' 274' ' ' LEU . 29.2 mt -72.99 145.95 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -151.08 115.53 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.527 ' CE1' ' HA2' ' A' ' 214' ' ' GLY . 38.6 m-85 -38.55 105.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -56.55 139.99 47.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.157 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 4.9 ttp180 -62.61 -44.9 88.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.893 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.7 Cg_endo -80.36 150.87 19.94 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.698 2.266 . . . . 0.0 112.354 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 41.2 p -92.28 -24.45 18.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -125.59 158.89 33.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.481 HD21 ' SD ' ' A' ' 258' ' ' MET . 48.7 mt -115.78 178.25 4.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.18 116.7 14.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.403 HG21 ' HE ' ' A' ' 246' ' ' ARG . 61.3 t -114.95 102.89 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.77 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.2 mp -66.17 -57.46 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -130.31 176.81 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -107.5 100.83 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -144.63 171.26 14.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.539 ' O ' HG13 ' A' ' 231' ' ' VAL . 2.7 m120 -39.6 -44.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.945 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.88 -57.24 10.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.841 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 26.0 p -133.94 138.66 45.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.847 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -135.68 122.62 21.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -106.74 133.26 51.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -99.81 -47.1 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 73.3 p -44.34 -46.21 9.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.168 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.591 ' CD ' HD13 ' A' ' 313' ' ' LEU . 37.9 mttp -110.07 94.26 17.42 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.901 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.16 -50.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.701 2.267 . . . . 0.0 112.352 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 312' ' ' TYR . 0.2 OUTLIER -81.37 39.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.591 HD13 ' CD ' ' A' ' 310' ' ' LYS . 12.3 tp -89.99 84.6 6.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.949 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 102.78 138.72 10.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -57.62 4.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.813 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.882 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.516 -0.233 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 63.1 p -38.41 -35.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.853 0.358 . . . . 0.0 110.869 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.5 p -132.94 167.27 20.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.847 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -140.69 160.76 26.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.5 m -141.27 165.13 28.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.872 0.368 . . . . 0.0 110.87 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 77.1 p -169.46 155.0 5.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -169.08 174.17 43.57 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.514 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.03 138.52 30.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -107.91 123.09 48.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 34.4 mt -96.94 84.28 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 66.6 p -53.18 110.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -53.07 130.67 50.07 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.664 0.745 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.51 140.61 19.24 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.255 . . . . 0.0 112.354 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -63.96 167.93 25.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.509 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -86.04 99.58 11.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 110.899 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.0 p -113.92 98.03 6.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -166.91 115.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -134.95 143.69 47.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.567 0.698 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.11 152.1 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.709 2.273 . . . . 0.0 112.35 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 91.0 p -102.5 40.9 1.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 49.08 -104.16 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 177.08 168.24 36.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -156.6 124.41 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.892 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -47.06 -47.2 22.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.405 HG12 ' CB ' ' A' ' 291' ' ' ALA . 92.2 t -74.45 123.73 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.076 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' A' ' 288' ' ' ILE . 26.2 mt -116.69 130.91 57.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.572 HD13 ' HE2' ' A' ' 258' ' ' MET . 33.5 tp -84.88 112.22 20.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.33 141.95 30.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.6 t -130.66 137.76 49.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.63 117.48 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.132 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -79.34 140.53 37.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.511 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 35.8 t30 38.33 54.0 4.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.607 0.718 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.2 Cg_exo -44.67 100.37 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.674 2.249 . . . . 0.0 112.386 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 46.0 mt -91.75 -51.06 5.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -109.52 132.57 21.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.663 0.744 . . . . 0.0 110.892 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.23 111.86 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.268 . . . . 0.0 112.31 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.598 HD12 HG11 ' A' ' 233' ' ' VAL . 48.7 mm -90.65 112.46 25.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.125 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 20.7 p -105.98 160.93 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 19.3 m -38.41 -37.56 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 235' ' ' TYR . 7.8 m-20 -58.12 -65.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.598 HG11 HD12 ' A' ' 229' ' ' ILE . 73.9 t -37.63 -43.66 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 50.2 mt -76.64 -37.1 56.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 65.8 t80 -81.72 16.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 92.2 m -120.46 -37.11 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.156 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.428 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 86.6 t -98.66 -19.74 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.413 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 59.2 m -89.12 -44.4 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -51.97 -45.73 92.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 110.861 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.3 Cg_exo -47.94 -22.81 3.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.335 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.4 t -96.64 -45.26 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -155.21 152.57 24.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.525 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.89 131.84 51.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.848 0.356 . . . . 0.0 110.888 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.0 t -100.62 136.93 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.152 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -93.62 -65.35 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.545 HH11 HG23 ' A' ' 298' ' ' VAL . 4.0 tmm_? -143.69 152.36 41.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.597 HG23 HG22 ' A' ' 259' ' ' VAL . 74.0 mt -129.35 147.79 33.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.426 HG23 ' CD ' ' A' ' 246' ' ' ARG . 54.4 t -139.85 133.84 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 304' ' ' ASP . 43.7 mt -120.84 129.99 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -144.21 138.02 27.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -99.67 40.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -78.14 101.05 6.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 60.96 42.74 12.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.5 137.82 5.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.2 mm -56.14 112.66 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.128 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -141.89 173.42 11.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -164.63 126.36 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.572 ' HE2' HD13 ' A' ' 219' ' ' LEU . 36.2 mtt -94.66 120.32 34.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.597 HG22 HG23 ' A' ' 247' ' ' ILE . 94.2 t -110.54 135.38 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.083 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -105.67 153.46 21.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -126.85 163.61 23.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.895 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -47.48 -65.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 t -135.88 174.93 10.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 82.0 t -56.37 -55.3 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.1 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 18.5 tp -40.3 -50.27 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 61.4 m -55.94 -46.12 78.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 271' ' ' LYS . . . -53.84 -35.63 61.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -57.56 -65.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.914 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -59.49 -55.82 29.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.433 ' O ' HD13 ' A' ' 274' ' ' LEU . . . -49.22 -53.2 22.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.07 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.461 ' HA ' HD13 ' A' ' 288' ' ' ILE . 38.6 tttm -53.13 -43.96 67.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 275' ' ' ASN . . . -54.74 -63.45 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.085 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.672 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -53.8 -46.98 71.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.751 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.6 mp -67.0 -28.98 68.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 271' ' ' LYS . 8.9 t30 -65.33 102.87 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.61 19.72 65.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -83.33 92.26 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.32 135.19 57.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 286' ' ' LEU . 60.9 mt -104.65 -42.7 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -117.85 172.84 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -51.97 103.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 35.46 51.52 1.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.447 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.5 m -162.55 164.88 26.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.884 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.7 m 62.5 41.31 9.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 23.6 m -58.21 134.29 56.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.494 HD11 HD11 ' A' ' 279' ' ' ILE . 83.6 mt -88.13 124.92 34.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -119.54 106.79 12.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.751 HD11 ' CB ' ' A' ' 274' ' ' LEU . 18.9 mt -92.54 144.13 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.193 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -155.17 117.44 4.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -41.53 105.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.405 ' CB ' HG12 ' A' ' 217' ' ' VAL . . . -53.07 161.89 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.129 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 30.1 mtt180 -73.86 -56.69 2.72 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.67 0.748 . . . . 0.0 110.89 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 61.1 Cg_endo -74.67 150.42 39.87 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.631 2.221 . . . . 0.0 112.346 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 39.9 p -78.85 -30.14 45.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.456 ' HG2' ' N ' ' A' ' 296' ' ' LEU . 8.7 ttm180 -134.03 148.32 51.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.516 HD21 ' SD ' ' A' ' 258' ' ' MET . 23.6 mt -100.08 -178.14 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -137.42 117.86 13.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.545 HG23 HH11 ' A' ' 246' ' ' ARG . 73.8 t -104.37 112.96 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.123 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.527 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.8 mp -78.0 -51.73 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -127.26 151.96 48.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -92.34 46.94 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.3 172.52 8.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -41.55 -47.16 3.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.467 ' O ' HD12 ' A' ' 249' ' ' ILE . 0.1 OUTLIER -43.13 -62.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.9 p -133.45 147.17 51.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -139.72 140.87 36.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -119.88 115.34 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 309' ' ' THR . 52.9 m-85 -88.62 -48.27 7.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' TYR . 32.4 p -35.88 -40.9 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.193 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.428 ' HB2' HD21 ' A' ' 313' ' ' LEU . 43.3 mtmt -139.59 106.3 7.04 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.573 0.701 . . . . 0.0 110.902 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.86 -13.94 17.45 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.636 2.224 . . . . 0.0 112.387 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.692 ' O ' HD22 ' A' ' 313' ' ' LEU . 32.4 p90 -113.61 106.27 14.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.692 HD22 ' O ' ' A' ' 312' ' ' TYR . 4.4 mm? -132.32 99.76 4.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -129.34 -139.67 4.7 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.467 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.38 -59.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 -179.863 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 195' ' ' SER . 12.6 m 49.45 42.36 22.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.368 . . . . 0.0 110.856 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 194' ' ' SER . 33.5 p -37.91 -58.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 159.69 -179.22 35.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 61.9 m -158.97 171.23 20.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.836 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.4 t -117.71 149.28 41.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.81 94.27 1.64 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.507 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -129.36 88.84 2.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.725 0.298 . . . . 0.0 110.859 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -117.72 158.88 23.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.604 ' O ' HD12 ' A' ' 202' ' ' ILE . 2.7 pp -64.33 136.17 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 96.7 m -147.56 108.31 4.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -127.96 94.11 37.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.596 0.713 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.49 10.56 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.66 2.24 . . . . 0.0 112.35 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -127.79 130.7 6.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.485 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -109.22 124.32 50.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 0.0 110.916 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 209' ' ' ASP . 28.6 m -49.52 134.25 19.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 208' ' ' THR . 1.1 p30 -36.54 149.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -86.86 112.61 48.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.4 115.08 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.72 2.28 . . . . 0.0 112.33 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 62.8 m -42.28 157.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.98 -149.46 50.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.452 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.45 -126.84 2.45 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.47 158.73 39.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.391 . . . . 0.0 110.867 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 267' ' ' ALA . 6.2 pttt -76.19 -45.85 31.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.512 ' O ' HD23 ' A' ' 218' ' ' LEU . 51.1 t -67.83 146.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.116 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 220' ' ' LEU . 6.8 mt -147.72 123.51 10.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 50.8 tp -71.67 112.98 8.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 218' ' ' LEU . 7.4 mp -99.97 129.03 45.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -120.56 117.28 27.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.825 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.587 HD13 HG22 ' A' ' 255' ' ' ILE . 4.9 mp -81.84 123.32 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -89.3 138.77 31.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.706 ' O ' HD23 ' A' ' 226' ' ' LEU . 74.5 m-20 44.87 53.8 12.05 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.683 0.754 . . . . 0.0 110.927 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 77.0 Cg_exo -47.64 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.723 2.282 . . . . 0.0 112.329 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 224' ' ' ASN . 3.6 mm? -85.45 -56.96 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.447 ' CD2' ' CE2' ' A' ' 280' ' ' TYR . 2.2 m-85 -93.76 143.16 26.09 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.707 0.765 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.24 127.3 12.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 0.0 112.317 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.401 HG13 HG21 ' A' ' 222' ' ' ILE . 49.9 mm -114.75 102.11 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 232' ' ' ASP . 19.9 p -117.43 159.06 23.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.192 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.2 m -38.96 -26.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.4 m-20 -67.28 -61.01 2.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.8 t -47.39 -56.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 34.4 mt -56.72 -61.95 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.559 ' CD1' ' HB ' ' A' ' 244' ' ' VAL . 63.4 t80 -49.76 -33.41 16.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.486 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 98.7 m -64.14 -45.93 86.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.1 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 237' ' ' VAL . 62.0 t -87.88 -5.89 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.473 ' HB3' ' CG2' ' A' ' 244' ' ' VAL . 90.8 m -93.29 -47.23 7.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 8.2 t-20 -51.06 -45.61 88.41 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 0.0 110.886 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -47.97 -41.2 33.13 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 270' ' ' ALA . 40.4 t -70.62 -44.32 76.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.27 -105.48 0.21 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.502 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.8 115.84 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 110.916 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 247' ' ' ILE . 96.3 t -84.04 143.71 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.468 ' HB3' ' CG2' ' A' ' 309' ' ' THR . 21.5 mm-40 -104.2 -68.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -125.03 152.36 44.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.829 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 244' ' ' VAL . 48.6 mt -140.75 128.35 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.63 121.47 56.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.487 HG12 ' CB ' ' A' ' 257' ' ' ALA . 67.9 mt -110.86 119.06 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -126.32 146.11 50.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -102.42 44.71 1.0 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -70.29 86.16 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 55.2 49.22 17.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 135.33 129.67 2.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.587 HG22 HD13 ' A' ' 222' ' ' ILE . 21.3 mm -50.59 103.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.744 0.307 . . . . 0.0 111.158 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -135.47 164.37 27.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.487 ' CB ' HG12 ' A' ' 249' ' ' ILE . . . -166.49 130.75 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 32.8 mtt -94.76 123.31 38.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 247' ' ' ILE . 88.4 t -114.92 130.19 69.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.132 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -109.1 160.36 16.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -130.26 167.85 17.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -40.64 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.5 t -126.1 -176.01 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 267' ' ' ALA . 63.3 t -63.62 -56.96 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 264' ' ' VAL . 25.1 tp -35.47 -59.73 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.4 -37.98 57.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 264' ' ' VAL . . . -61.42 -36.86 81.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.117 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -58.7 -57.85 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -66.72 -47.98 70.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.819 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -51.87 -52.47 49.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.656 ' HG3' HG21 ' A' ' 288' ' ' ILE . 25.8 tttp -48.81 -48.46 41.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -61.41 -69.08 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.088 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -40.96 -36.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.846 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.1 mp -88.65 -25.31 22.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 272' ' ' ALA . 19.5 t30 -60.08 104.22 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 75.1 24.25 72.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -85.87 93.64 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 0.0 111.084 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.73 137.5 57.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.42 HG22 ' CD1' ' A' ' 280' ' ' TYR . 46.9 mt -106.45 -34.42 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' TYR . . . . . 0.447 ' CE2' ' CD2' ' A' ' 227' ' ' TYR . 50.7 m-85 -129.54 172.37 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -45.11 102.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.08 61.34 0.52 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.537 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' CYS . . . . . 0.435 ' C ' ' SG ' ' A' ' 284' ' ' CYS . 92.6 m -156.81 179.01 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 110.91 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 283' ' ' CYS . 0.8 OUTLIER 40.15 43.98 1.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 40.5 m -59.21 85.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 277' ' ' ALA . 47.6 mt -38.59 120.01 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -120.1 85.44 2.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.846 HD11 ' CB ' ' A' ' 274' ' ' LEU . 50.5 mt -75.19 148.68 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.116 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -159.82 121.85 3.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -45.37 103.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -57.3 153.66 11.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.105 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.604 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 5.6 ttt180 -65.94 -44.87 63.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 291' ' ' ALA . 60.9 Cg_endo -80.5 153.02 20.52 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.328 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 37.9 p -96.91 -22.29 16.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -126.24 151.35 47.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.93 179.11 4.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -146.85 133.41 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 93.4 t -122.45 133.35 68.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.064 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.35 -51.2 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.141 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.97 166.35 16.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -114.53 109.97 19.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 303' ' ' ASN . 7.5 t70 -164.19 173.09 12.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 302' ' ' ASP . 39.4 m-20 -33.95 -50.49 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.55 -63.43 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 24.8 m -142.45 147.99 37.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -142.08 137.35 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -122.02 91.11 3.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' TYR . . . . . 0.451 ' O ' ' C ' ' A' ' 309' ' ' THR . 86.9 m-85 -62.99 -49.17 75.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 245' ' ' GLN . 29.0 p -33.95 -43.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.679 ' HG2' HD13 ' A' ' 313' ' ' LEU . 0.0 OUTLIER -114.92 83.99 10.09 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 0.0 110.897 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.14 -11.33 16.3 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.712 2.274 . . . . 0.0 112.301 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.514 ' CE1' ' HD3' ' A' ' 310' ' ' LYS . 43.5 p90 -105.21 50.02 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.983 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.679 HD13 ' HG2' ' A' ' 310' ' ' LYS . 9.4 tp -117.46 42.92 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 315' ' ' ARG . . . -112.01 162.48 12.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.431 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.495 ' O ' ' CD ' ' A' ' 315' ' ' ARG . 0.0 OUTLIER 33.63 50.96 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.843 0.354 . . . . 0.0 110.907 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.7 t -75.7 -44.24 43.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.881 0.372 . . . . 0.0 110.843 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 35.2 p 39.63 42.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.861 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -111.11 128.8 8.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.459 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.7 t -160.44 146.82 15.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.348 . . . . 0.0 110.833 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.1 t -142.1 163.41 32.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 141.94 67.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.67 170.84 15.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -134.4 126.53 29.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 26.3 pt -83.89 128.69 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 40.1 p -148.01 142.45 26.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -98.66 127.44 35.69 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.626 0.727 . . . . 0.0 110.828 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.36 89.89 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.692 2.261 . . . . 0.0 112.361 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 137.55 60.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -129.37 111.7 13.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.904 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 30.9 m -143.8 133.7 23.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.406 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 6.1 t0 -108.35 111.68 23.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.03 94.47 10.87 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.626 0.726 . . . . 0.0 110.871 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 209' ' ' ASP . 61.4 Cg_endo -75.94 89.56 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.276 . . . . 0.0 112.323 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 3.8 m -128.43 159.76 34.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.66 148.38 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.476 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.15 -100.19 0.14 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.468 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -169.16 123.87 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 267' ' ' ALA . 3.8 pttm -52.55 -43.31 65.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.6 134.51 29.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.2 mt -134.96 125.07 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.2 tp -82.46 112.8 19.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.411 HD23 HD22 ' A' ' 286' ' ' LEU . 6.9 mp -94.25 124.2 38.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.4 m -118.89 104.13 10.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.683 HD12 ' H ' ' A' ' 222' ' ' ILE . 4.4 mp -69.29 144.72 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.476 ' C ' ' CG ' ' A' ' 224' ' ' ASN . 8.9 mm100 -109.85 126.31 53.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 283' ' ' CYS . 0.5 OUTLIER 49.88 54.75 16.27 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.668 0.747 . . . . 0.0 110.894 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 59.2 Cg_endo -72.62 101.6 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.341 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 224' ' ' ASN . 10.1 mp -73.55 -62.55 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -83.79 137.66 40.95 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.662 0.744 . . . . 0.0 110.919 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.49 115.0 1.38 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.741 2.294 . . . . 0.0 112.324 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 29.7 mm -83.72 127.14 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.143 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 24.3 p -121.33 152.04 39.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.484 ' N ' HD11 ' A' ' 249' ' ' ILE . 32.0 m -37.65 -37.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.92 -61.67 2.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 96.6 t -42.46 -52.42 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 26.2 mt -62.04 -59.24 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.569 ' CD2' ' HB ' ' A' ' 244' ' ' VAL . 3.6 t80 -54.28 -24.11 17.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 92.9 m -69.87 -46.07 66.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.117 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.422 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 99.0 t -85.79 -17.38 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.448 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 81.9 m -84.23 -51.3 7.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.543 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -44.0 -48.61 22.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.688 0.756 . . . . 0.0 110.911 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.4 Cg_exo -47.9 -32.77 18.36 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.734 HG11 ' HA ' ' A' ' 270' ' ' ALA . 87.1 t -80.59 -42.91 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.94 -106.85 0.22 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.466 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 26.4 tttt -145.94 163.64 34.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.631 HG11 HD11 ' A' ' 247' ' ' ILE . 86.9 t -133.71 133.88 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.45 ' OE1' ' CG2' ' A' ' 309' ' ' THR . 32.0 mm-40 -92.83 -62.69 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 4.2 ptt-85 -143.36 155.11 44.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.631 HD11 HG11 ' A' ' 244' ' ' VAL . 57.7 mt -137.67 139.09 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.184 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 82.7 t -127.51 124.82 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.484 HD11 ' N ' ' A' ' 231' ' ' VAL . 53.8 mt -110.24 128.81 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.528 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 18.9 p90 -136.61 148.92 47.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -100.12 40.05 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -78.05 109.4 12.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 53.3 t30 55.25 43.45 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.08 -150.07 16.97 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.504 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 11.8 mm -114.4 106.46 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 111.101 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.528 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 21.3 mp0 -132.21 168.01 18.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -168.25 120.47 0.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.092 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 14.1 mtt -87.78 130.87 34.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 247' ' ' ILE . 58.7 t -120.63 137.88 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -101.28 162.77 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.914 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -135.48 158.31 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -46.67 -69.85 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.947 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 16.4 m -121.43 169.59 10.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 86.4 t -54.93 -52.35 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 15.8 tp -42.58 -64.26 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.84 -41.92 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -56.82 -45.67 82.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -63.52 -57.65 9.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -56.82 -37.03 70.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.734 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -71.56 -42.62 67.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.806 ' HA ' HD13 ' A' ' 288' ' ' ILE . 46.0 tttm -53.07 -48.9 67.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -59.64 -68.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.59 -38.17 1.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.706 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.4 mp -86.05 -23.36 26.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 272' ' ' ALA . 34.8 t30 -56.92 101.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.55 19.41 73.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -80.06 93.03 5.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 111.118 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.87 133.11 55.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.46 HD11 HD11 ' A' ' 286' ' ' LEU . 66.8 mt -101.28 -41.22 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' TYR . . . . . 0.404 ' CD1' HG22 ' A' ' 279' ' ' ILE . 13.3 m-85 -116.17 174.44 6.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.63 104.44 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 37.92 54.78 1.9 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' CYS . . . . . 0.485 ' HA ' ' ND2' ' A' ' 224' ' ' ASN . 24.9 p -175.14 155.01 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.866 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 225' ' ' PRO . 61.4 m 65.51 46.1 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 20.7 m -73.75 142.1 46.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.46 HD11 HD11 ' A' ' 279' ' ' ILE . 91.4 mt -86.2 123.8 31.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.939 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.24 81.85 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.806 HD13 ' HA ' ' A' ' 271' ' ' LYS . 31.7 mt -62.53 154.28 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.43 ' N ' HG22 ' A' ' 288' ' ' ILE . 17.1 mt-10 -159.56 114.65 2.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.477 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 45.0 m-85 -39.55 107.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.51 127.58 32.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.104 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.9 OUTLIER -60.68 -45.06 96.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.58 0.705 . . . . 0.0 110.853 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.8 Cg_endo -80.31 148.76 18.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.641 2.227 . . . . 0.0 112.37 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 78.8 p -93.0 -25.79 17.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.165 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -120.36 144.89 47.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 55.0 mt -111.92 -178.98 3.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -139.11 129.99 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.83 110.81 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.786 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.8 mp -62.72 -57.27 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -144.03 176.33 9.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -99.61 87.17 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 303' ' ' ASN . 28.2 t70 -140.99 170.54 15.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 302' ' ' ASP . 86.1 m-20 -36.3 -47.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.852 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -50.12 -56.87 9.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.6 p -138.26 142.78 39.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.81 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -138.94 134.78 33.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -115.38 128.43 56.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -100.8 -59.01 1.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.895 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.45 ' CG2' ' OE1' ' A' ' 245' ' ' GLN . 39.8 p -38.02 -47.87 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -123.2 93.91 47.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.66 -12.42 18.34 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.676 2.251 . . . . 0.0 112.353 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -104.85 83.21 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 74.8 mt -131.17 109.57 10.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -119.42 -144.37 7.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.502 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 52.8 mtt-85 -63.56 -44.41 94.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.811 0.339 . . . . 0.0 110.919 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.939 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.6 m -153.74 170.49 20.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.853 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 2.0 m -170.1 167.11 8.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.845 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 125.07 116.85 2.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.479 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.4 m -172.39 144.18 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 110.854 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 t -152.19 159.5 43.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.818 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -164.27 127.92 1.73 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.455 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -162.76 156.87 20.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -142.54 111.16 6.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.0 pt -67.37 134.11 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.163 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.9 p -138.98 131.9 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.38 143.1 43.56 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.54 0.686 . . . . 0.0 110.866 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.74 113.14 3.59 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.682 2.255 . . . . 0.0 112.369 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -127.63 48.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -112.75 80.75 1.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.939 0.4 . . . . 0.0 110.917 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 21.3 m -48.58 102.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.218 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -98.83 87.48 3.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -162.91 146.0 8.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.579 0.704 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 212' ' ' SER . 62.5 Cg_endo -76.92 152.07 31.72 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.699 2.266 . . . . 0.0 112.379 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 211' ' ' PRO . 3.4 m -36.91 138.47 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -70.42 -74.13 0.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 63.23 147.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.473 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 216' ' ' LYS . 13.0 t30 -169.47 128.49 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 215' ' ' ASN . 0.0 OUTLIER -33.27 -52.72 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 63.3 t -80.47 150.59 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.4 mt -141.48 126.7 18.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.447 HD11 ' OE1' ' A' ' 256' ' ' GLN . 7.8 tp -85.08 104.02 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 9.3 mp -87.87 134.56 33.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.0 m -124.32 111.4 15.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.501 HD12 ' H ' ' A' ' 222' ' ' ILE . 5.3 mp -71.99 140.88 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 224' ' ' ASN . 7.0 tp60 -95.38 143.99 26.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.543 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 53.7 t30 34.96 54.49 1.84 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.591 0.71 . . . . 0.0 110.869 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.1 Cg_exo -47.37 102.19 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.704 2.269 . . . . 0.0 112.3 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 42.7 mt -103.88 -54.03 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -89.88 154.17 47.59 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.705 0.764 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.43 113.69 3.7 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.671 2.247 . . . . 0.0 112.323 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.4 mm -93.73 142.28 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 16.5 p -139.4 163.26 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 303' ' ' ASN . 31.4 m -46.76 -27.81 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.28 -36.27 82.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.9 t -71.12 -47.53 60.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.093 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 18.9 mt -83.74 20.84 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.419 ' O ' ' HB3' ' A' ' 239' ' ' ASN . 75.7 t80 -129.95 -39.28 1.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.966 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.453 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 22.9 m -72.33 -37.43 68.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.19 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.449 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 44.7 t -85.02 -25.67 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.117 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.456 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 78.9 m -83.67 -47.82 10.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.53 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -41.37 -49.29 9.08 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.636 0.732 . . . . 0.0 110.862 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.9 Cg_exo -47.91 -62.17 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.728 2.285 . . . . 0.0 112.36 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 48.4 t -47.05 -50.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.24 -103.39 0.26 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.403 ' C ' ' HD3' ' A' ' 243' ' ' LYS . 1.1 tmtp? -163.75 120.26 1.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 110.916 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.474 HG11 HD11 ' A' ' 247' ' ' ILE . 90.2 t -85.43 142.46 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.494 ' O ' HG23 ' A' ' 309' ' ' THR . 11.0 mm-40 -95.83 -57.79 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -141.24 152.44 44.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.474 HD11 HG11 ' A' ' 244' ' ' VAL . 58.0 mt -137.38 119.37 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 95.1 t -117.96 115.96 50.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.126 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 62.0 mt -103.53 122.18 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 36.8 p90 -131.45 148.81 52.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -124.8 40.95 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.418 ' HB2' ' NH1' ' A' ' 252' ' ' ARG . 0.2 OUTLIER -72.9 -60.42 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.45 ' O ' ' NE2' ' A' ' 256' ' ' GLN . 93.5 m-20 -129.66 80.01 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 255' ' ' ILE . . . 88.04 116.34 1.26 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.506 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 254' ' ' GLY . 28.1 mm -33.42 104.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 111.141 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.478 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 34.7 mt-30 -136.19 166.42 23.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -165.13 121.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.404 ' SD ' HD21 ' A' ' 296' ' ' LEU . 13.9 mtt -86.06 137.36 32.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 94.8 t -126.84 129.48 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 261' ' ' PHE . 3.3 tp10 -102.1 148.23 25.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.691 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 41.1 m-85 -122.71 157.64 31.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.453 ' OE1' ' NE2' ' A' ' 245' ' ' GLN . 3.8 mm-40 -36.37 -63.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -143.13 176.19 9.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 87.0 t -52.75 -56.9 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 16.1 tp -39.26 -64.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 83.3 m -49.17 -43.45 42.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -54.89 -40.35 69.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -55.24 -59.09 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -63.3 -51.17 67.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.691 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -48.69 -49.99 35.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.672 ' HA ' HD13 ' A' ' 288' ' ' ILE . 55.0 tttm -54.07 -53.47 52.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -54.11 -70.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -42.43 -41.35 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.608 ' CB ' HD11 ' A' ' 288' ' ' ILE . 3.1 mp -79.64 -23.46 42.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 271' ' ' LYS . 18.4 t-20 -60.0 104.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 76.97 24.02 67.71 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.733 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -82.8 93.24 7.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.775 0.321 . . . . 0.0 111.077 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.44 117.02 2.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.546 HG22 ' CD1' ' A' ' 280' ' ' TYR . 70.1 mt -89.98 -39.82 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.129 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' TYR . . . . . 0.546 ' CD1' HG22 ' A' ' 279' ' ' ILE . 5.5 m-85 -117.73 173.44 6.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -52.86 103.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.071 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.23 59.59 0.62 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.473 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 20.0 p -175.08 163.84 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 82.0 m 60.19 44.41 12.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 30.2 m -59.52 150.0 28.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.733 HD12 ' HB3' ' A' ' 277' ' ' ALA . 40.5 mt -92.51 105.87 17.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -104.78 82.14 1.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.672 HD13 ' HA ' ' A' ' 271' ' ' LYS . 19.3 mt -70.56 142.63 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.09 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -149.04 122.01 8.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -49.15 101.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.442 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -60.45 135.08 57.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.051 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.605 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.4 OUTLIER -59.3 -44.65 98.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 0.0 110.918 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.4 Cg_endo -80.41 144.06 15.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.723 2.282 . . . . 0.0 112.318 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 65.3 p -111.35 34.65 3.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.163 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 296' ' ' LEU . 3.7 tpt180 -144.3 143.59 31.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.423 ' N ' ' HG3' ' A' ' 295' ' ' ARG . 49.2 mt -132.3 114.4 14.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -88.4 135.36 33.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 75.0 t -137.57 115.49 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -83.37 -59.01 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -115.86 166.52 11.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -102.55 44.06 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.05 169.75 17.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.75 ' O ' HG13 ' A' ' 231' ' ' VAL . 1.1 p30 -45.41 -47.24 13.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -44.31 -60.06 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.5 p -133.01 142.55 48.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -140.97 142.09 34.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.75 89.36 3.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.886 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -78.86 45.83 0.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 245' ' ' GLN . 67.4 p -124.98 -42.61 2.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.163 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.421 ' CD ' HD13 ' A' ' 313' ' ' LEU . 7.1 ttmm -126.14 94.18 41.92 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.547 0.689 . . . . 0.0 110.899 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.59 -19.05 14.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -103.81 41.69 1.26 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.88 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.421 HD13 ' CD ' ' A' ' 310' ' ' LYS . 24.5 tp -117.46 127.54 54.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.894 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -145.85 -144.7 4.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.491 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -74.01 -44.77 53.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.865 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.8 mmm-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 -179.928 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.1 m 63.8 42.42 6.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 0.0 110.891 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 97.0 p -108.85 174.01 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.811 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 162.05 136.87 2.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.534 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 5.2 m -165.95 166.84 17.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.857 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 24.4 p -157.53 174.37 15.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.83 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 165.19 137.51 2.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -132.09 120.25 22.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.707 0.289 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.87 162.82 40.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 67.1 mt -134.58 109.59 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 81.9 p -50.41 165.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.149 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -91.91 109.8 39.54 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 110.876 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.02 162.77 31.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.269 . . . . 0.0 112.372 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -178.72 -130.14 1.39 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.488 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -155.35 166.72 32.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 85.9 m -127.34 131.85 50.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -130.85 171.78 12.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.437 ' CG ' ' HD2' ' A' ' 211' ' ' PRO . 4.7 t70 -141.68 141.67 23.28 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.58 0.705 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 210' ' ' ASP . 62.2 Cg_endo -77.53 86.38 1.65 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.697 2.265 . . . . 0.0 112.377 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 79.3 p -113.81 116.75 29.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 55.15 -143.16 34.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 151.79 -120.73 1.11 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.45 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -144.65 129.83 18.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.884 0.374 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 15.8 mtmm -52.51 -40.75 62.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.841 HG22 ' HG2' ' A' ' 260' ' ' GLU . 42.9 t -84.12 148.25 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 220' ' ' LEU . 13.9 mt -144.89 127.79 16.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.0 tp -84.88 117.9 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.578 HD13 HG23 ' A' ' 259' ' ' VAL . 6.0 mp -101.1 128.77 47.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.5 m -123.22 111.46 16.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.422 HD12 ' H ' ' A' ' 222' ' ' ILE . 5.2 mp -75.94 143.09 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -103.23 137.69 41.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.541 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 17.5 t-20 42.18 52.82 7.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.609 0.719 . . . . 0.0 110.911 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.0 Cg_exo -45.31 119.84 2.8 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.371 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.481 HD22 ' O ' ' A' ' 224' ' ' ASN . 4.1 mm? -88.02 -56.73 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.557 ' CD1' ' CE2' ' A' ' 280' ' ' TYR . 16.5 m-85 -119.45 144.02 35.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.731 0.777 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.91 112.67 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.666 2.244 . . . . 0.0 112.343 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.442 HD12 HG11 ' A' ' 233' ' ' VAL . 48.2 mm -81.95 121.28 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.4 p -107.72 157.11 18.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.15 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 303' ' ' ASN . 27.5 m -40.42 -38.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.156 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 235' ' ' TYR . 48.8 m-20 -56.45 -61.24 2.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 229' ' ' ILE . 97.0 t -36.94 -44.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.15 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.54 -38.12 41.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 71.8 t80 -83.87 19.85 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.487 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 96.2 m -125.0 -36.69 2.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.432 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 98.8 t -97.21 -24.58 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.125 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 85.7 m -85.11 -45.48 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.548 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.1 m120 -49.86 -48.31 78.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.674 0.749 . . . . 0.0 110.903 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 67.0 Cg_exo -48.03 -22.03 3.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.315 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.6 t -89.63 -50.28 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.083 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -145.97 -127.48 1.88 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.433 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.491 ' CB ' ' OE2' ' A' ' 262' ' ' GLU . 32.5 tptt -130.24 131.9 45.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.848 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.501 HG11 HD11 ' A' ' 247' ' ' ILE . 84.2 t -108.29 125.26 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -79.94 -70.22 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -134.68 160.27 38.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.501 HD11 HG11 ' A' ' 244' ' ' VAL . 54.6 mt -137.84 136.61 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 298' ' ' VAL . 62.0 t -135.97 109.53 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 49.2 mt -99.92 100.88 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -105.79 134.61 48.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 78.51 2.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 113.74 18.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 47.12 43.9 14.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.13 119.03 2.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mm -42.38 107.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.329 . . . . 0.0 111.158 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -128.32 143.82 51.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.31 117.7 9.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.473 ' HB3' HD11 ' A' ' 296' ' ' LEU . 29.6 mtt -90.16 127.37 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.578 HG23 HD13 ' A' ' 220' ' ' LEU . 57.4 t -119.34 143.06 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.841 ' HG2' HG22 ' A' ' 217' ' ' VAL . 17.5 mt-10 -108.37 163.13 13.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.819 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 42.0 m-85 -134.07 158.05 44.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.491 ' OE2' ' CB ' ' A' ' 243' ' ' LYS . 31.2 mt-10 -40.65 -63.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.5 m -140.93 178.52 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.94 -51.06 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 17.5 tp -47.66 -58.83 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 62.8 m -49.86 -43.95 49.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -55.72 -38.01 69.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.084 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -56.69 -65.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -57.58 -53.16 61.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.819 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -50.03 -53.27 27.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.729 ' HG3' HG21 ' A' ' 288' ' ' ILE . 23.4 tttt -53.09 -44.19 67.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.7 -66.01 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.877 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -51.82 -47.27 64.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.504 ' CB ' HD11 ' A' ' 288' ' ' ILE . 2.8 mp -67.59 -28.19 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 271' ' ' LYS . 0.8 OUTLIER -66.85 104.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.07 20.8 75.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -82.15 91.87 6.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.64 128.38 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.654 HG22 ' CD1' ' A' ' 280' ' ' TYR . 73.2 mt -102.57 -41.92 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' TYR . . . . . 0.654 ' CD1' HG22 ' A' ' 279' ' ' ILE . 6.3 m-85 -118.3 173.54 6.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.93 105.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.59 59.99 0.65 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.522 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 31.8 p -175.16 167.11 3.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 2.2 m 62.57 44.11 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 57.3 m -61.55 136.74 58.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 277' ' ' ALA . 61.4 mt -87.38 115.85 25.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -111.12 90.21 3.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.889 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.729 HG21 ' HG3' ' A' ' 271' ' ' LYS . 35.1 mt -76.3 145.59 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 290' ' ' TYR . 18.8 mt-10 -153.71 111.19 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' A' ' 289' ' ' GLU . 26.4 m-85 -37.52 102.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -49.78 144.03 6.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.069 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.599 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 4.6 ttp180 -60.42 -45.04 97.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 0.0 110.801 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.8 Cg_endo -80.3 150.81 20.08 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.6 p -85.6 -24.28 27.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -128.59 175.04 8.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 258' ' ' MET . 80.1 mt -132.47 175.51 9.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -152.6 118.62 5.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 248' ' ' VAL . 63.2 t -102.07 104.71 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.685 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.9 mp -62.69 -59.82 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ARG . . . . . 0.424 ' HG3' HG22 ' A' ' 299' ' ' ILE . 37.6 mtm180 -115.36 154.96 28.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -105.77 105.46 15.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 303' ' ' ASN . 3.3 m-20 -149.02 167.71 25.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.674 ' O ' HG13 ' A' ' 231' ' ' VAL . 65.2 m-20 -34.37 -47.49 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -50.72 -60.77 2.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 248' ' ' VAL . 78.7 p -129.28 133.41 47.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -131.43 137.36 48.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.24 113.55 21.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -89.61 -59.85 2.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 72.1 p -43.18 -40.14 3.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.173 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.588 ' HD2' ' CE2' ' A' ' 312' ' ' TYR . 4.3 tppp? -113.27 80.53 4.45 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.581 0.705 . . . . 0.0 110.87 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.96 -10.94 15.23 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.351 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.588 ' CE2' ' HD2' ' A' ' 310' ' ' LYS . 48.4 p90 -101.14 46.32 0.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.908 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.47 ' HB2' ' CG ' ' A' ' 310' ' ' LYS . 18.8 tp -124.9 130.53 52.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -174.16 -89.52 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.504 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -80.4 45.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.519 ' C ' ' CD ' ' A' ' 316' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 52.9 p -161.52 172.29 16.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 93.7 p -164.27 133.55 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -165.2 55.18 0.26 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.485 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 198' ' ' SER . 12.8 t -84.38 101.5 12.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.87 0.367 . . . . 0.0 110.83 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 197' ' ' SER . 3.3 m -35.42 149.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -152.92 81.53 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.468 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -78.26 120.93 23.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 202' ' ' ILE . 1.6 mpt_? -72.03 83.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.473 ' C ' ' O ' ' A' ' 201' ' ' ARG . 11.2 mt 32.07 53.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 201' ' ' ARG . 44.3 p -100.96 39.16 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.52 155.05 56.98 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.624 0.726 . . . . 0.0 110.899 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -78.31 158.73 29.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.708 2.272 . . . . 0.0 112.302 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -160.86 153.06 23.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.498 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -102.52 131.51 49.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.929 0.395 . . . . 0.0 110.846 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 14.8 t -147.52 152.9 38.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.99 133.98 45.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.828 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.55 143.28 14.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 0.0 110.823 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.462 ' CG ' ' HB2' ' A' ' 215' ' ' ASN . 62.7 Cg_endo -77.78 139.77 17.97 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.62 2.213 . . . . 0.0 112.336 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 211' ' ' PRO . 55.8 p -37.32 120.91 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 39.93 75.28 0.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 55.88 -155.55 11.85 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.462 ' HB2' ' CG ' ' A' ' 211' ' ' PRO . 64.5 t30 -160.19 147.79 16.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.861 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -68.91 -44.15 73.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.541 HG11 HD21 ' A' ' 296' ' ' LEU . 84.1 t -81.11 142.76 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.415 HD21 ' HB1' ' A' ' 267' ' ' ALA . 20.5 mt -132.2 126.32 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.44 HD11 ' OE1' ' A' ' 256' ' ' GLN . 24.1 tp -82.5 111.92 18.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.568 HD23 HD22 ' A' ' 286' ' ' LEU . 7.7 mp -103.82 130.26 51.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 t -116.1 132.39 56.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.824 HD13 HG22 ' A' ' 255' ' ' ILE . 4.7 mp -92.42 69.02 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.164 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 222' ' ' ILE . 8.2 mm100 -35.73 141.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.53 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 34.4 m-20 44.76 54.22 12.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.646 0.736 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.8 Cg_exo -46.92 93.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.661 2.24 . . . . 0.0 112.331 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.507 HD12 ' HB2' ' A' ' 283' ' ' CYS . 12.3 mt -102.43 -44.62 5.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . 63.8 m-85 -107.6 130.27 23.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.734 0.778 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 227' ' ' TYR . 77.5 Cg_exo -49.47 126.27 15.64 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.7 2.267 . . . . 0.0 112.336 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.806 HD12 HG11 ' A' ' 233' ' ' VAL . 49.6 mm -117.92 118.86 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.407 ' HA ' ' CD1' ' A' ' 249' ' ' ILE . 21.5 p -121.75 167.36 13.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.174 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 35.3 m -40.08 -34.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.54 -43.89 96.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.806 HG11 HD12 ' A' ' 229' ' ' ILE . 61.2 t -66.17 -44.39 91.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 25.4 mt -83.19 20.15 1.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -124.81 -26.33 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 86.5 m -85.72 -36.35 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.444 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 13.3 t -89.15 -21.86 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.154 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 83.7 m -84.79 -47.66 10.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.541 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -46.86 -48.1 51.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.708 . . . . 0.0 110.917 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -48.03 -21.05 2.46 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.649 2.232 . . . . 0.0 112.323 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.937 HG11 ' HA ' ' A' ' 270' ' ' ALA . 77.7 t -96.98 -43.06 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.109 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.73 -158.52 9.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.98 120.55 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.829 0.347 . . . . 0.0 110.87 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.4 t -85.67 133.06 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -95.38 -60.55 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -150.58 153.32 35.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.509 HG23 HG22 ' A' ' 259' ' ' VAL . 68.5 mt -132.19 127.33 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.17 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 298' ' ' VAL . 57.3 t -119.92 112.12 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.432 HG12 ' HB2' ' A' ' 257' ' ' ALA . 58.2 mt -100.04 129.91 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.149 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -138.27 163.56 31.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.736 ' HG3' HD13 ' A' ' 255' ' ' ILE . 22.2 ttpt -120.86 86.03 2.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -120.52 88.58 2.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.5 m120 56.14 42.82 27.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 138.25 108.06 0.81 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.497 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.824 HG22 HD13 ' A' ' 222' ' ' ILE . 31.7 mm -39.79 114.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 111.097 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.44 ' OE1' HD11 ' A' ' 219' ' ' LEU . 13.0 mt-30 -139.69 173.58 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 249' ' ' ILE . . . -165.11 120.76 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.09 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.5 mtt -83.93 123.21 29.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.509 HG22 HG23 ' A' ' 247' ' ' ILE . 67.8 t -117.08 127.74 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -97.3 154.29 17.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -127.32 164.33 22.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -43.85 -65.11 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 25.1 p -138.47 169.61 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 265' ' ' LEU . 75.5 t -49.62 -53.83 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.141 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 264' ' ' VAL . 19.5 tp -38.3 -57.88 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 84.8 m -50.43 -44.84 55.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.415 ' HB1' HD21 ' A' ' 218' ' ' LEU . . . -54.11 -38.8 65.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.091 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -57.02 -60.84 2.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -63.71 -54.1 40.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.937 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.63 -48.8 28.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.643 ' HA ' HD13 ' A' ' 288' ' ' ILE . 49.4 tttm -51.19 -52.19 46.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -57.16 -67.32 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.79 -40.0 1.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.581 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.4 mp -84.98 -22.39 29.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 271' ' ' LYS . 41.1 t30 -60.16 100.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.05 19.95 68.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.513 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.477 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -78.32 91.68 4.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.737 0.303 . . . . 0.0 111.117 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.21 123.37 14.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.873 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.465 HD11 HD11 ' A' ' 286' ' ' LEU . 84.9 mt -95.87 -41.55 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -116.17 173.04 6.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -51.09 102.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.33 61.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' CYS . . . . . 0.507 ' HB2' HD12 ' A' ' 226' ' ' LEU . 28.2 p -175.06 168.83 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.807 0.337 . . . . 0.0 110.883 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 53.5 m 58.99 47.78 11.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 19.7 m -61.81 145.81 51.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.143 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.568 HD22 HD23 ' A' ' 220' ' ' LEU . 50.0 mt -93.71 95.65 9.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -91.22 97.32 11.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' A' ' 271' ' ' LYS . 21.6 mt -83.86 138.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -143.97 124.87 14.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -51.61 97.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.59 156.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.086 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 1.1 mpt_? -71.45 -60.27 2.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.631 0.729 . . . . 0.0 110.882 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 58.8 Cg_endo -71.78 161.59 44.63 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.7 2.267 . . . . 0.0 112.341 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.6 p -97.31 -34.23 11.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -106.85 163.37 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.541 HD21 HG11 ' A' ' 217' ' ' VAL . 40.8 mt -124.04 -177.24 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -144.39 132.62 21.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.546 HG11 ' OD1' ' A' ' 307' ' ' ASP . 75.5 t -122.29 103.01 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.742 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -55.42 -62.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.3 154.47 49.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -84.21 81.38 8.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -124.57 171.76 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -43.0 -47.63 5.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -47.39 -56.74 6.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.2 p -137.6 142.12 41.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -136.43 136.85 39.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.546 ' OD1' HG11 ' A' ' 298' ' ' VAL . 0.8 OUTLIER -114.84 110.92 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.97 -49.34 8.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.964 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 31.3 p -38.0 -50.18 1.31 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.174 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.575 ' O ' HD23 ' A' ' 313' ' ' LEU . 27.4 mtmm -122.29 93.71 48.35 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.576 0.703 . . . . 0.0 110.83 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.86 -11.18 16.75 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.358 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.566 ' O ' HD22 ' A' ' 313' ' ' LEU . 11.0 p90 -105.67 94.63 5.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 310' ' ' LYS . 4.4 mm? -128.4 131.63 48.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 169.95 -101.62 0.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -76.78 -35.42 57.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.776 0.322 . . . . 0.0 110.839 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 25.5 mtt85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.6 t -157.87 139.71 14.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 110.866 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.3 t -152.13 155.1 37.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 122.16 89.88 1.01 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.505 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 30.1 t -148.98 140.77 23.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.916 0.389 . . . . 0.0 110.833 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.3 m -147.74 166.81 26.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 159.09 84.93 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -161.27 150.2 16.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -140.2 106.41 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 202' ' ' ILE . 0.2 OUTLIER -76.29 140.5 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 58.4 p -155.75 127.88 7.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -145.74 142.96 18.57 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.61 0.719 . . . . 0.0 110.858 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.28 153.42 31.47 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.676 2.251 . . . . 0.0 112.316 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -159.65 -89.06 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -67.62 91.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.953 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 32.2 m -135.8 115.93 13.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -145.48 120.19 9.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -128.29 153.71 78.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.7 . . . . 0.0 110.846 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.08 103.28 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.683 2.255 . . . . 0.0 112.341 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 4.8 t -121.03 142.06 50.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.98 96.53 0.88 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -55.25 -164.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -141.06 121.55 14.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 0.0 110.921 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -38.73 -43.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.508 HG13 HD11 ' A' ' 296' ' ' LEU . 76.6 t -82.07 147.8 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 220' ' ' LEU . 15.4 mt -145.3 123.68 12.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.2 tp -78.91 104.52 9.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.44 HD13 HG23 ' A' ' 259' ' ' VAL . 6.9 mp -87.29 126.06 34.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 54.0 m -117.34 112.79 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 1.021 HD13 HG22 ' A' ' 255' ' ' ILE . 2.4 mp -80.85 118.0 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.471 ' C ' ' CG ' ' A' ' 224' ' ' ASN . 17.8 mm100 -85.28 133.28 34.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.932 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.471 ' CG ' ' C ' ' A' ' 223' ' ' GLN . 0.7 OUTLIER 49.39 54.97 16.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.64 0.733 . . . . 0.0 110.897 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 59.9 Cg_endo -73.36 99.69 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.328 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.87 -40.31 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -88.74 153.47 49.96 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.657 0.742 . . . . 0.0 110.941 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.39 115.93 4.52 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.7 2.266 . . . . 0.0 112.316 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 22.3 mm -97.24 148.17 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 232' ' ' ASP . 16.1 p -148.23 156.13 42.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 303' ' ' ASN . 34.7 m -35.16 -35.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 230' ' ' THR . 6.4 t0 -65.48 -61.58 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 71.6 t -42.02 -46.32 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.437 HD12 HG21 ' A' ' 247' ' ' ILE . 34.8 mt -66.7 -65.6 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.535 ' CD2' ' HB ' ' A' ' 244' ' ' VAL . 5.9 t80 -48.0 -27.44 2.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.428 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 83.6 m -66.01 -47.58 73.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.145 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.441 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 63.5 t -87.42 -15.14 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.428 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 77.3 m -86.13 -46.75 10.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.56 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -47.36 -47.52 57.8 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.626 0.727 . . . . 0.0 110.902 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.8 Cg_exo -47.98 -18.6 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 270' ' ' ALA . 78.6 t -98.6 -42.4 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -162.72 -145.25 4.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.405 ' HD3' ' C ' ' A' ' 243' ' ' LYS . 8.9 tmtm? -116.53 119.21 34.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.535 ' HB ' ' CD2' ' A' ' 235' ' ' TYR . 89.1 t -82.49 141.1 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -96.03 -51.85 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.411 ' NE ' ' OE1' ' A' ' 260' ' ' GLU . 22.9 ptt180 -159.89 153.1 21.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.437 HG21 HD12 ' A' ' 234' ' ' LEU . 53.6 mt -131.82 139.26 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 38.1 t -130.45 110.53 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.138 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 52.9 mt -98.55 140.69 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 8.2 p90 -146.68 139.98 25.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -98.25 43.19 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -79.55 95.46 5.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 62.76 45.79 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 131.28 -155.56 21.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 1.021 HG22 HD13 ' A' ' 222' ' ' ILE . 32.2 mm -116.04 103.38 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 0.0 111.116 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.569 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 19.0 mp0 -131.56 157.31 43.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -162.12 118.63 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.116 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.8 mtt -82.2 128.81 34.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 220' ' ' LEU . 65.4 t -119.33 127.73 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 24.6 tt0 -104.34 149.43 25.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.45 ' N ' ' HG2' ' A' ' 260' ' ' GLU . 60.1 m-85 -118.93 166.51 12.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.839 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -45.67 -64.58 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.4 t -130.87 177.81 7.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.54 -54.54 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.16 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 24.4 tp -40.89 -54.49 2.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.919 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 68.6 m -53.57 -43.05 68.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -56.33 -40.21 74.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.085 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -62.49 -63.55 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -55.48 -44.43 76.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.821 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -64.15 -42.28 96.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.695 ' HA ' HD13 ' A' ' 288' ' ' ILE . 42.6 tttm -55.27 -47.65 75.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.62 -62.12 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.102 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -47.13 -37.17 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.097 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.785 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.7 mp -88.38 -22.77 23.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 271' ' ' LYS . 2.0 t30 -60.52 101.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.46 21.44 69.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.506 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -84.55 93.41 8.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.329 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -49.53 143.53 6.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.615 HG22 ' CD1' ' A' ' 280' ' ' TYR . 68.2 mt -102.17 -36.59 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.157 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' TYR . . . . . 0.615 ' CD1' HG22 ' A' ' 279' ' ' ILE . 62.3 m-85 -139.02 175.88 9.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -39.82 101.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.045 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 29.3 73.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.472 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' CYS . . . . . 0.464 ' HA ' ' ND2' ' A' ' 224' ' ' ASN . 23.5 p -175.96 173.46 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 110.881 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 283' ' ' CYS . 2.0 p 40.25 43.85 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 90.2 m -60.76 139.3 57.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.167 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.435 HD22 HD23 ' A' ' 220' ' ' LEU . 31.5 mt -82.42 123.48 29.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.431 ' C ' ' HE3' ' A' ' 287' ' ' LYS . 0.1 OUTLIER -124.35 87.14 2.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.925 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.785 HD11 ' CB ' ' A' ' 274' ' ' LEU . 17.9 mt -71.38 142.58 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -142.51 115.89 9.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -39.71 100.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -52.24 151.85 3.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.138 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 13.0 mmt180 -73.27 -58.05 2.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.594 0.712 . . . . 0.0 110.869 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 60.0 Cg_endo -73.74 159.09 46.12 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.724 2.282 . . . . 0.0 112.344 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 69.5 p -95.65 -34.84 11.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 296' ' ' LEU . 1.4 tmm_? -105.78 152.8 22.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.508 HD11 HG13 ' A' ' 217' ' ' VAL . 74.9 mt -118.54 154.79 31.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.962 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -116.29 127.33 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' A' ' 307' ' ' ASP . 89.3 t -106.27 105.65 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.158 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.703 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.4 mp -59.2 -62.01 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -131.8 170.42 14.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.43 ' ND2' ' OD1' ' A' ' 307' ' ' ASP . 1.8 m-20 -106.56 100.01 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 303' ' ' ASN . 29.3 t70 -165.58 172.52 11.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.728 ' O ' HG13 ' A' ' 231' ' ' VAL . 1.9 m-80 -34.34 -46.09 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.99 -53.17 28.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 2.9 m -153.48 143.51 22.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.898 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -136.88 149.85 47.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.718 ' HB3' HG21 ' A' ' 298' ' ' VAL . 17.0 p-10 -129.44 95.62 4.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -71.35 -40.46 70.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 21.9 p -40.76 -33.19 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.853 ' HE3' HD13 ' A' ' 313' ' ' LEU . 15.5 mtpp -132.95 88.56 36.79 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.54 0.686 . . . . 0.0 110.868 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.31 -7.84 17.17 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.647 2.232 . . . . 0.0 112.341 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -108.93 40.09 1.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.853 HD13 ' HE3' ' A' ' 310' ' ' LYS . 10.0 tp -109.71 148.97 30.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 132.34 127.37 2.81 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.452 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -39.52 -58.12 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.408 ' C ' ' HD3' ' A' ' 316' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 93.8 p -161.47 135.18 6.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 0.0 110.868 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.9 t -89.36 171.9 9.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.884 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 127.2 178.46 15.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.5 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 51.4 p -160.4 152.54 20.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 110.848 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 20.9 t -63.1 -48.31 79.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.882 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.05 157.73 9.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -165.49 130.78 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 202' ' ' ILE . 17.3 tpt180 -162.27 149.01 13.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.413 ' N ' ' HG3' ' A' ' 201' ' ' ARG . 32.4 pt -78.33 129.51 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.9 t -174.9 133.18 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -174.59 113.79 0.3 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.601 0.715 . . . . 0.0 110.864 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.72 161.18 33.94 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.638 2.226 . . . . 0.0 112.375 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 133.87 64.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -116.61 132.75 56.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 110.862 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 21.5 p -122.93 90.21 3.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -146.83 130.05 16.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -156.71 154.51 26.88 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.55 12.4 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.288 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 213' ' ' GLY . 48.1 t -132.37 150.2 52.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.649 ' HA3' HG11 ' A' ' 264' ' ' VAL . . . -37.25 155.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.501 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -49.45 -100.53 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.527 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.416 ' ND2' ' HB ' ' A' ' 217' ' ' VAL . 13.4 t30 -160.02 136.75 9.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -59.65 -42.77 93.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.547 HG11 HD21 ' A' ' 296' ' ' LEU . 91.5 t -76.06 138.29 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.402 ' HB3' HG23 ' A' ' 288' ' ' ILE . 12.4 mt -136.44 128.58 29.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 54.5 tp -83.18 113.47 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.514 HD23 HD22 ' A' ' 286' ' ' LEU . 6.9 mp -99.56 125.71 45.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.3 t -115.38 115.37 26.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.573 HD13 HG22 ' A' ' 255' ' ' ILE . 5.4 mp -77.03 122.24 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -80.05 139.09 37.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.543 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 31.6 m-20 43.44 53.82 10.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.666 0.746 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.6 Cg_exo -47.08 94.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.379 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 13.8 mt -109.91 -44.46 3.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.448 ' CG ' ' CE2' ' A' ' 280' ' ' TYR . 91.6 m-85 -94.66 137.8 22.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.674 0.75 . . . . 0.0 110.912 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.2 132.4 23.41 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.716 2.277 . . . . 0.0 112.341 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.9 mm -122.61 129.9 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.42 ' HA ' ' CD1' ' A' ' 249' ' ' ILE . 21.7 p -144.46 168.58 19.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 33.5 m -42.76 -36.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.2 -44.44 88.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.05 -47.9 88.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.106 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 26.1 mt -84.83 23.68 1.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -130.89 -36.14 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.502 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 26.5 m -79.45 -35.71 39.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.133 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 237' ' ' VAL . 87.6 t -90.62 -14.65 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 76.2 m -87.99 -48.07 8.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.908 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.574 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.8 t-20 -49.78 -46.01 80.01 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.67 0.748 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.0 Cg_exo -47.92 -21.68 2.81 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.68 2.253 . . . . 0.0 112.358 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.482 HG11 ' HB3' ' A' ' 273' ' ' ALA . 21.9 t -99.8 -40.84 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.092 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -152.18 -132.64 1.85 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.46 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -131.8 115.45 15.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.879 HG11 HD11 ' A' ' 247' ' ' ILE . 84.7 t -87.82 137.2 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -109.84 -66.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -120.95 150.2 41.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.879 HD11 HG11 ' A' ' 244' ' ' VAL . 47.7 mt -141.98 121.77 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 66.6 t -119.27 129.45 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 230' ' ' THR . 56.8 mt -120.73 115.39 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -124.32 171.84 9.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -124.78 44.23 2.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.942 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -71.35 96.42 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 47.4 43.1 15.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 140.95 137.85 3.49 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.573 HG22 HD13 ' A' ' 222' ' ' ILE . 44.5 mm -58.33 101.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.328 . . . . 0.0 111.104 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -131.91 158.34 41.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -155.89 117.87 4.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 25.9 mtt -83.11 125.09 31.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 247' ' ' ILE . 90.4 t -115.59 124.33 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.17 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -98.43 145.4 26.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.671 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 40.3 m-85 -118.93 158.0 26.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 261' ' ' PHE . 4.4 mm-40 -34.64 -65.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 11.1 t -139.44 166.23 25.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.649 HG11 ' HA3' ' A' ' 213' ' ' GLY . 87.0 t -42.43 -59.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.124 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 264' ' ' VAL . 22.8 tp -35.82 -63.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 81.2 m -42.89 -45.06 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -52.87 -38.14 61.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -55.98 -59.87 4.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -65.49 -55.79 15.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.671 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -47.41 -48.21 26.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.073 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.735 ' HA ' HD13 ' A' ' 288' ' ' ILE . 17.5 tttt -56.51 -45.23 81.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -60.34 -71.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.093 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.704 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -41.38 -39.53 1.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.768 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.5 mp -81.68 -27.35 34.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 272' ' ' ALA . 18.9 t-20 -59.84 100.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.2 20.71 69.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.457 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -84.23 94.5 8.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.736 0.303 . . . . 0.0 111.093 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.74 128.42 26.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.561 HD11 HD11 ' A' ' 286' ' ' LEU . 77.4 mt -104.42 -44.05 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' TYR . . . . . 0.448 ' CE2' ' CG ' ' A' ' 227' ' ' TYR . 33.8 m-85 -112.37 174.35 5.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.73 103.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 33.91 56.86 0.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.467 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 27.7 p -175.18 168.19 3.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.338 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 87.0 m 62.63 41.41 9.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 15.3 m -59.54 149.94 28.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.21 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 279' ' ' ILE . 57.5 mt -94.77 105.8 17.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -101.59 80.2 2.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.768 HD11 ' CB ' ' A' ' 274' ' ' LEU . 44.4 mt -69.45 141.54 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.133 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -149.24 109.84 4.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -38.3 106.43 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.75 157.23 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.086 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.471 ' CB ' ' CD ' ' A' ' 293' ' ' PRO . 11.9 mmt180 -73.69 -61.41 1.36 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 292' ' ' ARG . 59.0 Cg_endo -71.88 161.21 45.65 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 40.2 p -93.01 -28.14 16.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.144 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.16 160.01 15.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.547 HD21 HG11 ' A' ' 217' ' ' VAL . 66.9 mt -120.95 172.67 7.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -119.51 119.71 34.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.27 93.36 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.441 ' N ' HD13 ' A' ' 299' ' ' ILE . 4.7 mm -46.0 -66.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.36 160.54 43.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -64.88 101.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.83 171.77 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.833 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -46.3 -52.8 11.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.32 -53.87 10.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.7 p -143.39 140.93 30.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -126.77 145.49 50.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -126.71 92.45 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 309' ' ' THR . 58.6 m-85 -69.44 -50.7 43.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.899 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 308' ' ' TYR . 76.3 p -34.99 -49.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.16 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -112.75 87.08 9.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.551 0.691 . . . . 0.0 110.897 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.54 -1.8 11.92 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.675 2.25 . . . . 0.0 112.301 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -105.79 46.11 0.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 34.4 mt -106.42 41.88 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.93 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -75.07 160.6 52.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.446 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -72.22 78.5 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 110.889 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.418 ' C ' ' HD3' ' A' ' 316' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 22.0 m -152.17 131.48 12.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 110.867 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 95.6 p -142.48 162.47 35.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.828 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 162.08 95.38 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.484 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 48.4 p -124.29 98.89 5.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 110.852 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 6.0 t -124.44 155.04 39.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.882 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 119.11 45.77 0.44 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.502 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -73.29 86.1 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.733 0.302 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 19.2 ttm105 -134.93 98.28 3.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.0 pt -41.18 124.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.1 m -147.01 105.21 3.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -62.19 155.2 66.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.606 0.717 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.74 -23.97 16.17 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.716 2.277 . . . . 0.0 112.331 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 178.61 81.78 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.45 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -89.12 139.07 30.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.872 0.368 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.1 p -71.14 116.34 11.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.06 108.03 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.28 112.76 46.21 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.624 0.726 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.5 167.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.71 2.273 . . . . 0.0 112.321 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 4.0 m -97.11 42.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 75.16 118.11 0.1 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.455 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -112.13 -177.88 19.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -149.86 158.98 44.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.908 0.385 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -74.79 -41.3 60.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' A' ' 260' ' ' GLU . 52.6 t -79.24 142.79 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.117 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.555 ' HB3' HG23 ' A' ' 288' ' ' ILE . 19.3 mt -139.81 132.35 28.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.86 111.96 18.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.33 127.3 49.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.3 t -115.33 138.72 50.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.85 131.03 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.136 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -94.7 133.46 38.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.581 ' O ' HD22 ' A' ' 226' ' ' LEU . 0.3 OUTLIER 46.17 53.34 12.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.884 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.0 Cg_exo -45.09 84.63 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.657 2.238 . . . . 0.0 112.351 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.581 HD22 ' O ' ' A' ' 224' ' ' ASN . 4.0 mm? -58.65 -59.79 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -117.57 146.38 38.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.666 0.746 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.78 114.86 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 0.0 112.336 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.554 HD12 HG11 ' A' ' 233' ' ' VAL . 27.6 mm -87.12 120.13 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.185 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 21.4 p -104.81 161.46 14.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 232' ' ' ASP . 30.4 m -42.37 -40.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 235' ' ' TYR . 7.8 m-20 -55.42 -60.72 3.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.554 HG11 HD12 ' A' ' 229' ' ' ILE . 95.5 t -38.03 -37.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 41.6 mt -88.54 -31.85 18.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.774 ' CD1' ' CE2' ' A' ' 308' ' ' TYR . 37.6 t80 -84.75 23.37 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.502 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 88.3 m -125.21 -38.74 2.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.14 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 237' ' ' VAL . 59.1 t -94.21 -15.4 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.428 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 97.1 m -88.72 -47.46 8.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.571 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 8.6 t-20 -50.58 -45.63 85.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.661 0.743 . . . . 0.0 110.928 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.2 Cg_exo -47.98 -22.97 3.87 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.27 . . . . 0.0 112.354 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' ' 270' ' ' ALA . 91.4 t -96.97 -45.58 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -146.6 -145.18 4.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.508 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.53 112.17 17.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.815 0.341 . . . . 0.0 110.937 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.509 ' HB ' ' CE1' ' A' ' 235' ' ' TYR . 51.4 t -80.73 141.7 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.165 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.493 ' NE2' ' OE1' ' A' ' 262' ' ' GLU . 13.0 mm100 -101.7 -60.89 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.9 mtm-85 -140.78 156.91 46.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.455 HD11 HG11 ' A' ' 244' ' ' VAL . 74.9 mt -142.56 138.45 28.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.11 134.76 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 87.6 mt -116.07 108.11 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -115.72 164.23 14.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -121.89 43.83 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -94.65 106.99 18.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.6 t30 68.1 44.12 1.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 105.91 151.05 19.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 39.1 mm -56.38 113.4 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -141.24 165.2 28.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -156.76 124.63 5.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 29.6 mtt -88.87 124.04 33.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.413 HG13 HG12 ' A' ' 247' ' ' ILE . 72.9 t -112.08 138.02 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.642 ' HG2' HG22 ' A' ' 217' ' ' VAL . 8.9 tm-20 -114.69 140.96 48.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -114.55 162.67 16.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.493 ' OE1' ' NE2' ' A' ' 245' ' ' GLN . 4.4 mm-40 -41.28 -65.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.2 m -137.5 176.31 8.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 265' ' ' LEU . 98.2 t -56.43 -56.75 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.158 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 264' ' ' VAL . 20.4 tp -37.51 -54.02 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 6.7 m -52.2 -47.0 65.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.25 -37.47 64.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -55.62 -63.44 1.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -61.34 -58.64 7.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.772 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -46.96 -49.65 20.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.133 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.612 ' HA ' HD13 ' A' ' 288' ' ' ILE . 49.3 tttm -47.82 -54.59 11.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -53.17 -66.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -42.98 -43.81 4.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.873 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.9 mp -77.52 -22.33 51.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 272' ' ' ALA . 44.4 t-20 -55.94 99.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.99 19.72 72.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.498 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -86.31 95.82 9.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 111.103 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.56 155.23 39.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 44.4 mt -113.89 -53.9 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -95.7 172.47 8.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -52.68 107.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.139 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.37 48.18 0.62 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 23.0 m -161.1 177.4 10.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.7 m 49.42 44.26 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 41.1 m -63.51 143.93 57.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.124 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 90.3 mt -94.19 122.99 37.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -116.35 98.74 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.873 HD11 ' CB ' ' A' ' 274' ' ' LEU . 28.3 mt -79.27 139.11 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.178 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -150.23 114.36 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.441 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 77.6 m-85 -41.32 103.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.958 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -55.08 159.67 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.121 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.491 ' CB ' ' CD ' ' A' ' 293' ' ' PRO . 47.6 mtt180 -73.94 -62.17 1.14 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.583 0.706 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 292' ' ' ARG . 58.3 Cg_endo -71.8 156.96 56.24 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.673 2.249 . . . . 0.0 112.34 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 64.3 p -93.01 -36.33 12.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -107.28 148.7 28.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.48 HD11 HG13 ' A' ' 217' ' ' VAL . 31.3 mt -117.72 150.28 39.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -98.56 120.4 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.63 102.02 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.472 ' N ' HD13 ' A' ' 299' ' ' ILE . 4.6 mm -46.71 -61.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -175.05 162.53 3.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -52.71 94.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 305' ' ' SER . 2.3 m-20 -141.69 172.85 12.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -54.64 -41.83 70.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -56.73 -59.92 4.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 302' ' ' ASP . 3.3 t -130.3 152.52 49.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -134.03 138.54 45.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -122.5 98.86 6.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.844 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' TYR . . . . . 0.774 ' CE2' ' CD1' ' A' ' 235' ' ' TYR . 99.4 m-85 -76.21 -50.84 13.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 308' ' ' TYR . 46.1 p -36.72 -43.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.178 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.546 ' HG3' ' CE1' ' A' ' 312' ' ' TYR . 64.4 tttt -111.56 82.07 3.54 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.535 0.683 . . . . 0.0 110.906 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.72 -4.93 15.02 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.681 2.254 . . . . 0.0 112.367 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.546 ' CE1' ' HG3' ' A' ' 310' ' ' LYS . 5.0 p90 -104.73 80.45 1.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 56.8 mt -136.65 118.84 15.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.956 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 124.01 110.01 1.89 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.5 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -99.83 81.65 2.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.793 0.33 . . . . 0.0 110.891 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 75.9 p -163.66 168.85 19.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.371 . . . . 0.0 110.864 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.6 t -156.29 152.01 27.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.833 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -147.9 167.97 28.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.472 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 47.8 t -161.19 138.85 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 110.835 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 56.4 p -138.75 172.08 13.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 148.43 122.78 1.27 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.441 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -134.33 130.53 37.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -145.77 118.97 8.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.8 mt -123.82 110.88 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.9 m -116.46 86.21 2.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -69.75 140.98 89.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 0.0 110.835 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.96 84.74 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.302 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -114.24 87.17 0.44 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -81.66 110.93 17.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.936 0.398 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 41.6 p -97.82 84.42 3.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -127.05 142.05 51.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -40.47 133.49 1.62 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.604 0.716 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.88 -18.77 12.97 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.718 2.279 . . . . 0.0 112.347 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.2 m -97.31 104.61 16.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 107.41 130.0 6.27 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.44 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.84 -109.96 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -154.63 122.87 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 217' ' ' VAL . 0.1 OUTLIER -52.3 -33.67 43.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.579 HG12 ' CB ' ' A' ' 291' ' ' ALA . 62.0 t -77.77 137.73 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 15.2 mt -134.91 134.37 40.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.453 HD11 ' OE1' ' A' ' 256' ' ' GLN . 22.1 tp -89.94 110.29 21.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.982 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.2 mp -97.51 139.76 32.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -128.81 131.61 47.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.877 HD13 HG22 ' A' ' 255' ' ' ILE . 4.9 mp -91.56 122.02 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.158 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -82.22 143.64 31.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.536 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 15.6 m-20 39.8 54.42 5.83 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.615 0.721 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 74.4 Cg_exo -47.21 92.55 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.738 2.292 . . . . 0.0 112.31 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 11.6 mt -100.78 -48.83 4.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -100.47 137.11 19.86 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.67 0.748 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.51 113.54 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.671 2.248 . . . . 0.0 112.328 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.437 HG13 HG21 ' A' ' 222' ' ' ILE . 47.6 mm -101.11 104.04 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.7 p -104.5 159.44 15.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.17 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.462 ' N ' HD11 ' A' ' 249' ' ' ILE . 26.8 m -42.77 -35.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.25 -58.72 7.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 95.2 t -45.15 -45.17 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.093 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 40.1 mt -68.66 -61.89 1.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.46 ' C ' ' CD1' ' A' ' 235' ' ' TYR . 4.8 t80 -49.58 -29.21 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 98.1 m -64.71 -46.98 80.0 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.126 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 237' ' ' VAL . 61.1 t -87.49 -10.07 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.44 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 82.1 m -88.94 -45.17 9.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.909 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.577 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 4.8 t30 -49.59 -46.11 78.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -47.96 -19.92 1.8 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.694 2.262 . . . . 0.0 112.336 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.986 HG11 ' HA ' ' A' ' 270' ' ' ALA . 87.4 t -99.1 -46.92 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.42 -170.18 30.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 244' ' ' VAL . 6.6 tmtm? -82.59 151.14 26.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.368 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.564 HG11 HD11 ' A' ' 247' ' ' ILE . 91.0 t -121.52 128.99 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -80.69 -62.63 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -151.07 155.4 38.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.661 HG12 HG13 ' A' ' 259' ' ' VAL . 77.0 mt -136.85 150.95 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.638 HG22 HG22 ' A' ' 298' ' ' VAL . 94.0 t -136.52 139.91 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 231' ' ' VAL . 88.9 mt -125.38 116.63 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -129.05 158.39 39.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.87 41.84 2.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.402 ' HD3' ' C ' ' A' ' 252' ' ' ARG . 0.0 OUTLIER -67.54 86.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.854 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.2 t30 59.79 42.62 16.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.841 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 137.09 127.89 2.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.53 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.877 HG22 HD13 ' A' ' 222' ' ' ILE . 50.9 mm -48.4 113.11 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.766 0.317 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.453 ' OE1' HD11 ' A' ' 219' ' ' LEU . 37.1 mt-30 -137.67 165.46 26.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.32 127.07 4.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 11.0 mtt -95.67 126.25 40.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.661 HG13 HG12 ' A' ' 247' ' ' ILE . 61.2 t -123.83 127.02 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -105.85 172.74 6.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -142.24 169.78 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -54.27 -68.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 13.8 m -119.35 173.32 7.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 64.6 t -60.43 -52.39 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.139 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 55.2 tp -38.58 -63.48 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 80.7 m -48.03 -46.37 33.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -53.32 -45.57 69.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -63.74 -55.53 22.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -55.26 -58.27 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.986 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -51.24 -46.2 62.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.698 ' HA ' HD13 ' A' ' 288' ' ' ILE . 56.8 tttm -49.03 -52.0 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -56.82 -67.03 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.93 -41.12 2.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.547 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.9 mp -83.6 -22.15 32.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 271' ' ' LYS . 1.2 t30 -57.36 104.7 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.0 22.69 77.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -83.24 90.52 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 0.0 111.134 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.76 129.28 19.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.588 HD11 HD21 ' A' ' 286' ' ' LEU . 79.8 mt -99.4 -41.8 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -117.3 173.15 6.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -50.28 103.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.132 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.44 48.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.499 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.2 m -161.42 174.44 13.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.319 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 34.0 m 52.94 42.36 32.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 11.3 m -57.58 152.13 15.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.155 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.588 HD21 HD11 ' A' ' 279' ' ' ILE . 50.9 mt -97.85 125.93 42.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 94.88 4.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.698 HD13 ' HA ' ' A' ' 271' ' ' LYS . 34.0 mt -85.62 145.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 290' ' ' TYR . 25.7 mt-10 -155.28 113.82 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 289' ' ' GLU . 68.9 m-85 -34.74 107.27 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.579 ' CB ' HG12 ' A' ' 217' ' ' VAL . . . -50.51 135.95 21.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.084 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.576 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 5.9 ttt180 -64.14 -46.67 79.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.587 0.708 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.5 Cg_endo -79.37 149.81 21.93 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.667 2.245 . . . . 0.0 112.38 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.5 p -87.1 -27.52 23.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.11 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -121.22 154.47 36.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 48.1 mt -114.62 179.67 3.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -145.1 133.84 22.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.638 HG22 HG22 ' A' ' 248' ' ' VAL . 96.8 t -131.23 105.69 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.576 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.2 mp -63.41 -60.57 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.122 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ARG . . . . . 0.47 ' HG3' HG22 ' A' ' 299' ' ' ILE . 88.4 mtt-85 -124.82 166.97 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 302' ' ' ASP . 2.1 m-20 -106.67 95.19 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 303' ' ' ASN . 0.9 OUTLIER -141.19 172.38 12.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 302' ' ' ASP . 1.7 p-10 -34.23 -41.69 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -57.4 -63.35 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.4 p -129.57 149.47 51.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -150.9 120.94 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.81 100.66 12.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -84.1 38.51 0.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 67.6 p -119.36 -40.62 2.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.554 ' HB2' HD22 ' A' ' 313' ' ' LEU . 29.6 mttm -129.6 101.31 18.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.561 0.696 . . . . 0.0 110.889 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.52 -50.33 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.687 2.258 . . . . 0.0 112.3 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.566 ' CG ' ' O ' ' A' ' 312' ' ' TYR . 0.2 OUTLIER -81.0 39.83 0.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.554 HD22 ' HB2' ' A' ' 310' ' ' LYS . 11.6 tp -96.21 123.24 39.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -95.36 -125.5 4.62 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.471 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 316' ' ' ARG . 0.2 OUTLIER -75.27 -38.69 60.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.334 . . . . 0.0 110.865 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.423 ' N ' ' HG3' ' A' ' 315' ' ' ARG . 11.6 mmm180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.3 m -167.28 148.53 5.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 0.0 110.848 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 4.0 m -160.57 159.37 30.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 155.27 134.76 1.92 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 57.4 p -136.79 128.03 28.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.369 . . . . 0.0 110.821 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 8.0 t -112.16 103.22 11.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.64 113.63 0.54 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.536 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -168.8 120.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.791 0.329 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -141.25 128.06 20.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.1 mt -92.98 95.31 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.139 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 81.4 p -154.76 119.34 4.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.095 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 36.6 ttt85 -38.34 133.94 0.95 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.82 35.8 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.249 . . . . 0.0 112.344 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 178.4 63.42 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.58 83.07 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.865 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 44.5 p -132.63 100.22 4.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -88.42 95.12 10.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -88.06 111.06 40.4 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.54 160.61 34.96 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.672 2.248 . . . . 0.0 112.336 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.8 m -56.31 98.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -107.96 -176.8 22.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.422 ' HA2' ' CE1' ' A' ' 290' ' ' TYR . . . -165.52 108.53 0.33 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.535 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 291' ' ' ALA . 7.1 p-10 -157.57 139.42 14.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.494 ' HG2' ' N ' ' A' ' 264' ' ' VAL . 17.3 mtmm -42.99 -45.85 5.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.0 137.64 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.614 ' O ' HD12 ' A' ' 220' ' ' LEU . 19.7 mt -131.99 120.64 22.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.4 HD13 ' HZ ' ' A' ' 250' ' ' PHE . 17.0 tp -76.8 114.52 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.776 HD13 HG23 ' A' ' 259' ' ' VAL . 7.0 mp -102.34 147.95 26.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.0 120.82 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 229' ' ' ILE . 5.2 mp -80.62 123.93 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -81.54 137.57 35.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.561 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 50.4 t30 44.18 53.57 10.83 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.7 Cg_exo -47.3 103.98 0.06 OUTLIER 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.67 2.247 . . . . 0.0 112.38 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 37.8 mt -107.46 -47.65 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.543 ' CD2' ' CD2' ' A' ' 280' ' ' TYR . 94.8 m-85 -97.37 141.11 22.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.689 0.757 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.55 117.33 2.29 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.707 2.271 . . . . 0.0 112.371 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.481 HG21 HD11 ' A' ' 222' ' ' ILE . 30.5 mm -99.61 106.3 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.627 HG22 ' OD1' ' A' ' 303' ' ' ASN . 28.7 p -111.53 165.82 11.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 306' ' ' TRP . 28.9 m -47.38 -40.44 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.147 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 235' ' ' TYR . 9.7 t0 -57.22 -63.89 1.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 232' ' ' ASP . 90.8 t -35.67 -36.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.17 -37.6 18.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 49.2 t80 -84.11 25.85 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.497 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 89.8 m -130.78 -36.22 1.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.124 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.435 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 25.4 t -98.12 -23.58 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.12 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.446 ' SG ' HD21 ' A' ' 274' ' ' LEU . 98.1 m -86.18 -48.78 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.568 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 11.9 t30 -47.43 -47.04 59.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.592 0.71 . . . . 0.0 110.85 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.8 Cg_exo -48.02 -21.5 2.8 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.643 2.229 . . . . 0.0 112.333 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 273' ' ' ALA . 20.2 t -93.12 -48.64 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.097 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -138.12 -128.02 2.58 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -138.11 114.72 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.759 HG11 HD11 ' A' ' 247' ' ' ILE . 58.9 t -94.84 139.95 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.42 ' NE2' ' OE1' ' A' ' 262' ' ' GLU . 3.3 mm100 -108.09 -67.32 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -116.84 158.19 24.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.759 HD11 HG11 ' A' ' 244' ' ' VAL . 79.6 mt -149.72 108.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' A' ' 305' ' ' SER . 48.2 t -107.62 143.25 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 257' ' ' ALA . 73.1 mt -126.61 114.89 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.4 ' HZ ' HD13 ' A' ' 219' ' ' LEU . 15.8 p90 -125.69 146.2 49.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -91.95 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -67.17 89.76 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 12.5 m120 50.58 42.02 26.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 137.32 136.2 3.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.506 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 32.7 mm -51.12 97.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.767 0.318 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -127.38 152.74 47.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.564 ' HB2' HG12 ' A' ' 249' ' ' ILE . . . -146.51 124.58 12.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.091 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.496 ' SD ' HD21 ' A' ' 296' ' ' LEU . 25.9 mtt -86.68 118.62 26.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.776 HG23 HD13 ' A' ' 220' ' ' LEU . 57.8 t -102.97 138.06 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -111.26 143.05 42.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -119.07 174.47 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.856 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.42 ' OE1' ' NE2' ' A' ' 245' ' ' GLN . 3.9 mm-40 -56.71 -66.82 0.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.425 ' C ' ' HG2' ' A' ' 216' ' ' LYS . 93.0 p -139.02 165.64 26.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.83 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.494 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 90.7 t -43.15 -54.38 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.116 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 34.7 tp -45.11 -60.8 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 81.7 m -47.91 -39.27 18.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -59.6 -39.29 83.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -57.43 -59.82 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -56.79 -58.75 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.43 ' O ' HD13 ' A' ' 274' ' ' LEU . . . -49.06 -57.45 6.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.692 ' HG3' HG21 ' A' ' 288' ' ' ILE . 55.6 tttm -42.94 -50.26 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -47.5 -71.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.133 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.644 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -47.76 -48.61 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.886 ' HB3' HD11 ' A' ' 288' ' ' ILE . 6.5 mp -64.58 -24.75 67.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 271' ' ' LYS . 50.4 t30 -62.16 102.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 76.27 20.77 76.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.505 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -86.36 94.8 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.0 111.12 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.03 162.99 6.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 53.5 mt -121.5 -42.95 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' TYR . . . . . 0.543 ' CD2' ' CD2' ' A' ' 227' ' ' TYR . 52.4 m-85 -112.74 173.43 6.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -50.77 104.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.101 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.63 58.53 0.71 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.495 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 26.1 p -175.1 160.48 2.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 110.872 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.6 m 63.47 46.67 4.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 286' ' ' LEU . 18.0 m -67.9 155.93 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.404 ' N ' HG22 ' A' ' 285' ' ' THR . 80.3 mt -98.82 125.84 44.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -115.23 98.22 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.886 HD11 ' HB3' ' A' ' 274' ' ' LEU . 74.5 mt -84.05 146.77 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.15 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -159.67 113.32 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.422 ' CE1' ' HA2' ' A' ' 214' ' ' GLY . 62.8 m-85 -40.83 102.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -54.95 145.77 19.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.569 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 8.9 ttm180 -61.97 -47.26 91.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.601 0.715 . . . . 0.0 110.826 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 61.3 Cg_endo -78.9 148.89 22.53 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.682 2.255 . . . . 0.0 112.276 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.9 p -90.55 -26.36 19.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -123.81 149.85 45.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.496 HD21 ' SD ' ' A' ' 258' ' ' MET . 78.9 mt -105.37 178.85 4.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.924 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -138.39 110.37 7.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 85.5 t -120.99 110.7 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.8 mp -73.23 -54.03 16.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.18 151.62 51.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.36 97.15 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 303' ' ' ASN . 7.7 p-10 -130.9 166.11 21.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.627 ' OD1' HG22 ' A' ' 230' ' ' THR . 1.1 t30 -36.5 -45.54 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -60.66 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.544 ' HB2' HG22 ' A' ' 248' ' ' VAL . 55.7 p -134.31 128.42 33.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' TRP . . . . . 0.505 ' HB2' HG11 ' A' ' 231' ' ' VAL . 17.0 t-105 -114.14 149.48 35.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -129.29 106.24 8.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -82.62 -43.37 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 58.8 p -44.44 -45.46 9.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -110.59 86.21 5.39 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.544 0.687 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.68 -11.51 18.48 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.649 2.232 . . . . 0.0 112.34 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -101.04 44.01 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 20.7 mt -94.96 -51.26 4.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 100.02 129.4 6.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.468 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -59.98 -44.41 94.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.918 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 52.4 p -112.88 156.31 23.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 110.86 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 9.5 t -106.49 -45.6 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 97.63 52.92 1.37 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 33.1 t -122.35 160.15 25.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.3 t -77.79 -42.83 32.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.865 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.33 165.44 12.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -174.72 116.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.716 0.294 . . . . 0.0 110.856 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.21 155.58 28.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 29.8 pt -77.57 129.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 14.7 t -145.58 146.24 31.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.31 143.57 49.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.584 0.707 . . . . 0.0 110.919 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.06 145.57 24.81 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.708 2.272 . . . . 0.0 112.364 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -113.72 168.53 12.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -142.66 156.71 45.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 110.84 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 87.8 m -134.32 142.2 47.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 28.4 p30 -164.24 170.5 16.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -151.44 121.7 3.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.674 0.749 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -45.94 123.89 6.65 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.709 2.273 . . . . 0.0 112.325 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 92.7 p -44.13 135.22 4.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 81.92 123.55 0.7 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.488 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -56.32 -161.35 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.473 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.774 ' OD1' HG22 ' A' ' 294' ' ' THR . 23.5 t30 -166.77 131.46 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 110.886 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -52.54 -46.06 66.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 90.1 t -81.59 131.11 34.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.128 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.463 HD22 ' HZ2' ' A' ' 271' ' ' LYS . 14.9 mt -123.09 128.17 49.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.658 HD11 ' OE1' ' A' ' 256' ' ' GLN . 29.4 tp -81.97 102.73 11.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.491 HD13 HG23 ' A' ' 259' ' ' VAL . 8.4 mp -89.54 132.78 34.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m -123.64 118.12 26.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.2 mp -81.2 138.76 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.12 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.438 ' C ' ' HD3' ' A' ' 225' ' ' PRO . 2.1 tp-100 -96.68 141.45 29.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.542 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 48.7 t30 35.5 53.76 1.97 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.62 0.724 . . . . 0.0 110.843 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 77.6 Cg_exo -45.98 106.69 0.1 OUTLIER 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.367 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 66.7 mt -101.97 -48.4 4.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -112.49 126.1 28.92 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.675 0.75 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.55 112.25 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.63 HG21 HD21 ' A' ' 234' ' ' LEU . 29.5 mm -88.09 92.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.133 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.684 HG23 ' HB3' ' A' ' 303' ' ' ASN . 2.3 m -70.85 170.3 12.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.577 ' H ' HG22 ' A' ' 230' ' ' THR . 24.5 m -55.63 -41.31 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.408 ' N ' HG23 ' A' ' 231' ' ' VAL . 67.9 m-20 -58.05 -53.33 59.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.9 t -44.72 -37.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.63 HD21 HG21 ' A' ' 229' ' ' ILE . 52.6 mt -85.07 -35.65 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 81.8 t80 -82.55 19.95 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.412 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 93.0 m -122.78 -36.92 2.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.118 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.426 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 90.0 t -99.75 -18.84 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.441 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 58.5 m -89.07 -46.06 9.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.588 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.6 OUTLIER -50.58 -45.59 85.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.583 0.706 . . . . 0.0 110.896 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.4 Cg_exo -47.97 -28.19 9.93 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.681 2.254 . . . . 0.0 112.337 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 29.8 t -86.56 -49.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.097 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.92 -132.55 3.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -133.31 107.53 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.63 HG11 HD11 ' A' ' 247' ' ' ILE . 96.4 t -88.92 119.84 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.457 ' NE2' ' CD ' ' A' ' 262' ' ' GLU . 1.4 mm100 -81.13 -68.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.454 ' NH1' ' O ' ' A' ' 296' ' ' LEU . 7.5 ptp180 -132.97 154.9 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.63 HD11 HG11 ' A' ' 244' ' ' VAL . 70.4 mt -133.43 135.28 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.478 HG13 ' OG ' ' A' ' 305' ' ' SER . 58.7 t -126.98 132.05 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.16 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 23.4 mt -120.61 118.68 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.501 ' CE2' ' HB3' ' A' ' 256' ' ' GLN . 20.2 p90 -126.75 155.18 43.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -110.22 45.22 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -90.05 109.91 20.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 61.51 41.41 12.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 109.04 149.82 13.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.457 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.9 mm -51.37 123.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 111.113 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.658 ' OE1' HD11 ' A' ' 219' ' ' LEU . 17.2 tt0 -153.15 163.79 39.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.24 146.18 16.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 35.3 mtt -111.38 124.92 53.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.491 HG23 HD13 ' A' ' 220' ' ' LEU . 65.7 t -111.89 121.64 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.667 ' HB2' HD12 ' A' ' 296' ' ' LEU . 3.9 tp10 -98.36 140.81 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.527 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 42.0 m-85 -116.35 158.21 23.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.457 ' CD ' ' NE2' ' A' ' 245' ' ' GLN . 3.9 mm-40 -41.48 -67.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 10.0 m -130.52 173.84 10.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.856 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 92.1 t -57.02 -56.72 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 264' ' ' VAL . 17.4 tp -38.27 -64.06 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 61.6 m -45.59 -42.15 10.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -55.91 -40.35 72.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -52.04 -62.95 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -59.77 -59.99 4.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.527 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -42.78 -48.8 5.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.706 ' HG3' HG21 ' A' ' 288' ' ' ILE . 27.2 tttp -56.15 -44.29 79.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.04 -60.39 3.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.078 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -49.72 -40.45 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.732 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.7 mp -83.99 -22.61 31.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 271' ' ' LYS . 2.7 t30 -62.17 100.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.56 18.0 61.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.451 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.786 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -80.56 154.3 27.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.331 . . . . 0.0 111.135 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -118.24 134.85 54.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.576 HD11 HD21 ' A' ' 286' ' ' LEU . 65.7 mt -101.53 -40.33 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.148 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.2 172.73 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -54.2 105.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.063 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.84 56.89 0.8 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.1 m -167.54 161.1 13.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.8 m 62.3 39.27 12.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.9 m -55.48 143.47 29.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.186 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.786 HD12 ' HB3' ' A' ' 277' ' ' ALA . 67.8 mt -93.41 126.74 38.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.883 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -124.92 84.92 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.732 HD11 ' CB ' ' A' ' 274' ' ' LEU . 27.0 mt -71.27 144.95 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -147.68 120.07 8.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.549 ' CE2' ' HE2' ' A' ' 271' ' ' LYS . 59.0 m-85 -45.84 96.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.8 147.07 15.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.052 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.474 ' HB2' ' HD3' ' A' ' 293' ' ' PRO . 56.8 mtt-85 -65.41 -61.07 6.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.584 0.707 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 292' ' ' ARG . 58.9 Cg_endo -71.37 154.55 60.95 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.654 2.236 . . . . 0.0 112.34 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.774 HG22 ' OD1' ' A' ' 215' ' ' ASN . 37.0 p -116.14 38.54 3.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.475 ' HG2' ' N ' ' A' ' 296' ' ' LEU . 37.4 ttt180 -149.88 151.21 33.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.667 HD12 ' HB2' ' A' ' 260' ' ' GLU . 85.9 mt -141.58 120.91 13.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -106.96 135.05 49.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 92.0 t -120.25 98.34 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.163 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.8 mp -55.49 -62.55 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -119.88 169.65 9.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.424 ' ND2' ' OD1' ' A' ' 307' ' ' ASP . 3.2 m120 -107.49 114.83 29.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.414 ' CG ' ' C ' ' A' ' 301' ' ' ASN . 0.9 OUTLIER -162.56 172.15 15.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.684 ' HB3' HG23 ' A' ' 230' ' ' THR . 20.8 m120 -42.34 -40.28 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.62 -46.31 70.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.478 ' OG ' HG13 ' A' ' 248' ' ' VAL . 8.6 m -158.03 143.89 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -134.88 145.19 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.424 ' OD1' ' ND2' ' A' ' 301' ' ' ASN . 2.2 p-10 -119.34 106.65 12.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.836 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.44 -39.67 24.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 37.9 p -48.4 -47.4 37.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.52 ' HE3' HD21 ' A' ' 313' ' ' LEU . 16.3 mmmt -131.18 88.64 44.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.517 0.675 . . . . 0.0 110.885 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.06 -48.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 312' ' ' TYR . 0.1 OUTLIER -75.87 52.67 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.949 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.52 HD21 ' HE3' ' A' ' 310' ' ' LYS . 28.0 mt -89.78 112.35 23.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.93 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 95.25 79.17 1.45 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -87.11 39.58 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.801 0.334 . . . . 0.0 110.855 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 -179.906 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 82.7 p -172.52 136.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 1.1 t -167.88 175.25 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -148.13 73.71 0.29 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 83.7 p -82.53 92.29 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.878 0.371 . . . . 0.0 110.826 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.3 t -165.14 171.11 14.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.866 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 129.91 99.8 0.89 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.472 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -174.2 146.42 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 110.847 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -135.29 120.95 19.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 7.4 pt -48.86 161.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.163 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.1 t -162.05 160.75 27.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.153 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ARG . . . . . 0.459 ' CD ' ' HD2' ' A' ' 205' ' ' PRO . 23.9 tpt180 -95.97 136.98 21.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.55 0.691 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.459 ' HD2' ' CD ' ' A' ' 204' ' ' ARG . 72.4 Cg_exo -46.8 165.0 0.09 OUTLIER 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.673 2.249 . . . . 0.0 112.367 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -70.08 71.26 0.59 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.451 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -52.49 147.07 8.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.398 . . . . 0.0 110.873 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 61.8 p -73.04 164.08 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -67.36 145.61 54.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.905 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -71.63 129.91 87.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.34 142.74 12.13 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.667 2.245 . . . . 0.0 112.364 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.4 t -153.92 149.31 27.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -109.47 137.73 14.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.511 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -54.38 168.7 1.66 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.521 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -146.19 127.72 15.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 0.0 110.906 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -51.24 -41.26 60.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.418 HG11 HD21 ' A' ' 296' ' ' LEU . 50.4 t -78.64 147.38 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 10.1 mt -138.52 139.59 38.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.66 109.54 21.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.859 HD23 HD22 ' A' ' 286' ' ' LEU . 7.6 mp -97.87 129.33 44.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -119.77 115.72 24.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.85 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -82.46 134.98 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.161 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.426 ' C ' ' HD3' ' A' ' 225' ' ' PRO . 2.2 tp-100 -100.4 139.06 36.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.552 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 12.9 t-20 35.61 54.0 2.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.5 Cg_exo -47.18 113.9 0.84 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.358 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 224' ' ' ASN . 3.3 mm? -89.25 -58.82 2.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.24 143.63 26.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.74 0.781 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.16 112.68 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.714 2.276 . . . . 0.0 112.354 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.7 mm -89.32 116.54 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 18.6 p -126.73 169.29 13.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 303' ' ' ASN . 33.0 m -48.81 -20.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.97 -40.96 68.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.7 t -70.29 -31.8 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.17 10.48 35.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -121.94 -5.87 9.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.475 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 40.0 m -108.5 -32.51 7.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.134 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 237' ' ' VAL . 59.7 t -97.2 -7.56 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 61.2 m -100.73 -45.36 5.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.588 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.6 t-20 -52.04 -45.39 93.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.644 0.735 . . . . 0.0 110.878 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.6 Cg_exo -48.04 -23.78 4.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 34.1 t -92.18 -53.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.45 -134.89 3.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.525 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.492 ' HE2' ' N ' ' A' ' 244' ' ' VAL . 0.0 OUTLIER -128.49 94.93 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.87 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.634 HG11 HD11 ' A' ' 247' ' ' ILE . 72.9 t -53.11 132.94 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -110.53 -66.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.491 ' NE ' ' OD2' ' A' ' 307' ' ' ASP . 16.3 ttm105 -128.76 143.15 50.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.634 HD11 HG11 ' A' ' 244' ' ' VAL . 43.3 mt -128.63 132.51 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.093 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.49 HG22 HG22 ' A' ' 298' ' ' VAL . 46.8 t -136.55 132.45 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.2 mt -124.06 113.71 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.142 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -120.29 143.6 48.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -113.35 43.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -60.18 -70.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -107.15 48.16 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.58 -120.89 4.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.7 mm -133.81 93.92 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 111.172 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -125.99 167.9 14.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -161.89 124.98 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.596 ' HB3' HD11 ' A' ' 296' ' ' LEU . 10.7 mtt -93.59 119.23 32.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.78 130.42 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.092 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -104.65 153.92 20.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -125.27 169.43 12.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -37.91 -73.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.9 m -137.57 -175.27 4.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 60.1 t -55.15 -50.9 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.085 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 15.9 tp -46.28 -59.41 2.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 3.5 t -55.29 -30.84 60.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -70.26 -36.13 74.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -58.14 -54.4 47.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -68.52 -44.02 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.14 -49.57 71.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.677 ' HG3' HG21 ' A' ' 288' ' ' ILE . 27.0 tttm -50.97 -56.55 11.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.23 -59.45 5.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.13 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.61 -30.69 3.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.035 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.801 ' CB ' HD11 ' A' ' 288' ' ' ILE . 3.4 mp -98.07 -14.84 20.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 271' ' ' LYS . 8.9 t-20 -58.43 108.18 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 68.74 18.93 72.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.488 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -72.48 99.33 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.28 113.24 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.824 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 87.0 mt -72.36 -32.76 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' TYR . . . . . 0.424 ' O ' ' C ' ' A' ' 281' ' ' ALA . 63.2 m-85 -136.53 150.76 48.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 280' ' ' TYR . . . -35.85 105.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.1 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 39.86 70.87 0.31 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -174.84 150.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 0.0 110.919 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 3.3 m 57.36 51.56 9.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 28.1 m -60.59 109.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.859 HD22 HD23 ' A' ' 220' ' ' LEU . 35.5 mt -68.48 107.29 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -102.23 91.71 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.801 HD11 ' CB ' ' A' ' 274' ' ' LEU . 97.6 mt -79.59 139.58 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.1 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -149.1 125.97 11.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.537 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 32.4 m-85 -48.69 100.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.987 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -53.93 142.05 25.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.597 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.6 OUTLIER -64.55 -44.79 75.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.9 Cg_endo -80.46 147.53 17.92 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.709 2.272 . . . . 0.0 112.339 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 36.8 p -88.57 -14.32 37.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -127.59 164.95 20.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 258' ' ' MET . 42.9 mt -122.0 171.61 8.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.94 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -129.26 98.66 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 307' ' ' ASP . 85.9 t -81.09 101.76 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.123 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.484 HG22 ' HE ' ' A' ' 300' ' ' ARG . 3.2 mm -38.03 -63.24 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ARG . . . . . 0.484 ' HE ' HG22 ' A' ' 299' ' ' ILE . 16.1 ptp180 -170.17 142.29 2.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -39.49 100.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -167.63 172.52 9.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.712 ' O ' HG13 ' A' ' 231' ' ' VAL . 12.6 m-80 -47.68 -57.0 6.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.7 -41.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.43 ' OG ' HG13 ' A' ' 248' ' ' VAL . 8.5 m -162.39 136.94 6.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -126.77 129.06 47.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.587 ' HB2' HG21 ' A' ' 298' ' ' VAL . 19.8 t0 -121.8 81.02 1.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.859 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' TYR . . . . . 0.518 ' CZ ' HG22 ' A' ' 309' ' ' THR . 1.6 p90 -70.72 -37.66 73.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.518 HG22 ' CZ ' ' A' ' 308' ' ' TYR . 30.5 p -62.13 -21.31 64.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 312' ' ' TYR . 32.5 ttpt -127.09 90.16 50.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.57 0.7 . . . . 0.0 110.894 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.98 -3.1 12.95 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.702 2.268 . . . . 0.0 112.332 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.553 ' O ' ' CD2' ' A' ' 312' ' ' TYR . 36.5 p90 -107.44 93.7 4.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -119.78 120.06 35.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 51.66 71.61 0.63 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -71.25 85.4 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 0.0 110.868 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 62.7 m -108.76 160.27 16.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.887 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.3 t -69.25 167.45 16.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 98.71 97.2 2.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.526 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 51.3 p -128.6 -45.67 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.839 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 4.7 t -110.98 98.13 7.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -91.29 73.9 1.66 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 201' ' ' ARG . 0.0 OUTLIER -43.7 -26.42 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 110.899 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.4 ' N ' ' HG2' ' A' ' 200' ' ' LYS . 23.5 mtt180 -124.73 162.79 23.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.4 mt -122.87 141.15 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.6 m -41.32 -52.95 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -153.23 143.24 15.29 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.32 154.24 31.9 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.38 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -41.87 114.65 0.71 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.494 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -59.73 108.94 0.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.1 m -125.44 89.03 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -112.09 122.42 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.9 143.75 54.19 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.655 0.74 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.01 159.48 34.02 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.74 2.293 . . . . 0.0 112.345 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 6.0 t -122.01 42.7 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.9 -68.27 0.76 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 81.23 156.53 15.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -170.92 144.95 2.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.384 . . . . 0.0 110.856 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -43.72 79.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 296' ' ' LEU . 92.8 t -88.13 146.78 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.101 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.3 mt -135.43 124.99 25.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 36.0 tp -81.62 109.03 15.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.3 mp -95.84 129.47 43.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 63.1 m -112.73 127.07 56.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.575 HD13 HG22 ' A' ' 255' ' ' ILE . 4.8 mp -89.61 121.74 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.74 138.77 39.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.517 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 1.8 m-20 43.43 53.92 10.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.73 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.5 Cg_exo -45.87 90.24 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.337 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.7 mt -97.04 -42.45 7.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -111.45 153.54 44.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.732 0.777 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.75 115.81 4.28 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.537 HG21 HD21 ' A' ' 234' ' ' LEU . 30.3 mm -99.23 92.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 231' ' ' VAL . 1.6 m -71.81 167.22 20.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.093 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 230' ' ' THR . 21.2 m -54.44 -39.53 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.34 -52.05 67.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 96.0 t -46.05 -40.14 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.537 HD21 HG21 ' A' ' 229' ' ' ILE . 33.7 mt -76.05 -60.5 2.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.964 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -47.31 -34.06 6.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.481 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 87.2 m -63.35 -47.8 80.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.149 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 237' ' ' VAL . 59.6 t -86.94 -10.77 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.128 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.435 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 72.9 m -87.39 -49.2 7.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.571 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 14.3 t30 -48.53 -46.48 70.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.649 0.738 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.3 Cg_exo -47.96 -18.63 1.2 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.667 2.245 . . . . 0.0 112.399 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 37.0 t -104.4 -41.62 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.79 -144.71 4.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -123.16 126.4 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.914 HG11 HD11 ' A' ' 247' ' ' ILE . 85.4 t -96.19 147.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -108.22 -61.89 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 247' ' ' ILE . 21.3 ttm180 -134.6 147.82 50.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.914 HD11 HG11 ' A' ' 244' ' ' VAL . 61.3 mt -140.54 131.0 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.466 HG22 HG22 ' A' ' 298' ' ' VAL . 89.7 t -125.67 135.87 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 304' ' ' ASP . 58.5 mt -120.94 120.82 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -136.1 155.13 50.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -131.76 40.59 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -68.78 -57.26 5.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -119.77 45.77 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 116.69 128.49 4.17 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.443 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.575 HG22 HD13 ' A' ' 222' ' ' ILE . 42.9 mm -43.92 104.41 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -146.3 170.76 16.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.54 130.22 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.467 ' SD ' ' CD2' ' A' ' 296' ' ' LEU . 22.4 mtt -87.89 118.0 27.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 87.7 t -107.87 123.43 63.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -103.08 150.3 23.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 262' ' ' GLU . 56.4 m-85 -126.0 161.12 28.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 261' ' ' PHE . 23.4 mt-10 -34.15 -70.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 t -140.39 167.71 21.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 94.8 t -41.04 -57.14 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 264' ' ' VAL . 19.6 tp -37.22 -63.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 30.7 m -47.36 -42.2 21.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -56.33 -38.31 71.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -56.14 -59.44 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -66.32 -50.9 62.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.954 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -49.42 -49.92 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.68 ' HA ' HD13 ' A' ' 288' ' ' ILE . 58.9 tttm -52.57 -46.96 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -60.05 -70.52 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -42.29 -36.8 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.713 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.7 mp -85.94 -23.97 26.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 271' ' ' LYS . 14.3 t-20 -58.75 102.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.9 23.07 60.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -93.24 93.71 8.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.1 148.63 50.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 41.0 mt -104.5 -40.34 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.89 172.93 6.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -57.16 107.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.4 55.68 0.75 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.514 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 6.5 m -164.47 153.67 13.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 4.9 m 62.82 44.53 6.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 39.2 m -59.92 129.22 40.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.439 ' O ' ' NZ ' ' A' ' 287' ' ' LYS . 35.5 mt -78.28 123.31 26.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 286' ' ' LEU . 0.9 OUTLIER -121.83 84.96 2.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.713 HD11 ' CB ' ' A' ' 274' ' ' LEU . 28.6 mt -65.26 144.02 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.174 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -153.98 111.09 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -38.07 106.26 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.62 160.76 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.097 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 14.8 mtt-85 -73.04 -59.37 2.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 59.7 Cg_endo -73.23 159.09 47.89 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.711 2.274 . . . . 0.0 112.342 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 34.4 p -88.22 -25.1 23.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -173.88 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.606 HD21 HG11 ' A' ' 217' ' ' VAL . 17.8 mt -142.24 168.34 19.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -125.56 114.97 19.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.466 HG22 HG22 ' A' ' 248' ' ' VAL . 84.5 t -106.02 102.86 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.7 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.4 mp -57.25 -51.31 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.03 155.42 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -90.09 85.38 6.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.4 173.16 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -39.39 -51.12 2.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.402 ' O ' HD12 ' A' ' 249' ' ' ILE . 2.1 m-20 -45.46 -59.87 2.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 63.8 p -135.13 138.46 43.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -139.56 127.44 22.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -104.02 98.22 8.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -83.72 40.21 0.73 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 77.3 p -114.68 -39.34 3.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.138 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.46 ' HG2' ' CZ ' ' A' ' 312' ' ' TYR . 24.7 mttp -126.72 89.01 53.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.534 0.683 . . . . 0.0 110.877 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.72 -5.36 15.93 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.707 2.271 . . . . 0.0 112.36 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.46 ' CZ ' ' HG2' ' A' ' 310' ' ' LYS . 8.8 p90 -102.9 45.78 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 20.1 mt -121.61 106.21 11.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.939 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 161.99 46.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.511 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.34 80.27 1.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.813 0.339 . . . . 0.0 110.888 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -179.905 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.8 t -153.95 115.64 4.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.351 . . . . 0.0 110.866 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.3 m -75.21 122.03 23.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 159.19 87.05 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.491 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 66.7 m -119.43 123.62 44.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.888 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 83.8 p -171.32 146.56 2.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.43 -171.26 17.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -82.28 -44.77 15.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -117.56 95.45 4.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 4.5 pt -70.48 70.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.119 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.1 p -140.77 152.78 45.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.175 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -122.71 122.49 27.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.605 0.717 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.87 106.16 2.21 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.743 2.295 . . . . 0.0 112.327 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -129.2 51.12 0.87 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -170.35 157.47 6.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 110.899 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.7 m -116.78 154.26 30.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -96.87 121.82 39.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -107.98 151.75 41.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.576 0.703 . . . . 0.0 110.912 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.87 122.67 6.42 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.737 2.291 . . . . 0.0 112.371 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 8.4 t 49.96 41.51 23.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -110.13 -149.01 12.26 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.462 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 114.85 -172.1 14.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -156.25 142.31 18.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.859 0.362 . . . . 0.0 110.893 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -58.1 -42.95 86.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.438 ' O ' HD23 ' A' ' 218' ' ' LEU . 59.6 t -73.84 139.27 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.123 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 217' ' ' VAL . 29.5 mt -138.6 126.82 22.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.46 113.48 21.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.489 HD23 HD22 ' A' ' 286' ' ' LEU . 6.9 mp -100.53 132.68 45.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -119.33 137.92 53.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.599 HD13 HG22 ' A' ' 255' ' ' ILE . 5.2 mp -105.28 125.31 60.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -82.57 142.43 31.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.517 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 42.0 t30 40.12 53.49 5.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.3 Cg_exo -44.7 103.61 0.05 OUTLIER 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.697 2.265 . . . . 0.0 112.343 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 55.2 mt -105.08 -46.93 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -100.5 153.61 37.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.709 0.766 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.75 116.34 4.64 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.711 2.274 . . . . 0.0 112.35 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.534 HG21 HD21 ' A' ' 234' ' ' LEU . 43.7 mm -100.22 119.98 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 232' ' ' ASP . 18.2 p -122.57 156.16 34.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 303' ' ' ASN . 34.4 m -33.62 -35.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.2 m-20 -60.96 -65.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 87.3 t -43.62 -51.02 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.16 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.534 HD21 HG21 ' A' ' 229' ' ' ILE . 46.1 mt -60.93 -58.33 8.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.549 ' CE2' ' HB ' ' A' ' 244' ' ' VAL . 3.2 t80 -54.68 -25.86 29.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.422 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 66.6 m -70.19 -45.86 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.171 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.439 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 39.4 t -87.2 -15.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 71.0 m -86.27 -46.12 10.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.556 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -47.11 -47.76 54.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.866 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.0 Cg_exo -47.96 -21.07 2.41 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.723 2.282 . . . . 0.0 112.366 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.874 HG11 ' HA ' ' A' ' 270' ' ' ALA . 69.7 t -98.73 -39.09 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.13 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.53 -154.11 7.94 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.457 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.408 ' HB3' ' CD ' ' A' ' 262' ' ' GLU . 2.5 tmtm? -104.23 144.39 31.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.944 HG11 HD11 ' A' ' 247' ' ' ILE . 63.0 t -108.69 141.3 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -110.66 -65.11 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.446 ' HG2' ' N ' ' A' ' 247' ' ' ILE . 17.4 ttm180 -130.9 145.08 51.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.944 HD11 HG11 ' A' ' 244' ' ' VAL . 71.3 mt -138.34 140.17 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 305' ' ' SER . 17.1 t -131.37 139.98 49.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.418 HG12 ' CB ' ' A' ' 257' ' ' ALA . 77.2 mt -129.02 109.45 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -118.96 151.29 38.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 40.88 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -58.48 -63.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -109.19 43.6 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.31 -121.96 4.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.495 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.599 HG22 HD13 ' A' ' 222' ' ' ILE . 28.7 mm -129.61 91.21 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 111.102 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -124.83 159.68 30.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.418 ' CB ' HG12 ' A' ' 249' ' ' ILE . . . -155.91 122.93 5.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.464 ' SD ' HD21 ' A' ' 296' ' ' LEU . 19.3 mtt -86.07 125.07 33.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.447 HG23 HD13 ' A' ' 220' ' ' LEU . 95.6 t -111.85 118.86 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -94.31 156.44 16.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -130.67 169.04 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.892 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 262' ' ' GLU . 10.9 mp0 -54.26 -64.2 0.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 73.7 m -128.49 172.53 11.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 91.2 t -61.12 -51.43 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 24.9 tp -40.74 -63.49 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 33.5 m -46.03 -40.59 10.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -58.06 -39.21 77.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -56.75 -57.09 13.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -63.51 -60.35 3.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.874 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.62 -50.01 25.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.113 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.555 ' HG3' HG21 ' A' ' 288' ' ' ILE . 49.2 tttm -48.55 -51.67 26.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -59.36 -66.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.67 -37.75 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.473 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.4 mp -87.8 -22.1 24.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 272' ' ' ALA . 7.3 t30 -57.86 104.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.03 23.01 70.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.49 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -79.59 118.37 21.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.25 125.29 28.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 286' ' ' LEU . 78.4 mt -97.8 -41.04 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.146 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -117.77 172.58 7.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -54.38 105.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.12 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 35.63 54.26 1.07 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.497 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 4.3 m -165.45 163.77 19.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.01 41.89 7.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 54.0 m -55.8 118.49 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 279' ' ' ILE . 36.3 mt -71.39 127.08 31.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -127.02 95.03 4.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.555 HG21 ' HG3' ' A' ' 271' ' ' LYS . 38.7 mt -77.23 147.36 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -150.38 124.05 9.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -49.64 97.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -47.5 134.75 11.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.116 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.575 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 9.2 ttp180 -60.21 -46.61 97.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 0.0 110.817 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.2 Cg_endo -79.45 149.26 21.38 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.712 2.275 . . . . 0.0 112.349 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 60.6 p -92.66 -25.25 18.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -123.9 139.59 53.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.464 HD21 ' SD ' ' A' ' 258' ' ' MET . 40.0 mt -100.43 176.57 5.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -131.46 115.42 16.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.56 105.66 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.135 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.671 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -65.92 -59.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.136 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -132.9 175.58 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -104.16 105.69 15.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 303' ' ' ASN . 0.9 OUTLIER -149.7 166.74 28.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 231' ' ' VAL . 5.0 p30 -33.71 -39.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.58 -58.24 9.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.416 ' HB2' ' HA ' ' A' ' 248' ' ' VAL . 9.8 t -134.35 153.62 51.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -144.13 134.24 24.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -112.91 108.74 17.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.811 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -79.51 -50.58 10.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.902 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 68.6 p -41.9 -32.56 0.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -135.02 90.42 21.67 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.586 0.708 . . . . 0.0 110.86 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -79.26 -16.63 12.1 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.676 2.25 . . . . 0.0 112.365 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -104.14 69.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 31.4 mt -130.39 112.39 13.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.925 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 315' ' ' ARG . . . 99.78 156.24 28.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 314' ' ' GLY . 22.3 ttp180 -35.09 -53.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.845 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.883 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.8 m -155.73 176.07 13.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.902 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 74.3 m -152.32 170.5 19.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -150.09 176.46 28.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.501 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 70.2 m -153.79 116.08 4.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.878 0.371 . . . . 0.0 110.865 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.6 m -77.08 174.83 10.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -140.79 129.23 4.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.48 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -147.41 154.97 41.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -144.87 150.91 37.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.3 pt -70.21 166.8 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.158 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.2 t -136.27 151.67 49.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -98.61 154.73 37.36 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.606 0.717 . . . . 0.0 110.93 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.63 149.43 34.19 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.712 2.275 . . . . 0.0 112.312 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -114.39 127.41 7.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.464 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -71.01 165.67 22.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.892 0.377 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 31.4 m -118.29 139.4 51.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.0 168.78 19.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -119.46 133.19 23.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.627 0.727 . . . . 0.0 110.874 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -80.03 27.8 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.707 2.271 . . . . 0.0 112.361 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.7 m -44.45 98.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.839 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 79.62 -163.78 48.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.436 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.478 ' HA2' ' CE1' ' A' ' 290' ' ' TYR . . . 163.22 139.89 2.74 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.485 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.408 ' ND2' ' HB ' ' A' ' 217' ' ' VAL . 51.5 t30 -143.29 147.53 34.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.899 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 264' ' ' VAL . 40.2 mtmt -57.61 -41.91 82.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.674 HG11 HD21 ' A' ' 296' ' ' LEU . 55.8 t -77.59 138.58 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 220' ' ' LEU . 14.0 mt -133.79 119.2 18.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.9 tp -76.25 106.58 7.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.695 HD13 ' CG2' ' A' ' 259' ' ' VAL . 6.9 mp -92.98 123.76 36.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.0 m -114.27 118.96 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.0 mp -79.55 133.9 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.09 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.43 ' C ' ' HD3' ' A' ' 225' ' ' PRO . 43.8 mt-30 -91.15 141.91 28.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.547 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 62.7 t30 35.11 54.42 1.91 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.632 0.73 . . . . 0.0 110.874 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.8 Cg_exo -47.33 115.91 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.326 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 62.6 mt -108.17 -54.86 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -101.08 137.82 19.82 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.67 0.748 . . . . 0.0 110.867 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.77 125.94 13.76 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.673 2.248 . . . . 0.0 112.365 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.442 HD12 HG11 ' A' ' 233' ' ' VAL . 49.9 mm -104.55 126.4 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.107 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.0 p -125.77 163.84 21.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.131 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 235' ' ' TYR . 35.8 m -40.22 -35.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.166 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -55.99 -45.54 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 229' ' ' ILE . 94.7 t -61.9 -52.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 31.4 mt -84.11 24.38 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.455 ' CB ' ' O ' ' A' ' 231' ' ' VAL . 85.2 t80 -130.58 -37.25 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.971 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.499 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 85.2 m -80.58 -34.27 35.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.447 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 11.6 t -87.88 -19.4 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.462 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 73.0 m -84.63 -50.64 7.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.545 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 1.5 t-20 -45.31 -47.39 34.3 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.631 0.729 . . . . 0.0 110.904 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.6 Cg_exo -47.98 -30.93 14.76 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.259 . . . . 0.0 112.336 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.01 -39.86 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.168 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.47 -133.24 1.46 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.52 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -121.34 143.7 49.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.896 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.66 128.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.708 ' O ' HG23 ' A' ' 309' ' ' THR . 30.6 mm-40 -92.46 -59.44 2.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -147.27 154.3 40.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 79.5 mt -133.4 134.54 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 298' ' ' VAL . 58.1 t -133.47 116.06 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.5 mt -108.08 106.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -118.93 149.19 42.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.512 ' HG3' HD13 ' A' ' 255' ' ' ILE . 2.6 mppt? -118.16 41.45 2.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -54.25 -63.86 1.02 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -109.52 43.26 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.3 -118.82 3.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.512 HD13 ' HG3' ' A' ' 251' ' ' LYS . 41.8 mm -127.05 95.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 111.132 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -128.83 157.52 41.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -156.32 118.52 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 24.7 mtt -87.53 125.74 34.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.695 ' CG2' HD13 ' A' ' 220' ' ' LEU . 91.7 t -111.58 131.59 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.103 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 261' ' ' PHE . 5.0 tp10 -104.77 152.0 23.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.583 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 55.1 m-85 -130.08 157.6 41.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 261' ' ' PHE . 67.3 mt-10 -34.99 -66.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.2 p -143.68 174.54 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.432 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 74.5 t -47.82 -59.87 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 264' ' ' VAL . 18.1 tp -35.98 -60.12 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 85.9 m -53.22 -40.97 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -57.27 -36.88 71.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -58.76 -58.27 9.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -66.13 -53.03 42.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.583 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -49.38 -47.83 47.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.804 ' HG3' HG21 ' A' ' 288' ' ' ILE . 24.6 tttt -53.38 -55.57 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.847 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -53.64 -67.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.109 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -41.96 -42.29 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.602 ' CB ' HD11 ' A' ' 288' ' ' ILE . 3.6 mp -81.82 -22.0 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 271' ' ' LYS . 65.4 t30 -61.61 101.76 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.89 21.46 71.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.629 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -82.1 93.79 7.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.118 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.36 117.08 2.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.587 HD11 HD21 ' A' ' 286' ' ' LEU . 80.3 mt -91.14 -37.43 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.134 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -120.35 173.86 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -56.87 104.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.128 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.49 59.12 0.67 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.423 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 31.2 p -175.12 162.45 3.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.908 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 77.2 m 62.48 43.08 8.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 5.9 m -57.24 146.78 27.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.629 HD12 ' HB3' ' A' ' 277' ' ' ALA . 73.6 mt -91.81 119.33 31.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -116.71 79.53 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.804 HG21 ' HG3' ' A' ' 271' ' ' LYS . 47.6 mt -65.41 147.73 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -151.85 113.63 4.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.478 ' CE1' ' HA2' ' A' ' 214' ' ' GLY . 39.1 m-85 -41.12 101.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -50.67 138.9 17.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 6.2 ttt180 -66.08 -45.7 62.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.62 0.724 . . . . 0.0 110.889 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.3 Cg_endo -80.21 148.37 18.98 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.315 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.8 p -82.11 -25.75 34.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.438 ' HD3' ' N ' ' A' ' 296' ' ' LEU . 0.4 OUTLIER -119.21 -174.66 2.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.674 HD21 HG11 ' A' ' 217' ' ' VAL . 52.0 mt -139.17 173.35 11.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.928 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -124.83 117.9 25.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 248' ' ' VAL . 77.9 t -122.35 91.73 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.057 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.714 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -50.43 -56.55 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.44 177.23 8.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -99.19 96.47 7.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -136.16 171.55 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -42.11 -45.28 3.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -55.67 -62.3 1.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 97.4 p -129.05 137.15 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -140.98 132.16 26.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -116.21 92.47 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 309' ' ' THR . 53.3 m-85 -69.02 -43.58 74.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 245' ' ' GLN . 47.5 p -37.43 -49.89 1.04 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.136 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.8 102.34 44.77 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.55 0.691 . . . . 0.0 110.884 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.668 ' O ' ' CD1' ' A' ' 312' ' ' TYR . 43.4 Cg_endo -70.71 -159.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 0.0 112.295 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.668 ' CD1' ' O ' ' A' ' 311' ' ' PRO . 0.9 OUTLIER 34.08 55.01 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 313' ' ' LEU . 10.5 mt -123.92 149.28 46.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 315' ' ' ARG . . . 120.38 -60.28 0.53 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.479 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 314' ' ' GLY . 10.4 ttm180 -37.02 -45.35 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.925 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.6 p -152.47 153.08 32.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.858 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 50.0 m -114.62 167.77 10.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -78.79 119.5 5.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.446 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.6 t -118.33 -60.6 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 110.862 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 6.6 t -71.1 -50.88 28.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.821 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 160.48 90.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 201' ' ' ARG . 14.6 pttp -70.5 -44.17 68.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.308 . . . . 0.0 110.893 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.477 ' N ' ' HG3' ' A' ' 200' ' ' LYS . 13.1 tpp85 -146.31 120.02 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 2.3 pp -47.56 150.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 86.6 m -147.01 125.1 12.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.172 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -129.43 113.25 18.1 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.591 0.71 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.53 134.29 13.71 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.67 2.247 . . . . 0.0 112.351 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -169.71 43.06 0.21 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.452 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -141.95 159.18 42.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.913 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 14.8 t -152.98 142.45 21.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.105 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -162.68 134.15 5.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.819 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.48 143.88 98.41 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.563 0.697 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.35 -12.54 17.12 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.315 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 58.6 m 49.77 42.29 23.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.94 88.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -61.63 -144.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.515 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -165.85 125.38 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 110.901 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -46.2 -40.22 10.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 49.0 t -77.81 137.23 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.095 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 24.1 mt -136.93 129.98 30.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.03 118.88 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.52 134.7 50.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.8 t -119.63 137.6 53.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.76 HD13 HG22 ' A' ' 255' ' ' ILE . 5.2 mp -99.21 128.83 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -89.75 138.96 31.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.508 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 9.6 t-20 39.52 52.7 4.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.624 0.726 . . . . 0.0 110.935 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.5 Cg_exo -43.7 94.33 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.641 2.228 . . . . 0.0 112.334 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 20.2 mt -95.86 -43.78 7.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -102.71 153.48 38.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.715 0.769 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.29 115.77 4.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.696 2.264 . . . . 0.0 112.274 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.8 mm -98.41 110.48 26.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 232' ' ' ASP . 49.6 p -105.99 158.46 16.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.13 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 303' ' ' ASN . 18.3 m -41.49 -26.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.123 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.5 m-20 -68.22 -61.98 1.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 0.477 ' CG1' HD13 ' A' ' 279' ' ' ILE . 78.5 t -39.45 -45.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 31.5 mt -77.74 -37.92 48.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.595 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 76.9 t80 -83.42 20.14 1.4 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 99.2 m -124.43 -37.19 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.142 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.413 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 89.1 t -98.21 -19.26 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 65.3 m -89.75 -45.55 9.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.589 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.1 OUTLIER -51.37 -45.35 89.96 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.728 . . . . 0.0 110.944 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.1 Cg_exo -47.97 -56.87 2.71 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.711 2.274 . . . . 0.0 112.318 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.3 -47.04 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -142.74 -108.08 0.65 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.507 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.535 ' O ' ' CD2' ' A' ' 261' ' ' PHE . 13.7 tptp -152.33 151.34 30.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.74 HG11 HD11 ' A' ' 247' ' ' ILE . 95.1 t -127.94 122.36 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -82.64 -69.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -137.24 156.91 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.74 HD11 HG11 ' A' ' 244' ' ' VAL . 55.5 mt -137.06 133.47 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.721 HG22 HG22 ' A' ' 298' ' ' VAL . 94.9 t -126.54 110.18 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 257' ' ' ALA . 60.4 mt -94.09 126.14 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.159 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -141.35 135.16 30.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -84.5 41.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -89.59 119.19 29.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.8 m120 51.49 40.95 28.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 109.56 135.71 7.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.463 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.76 HG22 HD13 ' A' ' 222' ' ' ILE . 38.0 mm -46.56 104.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.321 . . . . 0.0 111.152 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -134.1 164.42 27.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.468 ' HB2' HG12 ' A' ' 249' ' ' ILE . . . -152.51 122.03 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.431 ' SD ' HD21 ' A' ' 296' ' ' LEU . 26.4 mtt -83.42 114.68 21.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.517 HG22 HG12 ' A' ' 247' ' ' ILE . 88.7 t -106.8 119.44 56.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 11.0 tt0 -91.54 151.01 20.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 243' ' ' LYS . 30.3 m-85 -123.5 163.74 20.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -52.97 -72.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 66.8 m -114.8 -174.95 2.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 58.6 t -77.66 -44.54 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 36.6 tp -51.61 -65.8 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 24.3 p -42.44 -38.22 1.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -60.04 -38.66 83.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -58.68 -59.39 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -56.56 -53.7 54.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.448 ' O ' HD13 ' A' ' 274' ' ' LEU . . . -52.57 -55.04 25.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.074 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.416 ' HA ' HD13 ' A' ' 288' ' ' ILE . 41.5 tttm -43.09 -51.34 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -46.86 -73.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -45.49 -50.18 12.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.071 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.919 ' HB3' HD11 ' A' ' 288' ' ' ILE . 5.1 mp -61.47 -26.79 68.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 271' ' ' LYS . 33.6 t30 -60.62 105.05 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.15 25.66 70.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.459 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -86.02 93.36 8.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 0.0 111.131 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.69 131.92 45.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.477 HD13 ' CG1' ' A' ' 233' ' ' VAL . 72.6 mt -88.56 -34.34 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -121.61 173.13 7.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -55.32 112.55 1.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.17 73.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.536 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.6 t -175.31 177.78 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.313 . . . . 0.0 110.911 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 27.8 p 39.44 46.61 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 55.8 m -57.86 90.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -45.72 131.13 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -127.8 96.85 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.919 HD11 ' HB3' ' A' ' 274' ' ' LEU . 66.3 mt -80.2 145.94 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -153.01 114.91 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -43.08 98.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -48.15 141.73 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.602 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 0.0 OUTLIER -69.86 -47.43 23.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.56 0.695 . . . . 0.0 110.859 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 62.5 Cg_endo -77.57 144.28 22.33 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.676 2.251 . . . . 0.0 112.34 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 81.1 p -83.7 -31.31 26.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -112.8 161.11 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.431 HD21 ' SD ' ' A' ' 258' ' ' MET . 74.6 mt -119.36 -178.28 3.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -143.02 113.53 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.721 HG22 HG22 ' A' ' 248' ' ' VAL . 87.9 t -116.16 106.07 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.515 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.2 mp -66.87 -55.88 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ARG . . . . . 0.42 ' CG ' ' OD2' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -133.83 153.13 51.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -90.09 87.19 6.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.42 ' OD2' ' CG ' ' A' ' 300' ' ' ARG . 5.0 p30 -123.18 171.78 9.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.683 ' O ' HG13 ' A' ' 231' ' ' VAL . 6.5 m120 -39.89 -45.9 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.468 ' O ' ' CG1' ' A' ' 249' ' ' ILE . 25.7 m-20 -57.42 -61.52 2.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.444 ' CB ' ' HA ' ' A' ' 248' ' ' VAL . 97.0 p -123.33 131.79 53.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -144.16 119.11 9.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -97.69 117.65 32.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.88 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -98.61 44.18 1.04 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 76.7 p -116.05 -41.3 3.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.139 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.594 ' HG3' ' CE1' ' A' ' 312' ' ' TYR . 19.3 ttpt -131.29 98.08 19.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.534 0.683 . . . . 0.0 110.875 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.64 -10.15 21.67 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.697 2.265 . . . . 0.0 112.386 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.815 ' O ' HD22 ' A' ' 313' ' ' LEU . 3.1 p90 -110.38 108.65 18.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.949 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.815 HD22 ' O ' ' A' ' 312' ' ' TYR . 4.4 mm? -134.97 44.6 2.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.937 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -83.45 177.08 52.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.504 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.24 -30.36 43.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 0.0 110.871 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.523 ' C ' ' CD ' ' A' ' 316' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.91 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 217' ' ' VAL . 4.1 p-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.88 0.371 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -30.99 69.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.499 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 95.7 t -86.86 140.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 14.0 mt -134.38 132.34 39.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 49.1 tp -81.89 103.82 11.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.9 mp -90.96 128.61 36.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.17 112.49 17.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.772 ' H ' HD12 ' A' ' 222' ' ' ILE . 3.5 mp -75.42 130.62 36.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.139 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -99.47 120.52 39.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 19.0 m-20 63.61 52.28 1.41 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 0.0 110.91 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 60.2 Cg_endo -74.41 47.09 1.53 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.654 2.236 . . . . 0.0 112.352 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.3 mt -39.86 -41.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -97.78 141.49 23.08 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.68 0.752 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.31 124.38 9.11 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.734 2.289 . . . . 0.0 112.282 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.6 mm -107.11 109.04 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.12 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.1 p -102.98 159.05 15.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.461 ' N ' HD11 ' A' ' 249' ' ' ILE . 21.8 m -44.37 -39.88 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -54.19 -55.84 24.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.1 t -45.12 -39.11 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 25.7 mt -78.49 -64.06 1.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.414 ' CZ ' ' ND2' ' A' ' 239' ' ' ASN . 55.6 t80 -46.9 -27.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.477 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 63.6 m -64.34 -47.69 78.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 237' ' ' VAL . 65.1 t -87.37 -11.2 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.115 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 64.4 m -87.39 -49.06 7.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.579 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.0 t-20 -48.65 -46.36 71.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.657 0.741 . . . . 0.0 110.896 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.2 Cg_exo -47.97 -17.4 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.8 HG11 ' HA ' ' A' ' 270' ' ' ALA . 96.2 t -102.59 -41.34 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -174.2 177.26 46.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 142.87 56.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.1 t -110.57 134.64 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -80.77 -60.84 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -161.74 155.07 21.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.791 HG12 HG22 ' A' ' 259' ' ' VAL . 74.9 mt -134.93 119.13 26.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 298' ' ' VAL . 49.1 t -110.76 115.03 48.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 231' ' ' VAL . 64.5 mt -97.35 114.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.173 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 7.5 p90 -116.3 162.38 17.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -117.87 90.92 3.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -133.04 94.45 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 59.51 38.95 22.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 131.06 131.17 3.25 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.47 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.569 HG22 HD13 ' A' ' 222' ' ' ILE . 33.1 mm -48.1 102.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.539 ' HB3' ' CE1' ' A' ' 250' ' ' PHE . 27.7 mt-30 -118.15 166.14 12.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -168.17 130.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.065 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 33.8 mtt -97.1 132.82 42.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.791 HG22 HG12 ' A' ' 247' ' ' ILE . 97.7 t -122.73 125.31 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.154 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -101.85 150.52 23.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -122.36 159.36 27.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -41.19 -65.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.7 t -130.71 176.23 8.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 85.7 t -60.24 -51.43 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.111 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 20.9 tp -39.07 -62.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 65.7 m -47.44 -41.82 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -55.87 -42.75 76.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -54.88 -58.56 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -62.25 -56.67 16.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.866 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.8 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.18 -47.96 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.122 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.484 ' HA ' HD13 ' A' ' 288' ' ' ILE . 22.7 tttt -50.27 -48.8 54.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -64.48 -67.71 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -39.78 -33.76 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.776 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.5 mp -92.39 -28.13 17.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 272' ' ' ALA . 6.0 t30 -55.27 100.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.3 21.95 61.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -84.35 92.41 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.33 129.21 39.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.566 HG22 ' CD1' ' A' ' 280' ' ' TYR . 74.4 mt -100.36 -41.64 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.177 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . 0.566 ' CD1' HG22 ' A' ' 279' ' ' ILE . 8.1 m-85 -117.38 171.56 7.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -55.11 108.62 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.115 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.7 53.75 0.82 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 25.5 p -174.51 172.01 3.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 69.5 m 56.08 41.12 29.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 54.4 m -68.98 143.94 54.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.171 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.466 HD11 HD11 ' A' ' 279' ' ' ILE . 88.5 mt -89.14 127.33 35.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -118.89 80.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.776 HD11 ' CB ' ' A' ' 274' ' ' LEU . 17.0 mt -71.28 144.32 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 290' ' ' TYR . 19.7 mt-10 -157.31 107.79 2.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 289' ' ' GLU . 41.9 m-85 -34.4 101.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -56.19 165.24 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 0.4 OUTLIER -71.82 -57.8 3.86 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.647 0.736 . . . . 0.0 110.856 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 59.5 Cg_endo -73.14 160.47 45.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.67 2.247 . . . . 0.0 112.345 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 217' ' ' VAL . 33.2 p -102.95 -27.58 12.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -111.81 144.9 40.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 80.5 mt -109.45 175.9 5.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -135.87 139.05 43.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 248' ' ' VAL . 95.2 t -134.97 97.29 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.141 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.733 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -51.5 -57.3 3.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -139.69 175.95 9.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.76 116.67 33.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -159.29 171.32 20.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -44.47 -39.93 5.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.16 -61.11 2.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 53.4 p -131.05 133.46 45.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -124.18 141.17 52.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -115.04 100.88 8.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.36 -47.95 38.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.5 t30 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.866 0.365 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 217' ' ' VAL . 0.0 OUTLIER -50.47 -35.21 27.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.408 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 95.0 t -89.59 141.85 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.548 ' HB3' HG23 ' A' ' 288' ' ' ILE . 52.6 mt -142.19 128.35 19.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.2 tp -87.0 105.24 17.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.468 HD13 ' CG2' ' A' ' 259' ' ' VAL . 7.1 mp -88.82 140.43 29.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -134.8 115.71 13.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -81.49 130.31 36.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -98.46 130.93 45.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.527 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 59.8 t30 48.34 52.74 13.16 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.6 Cg_exo -44.84 123.59 5.02 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.663 2.242 . . . . 0.0 112.381 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.442 ' CD2' ' HB2' ' A' ' 283' ' ' CYS . 4.0 mm? -91.81 -63.04 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -107.52 153.97 41.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.663 0.744 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.37 112.37 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.7 mm -90.83 116.59 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 29.8 p -127.11 159.84 32.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.163 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.9 m -37.7 -33.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -65.41 -60.45 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 90.4 t -45.63 -44.71 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.174 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 36.7 mt -70.45 -61.4 1.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -49.93 -27.35 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.483 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 98.3 m -65.62 -47.28 76.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.444 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 80.1 t -86.73 -16.98 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 85.1 m -83.87 -47.78 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.538 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -47.36 -48.78 55.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.594 0.711 . . . . 0.0 110.846 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.6 Cg_exo -48.0 -17.57 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 0.0 112.356 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.933 HG11 ' HA ' ' A' ' 270' ' ' ALA . 87.7 t -97.59 -43.93 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.56 -155.61 9.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.42 ' HD3' ' N ' ' A' ' 244' ' ' VAL . 0.6 OUTLIER -101.28 130.22 47.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.42 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 66.2 t -100.35 143.67 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -94.62 -58.75 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.415 ' CB ' ' HA ' ' A' ' 307' ' ' ASP . 14.8 ptt-85 -155.23 163.93 39.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.405 HG13 ' C ' ' A' ' 246' ' ' ARG . 63.8 mt -145.3 140.79 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.66 121.28 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 304' ' ' ASP . 46.1 mt -102.52 118.2 49.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -130.88 154.69 47.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -111.48 93.22 4.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -129.55 102.83 6.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 47.7 39.35 10.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 133.54 121.45 2.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.5 mm -41.12 106.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -126.48 151.03 48.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -152.31 117.82 5.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . 0.427 ' SD ' HD21 ' A' ' 296' ' ' LEU . 10.5 mtt -77.8 146.47 35.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.468 ' CG2' HD13 ' A' ' 220' ' ' LEU . 95.3 t -137.81 118.77 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.443 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 23.3 tt0 -97.83 152.24 19.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.443 ' N ' ' HG2' ' A' ' 260' ' ' GLU . 55.6 m-85 -126.5 154.91 43.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -41.13 -63.25 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.8 m -131.19 172.33 12.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 94.8 t -59.27 -51.96 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 264' ' ' VAL . 23.4 tp -37.43 -65.59 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 54.6 m -45.72 -42.77 12.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -57.76 -41.47 82.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -52.92 -61.6 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -62.36 -53.37 55.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.933 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -46.76 -49.22 20.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.553 ' HA ' HD13 ' A' ' 288' ' ' ILE . 61.5 tttm -52.19 -47.34 65.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.83 -62.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.101 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -46.17 -36.4 5.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.639 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.9 mp -89.54 -24.22 21.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 271' ' ' LYS . 5.3 t30 -57.43 99.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.83 19.97 69.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -91.99 94.41 9.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.102 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.36 171.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 286' ' ' LEU . 44.5 mt -119.74 -35.23 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . 0.408 ' HB2' ' SG ' ' A' ' 283' ' ' CYS . 60.2 m-85 -131.72 174.02 10.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -37.64 102.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.094 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.525 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 26.29 76.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.473 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . 0.442 ' HB2' ' CD2' ' A' ' 226' ' ' LEU . 20.2 p -176.13 -175.13 0.68 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.769 0.319 . . . . 0.0 110.897 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 283' ' ' CYS . 3.0 p 36.36 41.42 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 15.5 m -57.32 145.9 30.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 279' ' ' ILE . 69.0 mt -97.44 139.24 33.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -130.11 105.66 8.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.879 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.639 HD11 ' CB ' ' A' ' 274' ' ' LEU . 23.5 mt -91.96 139.21 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 290' ' ' TYR . 16.5 mm-40 -146.17 110.24 4.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.873 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 289' ' ' GLU . 28.5 m-85 -35.99 100.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.949 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.1 159.13 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.105 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.485 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 4.4 mtp-105 -73.16 -58.02 2.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.596 0.712 . . . . 0.0 110.891 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 60.3 Cg_endo -74.24 156.96 46.36 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.227 . . . . 0.0 112.337 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 28.9 p -96.55 -32.45 12.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.162 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.19 143.8 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.427 HD21 ' SD ' ' A' ' 258' ' ' MET . 35.7 mt -118.46 143.59 46.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -120.41 114.56 21.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 71.9 t -85.01 114.45 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.2 mp -67.13 -55.0 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -130.73 150.58 51.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -97.98 97.06 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 303' ' ' ASN . 2.7 p-10 -148.99 172.14 15.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 302' ' ' ASP . 4.7 m-20 -34.52 -44.67 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.415 ' O ' ' CG1' ' A' ' 249' ' ' ILE . 73.2 m-20 -55.5 -55.71 28.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 88.8 p -130.45 135.69 48.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -140.1 116.81 10.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.415 ' HA ' ' CB ' ' A' ' 246' ' ' ARG . 0.8 OUTLIER -105.48 91.93 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -53.98 -44.97 71.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 65.4 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 217' ' ' VAL . 22.2 p-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -64.67 -50.15 68.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.503 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 89.3 t -77.55 150.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.154 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 220' ' ' LEU . 14.1 mt -139.65 125.66 19.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 23.0 tp -84.12 103.34 13.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.503 HD13 HG23 ' A' ' 259' ' ' VAL . 6.9 mp -87.4 129.66 34.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.6 m -122.83 114.8 20.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.499 ' H ' HD12 ' A' ' 222' ' ' ILE . 4.9 mp -81.17 150.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.105 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -115.82 120.16 38.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.508 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 52.3 t30 59.37 50.49 2.96 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.619 0.723 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 57.7 Cg_endo -71.12 106.53 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.252 . . . . 0.0 112.371 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.1 mt -87.77 -47.65 8.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -91.65 133.55 30.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.662 0.744 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.08 117.4 2.49 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.699 2.266 . . . . 0.0 112.314 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.423 HG21 HD21 ' A' ' 234' ' ' LEU . 49.1 mm -85.18 109.23 17.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.166 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 82.8 p -105.24 151.78 23.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 303' ' ' ASN . 33.7 m -38.55 -38.56 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -60.64 -59.61 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.5 t -41.52 -48.28 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.423 HD21 HG21 ' A' ' 229' ' ' ILE . 49.5 mt -69.29 -62.7 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.455 ' CE1' ' HB ' ' A' ' 244' ' ' VAL . 43.9 t80 -48.06 -25.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.503 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 94.0 m -65.08 -48.29 74.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.431 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 89.0 t -84.43 -18.65 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.453 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 85.1 m -81.75 -53.52 6.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -41.69 -49.6 10.04 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 0.0 110.898 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.1 Cg_exo -47.94 -39.05 32.15 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.934 HG11 ' HA ' ' A' ' 270' ' ' ALA . 76.0 t -72.86 -42.46 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.95 -126.09 0.81 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm -116.47 165.97 12.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.677 HG11 HD11 ' A' ' 247' ' ' ILE . 99.2 t -143.02 114.44 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -73.08 -64.31 1.0 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.403 ' HE ' HG21 ' A' ' 298' ' ' VAL . 6.9 ptm180 -143.92 164.33 30.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.677 HD11 HG11 ' A' ' 244' ' ' VAL . 62.5 mt -142.14 141.54 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.55 134.46 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.449 HD11 ' N ' ' A' ' 231' ' ' VAL . 67.1 mt -119.29 131.59 71.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.539 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 6.4 p90 -142.41 173.31 11.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -129.64 42.62 3.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -80.8 97.68 7.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 62.51 42.8 8.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 121.52 142.98 6.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.458 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 27.6 mm -56.43 116.16 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 0.0 111.096 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.539 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 47.4 mt-30 -142.19 168.75 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -162.43 126.05 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . 0.481 ' SD ' HD21 ' A' ' 296' ' ' LEU . 15.4 mtt -91.06 120.61 32.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.53 HG22 HG23 ' A' ' 247' ' ' ILE . 86.2 t -110.29 133.16 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -108.22 137.96 45.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -109.57 160.27 16.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -47.28 -62.66 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.7 m -127.74 170.37 12.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 99.4 t -58.33 -52.36 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 14.6 tp -38.59 -62.2 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.941 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 60.8 m -43.39 -40.05 3.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -57.91 -40.65 80.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -54.62 -60.4 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -63.97 -53.92 42.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.934 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.07 -48.8 22.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.544 ' HA ' HD13 ' A' ' 288' ' ' ILE . 19.2 tttt -56.3 -45.29 80.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -65.35 -59.33 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.87 -37.35 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.79 ' CB ' HD11 ' A' ' 288' ' ' ILE . 6.0 mp -91.62 -22.25 20.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 271' ' ' LYS . 4.8 t30 -55.36 101.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.75 22.59 61.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.468 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.627 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -78.49 178.53 7.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.762 0.315 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -145.6 126.53 14.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 33.9 mt -91.83 -31.77 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -126.69 172.68 10.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.3 107.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.25 75.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 1.7 t -174.98 -177.57 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 286' ' ' LEU . 27.3 p 39.36 38.58 0.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 14.1 m -47.57 93.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.627 HD12 ' HB3' ' A' ' 277' ' ' ALA . 32.7 mt -45.97 127.25 8.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -127.12 83.74 2.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.79 HD11 ' CB ' ' A' ' 274' ' ' LEU . 29.2 mt -72.99 145.95 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -151.08 115.53 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -38.55 105.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -56.55 139.99 47.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.157 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 4.9 ttp180 -62.61 -44.9 88.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.893 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.7 Cg_endo -80.36 150.87 19.94 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.698 2.266 . . . . 0.0 112.354 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 41.2 p -92.28 -24.45 18.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -125.59 158.89 33.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.481 HD21 ' SD ' ' A' ' 258' ' ' MET . 48.7 mt -115.78 178.25 4.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.18 116.7 14.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.403 HG21 ' HE ' ' A' ' 246' ' ' ARG . 61.3 t -114.95 102.89 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.77 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.2 mp -66.17 -57.46 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -130.31 176.81 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -107.5 100.83 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -144.63 171.26 14.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.539 ' O ' HG13 ' A' ' 231' ' ' VAL . 2.7 m120 -39.6 -44.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.945 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.88 -57.24 10.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.841 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 26.0 p -133.94 138.66 45.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.847 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -135.68 122.62 21.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -106.74 133.26 51.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -99.81 -47.1 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.168 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.889 0.376 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -47.06 -47.2 22.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.405 HG12 ' CB ' ' A' ' 291' ' ' ALA . 92.2 t -74.45 123.73 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.076 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' A' ' 288' ' ' ILE . 26.2 mt -116.69 130.91 57.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.572 HD13 ' HE2' ' A' ' 258' ' ' MET . 33.5 tp -84.88 112.22 20.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.33 141.95 30.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.6 t -130.66 137.76 49.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.63 117.48 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.132 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -79.34 140.53 37.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.511 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 35.8 t30 38.33 54.0 4.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.607 0.718 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.2 Cg_exo -44.67 100.37 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.674 2.249 . . . . 0.0 112.386 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 46.0 mt -91.75 -51.06 5.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -109.52 132.57 21.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.663 0.744 . . . . 0.0 110.892 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.23 111.86 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.268 . . . . 0.0 112.31 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.598 HD12 HG11 ' A' ' 233' ' ' VAL . 48.7 mm -90.65 112.46 25.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.125 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 20.7 p -105.98 160.93 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 19.3 m -38.41 -37.56 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 235' ' ' TYR . 7.8 m-20 -58.12 -65.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.598 HG11 HD12 ' A' ' 229' ' ' ILE . 73.9 t -37.63 -43.66 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 50.2 mt -76.64 -37.1 56.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 65.8 t80 -81.72 16.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 92.2 m -120.46 -37.11 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.156 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.428 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 86.6 t -98.66 -19.74 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.413 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 59.2 m -89.12 -44.4 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.2 t-20 -51.97 -45.73 92.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 110.861 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.3 Cg_exo -47.94 -22.81 3.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.335 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.4 t -96.64 -45.26 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -155.21 152.57 24.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.525 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.89 131.84 51.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.848 0.356 . . . . 0.0 110.888 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.0 t -100.62 136.93 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.152 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -93.62 -65.35 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.545 HH11 HG23 ' A' ' 298' ' ' VAL . 4.0 tmm_? -143.69 152.36 41.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.597 HG23 HG22 ' A' ' 259' ' ' VAL . 74.0 mt -129.35 147.79 33.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.426 HG23 ' CD ' ' A' ' 246' ' ' ARG . 54.4 t -139.85 133.84 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 304' ' ' ASP . 43.7 mt -120.84 129.99 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -144.21 138.02 27.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -99.67 40.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -78.14 101.05 6.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 60.96 42.74 12.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.5 137.82 5.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.2 mm -56.14 112.66 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.128 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -141.89 173.42 11.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -164.63 126.36 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . 0.572 ' HE2' HD13 ' A' ' 219' ' ' LEU . 36.2 mtt -94.66 120.32 34.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.597 HG22 HG23 ' A' ' 247' ' ' ILE . 94.2 t -110.54 135.38 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.083 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -105.67 153.46 21.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -126.85 163.61 23.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.895 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -47.48 -65.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 t -135.88 174.93 10.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 82.0 t -56.37 -55.3 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.1 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 18.5 tp -40.3 -50.27 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 61.4 m -55.94 -46.12 78.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 271' ' ' LYS . . . -53.84 -35.63 61.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -57.56 -65.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.914 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -59.49 -55.82 29.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.433 ' O ' HD13 ' A' ' 274' ' ' LEU . . . -49.22 -53.2 22.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.07 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.461 ' HA ' HD13 ' A' ' 288' ' ' ILE . 38.6 tttm -53.13 -43.96 67.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 275' ' ' ASN . . . -54.74 -63.45 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.085 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.672 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -53.8 -46.98 71.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.751 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.6 mp -67.0 -28.98 68.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 271' ' ' LYS . 8.9 t30 -65.33 102.87 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.61 19.72 65.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -83.33 92.26 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.32 135.19 57.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 286' ' ' LEU . 60.9 mt -104.65 -42.7 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -117.85 172.84 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -51.97 103.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 35.46 51.52 1.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.447 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.5 m -162.55 164.88 26.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.884 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.7 m 62.5 41.31 9.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 23.6 m -58.21 134.29 56.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.494 HD11 HD11 ' A' ' 279' ' ' ILE . 83.6 mt -88.13 124.92 34.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -119.54 106.79 12.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.751 HD11 ' CB ' ' A' ' 274' ' ' LEU . 18.9 mt -92.54 144.13 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.193 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -155.17 117.44 4.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -41.53 105.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.405 ' CB ' HG12 ' A' ' 217' ' ' VAL . . . -53.07 161.89 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.129 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 30.1 mtt180 -73.86 -56.69 2.72 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.67 0.748 . . . . 0.0 110.89 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 61.1 Cg_endo -74.67 150.42 39.87 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.631 2.221 . . . . 0.0 112.346 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 39.9 p -78.85 -30.14 45.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.456 ' HG2' ' N ' ' A' ' 296' ' ' LEU . 8.7 ttm180 -134.03 148.32 51.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.516 HD21 ' SD ' ' A' ' 258' ' ' MET . 23.6 mt -100.08 -178.14 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . 0.497 HD21 HD11 ' A' ' 299' ' ' ILE . 2.4 p-10 -137.42 117.86 13.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.545 HG23 HH11 ' A' ' 246' ' ' ARG . 73.8 t -104.37 112.96 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.123 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.527 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.8 mp -78.0 -51.73 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -127.26 151.96 48.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -92.34 46.94 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.3 172.52 8.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -41.55 -47.16 3.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.467 ' O ' HD12 ' A' ' 249' ' ' ILE . 0.1 OUTLIER -43.13 -62.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.9 p -133.45 147.17 51.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -139.72 140.87 36.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -119.88 115.34 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 309' ' ' THR . 52.9 m-85 -88.62 -48.27 7.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' TYR . 32.4 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.193 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.8 t30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.92 0.391 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 267' ' ' ALA . 6.2 pttt -76.19 -45.85 31.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.512 ' O ' HD23 ' A' ' 218' ' ' LEU . 51.1 t -67.83 146.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.116 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 220' ' ' LEU . 6.8 mt -147.72 123.51 10.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 50.8 tp -71.67 112.98 8.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 218' ' ' LEU . 7.4 mp -99.97 129.03 45.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -120.56 117.28 27.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.825 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.587 HD13 HG22 ' A' ' 255' ' ' ILE . 4.9 mp -81.84 123.32 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -89.3 138.77 31.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.706 ' O ' HD23 ' A' ' 226' ' ' LEU . 74.5 m-20 44.87 53.8 12.05 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.683 0.754 . . . . 0.0 110.927 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 77.0 Cg_exo -47.64 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.723 2.282 . . . . 0.0 112.329 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 224' ' ' ASN . 3.6 mm? -85.45 -56.96 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.447 ' CD2' ' CE2' ' A' ' 280' ' ' TYR . 2.2 m-85 -93.76 143.16 26.09 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.707 0.765 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.24 127.3 12.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 0.0 112.317 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.401 HG13 HG21 ' A' ' 222' ' ' ILE . 49.9 mm -114.75 102.11 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 232' ' ' ASP . 19.9 p -117.43 159.06 23.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.192 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.2 m -38.96 -26.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.4 m-20 -67.28 -61.01 2.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.8 t -47.39 -56.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 34.4 mt -56.72 -61.95 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.559 ' CD1' ' HB ' ' A' ' 244' ' ' VAL . 63.4 t80 -49.76 -33.41 16.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.486 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 98.7 m -64.14 -45.93 86.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.1 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 237' ' ' VAL . 62.0 t -87.88 -5.89 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.473 ' HB3' ' CG2' ' A' ' 244' ' ' VAL . 90.8 m -93.29 -47.23 7.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 8.2 t-20 -51.06 -45.61 88.41 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 0.0 110.886 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -47.97 -41.2 33.13 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 270' ' ' ALA . 40.4 t -70.62 -44.32 76.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.27 -105.48 0.21 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.502 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.8 115.84 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 110.916 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 247' ' ' ILE . 96.3 t -84.04 143.71 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.468 ' HB3' ' CG2' ' A' ' 309' ' ' THR . 21.5 mm-40 -104.2 -68.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -125.03 152.36 44.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.829 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 244' ' ' VAL . 48.6 mt -140.75 128.35 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.63 121.47 56.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.487 HG12 ' CB ' ' A' ' 257' ' ' ALA . 67.9 mt -110.86 119.06 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -126.32 146.11 50.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -102.42 44.71 1.0 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -70.29 86.16 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 55.2 49.22 17.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 135.33 129.67 2.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.587 HG22 HD13 ' A' ' 222' ' ' ILE . 21.3 mm -50.59 103.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.744 0.307 . . . . 0.0 111.158 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -135.47 164.37 27.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.487 ' CB ' HG12 ' A' ' 249' ' ' ILE . . . -166.49 130.75 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 32.8 mtt -94.76 123.31 38.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 247' ' ' ILE . 88.4 t -114.92 130.19 69.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.132 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -109.1 160.36 16.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -130.26 167.85 17.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -40.64 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.5 t -126.1 -176.01 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 267' ' ' ALA . 63.3 t -63.62 -56.96 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 264' ' ' VAL . 25.1 tp -35.47 -59.73 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.4 -37.98 57.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 264' ' ' VAL . . . -61.42 -36.86 81.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.117 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -58.7 -57.85 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -66.72 -47.98 70.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.819 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -51.87 -52.47 49.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.656 ' HG3' HG21 ' A' ' 288' ' ' ILE . 25.8 tttp -48.81 -48.46 41.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -61.41 -69.08 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.088 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -40.96 -36.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.846 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.1 mp -88.65 -25.31 22.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 272' ' ' ALA . 19.5 t30 -60.08 104.22 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 75.1 24.25 72.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -85.87 93.64 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 0.0 111.084 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.73 137.5 57.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.42 HG22 ' CD1' ' A' ' 280' ' ' TYR . 46.9 mt -106.45 -34.42 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . 0.447 ' CE2' ' CD2' ' A' ' 227' ' ' TYR . 50.7 m-85 -129.54 172.37 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -45.11 102.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.08 61.34 0.52 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.537 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . 0.435 ' C ' ' SG ' ' A' ' 284' ' ' CYS . 92.6 m -156.81 179.01 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 110.91 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 283' ' ' CYS . 0.8 OUTLIER 40.15 43.98 1.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 40.5 m -59.21 85.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 277' ' ' ALA . 47.6 mt -38.59 120.01 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -120.1 85.44 2.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.846 HD11 ' CB ' ' A' ' 274' ' ' LEU . 50.5 mt -75.19 148.68 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.116 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -159.82 121.85 3.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -45.37 103.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -57.3 153.66 11.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.105 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.604 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 5.6 ttt180 -65.94 -44.87 63.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 291' ' ' ALA . 60.9 Cg_endo -80.5 153.02 20.52 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.328 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 37.9 p -96.91 -22.29 16.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -126.24 151.35 47.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.93 179.11 4.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -146.85 133.41 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 93.4 t -122.45 133.35 68.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.064 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.35 -51.2 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.141 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.97 166.35 16.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -114.53 109.97 19.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 303' ' ' ASN . 7.5 t70 -164.19 173.09 12.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 302' ' ' ASP . 39.4 m-20 -33.95 -50.49 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.55 -63.43 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 24.8 m -142.45 147.99 37.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -142.08 137.35 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -122.02 91.11 3.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . 0.451 ' O ' ' C ' ' A' ' 309' ' ' THR . 86.9 m-85 -62.99 -49.17 75.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 245' ' ' GLN . 29.0 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 50.1 t30 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.919 0.39 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 267' ' ' ALA . 3.8 pttm -52.55 -43.31 65.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.6 134.51 29.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.2 mt -134.96 125.07 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.2 tp -82.46 112.8 19.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.411 HD23 HD22 ' A' ' 286' ' ' LEU . 6.9 mp -94.25 124.2 38.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.4 m -118.89 104.13 10.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.683 ' H ' HD12 ' A' ' 222' ' ' ILE . 4.4 mp -69.29 144.72 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.476 ' C ' ' CG ' ' A' ' 224' ' ' ASN . 8.9 mm100 -109.85 126.31 53.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 283' ' ' CYS . 0.5 OUTLIER 49.88 54.75 16.27 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.668 0.747 . . . . 0.0 110.894 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 59.2 Cg_endo -72.62 101.6 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.341 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 224' ' ' ASN . 10.1 mp -73.55 -62.55 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -83.79 137.66 40.95 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.662 0.744 . . . . 0.0 110.919 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.49 115.0 1.38 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.741 2.294 . . . . 0.0 112.324 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 29.7 mm -83.72 127.14 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.143 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 24.3 p -121.33 152.04 39.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.484 ' N ' HD11 ' A' ' 249' ' ' ILE . 32.0 m -37.65 -37.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.92 -61.67 2.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 96.6 t -42.46 -52.42 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 26.2 mt -62.04 -59.24 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.569 ' CD2' ' HB ' ' A' ' 244' ' ' VAL . 3.6 t80 -54.28 -24.11 17.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 92.9 m -69.87 -46.07 66.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.117 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.422 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 99.0 t -85.79 -17.38 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.448 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 81.9 m -84.23 -51.3 7.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.543 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -44.0 -48.61 22.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.688 0.756 . . . . 0.0 110.911 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.4 Cg_exo -47.9 -32.77 18.36 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.734 HG11 ' HA ' ' A' ' 270' ' ' ALA . 87.1 t -80.59 -42.91 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.94 -106.85 0.22 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.466 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 26.4 tttt -145.94 163.64 34.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.631 HG11 HD11 ' A' ' 247' ' ' ILE . 86.9 t -133.71 133.88 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.45 ' OE1' ' CG2' ' A' ' 309' ' ' THR . 32.0 mm-40 -92.83 -62.69 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 4.2 ptt-85 -143.36 155.11 44.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.631 HD11 HG11 ' A' ' 244' ' ' VAL . 57.7 mt -137.67 139.09 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.184 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 82.7 t -127.51 124.82 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.484 HD11 ' N ' ' A' ' 231' ' ' VAL . 53.8 mt -110.24 128.81 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.528 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 18.9 p90 -136.61 148.92 47.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -100.12 40.05 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -78.05 109.4 12.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 53.3 t30 55.25 43.45 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.08 -150.07 16.97 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.504 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 11.8 mm -114.4 106.46 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 111.101 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.528 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 21.3 mp0 -132.21 168.01 18.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -168.25 120.47 0.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.092 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 14.1 mtt -87.78 130.87 34.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 247' ' ' ILE . 58.7 t -120.63 137.88 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -101.28 162.77 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.914 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -135.48 158.31 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -46.67 -69.85 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.947 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 16.4 m -121.43 169.59 10.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 86.4 t -54.93 -52.35 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 15.8 tp -42.58 -64.26 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.84 -41.92 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -56.82 -45.67 82.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -63.52 -57.65 9.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -56.82 -37.03 70.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.734 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -71.56 -42.62 67.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.806 ' HA ' HD13 ' A' ' 288' ' ' ILE . 46.0 tttm -53.07 -48.9 67.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -59.64 -68.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.59 -38.17 1.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.706 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.4 mp -86.05 -23.36 26.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 272' ' ' ALA . 34.8 t30 -56.92 101.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.55 19.41 73.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -80.06 93.03 5.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 111.118 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.87 133.11 55.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.46 HD11 HD11 ' A' ' 286' ' ' LEU . 66.8 mt -101.28 -41.22 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . 0.404 ' CD1' HG22 ' A' ' 279' ' ' ILE . 13.3 m-85 -116.17 174.44 6.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.63 104.44 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 37.92 54.78 1.9 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . 0.485 ' HA ' ' ND2' ' A' ' 224' ' ' ASN . 24.9 p -175.14 155.01 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.866 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 225' ' ' PRO . 61.4 m 65.51 46.1 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 20.7 m -73.75 142.1 46.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.46 HD11 HD11 ' A' ' 279' ' ' ILE . 91.4 mt -86.2 123.8 31.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.939 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.24 81.85 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.806 HD13 ' HA ' ' A' ' 271' ' ' LYS . 31.7 mt -62.53 154.28 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.43 ' N ' HG22 ' A' ' 288' ' ' ILE . 17.1 mt-10 -159.56 114.65 2.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.477 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 45.0 m-85 -39.55 107.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.51 127.58 32.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.104 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.9 OUTLIER -60.68 -45.06 96.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.58 0.705 . . . . 0.0 110.853 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.8 Cg_endo -80.31 148.76 18.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.641 2.227 . . . . 0.0 112.37 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 78.8 p -93.0 -25.79 17.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.165 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -120.36 144.89 47.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 55.0 mt -111.92 -178.98 3.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -139.11 129.99 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.83 110.81 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.786 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.8 mp -62.72 -57.27 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -144.03 176.33 9.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -99.61 87.17 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 303' ' ' ASN . 28.2 t70 -140.99 170.54 15.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 302' ' ' ASP . 86.1 m-20 -36.3 -47.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.852 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -50.12 -56.87 9.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.6 p -138.26 142.78 39.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.81 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -138.94 134.78 33.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -115.38 128.43 56.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -100.8 -59.01 1.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.895 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.45 ' CG2' ' OE1' ' A' ' 245' ' ' GLN . 39.8 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 216' ' ' LYS . 13.0 t30 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 215' ' ' ASN . 0.0 OUTLIER -33.27 -52.72 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 63.3 t -80.47 150.59 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.4 mt -141.48 126.7 18.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.852 HD11 HE21 ' A' ' 256' ' ' GLN . 7.8 tp -85.08 104.02 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 9.3 mp -87.87 134.56 33.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.0 m -124.32 111.4 15.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 222' ' ' ILE . 5.3 mp -71.99 140.88 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 224' ' ' ASN . 7.0 tp60 -95.38 143.99 26.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.543 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 53.7 t30 34.96 54.49 1.84 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.591 0.71 . . . . 0.0 110.869 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.1 Cg_exo -47.37 102.19 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.704 2.269 . . . . 0.0 112.3 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 42.7 mt -103.88 -54.03 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -89.88 154.17 47.59 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.705 0.764 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.43 113.69 3.7 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.671 2.247 . . . . 0.0 112.323 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.4 mm -93.73 142.28 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 16.5 p -139.4 163.26 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 303' ' ' ASN . 31.4 m -46.76 -27.81 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.28 -36.27 82.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.9 t -71.12 -47.53 60.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.093 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 18.9 mt -83.74 20.84 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.419 ' O ' ' HB3' ' A' ' 239' ' ' ASN . 75.7 t80 -129.95 -39.28 1.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.966 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.453 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 22.9 m -72.33 -37.43 68.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.19 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.449 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 44.7 t -85.02 -25.67 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.117 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.456 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 78.9 m -83.67 -47.82 10.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.53 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -41.37 -49.29 9.08 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.636 0.732 . . . . 0.0 110.862 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.9 Cg_exo -47.91 -62.17 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.728 2.285 . . . . 0.0 112.36 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 48.4 t -47.05 -50.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.24 -103.39 0.26 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.403 ' C ' ' HD3' ' A' ' 243' ' ' LYS . 1.1 tmtp? -163.75 120.26 1.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 110.916 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.474 HG11 HD11 ' A' ' 247' ' ' ILE . 90.2 t -85.43 142.46 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.494 ' O ' HG23 ' A' ' 309' ' ' THR . 11.0 mm-40 -95.83 -57.79 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -141.24 152.44 44.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.474 HD11 HG11 ' A' ' 244' ' ' VAL . 58.0 mt -137.38 119.37 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 95.1 t -117.96 115.96 50.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.126 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 62.0 mt -103.53 122.18 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 36.8 p90 -131.45 148.81 52.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -124.8 40.95 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . 0.418 ' HB2' ' NH1' ' A' ' 252' ' ' ARG . 0.2 OUTLIER -72.9 -60.42 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -129.66 80.01 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 255' ' ' ILE . . . 88.04 116.34 1.26 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.506 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 254' ' ' GLY . 28.1 mm -33.42 104.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 111.141 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.852 HE21 HD11 ' A' ' 219' ' ' LEU . 34.7 mt-30 -136.19 166.42 23.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -165.13 121.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . 0.404 ' SD ' HD21 ' A' ' 296' ' ' LEU . 13.9 mtt -86.06 137.36 32.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 94.8 t -126.84 129.48 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 261' ' ' PHE . 3.3 tp10 -102.1 148.23 25.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.691 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 41.1 m-85 -122.71 157.64 31.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.453 ' OE1' ' NE2' ' A' ' 245' ' ' GLN . 3.8 mm-40 -36.37 -63.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -143.13 176.19 9.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 87.0 t -52.75 -56.9 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 16.1 tp -39.26 -64.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 83.3 m -49.17 -43.45 42.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -54.89 -40.35 69.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -55.24 -59.09 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -63.3 -51.17 67.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.691 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -48.69 -49.99 35.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.672 ' HA ' HD13 ' A' ' 288' ' ' ILE . 55.0 tttm -54.07 -53.47 52.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -54.11 -70.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -42.43 -41.35 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.608 ' CB ' HD11 ' A' ' 288' ' ' ILE . 3.1 mp -79.64 -23.46 42.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 271' ' ' LYS . 18.4 t-20 -60.0 104.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 76.97 24.02 67.71 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.733 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -82.8 93.24 7.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.775 0.321 . . . . 0.0 111.077 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.44 117.02 2.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.546 HG22 ' CD1' ' A' ' 280' ' ' TYR . 70.1 mt -89.98 -39.82 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.129 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . 0.546 ' CD1' HG22 ' A' ' 279' ' ' ILE . 5.5 m-85 -117.73 173.44 6.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -52.86 103.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.071 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.23 59.59 0.62 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.473 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 20.0 p -175.08 163.84 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 82.0 m 60.19 44.41 12.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 30.2 m -59.52 150.0 28.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.733 HD12 ' HB3' ' A' ' 277' ' ' ALA . 40.5 mt -92.51 105.87 17.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -104.78 82.14 1.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.672 HD13 ' HA ' ' A' ' 271' ' ' LYS . 19.3 mt -70.56 142.63 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.09 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -149.04 122.01 8.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -49.15 101.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.442 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -60.45 135.08 57.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.051 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.605 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.4 OUTLIER -59.3 -44.65 98.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 0.0 110.918 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.4 Cg_endo -80.41 144.06 15.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.723 2.282 . . . . 0.0 112.318 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 65.3 p -111.35 34.65 3.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.163 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 296' ' ' LEU . 3.7 tpt180 -144.3 143.59 31.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.423 ' N ' ' HG3' ' A' ' 295' ' ' ARG . 49.2 mt -132.3 114.4 14.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -88.4 135.36 33.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 75.0 t -137.57 115.49 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -83.37 -59.01 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -115.86 166.52 11.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -102.55 44.06 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.05 169.75 17.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.75 ' O ' HG13 ' A' ' 231' ' ' VAL . 1.1 p30 -45.41 -47.24 13.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -44.31 -60.06 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.5 p -133.01 142.55 48.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -140.97 142.09 34.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.75 89.36 3.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.886 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -78.86 45.83 0.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 245' ' ' GLN . 67.4 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.163 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.8 t30 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.884 0.374 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 15.8 mtmm -52.51 -40.75 62.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.841 HG22 ' HG2' ' A' ' 260' ' ' GLU . 42.9 t -84.12 148.25 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 220' ' ' LEU . 13.9 mt -144.89 127.79 16.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.0 tp -84.88 117.9 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.578 HD13 HG23 ' A' ' 259' ' ' VAL . 6.0 mp -101.1 128.77 47.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.5 m -123.22 111.46 16.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 222' ' ' ILE . 5.2 mp -75.94 143.09 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -103.23 137.69 41.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.541 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 46.0 t30 42.18 52.82 7.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.609 0.719 . . . . 0.0 110.911 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.0 Cg_exo -45.31 119.84 2.8 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.371 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.481 HD22 ' O ' ' A' ' 224' ' ' ASN . 4.1 mm? -88.02 -56.73 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.557 ' CD1' ' CE2' ' A' ' 280' ' ' TYR . 16.5 m-85 -119.45 144.02 35.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.731 0.777 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.91 112.67 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.666 2.244 . . . . 0.0 112.343 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.442 HD12 HG11 ' A' ' 233' ' ' VAL . 48.2 mm -81.95 121.28 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.4 p -107.72 157.11 18.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.15 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 303' ' ' ASN . 27.5 m -40.42 -38.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.156 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 235' ' ' TYR . 48.8 m-20 -56.45 -61.24 2.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 229' ' ' ILE . 97.0 t -36.94 -44.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.15 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.54 -38.12 41.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 71.8 t80 -83.87 19.85 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.487 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 96.2 m -125.0 -36.69 2.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.432 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 98.8 t -97.21 -24.58 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.125 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 85.7 m -85.11 -45.48 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.548 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.1 m120 -49.86 -48.31 78.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.674 0.749 . . . . 0.0 110.903 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 67.0 Cg_exo -48.03 -22.03 3.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.315 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.6 t -89.63 -50.28 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.083 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -145.97 -127.48 1.88 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.433 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.491 ' CB ' ' OE2' ' A' ' 262' ' ' GLU . 32.5 tptt -130.24 131.9 45.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.848 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.501 HG11 HD11 ' A' ' 247' ' ' ILE . 84.2 t -108.29 125.26 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -79.94 -70.22 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -134.68 160.27 38.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.501 HD11 HG11 ' A' ' 244' ' ' VAL . 54.6 mt -137.84 136.61 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 298' ' ' VAL . 62.0 t -135.97 109.53 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 49.2 mt -99.92 100.88 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -105.79 134.61 48.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 78.51 2.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 113.74 18.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 47.12 43.9 14.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.13 119.03 2.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mm -42.38 107.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.329 . . . . 0.0 111.158 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -128.32 143.82 51.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.31 117.7 9.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . 0.473 ' HB3' HD11 ' A' ' 296' ' ' LEU . 29.6 mtt -90.16 127.37 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.578 HG23 HD13 ' A' ' 220' ' ' LEU . 57.4 t -119.34 143.06 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.841 ' HG2' HG22 ' A' ' 217' ' ' VAL . 17.5 mt-10 -108.37 163.13 13.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.819 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 42.0 m-85 -134.07 158.05 44.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.491 ' OE2' ' CB ' ' A' ' 243' ' ' LYS . 31.2 mt-10 -40.65 -63.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.5 m -140.93 178.52 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.94 -51.06 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 17.5 tp -47.66 -58.83 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 62.8 m -49.86 -43.95 49.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -55.72 -38.01 69.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.084 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -56.69 -65.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -57.58 -53.16 61.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.819 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -50.03 -53.27 27.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.729 ' HG3' HG21 ' A' ' 288' ' ' ILE . 23.4 tttt -53.09 -44.19 67.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.7 -66.01 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.877 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -51.82 -47.27 64.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.504 ' CB ' HD11 ' A' ' 288' ' ' ILE . 2.8 mp -67.59 -28.19 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 271' ' ' LYS . 0.8 OUTLIER -66.85 104.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.07 20.8 75.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -82.15 91.87 6.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.64 128.38 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.654 HG22 ' CD1' ' A' ' 280' ' ' TYR . 73.2 mt -102.57 -41.92 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . 0.654 ' CD1' HG22 ' A' ' 279' ' ' ILE . 6.3 m-85 -118.3 173.54 6.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.93 105.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.59 59.99 0.65 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.522 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 31.8 p -175.16 167.11 3.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 2.2 m 62.57 44.11 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 57.3 m -61.55 136.74 58.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 277' ' ' ALA . 61.4 mt -87.38 115.85 25.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -111.12 90.21 3.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.889 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.729 HG21 ' HG3' ' A' ' 271' ' ' LYS . 35.1 mt -76.3 145.59 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 290' ' ' TYR . 18.8 mt-10 -153.71 111.19 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' A' ' 289' ' ' GLU . 26.4 m-85 -37.52 102.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -49.78 144.03 6.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.069 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.599 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 4.6 ttp180 -60.42 -45.04 97.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 0.0 110.801 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.8 Cg_endo -80.3 150.81 20.08 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.6 p -85.6 -24.28 27.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -128.59 175.04 8.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 258' ' ' MET . 80.1 mt -132.47 175.51 9.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -152.6 118.62 5.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 248' ' ' VAL . 63.2 t -102.07 104.71 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.685 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.9 mp -62.69 -59.82 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . 0.424 ' HG3' HG22 ' A' ' 299' ' ' ILE . 37.6 mtm180 -115.36 154.96 28.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -105.77 105.46 15.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 303' ' ' ASN . 3.3 m-20 -149.02 167.71 25.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.674 ' O ' HG13 ' A' ' 231' ' ' VAL . 65.2 m-20 -34.37 -47.49 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -50.72 -60.77 2.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 248' ' ' VAL . 78.7 p -129.28 133.41 47.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -131.43 137.36 48.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.24 113.55 21.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -89.61 -59.85 2.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 72.1 p . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.173 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 64.5 t30 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.919 0.39 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -68.91 -44.15 73.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.541 HG11 HD21 ' A' ' 296' ' ' LEU . 84.1 t -81.11 142.76 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.415 HD21 ' HB1' ' A' ' 267' ' ' ALA . 20.5 mt -132.2 126.32 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.44 HD11 ' OE1' ' A' ' 256' ' ' GLN . 24.1 tp -82.5 111.92 18.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.568 HD23 HD22 ' A' ' 286' ' ' LEU . 7.7 mp -103.82 130.26 51.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 t -116.1 132.39 56.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.824 HD13 HG22 ' A' ' 255' ' ' ILE . 4.7 mp -92.42 69.02 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.164 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 222' ' ' ILE . 8.2 mm100 -35.73 141.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.53 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 34.4 m-20 44.76 54.22 12.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.646 0.736 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.8 Cg_exo -46.92 93.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.661 2.24 . . . . 0.0 112.331 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.507 HD12 ' HB2' ' A' ' 283' ' ' CYS . 12.3 mt -102.43 -44.62 5.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . 63.8 m-85 -107.6 130.27 23.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.734 0.778 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 227' ' ' TYR . 77.5 Cg_exo -49.47 126.27 15.64 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.7 2.267 . . . . 0.0 112.336 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.806 HD12 HG11 ' A' ' 233' ' ' VAL . 49.6 mm -117.92 118.86 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.407 ' HA ' ' CD1' ' A' ' 249' ' ' ILE . 21.5 p -121.75 167.36 13.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.174 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 35.3 m -40.08 -34.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.54 -43.89 96.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.806 HG11 HD12 ' A' ' 229' ' ' ILE . 61.2 t -66.17 -44.39 91.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 25.4 mt -83.19 20.15 1.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -124.81 -26.33 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 86.5 m -85.72 -36.35 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.444 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 13.3 t -89.15 -21.86 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.154 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 83.7 m -84.79 -47.66 10.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.541 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -46.86 -48.1 51.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.708 . . . . 0.0 110.917 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -48.03 -21.05 2.46 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.649 2.232 . . . . 0.0 112.323 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.937 HG11 ' HA ' ' A' ' 270' ' ' ALA . 77.7 t -96.98 -43.06 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.109 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.73 -158.52 9.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.98 120.55 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.829 0.347 . . . . 0.0 110.87 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.4 t -85.67 133.06 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -95.38 -60.55 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -150.58 153.32 35.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.509 HG23 HG22 ' A' ' 259' ' ' VAL . 68.5 mt -132.19 127.33 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.17 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 298' ' ' VAL . 57.3 t -119.92 112.12 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.432 HG12 ' HB2' ' A' ' 257' ' ' ALA . 58.2 mt -100.04 129.91 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.149 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -138.27 163.56 31.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.736 ' HG3' HD13 ' A' ' 255' ' ' ILE . 22.2 ttpt -120.86 86.03 2.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -120.52 88.58 2.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.5 m120 56.14 42.82 27.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 138.25 108.06 0.81 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.497 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.824 HG22 HD13 ' A' ' 222' ' ' ILE . 31.7 mm -39.79 114.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 111.097 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.44 ' OE1' HD11 ' A' ' 219' ' ' LEU . 13.0 mt-30 -139.69 173.58 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 249' ' ' ILE . . . -165.11 120.76 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.09 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.5 mtt -83.93 123.21 29.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.509 HG22 HG23 ' A' ' 247' ' ' ILE . 67.8 t -117.08 127.74 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -97.3 154.29 17.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -127.32 164.33 22.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -43.85 -65.11 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 25.1 p -138.47 169.61 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 265' ' ' LEU . 75.5 t -49.62 -53.83 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.141 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 264' ' ' VAL . 19.5 tp -38.3 -57.88 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 84.8 m -50.43 -44.84 55.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.415 ' HB1' HD21 ' A' ' 218' ' ' LEU . . . -54.11 -38.8 65.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.091 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -57.02 -60.84 2.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -63.71 -54.1 40.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.937 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.63 -48.8 28.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.643 ' HA ' HD13 ' A' ' 288' ' ' ILE . 49.4 tttm -51.19 -52.19 46.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -57.16 -67.32 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.79 -40.0 1.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.581 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.4 mp -84.98 -22.39 29.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 271' ' ' LYS . 41.1 t30 -60.16 100.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.05 19.95 68.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.513 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.477 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -78.32 91.68 4.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.737 0.303 . . . . 0.0 111.117 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.21 123.37 14.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.873 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.465 HD11 HD11 ' A' ' 286' ' ' LEU . 84.9 mt -95.87 -41.55 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -116.17 173.04 6.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -51.09 102.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.33 61.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . 0.507 ' HB2' HD12 ' A' ' 226' ' ' LEU . 28.2 p -175.06 168.83 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.807 0.337 . . . . 0.0 110.883 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 53.5 m 58.99 47.78 11.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 19.7 m -61.81 145.81 51.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.143 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.568 HD22 HD23 ' A' ' 220' ' ' LEU . 50.0 mt -93.71 95.65 9.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -91.22 97.32 11.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' A' ' 271' ' ' LYS . 21.6 mt -83.86 138.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -143.97 124.87 14.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -51.61 97.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.59 156.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.086 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 1.1 mpt_? -71.45 -60.27 2.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.631 0.729 . . . . 0.0 110.882 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 58.8 Cg_endo -71.78 161.59 44.63 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.7 2.267 . . . . 0.0 112.341 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.6 p -97.31 -34.23 11.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -106.85 163.37 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.541 HD21 HG11 ' A' ' 217' ' ' VAL . 40.8 mt -124.04 -177.24 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -144.39 132.62 21.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.546 HG11 ' OD1' ' A' ' 307' ' ' ASP . 75.5 t -122.29 103.01 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.742 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -55.42 -62.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.3 154.47 49.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -84.21 81.38 8.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -124.57 171.76 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -43.0 -47.63 5.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -47.39 -56.74 6.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.2 p -137.6 142.12 41.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -136.43 136.85 39.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.546 ' OD1' HG11 ' A' ' 298' ' ' VAL . 0.8 OUTLIER -114.84 110.92 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.97 -49.34 8.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.964 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 31.3 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.174 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 41.5 t30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.855 0.36 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -38.73 -43.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.508 HG13 HD11 ' A' ' 296' ' ' LEU . 76.6 t -82.07 147.8 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 220' ' ' LEU . 15.4 mt -145.3 123.68 12.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.2 tp -78.91 104.52 9.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.44 HD13 HG23 ' A' ' 259' ' ' VAL . 6.9 mp -87.29 126.06 34.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 54.0 m -117.34 112.79 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 1.021 HD13 HG22 ' A' ' 255' ' ' ILE . 2.4 mp -80.85 118.0 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.471 ' C ' ' CG ' ' A' ' 224' ' ' ASN . 17.8 mm100 -85.28 133.28 34.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.932 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.471 ' CG ' ' C ' ' A' ' 223' ' ' GLN . 0.7 OUTLIER 49.39 54.97 16.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.64 0.733 . . . . 0.0 110.897 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 59.9 Cg_endo -73.36 99.69 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.328 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.87 -40.31 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -88.74 153.47 49.96 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.657 0.742 . . . . 0.0 110.941 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.39 115.93 4.52 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.7 2.266 . . . . 0.0 112.316 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 22.3 mm -97.24 148.17 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 232' ' ' ASP . 16.1 p -148.23 156.13 42.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 303' ' ' ASN . 34.7 m -35.16 -35.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 230' ' ' THR . 6.4 t0 -65.48 -61.58 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 71.6 t -42.02 -46.32 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.437 HD12 HG21 ' A' ' 247' ' ' ILE . 34.8 mt -66.7 -65.6 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.535 ' CD2' ' HB ' ' A' ' 244' ' ' VAL . 5.9 t80 -48.0 -27.44 2.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.428 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 83.6 m -66.01 -47.58 73.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.145 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.441 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 63.5 t -87.42 -15.14 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.428 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 77.3 m -86.13 -46.75 10.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.56 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -47.36 -47.52 57.8 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.626 0.727 . . . . 0.0 110.902 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.8 Cg_exo -47.98 -18.6 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 270' ' ' ALA . 78.6 t -98.6 -42.4 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -162.72 -145.25 4.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.405 ' HD3' ' C ' ' A' ' 243' ' ' LYS . 8.9 tmtm? -116.53 119.21 34.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.535 ' HB ' ' CD2' ' A' ' 235' ' ' TYR . 89.1 t -82.49 141.1 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -96.03 -51.85 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.411 ' NE ' ' OE1' ' A' ' 260' ' ' GLU . 22.9 ptt180 -159.89 153.1 21.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.437 HG21 HD12 ' A' ' 234' ' ' LEU . 53.6 mt -131.82 139.26 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 38.1 t -130.45 110.53 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.138 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 52.9 mt -98.55 140.69 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 8.2 p90 -146.68 139.98 25.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -98.25 43.19 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -79.55 95.46 5.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 62.76 45.79 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 131.28 -155.56 21.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 1.021 HG22 HD13 ' A' ' 222' ' ' ILE . 32.2 mm -116.04 103.38 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 0.0 111.116 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.569 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 19.0 mp0 -131.56 157.31 43.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -162.12 118.63 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.116 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.8 mtt -82.2 128.81 34.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 220' ' ' LEU . 65.4 t -119.33 127.73 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 24.6 tt0 -104.34 149.43 25.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.45 ' N ' ' HG2' ' A' ' 260' ' ' GLU . 60.1 m-85 -118.93 166.51 12.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.839 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -45.67 -64.58 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.4 t -130.87 177.81 7.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.54 -54.54 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.16 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 24.4 tp -40.89 -54.49 2.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.919 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 68.6 m -53.57 -43.05 68.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -56.33 -40.21 74.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.085 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -62.49 -63.55 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -55.48 -44.43 76.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.821 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -64.15 -42.28 96.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.695 ' HA ' HD13 ' A' ' 288' ' ' ILE . 42.6 tttm -55.27 -47.65 75.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.62 -62.12 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.102 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -47.13 -37.17 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.097 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.785 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.7 mp -88.38 -22.77 23.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 271' ' ' LYS . 2.0 t30 -60.52 101.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.46 21.44 69.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.506 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -84.55 93.41 8.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.329 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -49.53 143.53 6.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.615 HG22 ' CD1' ' A' ' 280' ' ' TYR . 68.2 mt -102.17 -36.59 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.157 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . 0.615 ' CD1' HG22 ' A' ' 279' ' ' ILE . 62.3 m-85 -139.02 175.88 9.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -39.82 101.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.045 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 29.3 73.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.472 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . 0.464 ' HA ' ' ND2' ' A' ' 224' ' ' ASN . 23.5 p -175.96 173.46 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 110.881 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 283' ' ' CYS . 2.0 p 40.25 43.85 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 90.2 m -60.76 139.3 57.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.167 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.435 HD22 HD23 ' A' ' 220' ' ' LEU . 31.5 mt -82.42 123.48 29.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.431 ' C ' ' HE3' ' A' ' 287' ' ' LYS . 0.1 OUTLIER -124.35 87.14 2.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.925 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.785 HD11 ' CB ' ' A' ' 274' ' ' LEU . 17.9 mt -71.38 142.58 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -142.51 115.89 9.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -39.71 100.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -52.24 151.85 3.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.138 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 13.0 mmt180 -73.27 -58.05 2.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.594 0.712 . . . . 0.0 110.869 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 60.0 Cg_endo -73.74 159.09 46.12 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.724 2.282 . . . . 0.0 112.344 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 69.5 p -95.65 -34.84 11.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 296' ' ' LEU . 1.4 tmm_? -105.78 152.8 22.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.508 HD11 HG13 ' A' ' 217' ' ' VAL . 74.9 mt -118.54 154.79 31.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.962 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -116.29 127.33 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' A' ' 307' ' ' ASP . 89.3 t -106.27 105.65 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.158 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.703 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.4 mp -59.2 -62.01 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -131.8 170.42 14.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.43 ' ND2' ' OD1' ' A' ' 307' ' ' ASP . 1.8 m-20 -106.56 100.01 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 303' ' ' ASN . 29.3 t70 -165.58 172.52 11.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.728 ' O ' HG13 ' A' ' 231' ' ' VAL . 1.9 m-80 -34.34 -46.09 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.99 -53.17 28.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 2.9 m -153.48 143.51 22.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.898 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -136.88 149.85 47.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.718 ' HB3' HG21 ' A' ' 298' ' ' VAL . 17.0 p-10 -129.44 95.62 4.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -71.35 -40.46 70.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.416 ' ND2' ' HB ' ' A' ' 217' ' ' VAL . 13.4 t30 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.919 0.39 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -59.65 -42.77 93.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.547 HG11 HD21 ' A' ' 296' ' ' LEU . 91.5 t -76.06 138.29 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.402 ' HB3' HG23 ' A' ' 288' ' ' ILE . 12.4 mt -136.44 128.58 29.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 54.5 tp -83.18 113.47 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.514 HD23 HD22 ' A' ' 286' ' ' LEU . 6.9 mp -99.56 125.71 45.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.3 t -115.38 115.37 26.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.573 HD13 HG22 ' A' ' 255' ' ' ILE . 5.4 mp -77.03 122.24 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -80.05 139.09 37.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.543 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 31.6 m-20 43.44 53.82 10.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.666 0.746 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.6 Cg_exo -47.08 94.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.379 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 13.8 mt -109.91 -44.46 3.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.448 ' CG ' ' CE2' ' A' ' 280' ' ' TYR . 91.6 m-85 -94.66 137.8 22.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.674 0.75 . . . . 0.0 110.912 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.2 132.4 23.41 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.716 2.277 . . . . 0.0 112.341 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.9 mm -122.61 129.9 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.42 ' HA ' ' CD1' ' A' ' 249' ' ' ILE . 21.7 p -144.46 168.58 19.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 33.5 m -42.76 -36.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.2 -44.44 88.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.05 -47.9 88.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.106 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 26.1 mt -84.83 23.68 1.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -130.89 -36.14 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.502 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 26.5 m -79.45 -35.71 39.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.133 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 237' ' ' VAL . 87.6 t -90.62 -14.65 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 76.2 m -87.99 -48.07 8.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.908 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.574 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.8 t-20 -49.78 -46.01 80.01 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.67 0.748 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.0 Cg_exo -47.92 -21.68 2.81 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.68 2.253 . . . . 0.0 112.358 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.482 HG11 ' HB3' ' A' ' 273' ' ' ALA . 21.9 t -99.8 -40.84 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.092 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -152.18 -132.64 1.85 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.46 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -131.8 115.45 15.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.879 HG11 HD11 ' A' ' 247' ' ' ILE . 84.7 t -87.82 137.2 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -109.84 -66.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -120.95 150.2 41.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.879 HD11 HG11 ' A' ' 244' ' ' VAL . 47.7 mt -141.98 121.77 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 66.6 t -119.27 129.45 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 230' ' ' THR . 56.8 mt -120.73 115.39 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -124.32 171.84 9.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -124.78 44.23 2.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.942 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -71.35 96.42 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 47.4 43.1 15.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 140.95 137.85 3.49 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.573 HG22 HD13 ' A' ' 222' ' ' ILE . 44.5 mm -58.33 101.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.328 . . . . 0.0 111.104 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -131.91 158.34 41.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -155.89 117.87 4.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 25.9 mtt -83.11 125.09 31.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 247' ' ' ILE . 90.4 t -115.59 124.33 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.17 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -98.43 145.4 26.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.671 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 40.3 m-85 -118.93 158.0 26.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 261' ' ' PHE . 4.4 mm-40 -34.64 -65.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 11.1 t -139.44 166.23 25.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 87.0 t -42.43 -59.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.124 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 264' ' ' VAL . 22.8 tp -35.82 -63.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 81.2 m -42.89 -45.06 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -52.87 -38.14 61.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -55.98 -59.87 4.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -65.49 -55.79 15.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.671 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -47.41 -48.21 26.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.073 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.735 ' HA ' HD13 ' A' ' 288' ' ' ILE . 17.5 tttt -56.51 -45.23 81.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -60.34 -71.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.093 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.704 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -41.38 -39.53 1.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.768 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.5 mp -81.68 -27.35 34.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 272' ' ' ALA . 18.9 t-20 -59.84 100.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.2 20.71 69.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.457 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -84.23 94.5 8.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.736 0.303 . . . . 0.0 111.093 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.74 128.42 26.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.561 HD11 HD11 ' A' ' 286' ' ' LEU . 77.4 mt -104.42 -44.05 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . 0.448 ' CE2' ' CG ' ' A' ' 227' ' ' TYR . 33.8 m-85 -112.37 174.35 5.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.73 103.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 33.91 56.86 0.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.467 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 27.7 p -175.18 168.19 3.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.338 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 87.0 m 62.63 41.41 9.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 15.3 m -59.54 149.94 28.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.21 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 279' ' ' ILE . 57.5 mt -94.77 105.8 17.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -101.59 80.2 2.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.768 HD11 ' CB ' ' A' ' 274' ' ' LEU . 44.4 mt -69.45 141.54 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.133 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -149.24 109.84 4.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -38.3 106.43 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.75 157.23 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.086 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.471 ' CB ' ' CD ' ' A' ' 293' ' ' PRO . 11.9 mmt180 -73.69 -61.41 1.36 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 292' ' ' ARG . 59.0 Cg_endo -71.88 161.21 45.65 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 40.2 p -93.01 -28.14 16.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.144 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.16 160.01 15.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.547 HD21 HG11 ' A' ' 217' ' ' VAL . 66.9 mt -120.95 172.67 7.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . 0.443 ' ND2' HD13 ' A' ' 299' ' ' ILE . 2.1 t30 -119.51 119.71 34.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.27 93.36 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.443 HD13 ' ND2' ' A' ' 297' ' ' ASN . 4.7 mm -46.0 -66.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.36 160.54 43.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -64.88 101.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.83 171.77 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.833 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -46.3 -52.8 11.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.32 -53.87 10.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.7 p -143.39 140.93 30.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -126.77 145.49 50.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -126.71 92.45 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 309' ' ' THR . 58.6 m-85 -69.44 -50.7 43.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.899 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 308' ' ' TYR . 76.3 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.16 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 65.0 t30 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.908 0.385 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -74.79 -41.3 60.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' A' ' 260' ' ' GLU . 52.6 t -79.24 142.79 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.117 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.555 ' HB3' HG23 ' A' ' 288' ' ' ILE . 19.3 mt -139.81 132.35 28.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.86 111.96 18.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.33 127.3 49.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.3 t -115.33 138.72 50.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.85 131.03 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.136 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -94.7 133.46 38.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.581 ' O ' HD22 ' A' ' 226' ' ' LEU . 0.3 OUTLIER 46.17 53.34 12.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.884 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.0 Cg_exo -45.09 84.63 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.657 2.238 . . . . 0.0 112.351 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.581 HD22 ' O ' ' A' ' 224' ' ' ASN . 4.0 mm? -58.65 -59.79 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -117.57 146.38 38.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.666 0.746 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.78 114.86 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 0.0 112.336 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.554 HD12 HG11 ' A' ' 233' ' ' VAL . 27.6 mm -87.12 120.13 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.185 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 21.4 p -104.81 161.46 14.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 232' ' ' ASP . 30.4 m -42.37 -40.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 235' ' ' TYR . 7.8 m-20 -55.42 -60.72 3.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.554 HG11 HD12 ' A' ' 229' ' ' ILE . 95.5 t -38.03 -37.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 41.6 mt -88.54 -31.85 18.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.774 ' CD1' ' CE2' ' A' ' 308' ' ' TYR . 37.6 t80 -84.75 23.37 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.502 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 88.3 m -125.21 -38.74 2.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.14 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 237' ' ' VAL . 59.1 t -94.21 -15.4 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.428 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 97.1 m -88.72 -47.46 8.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.571 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 8.6 t-20 -50.58 -45.63 85.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.661 0.743 . . . . 0.0 110.928 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.2 Cg_exo -47.98 -22.97 3.87 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.27 . . . . 0.0 112.354 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' ' 270' ' ' ALA . 91.4 t -96.97 -45.58 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -146.6 -145.18 4.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.508 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.53 112.17 17.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.815 0.341 . . . . 0.0 110.937 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.509 ' HB ' ' CE1' ' A' ' 235' ' ' TYR . 51.4 t -80.73 141.7 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.165 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.465 ' NE2' HG22 ' A' ' 309' ' ' THR . 5.1 mm-40 -101.7 -60.89 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.9 mtm-85 -140.78 156.91 46.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.455 HD11 HG11 ' A' ' 244' ' ' VAL . 74.9 mt -142.56 138.45 28.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.11 134.76 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 87.6 mt -116.07 108.11 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -115.72 164.23 14.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -121.89 43.83 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -94.65 106.99 18.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.6 t30 68.1 44.12 1.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 105.91 151.05 19.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 39.1 mm -56.38 113.4 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -141.24 165.2 28.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -156.76 124.63 5.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 29.6 mtt -88.87 124.04 33.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.413 HG13 HG12 ' A' ' 247' ' ' ILE . 72.9 t -112.08 138.02 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.642 ' HG2' HG22 ' A' ' 217' ' ' VAL . 8.9 tm-20 -114.69 140.96 48.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -114.55 162.67 16.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -41.28 -65.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.2 m -137.5 176.31 8.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 265' ' ' LEU . 98.2 t -56.43 -56.75 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.158 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 264' ' ' VAL . 20.4 tp -37.51 -54.02 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 6.7 m -52.2 -47.0 65.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.25 -37.47 64.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -55.62 -63.44 1.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -61.34 -58.64 7.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.772 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -46.96 -49.65 20.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.133 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.612 ' HA ' HD13 ' A' ' 288' ' ' ILE . 49.3 tttm -47.82 -54.59 11.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -53.17 -66.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -42.98 -43.81 4.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.873 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.9 mp -77.52 -22.33 51.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 272' ' ' ALA . 44.4 t-20 -55.94 99.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.99 19.72 72.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.498 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -86.31 95.82 9.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 111.103 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.56 155.23 39.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 44.4 mt -113.89 -53.9 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -95.7 172.47 8.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -52.68 107.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.139 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.37 48.18 0.62 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 23.0 m -161.1 177.4 10.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.7 m 49.42 44.26 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 41.1 m -63.51 143.93 57.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.124 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 90.3 mt -94.19 122.99 37.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -116.35 98.74 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.873 HD11 ' CB ' ' A' ' 274' ' ' LEU . 28.3 mt -79.27 139.11 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.178 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -150.23 114.36 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.441 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 77.6 m-85 -41.32 103.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.958 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -55.08 159.67 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.121 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.491 ' CB ' ' CD ' ' A' ' 293' ' ' PRO . 47.6 mtt180 -73.94 -62.17 1.14 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.583 0.706 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 292' ' ' ARG . 58.3 Cg_endo -71.8 156.96 56.24 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.673 2.249 . . . . 0.0 112.34 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 64.3 p -93.01 -36.33 12.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -107.28 148.7 28.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.48 HD11 HG13 ' A' ' 217' ' ' VAL . 31.3 mt -117.72 150.28 39.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . 0.442 HD21 ' CD1' ' A' ' 299' ' ' ILE . 16.3 t30 -98.56 120.4 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.63 102.02 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.472 ' N ' HD13 ' A' ' 299' ' ' ILE . 4.6 mm -46.71 -61.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -175.05 162.53 3.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -52.71 94.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 305' ' ' SER . 2.3 m-20 -141.69 172.85 12.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -54.64 -41.83 70.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -56.73 -59.92 4.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 302' ' ' ASP . 3.3 t -130.3 152.52 49.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -134.03 138.54 45.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -122.5 98.86 6.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.844 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . 0.774 ' CE2' ' CD1' ' A' ' 235' ' ' TYR . 99.4 m-85 -76.21 -50.84 13.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.465 HG22 ' NE2' ' A' ' 245' ' ' GLN . 46.1 p . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.178 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 217' ' ' VAL . 0.1 OUTLIER -52.3 -33.67 43.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.579 HG12 ' CB ' ' A' ' 291' ' ' ALA . 62.0 t -77.77 137.73 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 15.2 mt -134.91 134.37 40.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.453 HD11 ' OE1' ' A' ' 256' ' ' GLN . 22.1 tp -89.94 110.29 21.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.982 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.2 mp -97.51 139.76 32.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -128.81 131.61 47.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.877 HD13 HG22 ' A' ' 255' ' ' ILE . 4.9 mp -91.56 122.02 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.158 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -82.22 143.64 31.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.536 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 15.6 m-20 39.8 54.42 5.83 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.615 0.721 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 74.4 Cg_exo -47.21 92.55 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.738 2.292 . . . . 0.0 112.31 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 11.6 mt -100.78 -48.83 4.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -100.47 137.11 19.86 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.67 0.748 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.51 113.54 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.671 2.248 . . . . 0.0 112.328 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.437 HG13 HG21 ' A' ' 222' ' ' ILE . 47.6 mm -101.11 104.04 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.7 p -104.5 159.44 15.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.17 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.462 ' N ' HD11 ' A' ' 249' ' ' ILE . 26.8 m -42.77 -35.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.25 -58.72 7.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 95.2 t -45.15 -45.17 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.093 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 40.1 mt -68.66 -61.89 1.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.46 ' C ' ' CD1' ' A' ' 235' ' ' TYR . 4.8 t80 -49.58 -29.21 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 98.1 m -64.71 -46.98 80.0 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.126 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 237' ' ' VAL . 61.1 t -87.49 -10.07 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.44 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 82.1 m -88.94 -45.17 9.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.909 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.577 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 1.9 t-20 -49.59 -46.11 78.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -47.96 -19.92 1.8 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.694 2.262 . . . . 0.0 112.336 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.986 HG11 ' HA ' ' A' ' 270' ' ' ALA . 87.4 t -99.1 -46.92 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.42 -170.18 30.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 244' ' ' VAL . 6.6 tmtm? -82.59 151.14 26.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.368 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.564 HG11 HD11 ' A' ' 247' ' ' ILE . 91.0 t -121.52 128.99 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -80.69 -62.63 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -151.07 155.4 38.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.661 HG12 HG13 ' A' ' 259' ' ' VAL . 77.0 mt -136.85 150.95 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.638 HG22 HG22 ' A' ' 298' ' ' VAL . 94.0 t -136.52 139.91 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 231' ' ' VAL . 88.9 mt -125.38 116.63 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -129.05 158.39 39.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.87 41.84 2.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . 0.402 ' HD3' ' C ' ' A' ' 252' ' ' ARG . 0.0 OUTLIER -67.54 86.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.854 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.2 t30 59.79 42.62 16.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.841 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 137.09 127.89 2.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.53 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.877 HG22 HD13 ' A' ' 222' ' ' ILE . 50.9 mm -48.4 113.11 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.766 0.317 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.453 ' OE1' HD11 ' A' ' 219' ' ' LEU . 37.1 mt-30 -137.67 165.46 26.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.32 127.07 4.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 11.0 mtt -95.67 126.25 40.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.661 HG13 HG12 ' A' ' 247' ' ' ILE . 61.2 t -123.83 127.02 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -105.85 172.74 6.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -142.24 169.78 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -54.27 -68.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 13.8 m -119.35 173.32 7.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 64.6 t -60.43 -52.39 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.139 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 55.2 tp -38.58 -63.48 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 80.7 m -48.03 -46.37 33.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -53.32 -45.57 69.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -63.74 -55.53 22.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -55.26 -58.27 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.986 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -51.24 -46.2 62.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.698 ' HA ' HD13 ' A' ' 288' ' ' ILE . 56.8 tttm -49.03 -52.0 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -56.82 -67.03 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.93 -41.12 2.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.547 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.9 mp -83.6 -22.15 32.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 271' ' ' LYS . 1.2 t30 -57.36 104.7 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.0 22.69 77.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -83.24 90.52 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 0.0 111.134 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.76 129.28 19.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.588 HD11 HD21 ' A' ' 286' ' ' LEU . 79.8 mt -99.4 -41.8 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -117.3 173.15 6.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -50.28 103.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.132 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.44 48.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.499 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.2 m -161.42 174.44 13.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.319 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 34.0 m 52.94 42.36 32.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 11.3 m -57.58 152.13 15.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.155 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.588 HD21 HD11 ' A' ' 279' ' ' ILE . 50.9 mt -97.85 125.93 42.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 94.88 4.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.698 HD13 ' HA ' ' A' ' 271' ' ' LYS . 34.0 mt -85.62 145.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 290' ' ' TYR . 25.7 mt-10 -155.28 113.82 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 289' ' ' GLU . 68.9 m-85 -34.74 107.27 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.579 ' CB ' HG12 ' A' ' 217' ' ' VAL . . . -50.51 135.95 21.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.084 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.576 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 5.9 ttt180 -64.14 -46.67 79.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.587 0.708 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.5 Cg_endo -79.37 149.81 21.93 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.667 2.245 . . . . 0.0 112.38 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.5 p -87.1 -27.52 23.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.11 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -121.22 154.47 36.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 48.1 mt -114.62 179.67 3.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -145.1 133.84 22.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.638 HG22 HG22 ' A' ' 248' ' ' VAL . 96.8 t -131.23 105.69 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.576 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.2 mp -63.41 -60.57 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.122 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . 0.47 ' HG3' HG22 ' A' ' 299' ' ' ILE . 88.4 mtt-85 -124.82 166.97 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 302' ' ' ASP . 2.1 m-20 -106.67 95.19 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 303' ' ' ASN . 0.9 OUTLIER -141.19 172.38 12.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 302' ' ' ASP . 0.8 OUTLIER -34.23 -41.69 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -57.4 -63.35 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.4 p -129.57 149.47 51.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -150.9 120.94 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.81 100.66 12.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -84.1 38.51 0.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 291' ' ' ALA . 7.1 p-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.494 ' HG2' ' N ' ' A' ' 264' ' ' VAL . 17.3 mtmm -42.99 -45.85 5.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.0 137.64 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.614 ' O ' HD12 ' A' ' 220' ' ' LEU . 19.7 mt -131.99 120.64 22.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.4 HD13 ' HZ ' ' A' ' 250' ' ' PHE . 17.0 tp -76.8 114.52 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.776 HD13 HG23 ' A' ' 259' ' ' VAL . 7.0 mp -102.34 147.95 26.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.0 120.82 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 229' ' ' ILE . 5.2 mp -80.62 123.93 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -81.54 137.57 35.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.561 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 50.4 t30 44.18 53.57 10.83 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.7 Cg_exo -47.3 103.98 0.06 OUTLIER 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.67 2.247 . . . . 0.0 112.38 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 37.8 mt -107.46 -47.65 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.543 ' CD2' ' CD2' ' A' ' 280' ' ' TYR . 94.8 m-85 -97.37 141.11 22.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.689 0.757 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.55 117.33 2.29 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.707 2.271 . . . . 0.0 112.371 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.481 HG21 HD11 ' A' ' 222' ' ' ILE . 30.5 mm -99.61 106.3 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.627 HG22 ' OD1' ' A' ' 303' ' ' ASN . 28.7 p -111.53 165.82 11.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 306' ' ' TRP . 28.9 m -47.38 -40.44 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.147 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 235' ' ' TYR . 9.7 t0 -57.22 -63.89 1.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 232' ' ' ASP . 90.8 t -35.67 -36.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.17 -37.6 18.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 49.2 t80 -84.11 25.85 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.497 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 89.8 m -130.78 -36.22 1.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.124 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.435 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 25.4 t -98.12 -23.58 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.12 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.446 ' SG ' HD21 ' A' ' 274' ' ' LEU . 98.1 m -86.18 -48.78 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.568 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 11.9 t30 -47.43 -47.04 59.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.592 0.71 . . . . 0.0 110.85 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.8 Cg_exo -48.02 -21.5 2.8 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.643 2.229 . . . . 0.0 112.333 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 273' ' ' ALA . 20.2 t -93.12 -48.64 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.097 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -138.12 -128.02 2.58 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -138.11 114.72 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.759 HG11 HD11 ' A' ' 247' ' ' ILE . 58.9 t -94.84 139.95 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.42 ' NE2' ' OE1' ' A' ' 262' ' ' GLU . 3.3 mm100 -108.09 -67.32 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -116.84 158.19 24.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.759 HD11 HG11 ' A' ' 244' ' ' VAL . 79.6 mt -149.72 108.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' A' ' 305' ' ' SER . 48.2 t -107.62 143.25 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 257' ' ' ALA . 73.1 mt -126.61 114.89 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.4 ' HZ ' HD13 ' A' ' 219' ' ' LEU . 15.8 p90 -125.69 146.2 49.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -91.95 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -67.17 89.76 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 12.5 m120 50.58 42.02 26.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 137.32 136.2 3.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.506 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 32.7 mm -51.12 97.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.767 0.318 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -127.38 152.74 47.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.564 ' HB2' HG12 ' A' ' 249' ' ' ILE . . . -146.51 124.58 12.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.091 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . 0.496 ' SD ' HD21 ' A' ' 296' ' ' LEU . 25.9 mtt -86.68 118.62 26.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.776 HG23 HD13 ' A' ' 220' ' ' LEU . 57.8 t -102.97 138.06 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -111.26 143.05 42.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -119.07 174.47 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.856 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.42 ' OE1' ' NE2' ' A' ' 245' ' ' GLN . 3.9 mm-40 -56.71 -66.82 0.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.425 ' C ' ' HG2' ' A' ' 216' ' ' LYS . 93.0 p -139.02 165.64 26.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.83 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.494 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 90.7 t -43.15 -54.38 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.116 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 34.7 tp -45.11 -60.8 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 81.7 m -47.91 -39.27 18.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -59.6 -39.29 83.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -57.43 -59.82 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -56.79 -58.75 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.43 ' O ' HD13 ' A' ' 274' ' ' LEU . . . -49.06 -57.45 6.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.692 ' HG3' HG21 ' A' ' 288' ' ' ILE . 55.6 tttm -42.94 -50.26 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -47.5 -71.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.133 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.644 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -47.76 -48.61 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.886 ' HB3' HD11 ' A' ' 288' ' ' ILE . 6.5 mp -64.58 -24.75 67.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 271' ' ' LYS . 50.4 t30 -62.16 102.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 76.27 20.77 76.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.505 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -86.36 94.8 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.0 111.12 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.03 162.99 6.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 53.5 mt -121.5 -42.95 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . 0.543 ' CD2' ' CD2' ' A' ' 227' ' ' TYR . 52.4 m-85 -112.74 173.43 6.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -50.77 104.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.101 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.63 58.53 0.71 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.495 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 26.1 p -175.1 160.48 2.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 110.872 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.6 m 63.47 46.67 4.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 286' ' ' LEU . 18.0 m -67.9 155.93 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.404 ' N ' HG22 ' A' ' 285' ' ' THR . 80.3 mt -98.82 125.84 44.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -115.23 98.22 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.886 HD11 ' HB3' ' A' ' 274' ' ' LEU . 74.5 mt -84.05 146.77 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.15 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -159.67 113.32 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -40.83 102.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -54.95 145.77 19.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.569 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 8.9 ttm180 -61.97 -47.26 91.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.601 0.715 . . . . 0.0 110.826 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 61.3 Cg_endo -78.9 148.89 22.53 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.682 2.255 . . . . 0.0 112.276 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.9 p -90.55 -26.36 19.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -123.81 149.85 45.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.496 HD21 ' SD ' ' A' ' 258' ' ' MET . 78.9 mt -105.37 178.85 4.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.924 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -138.39 110.37 7.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 85.5 t -120.99 110.7 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.8 mp -73.23 -54.03 16.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.18 151.62 51.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.36 97.15 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 303' ' ' ASN . 7.7 p-10 -130.9 166.11 21.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.627 ' OD1' HG22 ' A' ' 230' ' ' THR . 1.1 t30 -36.5 -45.54 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -60.66 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . 0.544 ' HB2' HG22 ' A' ' 248' ' ' VAL . 55.7 p -134.31 128.42 33.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . 0.505 ' HB2' HG11 ' A' ' 231' ' ' VAL . 17.0 t-105 -114.14 149.48 35.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -129.29 106.24 8.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -82.62 -43.37 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 -179.975 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.774 ' OD1' HG22 ' A' ' 294' ' ' THR . 23.5 t30 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.922 0.391 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -52.54 -46.06 66.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 90.1 t -81.59 131.11 34.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.128 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.463 HD22 ' HZ2' ' A' ' 271' ' ' LYS . 14.9 mt -123.09 128.17 49.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.658 HD11 ' OE1' ' A' ' 256' ' ' GLN . 29.4 tp -81.97 102.73 11.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.491 HD13 HG23 ' A' ' 259' ' ' VAL . 8.4 mp -89.54 132.78 34.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m -123.64 118.12 26.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.2 mp -81.2 138.76 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.12 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.438 ' C ' ' HD3' ' A' ' 225' ' ' PRO . 2.1 tp-100 -96.68 141.45 29.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.542 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 48.7 t30 35.5 53.76 1.97 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.62 0.724 . . . . 0.0 110.843 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 77.6 Cg_exo -45.98 106.69 0.1 OUTLIER 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.367 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 66.7 mt -101.97 -48.4 4.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -112.49 126.1 28.92 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.675 0.75 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.55 112.25 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.63 HG21 HD21 ' A' ' 234' ' ' LEU . 29.5 mm -88.09 92.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.133 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.684 HG23 ' HB3' ' A' ' 303' ' ' ASN . 2.3 m -70.85 170.3 12.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.577 ' H ' HG22 ' A' ' 230' ' ' THR . 24.5 m -55.63 -41.31 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.408 ' N ' HG23 ' A' ' 231' ' ' VAL . 67.9 m-20 -58.05 -53.33 59.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.9 t -44.72 -37.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.63 HD21 HG21 ' A' ' 229' ' ' ILE . 52.6 mt -85.07 -35.65 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 81.8 t80 -82.55 19.95 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.412 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 93.0 m -122.78 -36.92 2.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.118 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.426 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 90.0 t -99.75 -18.84 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.441 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 58.5 m -89.07 -46.06 9.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.588 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.7 OUTLIER -50.58 -45.59 85.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.583 0.706 . . . . 0.0 110.896 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.4 Cg_exo -47.97 -28.19 9.93 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.681 2.254 . . . . 0.0 112.337 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 29.8 t -86.56 -49.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.097 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.92 -132.55 3.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -133.31 107.53 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.63 HG11 HD11 ' A' ' 247' ' ' ILE . 96.4 t -88.92 119.84 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.457 ' NE2' ' CD ' ' A' ' 262' ' ' GLU . 1.4 mm100 -81.13 -68.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.454 ' NH1' ' O ' ' A' ' 296' ' ' LEU . 7.5 ptp180 -132.97 154.9 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.63 HD11 HG11 ' A' ' 244' ' ' VAL . 70.4 mt -133.43 135.28 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.478 HG13 ' OG ' ' A' ' 305' ' ' SER . 58.7 t -126.98 132.05 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.16 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 23.4 mt -120.61 118.68 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.501 ' CE2' ' HB3' ' A' ' 256' ' ' GLN . 20.2 p90 -126.75 155.18 43.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -110.22 45.22 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -90.05 109.91 20.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 61.51 41.41 12.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 109.04 149.82 13.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.457 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.9 mm -51.37 123.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 111.113 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.658 ' OE1' HD11 ' A' ' 219' ' ' LEU . 17.2 tt0 -153.15 163.79 39.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.24 146.18 16.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 35.3 mtt -111.38 124.92 53.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.491 HG23 HD13 ' A' ' 220' ' ' LEU . 65.7 t -111.89 121.64 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.667 ' HB2' HD12 ' A' ' 296' ' ' LEU . 3.9 tp10 -98.36 140.81 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.527 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 42.0 m-85 -116.35 158.21 23.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.457 ' CD ' ' NE2' ' A' ' 245' ' ' GLN . 3.9 mm-40 -41.48 -67.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 10.0 m -130.52 173.84 10.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.856 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 92.1 t -57.02 -56.72 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 264' ' ' VAL . 17.4 tp -38.27 -64.06 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 61.6 m -45.59 -42.15 10.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -55.91 -40.35 72.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -52.04 -62.95 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -59.77 -59.99 4.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.527 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -42.78 -48.8 5.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.706 ' HG3' HG21 ' A' ' 288' ' ' ILE . 27.2 tttp -56.15 -44.29 79.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.04 -60.39 3.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.078 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -49.72 -40.45 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.732 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.7 mp -83.99 -22.61 31.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 271' ' ' LYS . 2.7 t30 -62.17 100.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.56 18.0 61.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.451 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.786 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -80.56 154.3 27.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.331 . . . . 0.0 111.135 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -118.24 134.85 54.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.576 HD11 HD21 ' A' ' 286' ' ' LEU . 65.7 mt -101.53 -40.33 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.148 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.2 172.73 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -54.2 105.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.063 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.84 56.89 0.8 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.1 m -167.54 161.1 13.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.8 m 62.3 39.27 12.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.9 m -55.48 143.47 29.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.186 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.786 HD12 ' HB3' ' A' ' 277' ' ' ALA . 67.8 mt -93.41 126.74 38.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.883 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -124.92 84.92 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.732 HD11 ' CB ' ' A' ' 274' ' ' LEU . 27.0 mt -71.27 144.95 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -147.68 120.07 8.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.549 ' CE2' ' HE2' ' A' ' 271' ' ' LYS . 59.0 m-85 -45.84 96.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.8 147.07 15.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.052 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.474 ' HB2' ' HD3' ' A' ' 293' ' ' PRO . 56.8 mtt-85 -65.41 -61.07 6.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.584 0.707 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 292' ' ' ARG . 58.9 Cg_endo -71.37 154.55 60.95 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.654 2.236 . . . . 0.0 112.34 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.774 HG22 ' OD1' ' A' ' 215' ' ' ASN . 37.0 p -116.14 38.54 3.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.475 ' HG2' ' N ' ' A' ' 296' ' ' LEU . 37.4 ttt180 -149.88 151.21 33.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.667 HD12 ' HB2' ' A' ' 260' ' ' GLU . 85.9 mt -141.58 120.91 13.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -106.96 135.05 49.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 92.0 t -120.25 98.34 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.163 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.8 mp -55.49 -62.55 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -119.88 169.65 9.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.424 ' ND2' ' OD1' ' A' ' 307' ' ' ASP . 3.2 m120 -107.49 114.83 29.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.414 ' CG ' ' C ' ' A' ' 301' ' ' ASN . 0.9 OUTLIER -162.56 172.15 15.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.684 ' HB3' HG23 ' A' ' 230' ' ' THR . 20.8 m120 -42.34 -40.28 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.62 -46.31 70.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . 0.478 ' OG ' HG13 ' A' ' 248' ' ' VAL . 8.6 m -158.03 143.89 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -134.88 145.19 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.424 ' OD1' ' ND2' ' A' ' 301' ' ' ASN . 2.2 p-10 -119.34 106.65 12.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.836 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.44 -39.67 24.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 37.9 p . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.16 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.0 t30 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.89 0.376 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -51.24 -41.26 60.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.418 HG11 HD21 ' A' ' 296' ' ' LEU . 50.4 t -78.64 147.38 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 10.1 mt -138.52 139.59 38.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.66 109.54 21.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.859 HD23 HD22 ' A' ' 286' ' ' LEU . 7.6 mp -97.87 129.33 44.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -119.77 115.72 24.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.85 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -82.46 134.98 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.161 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.426 ' C ' ' HD3' ' A' ' 225' ' ' PRO . 2.2 tp-100 -100.4 139.06 36.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.552 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 55.8 t30 35.61 54.0 2.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.5 Cg_exo -47.18 113.9 0.84 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.358 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 224' ' ' ASN . 3.3 mm? -89.25 -58.82 2.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.24 143.63 26.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.74 0.781 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.16 112.68 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.714 2.276 . . . . 0.0 112.354 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.7 mm -89.32 116.54 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 18.6 p -126.73 169.29 13.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 303' ' ' ASN . 33.0 m -48.81 -20.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.97 -40.96 68.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.7 t -70.29 -31.8 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.17 10.48 35.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -121.94 -5.87 9.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.475 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 40.0 m -108.5 -32.51 7.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.134 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 237' ' ' VAL . 59.7 t -97.2 -7.56 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 61.2 m -100.73 -45.36 5.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.588 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.6 t-20 -52.04 -45.39 93.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.644 0.735 . . . . 0.0 110.878 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.6 Cg_exo -48.04 -23.78 4.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 34.1 t -92.18 -53.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.45 -134.89 3.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.525 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.492 ' HE2' ' N ' ' A' ' 244' ' ' VAL . 0.0 OUTLIER -128.49 94.93 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.87 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.634 HG11 HD11 ' A' ' 247' ' ' ILE . 72.9 t -53.11 132.94 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -110.53 -66.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.491 ' NE ' ' OD2' ' A' ' 307' ' ' ASP . 16.3 ttm105 -128.76 143.15 50.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.634 HD11 HG11 ' A' ' 244' ' ' VAL . 43.3 mt -128.63 132.51 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.093 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.49 HG22 HG22 ' A' ' 298' ' ' VAL . 46.8 t -136.55 132.45 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.2 mt -124.06 113.71 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.142 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -120.29 143.6 48.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -113.35 43.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -60.18 -70.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -107.15 48.16 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.58 -120.89 4.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.7 mm -133.81 93.92 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 111.172 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -125.99 167.9 14.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -161.89 124.98 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . 0.596 ' HB3' HD11 ' A' ' 296' ' ' LEU . 10.7 mtt -93.59 119.23 32.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.78 130.42 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.092 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -104.65 153.92 20.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -125.27 169.43 12.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -37.91 -73.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.9 m -137.57 -175.27 4.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 60.1 t -55.15 -50.9 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.085 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 15.9 tp -46.28 -59.41 2.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 3.5 t -55.29 -30.84 60.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -70.26 -36.13 74.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -58.14 -54.4 47.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -68.52 -44.02 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.14 -49.57 71.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.677 ' HG3' HG21 ' A' ' 288' ' ' ILE . 27.0 tttm -50.97 -56.55 11.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.23 -59.45 5.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.13 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.61 -30.69 3.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.035 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.801 ' CB ' HD11 ' A' ' 288' ' ' ILE . 3.4 mp -98.07 -14.84 20.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 271' ' ' LYS . 8.9 t-20 -58.43 108.18 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 68.74 18.93 72.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.488 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -72.48 99.33 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.28 113.24 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.824 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 87.0 mt -72.36 -32.76 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . 0.424 ' O ' ' C ' ' A' ' 281' ' ' ALA . 63.2 m-85 -136.53 150.76 48.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 280' ' ' TYR . . . -35.85 105.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.1 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 39.86 70.87 0.31 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -174.84 150.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 0.0 110.919 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 3.3 m 57.36 51.56 9.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 28.1 m -60.59 109.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.859 HD22 HD23 ' A' ' 220' ' ' LEU . 35.5 mt -68.48 107.29 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -102.23 91.71 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.801 HD11 ' CB ' ' A' ' 274' ' ' LEU . 97.6 mt -79.59 139.58 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.1 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -149.1 125.97 11.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.537 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 32.4 m-85 -48.69 100.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.987 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -53.93 142.05 25.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.597 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.6 OUTLIER -64.55 -44.79 75.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.9 Cg_endo -80.46 147.53 17.92 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.709 2.272 . . . . 0.0 112.339 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 36.8 p -88.57 -14.32 37.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -127.59 164.95 20.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 258' ' ' MET . 42.9 mt -122.0 171.61 8.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.94 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -129.26 98.66 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 307' ' ' ASP . 85.9 t -81.09 101.76 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.123 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.484 HG22 ' HE ' ' A' ' 300' ' ' ARG . 3.2 mm -38.03 -63.24 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . 0.484 ' HE ' HG22 ' A' ' 299' ' ' ILE . 16.1 ptp180 -170.17 142.29 2.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -39.49 100.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -167.63 172.52 9.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.712 ' O ' HG13 ' A' ' 231' ' ' VAL . 12.6 m-80 -47.68 -57.0 6.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.7 -41.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . 0.43 ' OG ' HG13 ' A' ' 248' ' ' VAL . 8.5 m -162.39 136.94 6.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -126.77 129.06 47.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.587 ' HB2' HG21 ' A' ' 298' ' ' VAL . 19.8 t0 -121.8 81.02 1.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.859 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . 0.518 ' CZ ' HG22 ' A' ' 309' ' ' THR . 1.6 p90 -70.72 -37.66 73.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.518 HG22 ' CZ ' ' A' ' 308' ' ' TYR . 30.5 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 55.1 t30 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.905 0.384 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -43.72 79.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 296' ' ' LEU . 92.8 t -88.13 146.78 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.101 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.3 mt -135.43 124.99 25.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 36.0 tp -81.62 109.03 15.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.3 mp -95.84 129.47 43.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 63.1 m -112.73 127.07 56.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.575 HD13 HG22 ' A' ' 255' ' ' ILE . 4.8 mp -89.61 121.74 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.74 138.77 39.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.517 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 1.8 m-20 43.43 53.92 10.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.73 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.5 Cg_exo -45.87 90.24 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.337 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.7 mt -97.04 -42.45 7.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -111.45 153.54 44.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.732 0.777 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.75 115.81 4.28 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.537 HG21 HD21 ' A' ' 234' ' ' LEU . 30.3 mm -99.23 92.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 231' ' ' VAL . 1.6 m -71.81 167.22 20.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.093 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 230' ' ' THR . 21.2 m -54.44 -39.53 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.34 -52.05 67.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 96.0 t -46.05 -40.14 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.537 HD21 HG21 ' A' ' 229' ' ' ILE . 33.7 mt -76.05 -60.5 2.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.964 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -47.31 -34.06 6.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.481 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 87.2 m -63.35 -47.8 80.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.149 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 237' ' ' VAL . 59.6 t -86.94 -10.77 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.128 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.435 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 72.9 m -87.39 -49.2 7.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.571 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 14.3 t30 -48.53 -46.48 70.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.649 0.738 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.3 Cg_exo -47.96 -18.63 1.2 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.667 2.245 . . . . 0.0 112.399 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 37.0 t -104.4 -41.62 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.79 -144.71 4.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -123.16 126.4 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.914 HG11 HD11 ' A' ' 247' ' ' ILE . 85.4 t -96.19 147.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -108.22 -61.89 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 247' ' ' ILE . 21.3 ttm180 -134.6 147.82 50.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.914 HD11 HG11 ' A' ' 244' ' ' VAL . 61.3 mt -140.54 131.0 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.466 HG22 HG22 ' A' ' 298' ' ' VAL . 89.7 t -125.67 135.87 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 304' ' ' ASP . 58.5 mt -120.94 120.82 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -136.1 155.13 50.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -131.76 40.59 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -68.78 -57.26 5.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -119.77 45.77 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 116.69 128.49 4.17 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.443 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.575 HG22 HD13 ' A' ' 222' ' ' ILE . 42.9 mm -43.92 104.41 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -146.3 170.76 16.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.54 130.22 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . 0.467 ' SD ' ' CD2' ' A' ' 296' ' ' LEU . 22.4 mtt -87.89 118.0 27.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 87.7 t -107.87 123.43 63.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -103.08 150.3 23.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 262' ' ' GLU . 56.4 m-85 -126.0 161.12 28.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 261' ' ' PHE . 23.4 mt-10 -34.15 -70.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 t -140.39 167.71 21.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 94.8 t -41.04 -57.14 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 264' ' ' VAL . 19.6 tp -37.22 -63.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 30.7 m -47.36 -42.2 21.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -56.33 -38.31 71.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -56.14 -59.44 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -66.32 -50.9 62.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.954 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -49.42 -49.92 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.68 ' HA ' HD13 ' A' ' 288' ' ' ILE . 58.9 tttm -52.57 -46.96 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -60.05 -70.52 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -42.29 -36.8 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.713 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.7 mp -85.94 -23.97 26.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 271' ' ' LYS . 14.3 t-20 -58.75 102.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.9 23.07 60.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -93.24 93.71 8.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.1 148.63 50.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 41.0 mt -104.5 -40.34 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.89 172.93 6.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -57.16 107.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.4 55.68 0.75 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.514 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 6.5 m -164.47 153.67 13.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 4.9 m 62.82 44.53 6.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 39.2 m -59.92 129.22 40.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.439 ' O ' ' NZ ' ' A' ' 287' ' ' LYS . 35.5 mt -78.28 123.31 26.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 286' ' ' LEU . 0.9 OUTLIER -121.83 84.96 2.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.713 HD11 ' CB ' ' A' ' 274' ' ' LEU . 28.6 mt -65.26 144.02 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.174 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -153.98 111.09 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -38.07 106.26 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.62 160.76 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.097 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 14.8 mtt-85 -73.04 -59.37 2.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 59.7 Cg_endo -73.23 159.09 47.89 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.711 2.274 . . . . 0.0 112.342 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 34.4 p -88.22 -25.1 23.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -173.88 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.606 HD21 HG11 ' A' ' 217' ' ' VAL . 17.8 mt -142.24 168.34 19.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -125.56 114.97 19.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.466 HG22 HG22 ' A' ' 248' ' ' VAL . 84.5 t -106.02 102.86 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.7 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.4 mp -57.25 -51.31 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.03 155.42 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -90.09 85.38 6.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.4 173.16 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -39.39 -51.12 2.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.402 ' O ' HD12 ' A' ' 249' ' ' ILE . 2.1 m-20 -45.46 -59.87 2.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 63.8 p -135.13 138.46 43.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -139.56 127.44 22.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -104.02 98.22 8.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -83.72 40.21 0.73 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.138 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.6 t30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.859 0.362 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -58.1 -42.95 86.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.438 ' O ' HD23 ' A' ' 218' ' ' LEU . 59.6 t -73.84 139.27 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.123 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 217' ' ' VAL . 29.5 mt -138.6 126.82 22.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.46 113.48 21.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.489 HD23 HD22 ' A' ' 286' ' ' LEU . 6.9 mp -100.53 132.68 45.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -119.33 137.92 53.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.599 HD13 HG22 ' A' ' 255' ' ' ILE . 5.2 mp -105.28 125.31 60.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -82.57 142.43 31.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.517 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 42.0 t30 40.12 53.49 5.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.3 Cg_exo -44.7 103.61 0.05 OUTLIER 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.697 2.265 . . . . 0.0 112.343 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 55.2 mt -105.08 -46.93 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -100.5 153.61 37.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.709 0.766 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.75 116.34 4.64 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.711 2.274 . . . . 0.0 112.35 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.534 HG21 HD21 ' A' ' 234' ' ' LEU . 43.7 mm -100.22 119.98 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 232' ' ' ASP . 18.2 p -122.57 156.16 34.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 303' ' ' ASN . 34.4 m -33.62 -35.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.2 m-20 -60.96 -65.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 87.3 t -43.62 -51.02 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.16 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.534 HD21 HG21 ' A' ' 229' ' ' ILE . 46.1 mt -60.93 -58.33 8.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.549 ' CE2' ' HB ' ' A' ' 244' ' ' VAL . 3.2 t80 -54.68 -25.86 29.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.422 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 66.6 m -70.19 -45.86 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.171 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.439 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 39.4 t -87.2 -15.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 71.0 m -86.27 -46.12 10.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.556 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -47.11 -47.76 54.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.866 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.0 Cg_exo -47.96 -21.07 2.41 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.723 2.282 . . . . 0.0 112.366 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.874 HG11 ' HA ' ' A' ' 270' ' ' ALA . 69.7 t -98.73 -39.09 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.13 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.53 -154.11 7.94 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.457 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.408 ' HB3' ' CD ' ' A' ' 262' ' ' GLU . 2.5 tmtm? -104.23 144.39 31.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.944 HG11 HD11 ' A' ' 247' ' ' ILE . 63.0 t -108.69 141.3 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.42 ' NE2' ' HG3' ' A' ' 262' ' ' GLU . 20.2 mt-30 -110.66 -65.11 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.446 ' HG2' ' N ' ' A' ' 247' ' ' ILE . 17.4 ttm180 -130.9 145.08 51.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.944 HD11 HG11 ' A' ' 244' ' ' VAL . 71.3 mt -138.34 140.17 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 305' ' ' SER . 17.1 t -131.37 139.98 49.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.418 HG12 ' CB ' ' A' ' 257' ' ' ALA . 77.2 mt -129.02 109.45 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -118.96 151.29 38.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 40.88 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -58.48 -63.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -109.19 43.6 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.31 -121.96 4.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.495 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.599 HG22 HD13 ' A' ' 222' ' ' ILE . 28.7 mm -129.61 91.21 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 111.102 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -124.83 159.68 30.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.418 ' CB ' HG12 ' A' ' 249' ' ' ILE . . . -155.91 122.93 5.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . 0.464 ' SD ' HD21 ' A' ' 296' ' ' LEU . 19.3 mtt -86.07 125.07 33.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.447 HG23 HD13 ' A' ' 220' ' ' LEU . 95.6 t -111.85 118.86 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -94.31 156.44 16.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -130.67 169.04 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.892 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 262' ' ' GLU . 10.9 mp0 -54.26 -64.2 0.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 73.7 m -128.49 172.53 11.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 91.2 t -61.12 -51.43 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 24.9 tp -40.74 -63.49 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 33.5 m -46.03 -40.59 10.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -58.06 -39.21 77.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -56.75 -57.09 13.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -63.51 -60.35 3.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.874 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.62 -50.01 25.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.113 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.555 ' HG3' HG21 ' A' ' 288' ' ' ILE . 49.2 tttm -48.55 -51.67 26.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -59.36 -66.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.67 -37.75 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.473 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.4 mp -87.8 -22.1 24.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 272' ' ' ALA . 7.3 t30 -57.86 104.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.03 23.01 70.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.49 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -79.59 118.37 21.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.25 125.29 28.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 286' ' ' LEU . 78.4 mt -97.8 -41.04 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.146 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -117.77 172.58 7.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -54.38 105.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.12 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 35.63 54.26 1.07 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.497 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 4.3 m -165.45 163.77 19.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.01 41.89 7.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 54.0 m -55.8 118.49 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 279' ' ' ILE . 36.3 mt -71.39 127.08 31.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -127.02 95.03 4.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.555 HG21 ' HG3' ' A' ' 271' ' ' LYS . 38.7 mt -77.23 147.36 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -150.38 124.05 9.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -49.64 97.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -47.5 134.75 11.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.116 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.575 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 9.2 ttp180 -60.21 -46.61 97.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 0.0 110.817 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.2 Cg_endo -79.45 149.26 21.38 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.712 2.275 . . . . 0.0 112.349 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 60.6 p -92.66 -25.25 18.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -123.9 139.59 53.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.464 HD21 ' SD ' ' A' ' 258' ' ' MET . 40.0 mt -100.43 176.57 5.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -131.46 115.42 16.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.56 105.66 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.135 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.671 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -65.92 -59.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.136 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -132.9 175.58 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -104.16 105.69 15.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 303' ' ' ASN . 0.9 OUTLIER -149.7 166.74 28.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 231' ' ' VAL . 5.0 p30 -33.71 -39.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.58 -58.24 9.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . 0.416 ' HB2' ' HA ' ' A' ' 248' ' ' VAL . 9.8 t -134.35 153.62 51.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -144.13 134.24 24.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -112.91 108.74 17.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.811 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -79.51 -50.58 10.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.902 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 68.6 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 -179.937 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.408 ' ND2' ' HB ' ' A' ' 217' ' ' VAL . 51.5 t30 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.921 0.391 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 264' ' ' VAL . 40.2 mtmt -57.61 -41.91 82.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.674 HG11 HD21 ' A' ' 296' ' ' LEU . 55.8 t -77.59 138.58 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 220' ' ' LEU . 14.0 mt -133.79 119.2 18.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.9 tp -76.25 106.58 7.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.695 HD13 ' CG2' ' A' ' 259' ' ' VAL . 6.9 mp -92.98 123.76 36.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.0 m -114.27 118.96 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.0 mp -79.55 133.9 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.09 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.43 ' C ' ' HD3' ' A' ' 225' ' ' PRO . 43.8 mt-30 -91.15 141.91 28.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.547 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 62.7 t30 35.11 54.42 1.91 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.632 0.73 . . . . 0.0 110.874 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.8 Cg_exo -47.33 115.91 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.326 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 62.6 mt -108.17 -54.86 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -101.08 137.82 19.82 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.67 0.748 . . . . 0.0 110.867 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.77 125.94 13.76 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.673 2.248 . . . . 0.0 112.365 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.442 HD12 HG11 ' A' ' 233' ' ' VAL . 49.9 mm -104.55 126.4 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.107 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.0 p -125.77 163.84 21.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.131 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 235' ' ' TYR . 35.8 m -40.22 -35.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.166 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -55.99 -45.54 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 229' ' ' ILE . 94.7 t -61.9 -52.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 31.4 mt -84.11 24.38 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.455 ' CB ' ' O ' ' A' ' 231' ' ' VAL . 85.2 t80 -130.58 -37.25 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.971 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.499 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 85.2 m -80.58 -34.27 35.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.447 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 11.6 t -87.88 -19.4 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.462 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 73.0 m -84.63 -50.64 7.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.545 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 1.5 t-20 -45.31 -47.39 34.3 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.631 0.729 . . . . 0.0 110.904 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.6 Cg_exo -47.98 -30.93 14.76 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.259 . . . . 0.0 112.336 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.01 -39.86 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.168 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.47 -133.24 1.46 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.52 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -121.34 143.7 49.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.896 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.66 128.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.708 ' O ' HG23 ' A' ' 309' ' ' THR . 30.6 mm-40 -92.46 -59.44 2.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -147.27 154.3 40.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 79.5 mt -133.4 134.54 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 298' ' ' VAL . 58.1 t -133.47 116.06 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.5 mt -108.08 106.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -118.93 149.19 42.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.512 ' HG3' HD13 ' A' ' 255' ' ' ILE . 2.6 mppt? -118.16 41.45 2.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -54.25 -63.86 1.02 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -109.52 43.26 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.3 -118.82 3.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.512 HD13 ' HG3' ' A' ' 251' ' ' LYS . 41.8 mm -127.05 95.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 111.132 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -128.83 157.52 41.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -156.32 118.52 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 24.7 mtt -87.53 125.74 34.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.695 ' CG2' HD13 ' A' ' 220' ' ' LEU . 91.7 t -111.58 131.59 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.103 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 261' ' ' PHE . 5.0 tp10 -104.77 152.0 23.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.583 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 55.1 m-85 -130.08 157.6 41.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 261' ' ' PHE . 67.3 mt-10 -34.99 -66.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.2 p -143.68 174.54 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.432 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 74.5 t -47.82 -59.87 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 264' ' ' VAL . 18.1 tp -35.98 -60.12 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 85.9 m -53.22 -40.97 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -57.27 -36.88 71.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -58.76 -58.27 9.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -66.13 -53.03 42.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.583 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -49.38 -47.83 47.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.804 ' HG3' HG21 ' A' ' 288' ' ' ILE . 24.6 tttt -53.38 -55.57 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.847 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -53.64 -67.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.109 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -41.96 -42.29 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.602 ' CB ' HD11 ' A' ' 288' ' ' ILE . 3.6 mp -81.82 -22.0 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 271' ' ' LYS . 65.4 t30 -61.61 101.76 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.89 21.46 71.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.629 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -82.1 93.79 7.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.118 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.36 117.08 2.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.587 HD11 HD21 ' A' ' 286' ' ' LEU . 80.3 mt -91.14 -37.43 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.134 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -120.35 173.86 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -56.87 104.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.128 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.49 59.12 0.67 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.423 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 31.2 p -175.12 162.45 3.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.908 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 77.2 m 62.48 43.08 8.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 5.9 m -57.24 146.78 27.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.629 HD12 ' HB3' ' A' ' 277' ' ' ALA . 73.6 mt -91.81 119.33 31.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -116.71 79.53 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.804 HG21 ' HG3' ' A' ' 271' ' ' LYS . 47.6 mt -65.41 147.73 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -151.85 113.63 4.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.435 ' HE2' ' HZ1' ' A' ' 271' ' ' LYS . 39.1 m-85 -41.12 101.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -50.67 138.9 17.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 6.2 ttt180 -66.08 -45.7 62.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.62 0.724 . . . . 0.0 110.889 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.3 Cg_endo -80.21 148.37 18.98 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.315 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.8 p -82.11 -25.75 34.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.438 ' HD3' ' N ' ' A' ' 296' ' ' LEU . 0.4 OUTLIER -119.21 -174.66 2.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.674 HD21 HG11 ' A' ' 217' ' ' VAL . 52.0 mt -139.17 173.35 11.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.928 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -124.83 117.9 25.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 248' ' ' VAL . 77.9 t -122.35 91.73 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.057 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.714 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -50.43 -56.55 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.44 177.23 8.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -99.19 96.47 7.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -136.16 171.55 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -42.11 -45.28 3.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -55.67 -62.3 1.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 97.4 p -129.05 137.15 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -140.98 132.16 26.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -116.21 92.47 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 309' ' ' THR . 53.3 m-85 -69.02 -43.58 74.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 245' ' ' GLN . 47.5 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.136 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 49.7 t30 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.862 0.363 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -46.2 -40.22 10.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 49.0 t -77.81 137.23 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.095 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 24.1 mt -136.93 129.98 30.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.03 118.88 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.52 134.7 50.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.8 t -119.63 137.6 53.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.76 HD13 HG22 ' A' ' 255' ' ' ILE . 5.2 mp -99.21 128.83 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -89.75 138.96 31.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.508 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 49.7 t30 39.52 52.7 4.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.624 0.726 . . . . 0.0 110.935 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.5 Cg_exo -43.7 94.33 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.641 2.228 . . . . 0.0 112.334 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 20.2 mt -95.86 -43.78 7.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -102.71 153.48 38.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.715 0.769 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.29 115.77 4.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.696 2.264 . . . . 0.0 112.274 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.8 mm -98.41 110.48 26.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 232' ' ' ASP . 49.6 p -105.99 158.46 16.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.13 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 303' ' ' ASN . 18.3 m -41.49 -26.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.123 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.5 m-20 -68.22 -61.98 1.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . 0.477 ' CG1' HD13 ' A' ' 279' ' ' ILE . 78.5 t -39.45 -45.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 31.5 mt -77.74 -37.92 48.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.595 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 76.9 t80 -83.42 20.14 1.4 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 99.2 m -124.43 -37.19 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.142 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.413 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 89.1 t -98.21 -19.26 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 65.3 m -89.75 -45.55 9.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.589 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 4.8 t-20 -51.37 -45.35 89.96 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.728 . . . . 0.0 110.944 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.1 Cg_exo -47.97 -56.87 2.71 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.711 2.274 . . . . 0.0 112.318 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.3 -47.04 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -142.74 -108.08 0.65 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.507 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.535 ' O ' ' CD2' ' A' ' 261' ' ' PHE . 13.7 tptp -152.33 151.34 30.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.74 HG11 HD11 ' A' ' 247' ' ' ILE . 95.1 t -127.94 122.36 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -82.64 -69.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -137.24 156.91 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.74 HD11 HG11 ' A' ' 244' ' ' VAL . 55.5 mt -137.06 133.47 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.721 HG22 HG22 ' A' ' 298' ' ' VAL . 94.9 t -126.54 110.18 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 257' ' ' ALA . 60.4 mt -94.09 126.14 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.159 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -141.35 135.16 30.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -84.5 41.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -89.59 119.19 29.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.8 m120 51.49 40.95 28.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 109.56 135.71 7.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.463 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.76 HG22 HD13 ' A' ' 222' ' ' ILE . 38.0 mm -46.56 104.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.321 . . . . 0.0 111.152 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -134.1 164.42 27.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.468 ' HB2' HG12 ' A' ' 249' ' ' ILE . . . -152.51 122.03 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . 0.431 ' SD ' HD21 ' A' ' 296' ' ' LEU . 26.4 mtt -83.42 114.68 21.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.517 HG22 HG12 ' A' ' 247' ' ' ILE . 88.7 t -106.8 119.44 56.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 11.0 tt0 -91.54 151.01 20.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 243' ' ' LYS . 30.3 m-85 -123.5 163.74 20.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -52.97 -72.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 66.8 m -114.8 -174.95 2.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 58.6 t -77.66 -44.54 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 36.6 tp -51.61 -65.8 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 24.3 p -42.44 -38.22 1.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -60.04 -38.66 83.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -58.68 -59.39 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -56.56 -53.7 54.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.448 ' O ' HD13 ' A' ' 274' ' ' LEU . . . -52.57 -55.04 25.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.074 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.416 ' HA ' HD13 ' A' ' 288' ' ' ILE . 41.5 tttm -43.09 -51.34 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -46.86 -73.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -45.49 -50.18 12.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.071 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.919 ' HB3' HD11 ' A' ' 288' ' ' ILE . 5.1 mp -61.47 -26.79 68.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 271' ' ' LYS . 33.6 t30 -60.62 105.05 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.15 25.66 70.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.459 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -86.02 93.36 8.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 0.0 111.131 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.69 131.92 45.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.477 HD13 ' CG1' ' A' ' 233' ' ' VAL . 72.6 mt -88.56 -34.34 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -121.61 173.13 7.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -55.32 112.55 1.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.17 73.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.536 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.6 t -175.31 177.78 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.313 . . . . 0.0 110.911 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 27.8 p 39.44 46.61 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 55.8 m -57.86 90.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -45.72 131.13 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -127.8 96.85 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' ILE . . . . . 0.919 HD11 ' HB3' ' A' ' 274' ' ' LEU . 66.3 mt -80.2 145.94 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -153.01 114.91 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -43.08 98.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -48.15 141.73 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.602 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 0.0 OUTLIER -69.86 -47.43 23.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.56 0.695 . . . . 0.0 110.859 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 62.5 Cg_endo -77.57 144.28 22.33 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.676 2.251 . . . . 0.0 112.34 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 81.1 p -83.7 -31.31 26.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -112.8 161.11 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.431 HD21 ' SD ' ' A' ' 258' ' ' MET . 74.6 mt -119.36 -178.28 3.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -143.02 113.53 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.721 HG22 HG22 ' A' ' 248' ' ' VAL . 87.9 t -116.16 106.07 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.515 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.2 mp -66.87 -55.88 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . 0.42 ' CG ' ' OD2' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -133.83 153.13 51.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -90.09 87.19 6.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.42 ' OD2' ' CG ' ' A' ' 300' ' ' ARG . 5.0 p30 -123.18 171.78 9.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.683 ' O ' HG13 ' A' ' 231' ' ' VAL . 6.5 m120 -39.89 -45.9 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.468 ' O ' ' CG1' ' A' ' 249' ' ' ILE . 25.7 m-20 -57.42 -61.52 2.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . 0.444 ' CB ' ' HA ' ' A' ' 248' ' ' VAL . 97.0 p -123.33 131.79 53.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -144.16 119.11 9.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -97.69 117.65 32.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.88 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -98.61 44.18 1.04 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 76.7 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.139 -179.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 48.3 t -171.44 157.22 4.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.899 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.2 m -162.92 143.89 9.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.854 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -167.93 147.6 11.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 54.3 m -107.96 142.59 37.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.796 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 95.9 p -126.85 118.39 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.866 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -134.77 156.09 22.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.513 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -156.05 162.64 40.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -126.47 135.24 51.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.2 mt -41.28 137.59 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.0 m -154.95 124.24 6.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.51 145.85 54.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.564 0.697 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.3 -25.61 6.89 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.699 2.266 . . . . 0.0 112.315 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -62.11 145.78 49.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.434 ' O ' ' C ' ' A' ' 208' ' ' THR . 47.2 t30 -120.06 151.17 39.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.901 0.381 . . . . 0.0 110.899 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 207' ' ' ASN . 97.0 m -34.35 125.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -93.52 164.36 13.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.839 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.43 ' CG ' ' HD2' ' A' ' 211' ' ' PRO . 11.5 t70 -151.09 140.94 14.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.608 0.718 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 210' ' ' ASP . 62.6 Cg_endo -77.66 14.2 1.5 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.714 2.276 . . . . 0.0 112.373 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 211' ' ' PRO . 2.0 m -37.25 115.28 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.821 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.26 147.83 16.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.509 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 120.53 110.86 2.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.537 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 217' ' ' VAL . 4.1 p-10 -151.33 153.01 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 110.9 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -30.99 69.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.499 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 95.7 t -86.86 140.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 14.0 mt -134.38 132.34 39.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 49.1 tp -81.89 103.82 11.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.9 mp -90.96 128.61 36.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.17 112.49 17.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.772 ' H ' HD12 ' A' ' 222' ' ' ILE . 3.5 mp -75.42 130.62 36.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.139 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -99.47 120.52 39.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 19.0 m-20 63.61 52.28 1.41 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 0.0 110.91 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 60.2 Cg_endo -74.41 47.09 1.53 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.654 2.236 . . . . 0.0 112.352 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.3 mt -39.86 -41.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -97.78 141.49 23.08 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.68 0.752 . . . . 0.0 110.919 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.31 124.38 9.11 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.734 2.289 . . . . 0.0 112.282 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.6 mm -107.11 109.04 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.12 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.1 p -102.98 159.05 15.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.461 ' N ' HD11 ' A' ' 249' ' ' ILE . 21.8 m -44.37 -39.88 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -54.19 -55.84 24.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.1 t -45.12 -39.11 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 25.7 mt -78.49 -64.06 1.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.959 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.414 ' CZ ' ' ND2' ' A' ' 239' ' ' ASN . 55.6 t80 -46.9 -27.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.477 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 63.6 m -64.34 -47.69 78.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 237' ' ' VAL . 65.1 t -87.37 -11.2 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.115 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 64.4 m -87.39 -49.06 7.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.579 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.0 t-20 -48.65 -46.36 71.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.657 0.741 . . . . 0.0 110.896 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.2 Cg_exo -47.97 -17.4 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.8 HG11 ' HA ' ' A' ' 270' ' ' ALA . 96.2 t -102.59 -41.34 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -174.2 177.26 46.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 142.87 56.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.1 t -110.57 134.64 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -80.77 -60.84 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -161.74 155.07 21.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.791 HG12 HG22 ' A' ' 259' ' ' VAL . 74.9 mt -134.93 119.13 26.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.146 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 298' ' ' VAL . 49.1 t -110.76 115.03 48.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 231' ' ' VAL . 64.5 mt -97.35 114.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.173 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 7.5 p90 -116.3 162.38 17.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -117.87 90.92 3.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -133.04 94.45 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 59.51 38.95 22.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 131.06 131.17 3.25 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.47 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.569 HG22 HD13 ' A' ' 222' ' ' ILE . 33.1 mm -48.1 102.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 111.156 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.539 ' HB3' ' CE1' ' A' ' 250' ' ' PHE . 27.7 mt-30 -118.15 166.14 12.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -168.17 130.28 1.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.065 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 33.8 mtt -97.1 132.82 42.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.791 HG22 HG12 ' A' ' 247' ' ' ILE . 97.7 t -122.73 125.31 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.154 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -101.85 150.52 23.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -122.36 159.36 27.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -41.19 -65.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.7 t -130.71 176.23 8.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 85.7 t -60.24 -51.43 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.111 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 20.9 tp -39.07 -62.93 0.58 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 65.7 m -47.44 -41.82 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -55.87 -42.75 76.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -54.88 -58.56 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -62.25 -56.67 16.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.866 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.8 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.18 -47.96 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.122 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.484 ' HA ' HD13 ' A' ' 288' ' ' ILE . 22.7 tttt -50.27 -48.8 54.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -64.48 -67.71 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -39.78 -33.76 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.776 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.5 mp -92.39 -28.13 17.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 272' ' ' ALA . 6.0 t30 -55.27 100.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.3 21.95 61.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -84.35 92.41 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 111.074 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.33 129.21 39.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.566 HG22 ' CD1' ' A' ' 280' ' ' TYR . 74.4 mt -100.36 -41.64 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.177 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . 0.566 ' CD1' HG22 ' A' ' 279' ' ' ILE . 8.1 m-85 -117.38 171.56 7.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -55.11 108.62 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.115 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.7 53.75 0.82 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 25.5 p -174.51 172.01 3.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 69.5 m 56.08 41.12 29.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 54.4 m -68.98 143.94 54.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.171 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.466 HD11 HD11 ' A' ' 279' ' ' ILE . 88.5 mt -89.14 127.33 35.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -118.89 80.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.776 HD11 ' CB ' ' A' ' 274' ' ' LEU . 17.0 mt -71.28 144.32 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 290' ' ' TYR . 19.7 mt-10 -157.31 107.79 2.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 289' ' ' GLU . 41.9 m-85 -34.4 101.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -56.19 165.24 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 0.4 OUTLIER -71.82 -57.8 3.86 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.647 0.736 . . . . 0.0 110.856 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 59.5 Cg_endo -73.14 160.47 45.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.67 2.247 . . . . 0.0 112.345 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 217' ' ' VAL . 33.2 p -102.95 -27.58 12.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.7 ttt85 -111.81 144.9 40.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 80.5 mt -109.45 175.9 5.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -135.87 139.05 43.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 248' ' ' VAL . 95.2 t -134.97 97.29 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.141 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.733 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -51.5 -57.3 3.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -139.69 175.95 9.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.76 116.67 33.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -159.29 171.32 20.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -44.47 -39.93 5.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.16 -61.11 2.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 53.4 p -131.05 133.46 45.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -124.18 141.17 52.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -115.04 100.88 8.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.36 -47.95 38.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 25.6 p -37.88 -43.55 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.123 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.526 ' HG3' ' CE1' ' A' ' 312' ' ' TYR . 28.0 ttpt -126.84 89.12 52.87 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.568 0.699 . . . . 0.0 110.93 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.31 -4.91 14.04 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.679 2.253 . . . . 0.0 112.36 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.594 ' C ' HD22 ' A' ' 313' ' ' LEU . 15.9 p90 -101.8 103.76 14.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.594 HD22 ' C ' ' A' ' 312' ' ' TYR . 3.9 mm? -130.4 -61.21 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -103.15 101.64 2.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.509 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -84.32 41.84 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.897 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.409 ' C ' ' HD2' ' A' ' 316' ' ' ARG . 1.9 ppt_? . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.9 m -162.85 147.09 11.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 110.891 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.8 m -167.94 164.69 13.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -152.58 161.57 29.55 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.527 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 47.5 t -173.19 132.54 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 0.0 110.831 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.2 t -174.21 127.84 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -174.36 136.4 3.52 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.49 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -170.7 150.92 3.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.722 0.296 . . . . 0.0 110.916 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 45.4 mtt85 -151.12 125.01 9.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 43.1 mt -120.01 108.79 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.137 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.5 p -147.63 130.5 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -148.94 131.63 7.94 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.732 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.82 157.85 31.36 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.692 2.261 . . . . 0.0 112.348 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 176.68 110.79 0.27 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -155.23 142.22 19.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.3 p -150.66 136.41 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -93.91 172.44 8.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.826 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.52 135.66 20.0 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.64 0.733 . . . . 0.0 110.879 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.79 134.07 13.17 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.655 2.237 . . . . 0.0 112.378 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 58.3 m -130.84 118.54 20.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 143.78 -168.51 26.38 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.461 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 161.95 -150.12 19.2 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.531 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -159.59 127.24 4.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.866 0.365 . . . . 0.0 110.884 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 217' ' ' VAL . 0.0 OUTLIER -50.47 -35.21 27.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.408 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 95.0 t -89.59 141.85 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.548 ' HB3' HG23 ' A' ' 288' ' ' ILE . 52.6 mt -142.19 128.35 19.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.2 tp -87.0 105.24 17.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.468 HD13 ' CG2' ' A' ' 259' ' ' VAL . 7.1 mp -88.82 140.43 29.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -134.8 115.71 13.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -81.49 130.31 36.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -98.46 130.93 45.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.527 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 59.8 t30 48.34 52.74 13.16 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.848 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.6 Cg_exo -44.84 123.59 5.02 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.663 2.242 . . . . 0.0 112.381 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.442 ' CD2' ' HB2' ' A' ' 283' ' ' CYS . 4.0 mm? -91.81 -63.04 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -107.52 153.97 41.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.663 0.744 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.37 112.37 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.7 mm -90.83 116.59 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 29.8 p -127.11 159.84 32.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.163 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.9 m -37.7 -33.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -65.41 -60.45 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 90.4 t -45.63 -44.71 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.174 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 36.7 mt -70.45 -61.4 1.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -49.93 -27.35 5.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.483 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 98.3 m -65.62 -47.28 76.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.115 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.444 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 80.1 t -86.73 -16.98 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 85.1 m -83.87 -47.78 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.538 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -47.36 -48.78 55.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.594 0.711 . . . . 0.0 110.846 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.6 Cg_exo -48.0 -17.57 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 0.0 112.356 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.933 HG11 ' HA ' ' A' ' 270' ' ' ALA . 87.7 t -97.59 -43.93 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.56 -155.61 9.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.42 ' HD3' ' N ' ' A' ' 244' ' ' VAL . 0.6 OUTLIER -101.28 130.22 47.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.42 ' N ' ' HD3' ' A' ' 243' ' ' LYS . 66.2 t -100.35 143.67 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -94.62 -58.75 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.415 ' CB ' ' HA ' ' A' ' 307' ' ' ASP . 14.8 ptt-85 -155.23 163.93 39.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.405 HG13 ' C ' ' A' ' 246' ' ' ARG . 63.8 mt -145.3 140.79 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.66 121.28 58.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 304' ' ' ASP . 46.1 mt -102.52 118.2 49.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -130.88 154.69 47.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -111.48 93.22 4.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 14.9 mmt85 -129.55 102.83 6.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 47.7 39.35 10.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 133.54 121.45 2.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.5 mm -41.12 106.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -126.48 151.03 48.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -152.31 117.82 5.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.427 ' SD ' HD21 ' A' ' 296' ' ' LEU . 10.5 mtt -77.8 146.47 35.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.468 ' CG2' HD13 ' A' ' 220' ' ' LEU . 95.3 t -137.81 118.77 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.443 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 23.3 tt0 -97.83 152.24 19.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.443 ' N ' ' HG2' ' A' ' 260' ' ' GLU . 55.6 m-85 -126.5 154.91 43.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -41.13 -63.25 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.8 m -131.19 172.33 12.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 94.8 t -59.27 -51.96 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.112 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 264' ' ' VAL . 23.4 tp -37.43 -65.59 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 54.6 m -45.72 -42.77 12.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -57.76 -41.47 82.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -52.92 -61.6 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -62.36 -53.37 55.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.933 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -46.76 -49.22 20.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.553 ' HA ' HD13 ' A' ' 288' ' ' ILE . 61.5 tttm -52.19 -47.34 65.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.83 -62.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.101 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -46.17 -36.4 5.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.639 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.9 mp -89.54 -24.22 21.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 271' ' ' LYS . 5.3 t30 -57.43 99.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.83 19.97 69.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -91.99 94.41 9.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.102 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.36 171.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 286' ' ' LEU . 44.5 mt -119.74 -35.23 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . 0.408 ' HB2' ' SG ' ' A' ' 283' ' ' CYS . 60.2 m-85 -131.72 174.02 10.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -37.64 102.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.094 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.525 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 26.29 76.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.473 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . 0.442 ' HB2' ' CD2' ' A' ' 226' ' ' LEU . 20.2 p -176.13 -175.13 0.68 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.769 0.319 . . . . 0.0 110.897 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 283' ' ' CYS . 3.0 p 36.36 41.42 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 15.5 m -57.32 145.9 30.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 279' ' ' ILE . 69.0 mt -97.44 139.24 33.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -130.11 105.66 8.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.879 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.639 HD11 ' CB ' ' A' ' 274' ' ' LEU . 23.5 mt -91.96 139.21 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 290' ' ' TYR . 16.5 mm-40 -146.17 110.24 4.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.873 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 289' ' ' GLU . 28.5 m-85 -35.99 100.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.949 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.1 159.13 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.105 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.485 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 4.4 mtp-105 -73.16 -58.02 2.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.596 0.712 . . . . 0.0 110.891 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 60.3 Cg_endo -74.24 156.96 46.36 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.227 . . . . 0.0 112.337 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 28.9 p -96.55 -32.45 12.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.162 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.19 143.8 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.427 HD21 ' SD ' ' A' ' 258' ' ' MET . 35.7 mt -118.46 143.59 46.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -120.41 114.56 21.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 71.9 t -85.01 114.45 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.2 mp -67.13 -55.0 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -130.73 150.58 51.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -97.98 97.06 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 303' ' ' ASN . 2.7 p-10 -148.99 172.14 15.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 302' ' ' ASP . 4.7 m-20 -34.52 -44.67 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.415 ' O ' ' CG1' ' A' ' 249' ' ' ILE . 73.2 m-20 -55.5 -55.71 28.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 88.8 p -130.45 135.69 48.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -140.1 116.81 10.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.415 ' HA ' ' CB ' ' A' ' 246' ' ' ARG . 0.8 OUTLIER -105.48 91.93 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -53.98 -44.97 71.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 65.4 p -40.55 -48.6 2.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -117.66 92.12 40.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.594 0.711 . . . . 0.0 110.928 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.24 -6.17 16.28 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.26 . . . . 0.0 112.327 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -96.95 -48.79 5.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.933 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 10.4 tp -42.83 146.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 157.55 -142.6 8.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.514 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -106.25 -50.25 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.772 0.32 . . . . 0.0 110.902 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.905 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.6 m -102.02 -44.94 5.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.873 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.7 m 56.38 42.34 27.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -125.07 119.42 3.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 67.0 m -130.04 160.64 33.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.876 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 82.6 p -164.63 160.76 20.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 42.48 46.51 5.66 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -46.03 -49.1 16.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 110.948 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.567 ' HD3' HG22 ' A' ' 203' ' ' THR . 8.0 tmm_? -123.74 111.48 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.4 mm -123.14 95.58 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.199 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.567 HG22 ' HD3' ' A' ' 201' ' ' ARG . 12.6 t -169.44 147.78 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -174.63 143.6 0.84 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.68 175.25 11.22 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.665 2.244 . . . . 0.0 112.343 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -166.27 57.07 0.24 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -146.08 159.42 43.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.871 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 37.0 p -138.95 107.53 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.65 158.22 43.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 24.2 p30 -154.35 145.25 16.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.84 -21.81 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 0.0 112.378 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 3.4 m -164.74 129.24 2.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 173.21 61.15 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.527 ' HA2' ' CE1' ' A' ' 290' ' ' TYR . . . -117.67 163.22 12.79 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.447 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 217' ' ' VAL . 22.2 p-10 -149.61 157.66 43.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -64.67 -50.15 68.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.503 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 89.3 t -77.55 150.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.154 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 220' ' ' LEU . 14.1 mt -139.65 125.66 19.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 23.0 tp -84.12 103.34 13.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.503 HD13 HG23 ' A' ' 259' ' ' VAL . 6.9 mp -87.4 129.66 34.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.6 m -122.83 114.8 20.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.499 ' H ' HD12 ' A' ' 222' ' ' ILE . 4.9 mp -81.17 150.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.105 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -115.82 120.16 38.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.508 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 52.3 t30 59.37 50.49 2.96 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.619 0.723 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 57.7 Cg_endo -71.12 106.53 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.252 . . . . 0.0 112.371 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.1 mt -87.77 -47.65 8.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -91.65 133.55 30.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.662 0.744 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.08 117.4 2.49 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.699 2.266 . . . . 0.0 112.314 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.423 HG21 HD21 ' A' ' 234' ' ' LEU . 49.1 mm -85.18 109.23 17.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.166 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 82.8 p -105.24 151.78 23.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 303' ' ' ASN . 33.7 m -38.55 -38.56 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -60.64 -59.61 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.5 t -41.52 -48.28 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.423 HD21 HG21 ' A' ' 229' ' ' ILE . 49.5 mt -69.29 -62.7 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.455 ' CE1' ' HB ' ' A' ' 244' ' ' VAL . 43.9 t80 -48.06 -25.92 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.503 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 94.0 m -65.08 -48.29 74.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.431 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 89.0 t -84.43 -18.65 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.453 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 85.1 m -81.75 -53.52 6.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -41.69 -49.6 10.04 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 0.0 110.898 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.1 Cg_exo -47.94 -39.05 32.15 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.934 HG11 ' HA ' ' A' ' 270' ' ' ALA . 76.0 t -72.86 -42.46 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.124 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.95 -126.09 0.81 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 10.7 mmtm -116.47 165.97 12.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.677 HG11 HD11 ' A' ' 247' ' ' ILE . 99.2 t -143.02 114.44 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -73.08 -64.31 1.0 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.403 ' HE ' HG21 ' A' ' 298' ' ' VAL . 6.9 ptm180 -143.92 164.33 30.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.677 HD11 HG11 ' A' ' 244' ' ' VAL . 62.5 mt -142.14 141.54 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.55 134.46 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.449 HD11 ' N ' ' A' ' 231' ' ' VAL . 67.1 mt -119.29 131.59 71.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.539 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 6.4 p90 -142.41 173.31 11.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -129.64 42.62 3.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -80.8 97.68 7.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 62.51 42.8 8.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 121.52 142.98 6.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.458 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 27.6 mm -56.43 116.16 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 0.0 111.096 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.539 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 47.4 mt-30 -142.19 168.75 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -162.43 126.05 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.481 ' SD ' HD21 ' A' ' 296' ' ' LEU . 15.4 mtt -91.06 120.61 32.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.53 HG22 HG23 ' A' ' 247' ' ' ILE . 86.2 t -110.29 133.16 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -108.22 137.96 45.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -109.57 160.27 16.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -47.28 -62.66 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.7 m -127.74 170.37 12.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 99.4 t -58.33 -52.36 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 14.6 tp -38.59 -62.2 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.941 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 60.8 m -43.39 -40.05 3.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -57.91 -40.65 80.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -54.62 -60.4 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -63.97 -53.92 42.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.934 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.07 -48.8 22.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.544 ' HA ' HD13 ' A' ' 288' ' ' ILE . 19.2 tttt -56.3 -45.29 80.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -65.35 -59.33 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.87 -37.35 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.79 ' CB ' HD11 ' A' ' 288' ' ' ILE . 6.0 mp -91.62 -22.25 20.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 271' ' ' LYS . 4.8 t30 -55.36 101.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.75 22.59 61.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.468 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.627 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -78.49 178.53 7.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.762 0.315 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -145.6 126.53 14.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 33.9 mt -91.83 -31.77 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -126.69 172.68 10.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.3 107.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.25 75.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 1.7 t -174.98 -177.57 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 286' ' ' LEU . 27.3 p 39.36 38.58 0.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 14.1 m -47.57 93.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.627 HD12 ' HB3' ' A' ' 277' ' ' ALA . 32.7 mt -45.97 127.25 8.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -127.12 83.74 2.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.79 HD11 ' CB ' ' A' ' 274' ' ' LEU . 29.2 mt -72.99 145.95 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -151.08 115.53 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.527 ' CE1' ' HA2' ' A' ' 214' ' ' GLY . 38.6 m-85 -38.55 105.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -56.55 139.99 47.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.157 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 4.9 ttp180 -62.61 -44.9 88.18 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.893 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.7 Cg_endo -80.36 150.87 19.94 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.698 2.266 . . . . 0.0 112.354 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 41.2 p -92.28 -24.45 18.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -125.59 158.89 33.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.481 HD21 ' SD ' ' A' ' 258' ' ' MET . 48.7 mt -115.78 178.25 4.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.18 116.7 14.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.403 HG21 ' HE ' ' A' ' 246' ' ' ARG . 61.3 t -114.95 102.89 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.77 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.2 mp -66.17 -57.46 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -130.31 176.81 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -107.5 100.83 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -144.63 171.26 14.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.539 ' O ' HG13 ' A' ' 231' ' ' VAL . 2.7 m120 -39.6 -44.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.945 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.88 -57.24 10.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.841 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 26.0 p -133.94 138.66 45.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.847 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -135.68 122.62 21.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -106.74 133.26 51.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -99.81 -47.1 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 73.3 p -44.34 -46.21 9.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.168 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.591 ' CD ' HD13 ' A' ' 313' ' ' LEU . 37.9 mttp -110.07 94.26 17.42 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 0.0 110.901 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.16 -50.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.701 2.267 . . . . 0.0 112.352 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 312' ' ' TYR . 0.2 OUTLIER -81.37 39.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.591 HD13 ' CD ' ' A' ' 310' ' ' LYS . 12.3 tp -89.99 84.6 6.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.949 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 102.78 138.72 10.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -57.62 4.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.813 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.882 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.516 -0.233 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 63.1 p -38.41 -35.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.853 0.358 . . . . 0.0 110.869 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.5 p -132.94 167.27 20.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.847 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -140.69 160.76 26.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.5 m -141.27 165.13 28.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.872 0.368 . . . . 0.0 110.87 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 77.1 p -169.46 155.0 5.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -169.08 174.17 43.57 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.514 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.03 138.52 30.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -107.91 123.09 48.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 34.4 mt -96.94 84.28 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 66.6 p -53.18 110.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -53.07 130.67 50.07 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.664 0.745 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.51 140.61 19.24 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.255 . . . . 0.0 112.354 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -63.96 167.93 25.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.509 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -86.04 99.58 11.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 110.899 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.0 p -113.92 98.03 6.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -166.91 115.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -134.95 143.69 47.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.567 0.698 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -46.11 152.1 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.709 2.273 . . . . 0.0 112.35 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 91.0 p -102.5 40.9 1.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 49.08 -104.16 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.463 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 177.08 168.24 36.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -156.6 124.41 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.892 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -47.06 -47.2 22.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.405 HG12 ' CB ' ' A' ' 291' ' ' ALA . 92.2 t -74.45 123.73 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.076 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' A' ' 288' ' ' ILE . 26.2 mt -116.69 130.91 57.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.572 HD13 ' HE2' ' A' ' 258' ' ' MET . 33.5 tp -84.88 112.22 20.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.33 141.95 30.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.6 t -130.66 137.76 49.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.63 117.48 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.132 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -79.34 140.53 37.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.511 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 35.8 t30 38.33 54.0 4.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.607 0.718 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.2 Cg_exo -44.67 100.37 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.674 2.249 . . . . 0.0 112.386 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 46.0 mt -91.75 -51.06 5.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -109.52 132.57 21.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.663 0.744 . . . . 0.0 110.892 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.23 111.86 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.268 . . . . 0.0 112.31 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.598 HD12 HG11 ' A' ' 233' ' ' VAL . 48.7 mm -90.65 112.46 25.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.125 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 20.7 p -105.98 160.93 14.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 19.3 m -38.41 -37.56 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 235' ' ' TYR . 7.8 m-20 -58.12 -65.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.598 HG11 HD12 ' A' ' 229' ' ' ILE . 73.9 t -37.63 -43.66 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 50.2 mt -76.64 -37.1 56.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 65.8 t80 -81.72 16.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 92.2 m -120.46 -37.11 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.156 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.428 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 86.6 t -98.66 -19.74 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.413 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 59.2 m -89.12 -44.4 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.2 t-20 -51.97 -45.73 92.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 110.861 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.3 Cg_exo -47.94 -22.81 3.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.335 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.4 t -96.64 -45.26 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -155.21 152.57 24.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.525 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -57.89 131.84 51.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.848 0.356 . . . . 0.0 110.888 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.0 t -100.62 136.93 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.152 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -93.62 -65.35 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.545 HH11 HG23 ' A' ' 298' ' ' VAL . 4.0 tmm_? -143.69 152.36 41.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.597 HG23 HG22 ' A' ' 259' ' ' VAL . 74.0 mt -129.35 147.79 33.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.426 HG23 ' CD ' ' A' ' 246' ' ' ARG . 54.4 t -139.85 133.84 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 304' ' ' ASP . 43.7 mt -120.84 129.99 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -144.21 138.02 27.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -99.67 40.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -78.14 101.05 6.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 60.96 42.74 12.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.5 137.82 5.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.2 mm -56.14 112.66 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.128 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -141.89 173.42 11.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -164.63 126.36 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.572 ' HE2' HD13 ' A' ' 219' ' ' LEU . 36.2 mtt -94.66 120.32 34.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.597 HG22 HG23 ' A' ' 247' ' ' ILE . 94.2 t -110.54 135.38 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.083 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -105.67 153.46 21.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -126.85 163.61 23.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.895 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -47.48 -65.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 t -135.88 174.93 10.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 82.0 t -56.37 -55.3 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.1 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 18.5 tp -40.3 -50.27 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 61.4 m -55.94 -46.12 78.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 271' ' ' LYS . . . -53.84 -35.63 61.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -57.56 -65.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.914 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -59.49 -55.82 29.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.433 ' O ' HD13 ' A' ' 274' ' ' LEU . . . -49.22 -53.2 22.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.07 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.461 ' HA ' HD13 ' A' ' 288' ' ' ILE . 38.6 tttm -53.13 -43.96 67.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 275' ' ' ASN . . . -54.74 -63.45 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.085 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.672 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -53.8 -46.98 71.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.751 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.6 mp -67.0 -28.98 68.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 271' ' ' LYS . 8.9 t30 -65.33 102.87 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 81.61 19.72 65.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -83.33 92.26 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.32 135.19 57.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.494 HD11 HD11 ' A' ' 286' ' ' LEU . 60.9 mt -104.65 -42.7 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -117.85 172.84 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -51.97 103.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 35.46 51.52 1.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.447 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.5 m -162.55 164.88 26.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.884 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.7 m 62.5 41.31 9.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 23.6 m -58.21 134.29 56.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.494 HD11 HD11 ' A' ' 279' ' ' ILE . 83.6 mt -88.13 124.92 34.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -119.54 106.79 12.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.751 HD11 ' CB ' ' A' ' 274' ' ' LEU . 18.9 mt -92.54 144.13 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.193 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -155.17 117.44 4.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -41.53 105.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.405 ' CB ' HG12 ' A' ' 217' ' ' VAL . . . -53.07 161.89 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.129 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 30.1 mtt180 -73.86 -56.69 2.72 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.67 0.748 . . . . 0.0 110.89 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 61.1 Cg_endo -74.67 150.42 39.87 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.631 2.221 . . . . 0.0 112.346 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 39.9 p -78.85 -30.14 45.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.456 ' HG2' ' N ' ' A' ' 296' ' ' LEU . 8.7 ttm180 -134.03 148.32 51.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.516 HD21 ' SD ' ' A' ' 258' ' ' MET . 23.6 mt -100.08 -178.14 3.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . 0.497 HD21 HD11 ' A' ' 299' ' ' ILE . 2.4 p-10 -137.42 117.86 13.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.545 HG23 HH11 ' A' ' 246' ' ' ARG . 73.8 t -104.37 112.96 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.123 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.527 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.8 mp -78.0 -51.73 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -127.26 151.96 48.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -92.34 46.94 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.3 172.52 8.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -41.55 -47.16 3.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.467 ' O ' HD12 ' A' ' 249' ' ' ILE . 0.1 OUTLIER -43.13 -62.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.9 p -133.45 147.17 51.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -139.72 140.87 36.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -119.88 115.34 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 309' ' ' THR . 52.9 m-85 -88.62 -48.27 7.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' TYR . 32.4 p -35.88 -40.9 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.193 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.428 ' HB2' HD21 ' A' ' 313' ' ' LEU . 43.3 mtmt -139.59 106.3 7.04 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.573 0.701 . . . . 0.0 110.902 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.86 -13.94 17.45 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.636 2.224 . . . . 0.0 112.387 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.692 ' O ' HD22 ' A' ' 313' ' ' LEU . 32.4 p90 -113.61 106.27 14.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.692 HD22 ' O ' ' A' ' 312' ' ' TYR . 4.4 mm? -132.32 99.76 4.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -129.34 -139.67 4.7 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.467 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -40.38 -59.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 -179.863 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 195' ' ' SER . 12.6 m 49.45 42.36 22.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.368 . . . . 0.0 110.856 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 194' ' ' SER . 33.5 p -37.91 -58.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 159.69 -179.22 35.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 61.9 m -158.97 171.23 20.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.836 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.4 t -117.71 149.28 41.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.81 94.27 1.64 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.507 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -129.36 88.84 2.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.725 0.298 . . . . 0.0 110.859 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -117.72 158.88 23.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.604 ' O ' HD12 ' A' ' 202' ' ' ILE . 2.7 pp -64.33 136.17 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 96.7 m -147.56 108.31 4.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -127.96 94.11 37.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.596 0.713 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.49 10.56 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.66 2.24 . . . . 0.0 112.35 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -127.79 130.7 6.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.485 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -109.22 124.32 50.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 0.0 110.916 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 209' ' ' ASP . 28.6 m -49.52 134.25 19.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 208' ' ' THR . 1.1 p30 -36.54 149.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -86.86 112.61 48.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.4 115.08 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.72 2.28 . . . . 0.0 112.33 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 62.8 m -42.28 157.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.98 -149.46 50.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.452 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.45 -126.84 2.45 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.47 158.73 39.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.391 . . . . 0.0 110.867 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 267' ' ' ALA . 6.2 pttt -76.19 -45.85 31.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.512 ' O ' HD23 ' A' ' 218' ' ' LEU . 51.1 t -67.83 146.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.116 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 220' ' ' LEU . 6.8 mt -147.72 123.51 10.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 50.8 tp -71.67 112.98 8.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 218' ' ' LEU . 7.4 mp -99.97 129.03 45.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -120.56 117.28 27.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.825 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.587 HD13 HG22 ' A' ' 255' ' ' ILE . 4.9 mp -81.84 123.32 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -89.3 138.77 31.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.706 ' O ' HD23 ' A' ' 226' ' ' LEU . 74.5 m-20 44.87 53.8 12.05 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.683 0.754 . . . . 0.0 110.927 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 77.0 Cg_exo -47.64 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.723 2.282 . . . . 0.0 112.329 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 224' ' ' ASN . 3.6 mm? -85.45 -56.96 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.447 ' CD2' ' CE2' ' A' ' 280' ' ' TYR . 2.2 m-85 -93.76 143.16 26.09 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.707 0.765 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.24 127.3 12.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 0.0 112.317 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.401 HG13 HG21 ' A' ' 222' ' ' ILE . 49.9 mm -114.75 102.11 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 232' ' ' ASP . 19.9 p -117.43 159.06 23.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.192 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.2 m -38.96 -26.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.4 m-20 -67.28 -61.01 2.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.8 t -47.39 -56.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 34.4 mt -56.72 -61.95 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.559 ' CD1' ' HB ' ' A' ' 244' ' ' VAL . 63.4 t80 -49.76 -33.41 16.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.486 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 98.7 m -64.14 -45.93 86.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.1 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 237' ' ' VAL . 62.0 t -87.88 -5.89 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.473 ' HB3' ' CG2' ' A' ' 244' ' ' VAL . 90.8 m -93.29 -47.23 7.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 8.2 t-20 -51.06 -45.61 88.41 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.712 . . . . 0.0 110.886 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -47.97 -41.2 33.13 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.708 2.272 . . . . 0.0 112.318 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 270' ' ' ALA . 40.4 t -70.62 -44.32 76.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.27 -105.48 0.21 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.502 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.8 115.84 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.865 0.364 . . . . 0.0 110.916 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 247' ' ' ILE . 96.3 t -84.04 143.71 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.468 ' HB3' ' CG2' ' A' ' 309' ' ' THR . 21.5 mm-40 -104.2 -68.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -125.03 152.36 44.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.829 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 244' ' ' VAL . 48.6 mt -140.75 128.35 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.63 121.47 56.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.487 HG12 ' CB ' ' A' ' 257' ' ' ALA . 67.9 mt -110.86 119.06 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -126.32 146.11 50.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -102.42 44.71 1.0 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -70.29 86.16 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 55.2 49.22 17.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 135.33 129.67 2.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.504 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.587 HG22 HD13 ' A' ' 222' ' ' ILE . 21.3 mm -50.59 103.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.744 0.307 . . . . 0.0 111.158 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -135.47 164.37 27.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.487 ' CB ' HG12 ' A' ' 249' ' ' ILE . . . -166.49 130.75 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 32.8 mtt -94.76 123.31 38.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 247' ' ' ILE . 88.4 t -114.92 130.19 69.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.132 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -109.1 160.36 16.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -130.26 167.85 17.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -40.64 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.5 t -126.1 -176.01 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 267' ' ' ALA . 63.3 t -63.62 -56.96 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 264' ' ' VAL . 25.1 tp -35.47 -59.73 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 68.1 m -52.4 -37.98 57.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 264' ' ' VAL . . . -61.42 -36.86 81.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.117 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -58.7 -57.85 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -66.72 -47.98 70.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.819 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -51.87 -52.47 49.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.656 ' HG3' HG21 ' A' ' 288' ' ' ILE . 25.8 tttp -48.81 -48.46 41.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -61.41 -69.08 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.088 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -40.96 -36.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.846 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.1 mp -88.65 -25.31 22.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 272' ' ' ALA . 19.5 t30 -60.08 104.22 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 75.1 24.25 72.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -85.87 93.64 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 0.0 111.084 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.73 137.5 57.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.42 HG22 ' CD1' ' A' ' 280' ' ' TYR . 46.9 mt -106.45 -34.42 2.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . 0.447 ' CE2' ' CD2' ' A' ' 227' ' ' TYR . 50.7 m-85 -129.54 172.37 11.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -45.11 102.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.08 61.34 0.52 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.537 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . 0.435 ' C ' ' SG ' ' A' ' 284' ' ' CYS . 92.6 m -156.81 179.01 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 110.91 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 283' ' ' CYS . 0.8 OUTLIER 40.15 43.98 1.45 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 40.5 m -59.21 85.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 277' ' ' ALA . 47.6 mt -38.59 120.01 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -120.1 85.44 2.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.846 HD11 ' CB ' ' A' ' 274' ' ' LEU . 50.5 mt -75.19 148.68 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.116 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -159.82 121.85 3.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -45.37 103.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -57.3 153.66 11.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.105 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.604 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 5.6 ttt180 -65.94 -44.87 63.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 291' ' ' ALA . 60.9 Cg_endo -80.5 153.02 20.52 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.328 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 37.9 p -96.91 -22.29 16.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -126.24 151.35 47.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.93 179.11 4.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -146.85 133.41 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 93.4 t -122.45 133.35 68.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.064 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.35 -51.2 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.141 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.97 166.35 16.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -114.53 109.97 19.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 303' ' ' ASN . 7.5 t70 -164.19 173.09 12.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 302' ' ' ASP . 39.4 m-20 -33.95 -50.49 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.55 -63.43 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 24.8 m -142.45 147.99 37.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -142.08 137.35 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -122.02 91.11 3.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . 0.451 ' O ' ' C ' ' A' ' 309' ' ' THR . 86.9 m-85 -62.99 -49.17 75.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 245' ' ' GLN . 29.0 p -33.95 -43.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.679 ' HG2' HD13 ' A' ' 313' ' ' LEU . 0.0 OUTLIER -114.92 83.99 10.09 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 0.0 110.897 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.14 -11.33 16.3 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.712 2.274 . . . . 0.0 112.301 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.514 ' CE1' ' HD3' ' A' ' 310' ' ' LYS . 43.5 p90 -105.21 50.02 0.79 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.983 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.679 HD13 ' HG2' ' A' ' 310' ' ' LYS . 9.4 tp -117.46 42.92 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 315' ' ' ARG . . . -112.01 162.48 12.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.431 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.495 ' O ' ' CD ' ' A' ' 315' ' ' ARG . 0.0 OUTLIER 33.63 50.96 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.843 0.354 . . . . 0.0 110.907 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.7 t -75.7 -44.24 43.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.881 0.372 . . . . 0.0 110.843 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 35.2 p 39.63 42.34 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.861 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -111.11 128.8 8.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.459 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.7 t -160.44 146.82 15.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.348 . . . . 0.0 110.833 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.1 t -142.1 163.41 32.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 141.94 67.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.67 170.84 15.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -134.4 126.53 29.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 26.3 pt -83.89 128.69 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 40.1 p -148.01 142.45 26.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -98.66 127.44 35.69 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.626 0.727 . . . . 0.0 110.828 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.36 89.89 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.692 2.261 . . . . 0.0 112.361 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 137.55 60.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -129.37 111.7 13.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.904 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 30.9 m -143.8 133.7 23.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.406 ' O ' ' HD3' ' A' ' 211' ' ' PRO . 6.1 t0 -108.35 111.68 23.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.03 94.47 10.87 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.626 0.726 . . . . 0.0 110.871 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 209' ' ' ASP . 61.4 Cg_endo -75.94 89.56 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.276 . . . . 0.0 112.323 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 3.8 m -128.43 159.76 34.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.66 148.38 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.476 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.15 -100.19 0.14 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.468 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -169.16 123.87 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 267' ' ' ALA . 3.8 pttm -52.55 -43.31 65.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.6 134.51 29.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.2 mt -134.96 125.07 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.2 tp -82.46 112.8 19.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.411 HD23 HD22 ' A' ' 286' ' ' LEU . 6.9 mp -94.25 124.2 38.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.4 m -118.89 104.13 10.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.683 ' H ' HD12 ' A' ' 222' ' ' ILE . 4.4 mp -69.29 144.72 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.476 ' C ' ' CG ' ' A' ' 224' ' ' ASN . 8.9 mm100 -109.85 126.31 53.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.948 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 283' ' ' CYS . 0.5 OUTLIER 49.88 54.75 16.27 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.668 0.747 . . . . 0.0 110.894 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 59.2 Cg_endo -72.62 101.6 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.341 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 224' ' ' ASN . 10.1 mp -73.55 -62.55 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -83.79 137.66 40.95 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.662 0.744 . . . . 0.0 110.919 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.49 115.0 1.38 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.741 2.294 . . . . 0.0 112.324 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 29.7 mm -83.72 127.14 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.143 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 24.3 p -121.33 152.04 39.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.484 ' N ' HD11 ' A' ' 249' ' ' ILE . 32.0 m -37.65 -37.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.92 -61.67 2.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.918 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 96.6 t -42.46 -52.42 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 26.2 mt -62.04 -59.24 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.569 ' CD2' ' HB ' ' A' ' 244' ' ' VAL . 3.6 t80 -54.28 -24.11 17.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 92.9 m -69.87 -46.07 66.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.117 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.422 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 99.0 t -85.79 -17.38 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.448 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 81.9 m -84.23 -51.3 7.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.543 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -44.0 -48.61 22.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.688 0.756 . . . . 0.0 110.911 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.4 Cg_exo -47.9 -32.77 18.36 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.734 HG11 ' HA ' ' A' ' 270' ' ' ALA . 87.1 t -80.59 -42.91 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.94 -106.85 0.22 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.466 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 26.4 tttt -145.94 163.64 34.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.631 HG11 HD11 ' A' ' 247' ' ' ILE . 86.9 t -133.71 133.88 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.45 ' OE1' ' CG2' ' A' ' 309' ' ' THR . 32.0 mm-40 -92.83 -62.69 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 4.2 ptt-85 -143.36 155.11 44.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.631 HD11 HG11 ' A' ' 244' ' ' VAL . 57.7 mt -137.67 139.09 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.184 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 82.7 t -127.51 124.82 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.484 HD11 ' N ' ' A' ' 231' ' ' VAL . 53.8 mt -110.24 128.81 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.528 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 18.9 p90 -136.61 148.92 47.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -100.12 40.05 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -78.05 109.4 12.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 53.3 t30 55.25 43.45 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.08 -150.07 16.97 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.504 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 11.8 mm -114.4 106.46 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 111.101 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.528 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 21.3 mp0 -132.21 168.01 18.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -168.25 120.47 0.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.092 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 14.1 mtt -87.78 130.87 34.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 247' ' ' ILE . 58.7 t -120.63 137.88 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -101.28 162.77 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.914 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -135.48 158.31 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -46.67 -69.85 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.947 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 16.4 m -121.43 169.59 10.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 86.4 t -54.93 -52.35 44.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 15.8 tp -42.58 -64.26 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.84 -41.92 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -56.82 -45.67 82.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -63.52 -57.65 9.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -56.82 -37.03 70.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.734 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -71.56 -42.62 67.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.806 ' HA ' HD13 ' A' ' 288' ' ' ILE . 46.0 tttm -53.07 -48.9 67.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -59.64 -68.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.59 -38.17 1.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.706 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.4 mp -86.05 -23.36 26.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 272' ' ' ALA . 34.8 t30 -56.92 101.03 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.55 19.41 73.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -80.06 93.03 5.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 111.118 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.87 133.11 55.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.46 HD11 HD11 ' A' ' 286' ' ' LEU . 66.8 mt -101.28 -41.22 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . 0.404 ' CD1' HG22 ' A' ' 279' ' ' ILE . 13.3 m-85 -116.17 174.44 6.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.63 104.44 0.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.116 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 37.92 54.78 1.9 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . 0.485 ' HA ' ' ND2' ' A' ' 224' ' ' ASN . 24.9 p -175.14 155.01 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.866 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 225' ' ' PRO . 61.4 m 65.51 46.1 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 20.7 m -73.75 142.1 46.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.46 HD11 HD11 ' A' ' 279' ' ' ILE . 91.4 mt -86.2 123.8 31.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.939 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.24 81.85 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.806 HD13 ' HA ' ' A' ' 271' ' ' LYS . 31.7 mt -62.53 154.28 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.43 ' N ' HG22 ' A' ' 288' ' ' ILE . 17.1 mt-10 -159.56 114.65 2.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.477 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 45.0 m-85 -39.55 107.38 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -59.51 127.58 32.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.104 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.9 OUTLIER -60.68 -45.06 96.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.58 0.705 . . . . 0.0 110.853 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.8 Cg_endo -80.31 148.76 18.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.641 2.227 . . . . 0.0 112.37 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 78.8 p -93.0 -25.79 17.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.165 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -120.36 144.89 47.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 55.0 mt -111.92 -178.98 3.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -139.11 129.99 26.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.83 110.81 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.786 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.8 mp -62.72 -57.27 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -144.03 176.33 9.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -99.61 87.17 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 303' ' ' ASN . 28.2 t70 -140.99 170.54 15.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 302' ' ' ASP . 86.1 m-20 -36.3 -47.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.852 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -50.12 -56.87 9.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.6 p -138.26 142.78 39.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.81 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -138.94 134.78 33.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -115.38 128.43 56.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -100.8 -59.01 1.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.895 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.45 ' CG2' ' OE1' ' A' ' 245' ' ' GLN . 39.8 p -38.02 -47.87 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.096 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -123.2 93.91 47.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.66 -12.42 18.34 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.676 2.251 . . . . 0.0 112.353 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -104.85 83.21 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 74.8 mt -131.17 109.57 10.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -119.42 -144.37 7.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.502 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 52.8 mtt-85 -63.56 -44.41 94.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.811 0.339 . . . . 0.0 110.919 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.939 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.6 m -153.74 170.49 20.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.853 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 2.0 m -170.1 167.11 8.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.845 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 125.07 116.85 2.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.479 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.4 m -172.39 144.18 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 110.854 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 t -152.19 159.5 43.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.818 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -164.27 127.92 1.73 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.455 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -162.76 156.87 20.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 18.2 mtt-85 -142.54 111.16 6.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.0 pt -67.37 134.11 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.163 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.9 p -138.98 131.9 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.38 143.1 43.56 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.54 0.686 . . . . 0.0 110.866 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.74 113.14 3.59 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.682 2.255 . . . . 0.0 112.369 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -127.63 48.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -112.75 80.75 1.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.939 0.4 . . . . 0.0 110.917 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 21.3 m -48.58 102.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.218 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -98.83 87.48 3.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -162.91 146.0 8.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.579 0.704 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 212' ' ' SER . 62.5 Cg_endo -76.92 152.07 31.72 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.699 2.266 . . . . 0.0 112.379 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 211' ' ' PRO . 3.4 m -36.91 138.47 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -70.42 -74.13 0.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 63.23 147.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.473 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 216' ' ' LYS . 13.0 t30 -169.47 128.49 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 215' ' ' ASN . 0.0 OUTLIER -33.27 -52.72 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 63.3 t -80.47 150.59 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 18.4 mt -141.48 126.7 18.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.852 HD11 HE21 ' A' ' 256' ' ' GLN . 7.8 tp -85.08 104.02 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 9.3 mp -87.87 134.56 33.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.0 m -124.32 111.4 15.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 222' ' ' ILE . 5.3 mp -71.99 140.88 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 224' ' ' ASN . 7.0 tp60 -95.38 143.99 26.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.543 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 53.7 t30 34.96 54.49 1.84 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.591 0.71 . . . . 0.0 110.869 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.1 Cg_exo -47.37 102.19 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.704 2.269 . . . . 0.0 112.3 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 42.7 mt -103.88 -54.03 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -89.88 154.17 47.59 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.705 0.764 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.43 113.69 3.7 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.671 2.247 . . . . 0.0 112.323 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.4 mm -93.73 142.28 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 16.5 p -139.4 163.26 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 303' ' ' ASN . 31.4 m -46.76 -27.81 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.28 -36.27 82.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 94.9 t -71.12 -47.53 60.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.093 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 18.9 mt -83.74 20.84 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.419 ' O ' ' HB3' ' A' ' 239' ' ' ASN . 75.7 t80 -129.95 -39.28 1.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.966 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.453 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 22.9 m -72.33 -37.43 68.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.19 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.449 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 44.7 t -85.02 -25.67 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.117 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.456 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 78.9 m -83.67 -47.82 10.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.53 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -41.37 -49.29 9.08 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.636 0.732 . . . . 0.0 110.862 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.9 Cg_exo -47.91 -62.17 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.728 2.285 . . . . 0.0 112.36 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 48.4 t -47.05 -50.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.24 -103.39 0.26 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.403 ' C ' ' HD3' ' A' ' 243' ' ' LYS . 1.1 tmtp? -163.75 120.26 1.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 110.916 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.474 HG11 HD11 ' A' ' 247' ' ' ILE . 90.2 t -85.43 142.46 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.114 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.494 ' O ' HG23 ' A' ' 309' ' ' THR . 11.0 mm-40 -95.83 -57.79 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -141.24 152.44 44.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.474 HD11 HG11 ' A' ' 244' ' ' VAL . 58.0 mt -137.38 119.37 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 95.1 t -117.96 115.96 50.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.126 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 62.0 mt -103.53 122.18 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 36.8 p90 -131.45 148.81 52.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -124.8 40.95 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.418 ' HB2' ' NH1' ' A' ' 252' ' ' ARG . 0.2 OUTLIER -72.9 -60.42 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -129.66 80.01 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 255' ' ' ILE . . . 88.04 116.34 1.26 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.506 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 254' ' ' GLY . 28.1 mm -33.42 104.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 111.141 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.852 HE21 HD11 ' A' ' 219' ' ' LEU . 34.7 mt-30 -136.19 166.42 23.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -165.13 121.45 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.404 ' SD ' HD21 ' A' ' 296' ' ' LEU . 13.9 mtt -86.06 137.36 32.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 94.8 t -126.84 129.48 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.104 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 261' ' ' PHE . 3.3 tp10 -102.1 148.23 25.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.691 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 41.1 m-85 -122.71 157.64 31.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.453 ' OE1' ' NE2' ' A' ' 245' ' ' GLN . 3.8 mm-40 -36.37 -63.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -143.13 176.19 9.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 87.0 t -52.75 -56.9 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 16.1 tp -39.26 -64.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 83.3 m -49.17 -43.45 42.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -54.89 -40.35 69.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -55.24 -59.09 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -63.3 -51.17 67.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.691 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -48.69 -49.99 35.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.672 ' HA ' HD13 ' A' ' 288' ' ' ILE . 55.0 tttm -54.07 -53.47 52.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -54.11 -70.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -42.43 -41.35 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.608 ' CB ' HD11 ' A' ' 288' ' ' ILE . 3.1 mp -79.64 -23.46 42.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 271' ' ' LYS . 18.4 t-20 -60.0 104.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 76.97 24.02 67.71 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.733 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -82.8 93.24 7.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.775 0.321 . . . . 0.0 111.077 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.44 117.02 2.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.546 HG22 ' CD1' ' A' ' 280' ' ' TYR . 70.1 mt -89.98 -39.82 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.129 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . 0.546 ' CD1' HG22 ' A' ' 279' ' ' ILE . 5.5 m-85 -117.73 173.44 6.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -52.86 103.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.071 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.23 59.59 0.62 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.473 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 20.0 p -175.08 163.84 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 82.0 m 60.19 44.41 12.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 30.2 m -59.52 150.0 28.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.733 HD12 ' HB3' ' A' ' 277' ' ' ALA . 40.5 mt -92.51 105.87 17.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 25.6 tttp -104.78 82.14 1.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.672 HD13 ' HA ' ' A' ' 271' ' ' LYS . 19.3 mt -70.56 142.63 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.09 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -149.04 122.01 8.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -49.15 101.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.442 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -60.45 135.08 57.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.051 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.605 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.4 OUTLIER -59.3 -44.65 98.57 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 0.0 110.918 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.4 Cg_endo -80.41 144.06 15.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.723 2.282 . . . . 0.0 112.318 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 65.3 p -111.35 34.65 3.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.163 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 296' ' ' LEU . 3.7 tpt180 -144.3 143.59 31.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.423 ' N ' ' HG3' ' A' ' 295' ' ' ARG . 49.2 mt -132.3 114.4 14.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -88.4 135.36 33.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 75.0 t -137.57 115.49 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -83.37 -59.01 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -115.86 166.52 11.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -102.55 44.06 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.05 169.75 17.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.75 ' O ' HG13 ' A' ' 231' ' ' VAL . 1.1 p30 -45.41 -47.24 13.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -44.31 -60.06 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.5 p -133.01 142.55 48.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -140.97 142.09 34.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.75 89.36 3.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.886 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -78.86 45.83 0.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 245' ' ' GLN . 67.4 p -124.98 -42.61 2.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.163 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.421 ' CD ' HD13 ' A' ' 313' ' ' LEU . 7.1 ttmm -126.14 94.18 41.92 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.547 0.689 . . . . 0.0 110.899 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.59 -19.05 14.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -103.81 41.69 1.26 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.88 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.421 HD13 ' CD ' ' A' ' 310' ' ' LYS . 24.5 tp -117.46 127.54 54.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.894 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -145.85 -144.7 4.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.491 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -74.01 -44.77 53.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.865 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 32.8 mmm-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.877 -179.928 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.1 m 63.8 42.42 6.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 0.0 110.891 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 97.0 p -108.85 174.01 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.811 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 162.05 136.87 2.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.534 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 5.2 m -165.95 166.84 17.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.857 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 24.4 p -157.53 174.37 15.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.83 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 165.19 137.51 2.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -132.09 120.25 22.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.707 0.289 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.87 162.82 40.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 67.1 mt -134.58 109.59 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 81.9 p -50.41 165.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.149 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -91.91 109.8 39.54 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 110.876 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.02 162.77 31.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.269 . . . . 0.0 112.372 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -178.72 -130.14 1.39 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.488 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -155.35 166.72 32.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 85.9 m -127.34 131.85 50.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -130.85 171.78 12.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.437 ' CG ' ' HD2' ' A' ' 211' ' ' PRO . 4.7 t70 -141.68 141.67 23.28 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.58 0.705 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 210' ' ' ASP . 62.2 Cg_endo -77.53 86.38 1.65 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.697 2.265 . . . . 0.0 112.377 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 79.3 p -113.81 116.75 29.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 55.15 -143.16 34.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 151.79 -120.73 1.11 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.45 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -144.65 129.83 18.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.884 0.374 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 15.8 mtmm -52.51 -40.75 62.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.841 HG22 ' HG2' ' A' ' 260' ' ' GLU . 42.9 t -84.12 148.25 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 220' ' ' LEU . 13.9 mt -144.89 127.79 16.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.0 tp -84.88 117.9 24.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.578 HD13 HG23 ' A' ' 259' ' ' VAL . 6.0 mp -101.1 128.77 47.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.5 m -123.22 111.46 16.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 222' ' ' ILE . 5.2 mp -75.94 143.09 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -103.23 137.69 41.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.541 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 46.0 t30 42.18 52.82 7.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.609 0.719 . . . . 0.0 110.911 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.0 Cg_exo -45.31 119.84 2.8 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.371 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.481 HD22 ' O ' ' A' ' 224' ' ' ASN . 4.1 mm? -88.02 -56.73 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.557 ' CD1' ' CE2' ' A' ' 280' ' ' TYR . 16.5 m-85 -119.45 144.02 35.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.731 0.777 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.91 112.67 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.666 2.244 . . . . 0.0 112.343 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.442 HD12 HG11 ' A' ' 233' ' ' VAL . 48.2 mm -81.95 121.28 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.4 p -107.72 157.11 18.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.15 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 303' ' ' ASN . 27.5 m -40.42 -38.11 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.156 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 235' ' ' TYR . 48.8 m-20 -56.45 -61.24 2.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 229' ' ' ILE . 97.0 t -36.94 -44.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.15 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.54 -38.12 41.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 71.8 t80 -83.87 19.85 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.487 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 96.2 m -125.0 -36.69 2.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.432 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 98.8 t -97.21 -24.58 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.125 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 85.7 m -85.11 -45.48 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.548 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.1 m120 -49.86 -48.31 78.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.674 0.749 . . . . 0.0 110.903 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 67.0 Cg_exo -48.03 -22.03 3.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.315 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 20.6 t -89.63 -50.28 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.083 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -145.97 -127.48 1.88 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.433 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.491 ' CB ' ' OE2' ' A' ' 262' ' ' GLU . 32.5 tptt -130.24 131.9 45.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.848 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.501 HG11 HD11 ' A' ' 247' ' ' ILE . 84.2 t -108.29 125.26 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -79.94 -70.22 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -134.68 160.27 38.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.501 HD11 HG11 ' A' ' 244' ' ' VAL . 54.6 mt -137.84 136.61 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 298' ' ' VAL . 62.0 t -135.97 109.53 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 49.2 mt -99.92 100.88 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -105.79 134.61 48.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 78.51 2.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 113.74 18.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 47.12 43.9 14.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.13 119.03 2.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mm -42.38 107.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.329 . . . . 0.0 111.158 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -128.32 143.82 51.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.31 117.7 9.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.473 ' HB3' HD11 ' A' ' 296' ' ' LEU . 29.6 mtt -90.16 127.37 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.578 HG23 HD13 ' A' ' 220' ' ' LEU . 57.4 t -119.34 143.06 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.841 ' HG2' HG22 ' A' ' 217' ' ' VAL . 17.5 mt-10 -108.37 163.13 13.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.819 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 42.0 m-85 -134.07 158.05 44.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.491 ' OE2' ' CB ' ' A' ' 243' ' ' LYS . 31.2 mt-10 -40.65 -63.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.5 m -140.93 178.52 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 83.9 t -54.94 -51.06 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 17.5 tp -47.66 -58.83 3.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 62.8 m -49.86 -43.95 49.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -55.72 -38.01 69.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.084 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -56.69 -65.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -57.58 -53.16 61.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.819 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -50.03 -53.27 27.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.729 ' HG3' HG21 ' A' ' 288' ' ' ILE . 23.4 tttt -53.09 -44.19 67.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.7 -66.01 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.117 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.877 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -51.82 -47.27 64.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.504 ' CB ' HD11 ' A' ' 288' ' ' ILE . 2.8 mp -67.59 -28.19 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 271' ' ' LYS . 0.8 OUTLIER -66.85 104.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.07 20.8 75.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -82.15 91.87 6.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.64 128.38 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.654 HG22 ' CD1' ' A' ' 280' ' ' TYR . 73.2 mt -102.57 -41.92 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . 0.654 ' CD1' HG22 ' A' ' 279' ' ' ILE . 6.3 m-85 -118.3 173.54 6.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.93 105.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.59 59.99 0.65 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.522 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 31.8 p -175.16 167.11 3.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 2.2 m 62.57 44.11 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 57.3 m -61.55 136.74 58.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 277' ' ' ALA . 61.4 mt -87.38 115.85 25.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -111.12 90.21 3.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.889 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.729 HG21 ' HG3' ' A' ' 271' ' ' LYS . 35.1 mt -76.3 145.59 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 290' ' ' TYR . 18.8 mt-10 -153.71 111.19 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.406 ' C ' ' O ' ' A' ' 289' ' ' GLU . 26.4 m-85 -37.52 102.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -49.78 144.03 6.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.069 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.599 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 4.6 ttp180 -60.42 -45.04 97.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 0.0 110.801 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.8 Cg_endo -80.3 150.81 20.08 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.663 2.242 . . . . 0.0 112.346 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.6 p -85.6 -24.28 27.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -128.59 175.04 8.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 258' ' ' MET . 80.1 mt -132.47 175.51 9.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -152.6 118.62 5.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 248' ' ' VAL . 63.2 t -102.07 104.71 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.685 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.9 mp -62.69 -59.82 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . 0.424 ' HG3' HG22 ' A' ' 299' ' ' ILE . 37.6 mtm180 -115.36 154.96 28.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -105.77 105.46 15.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 303' ' ' ASN . 3.3 m-20 -149.02 167.71 25.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.674 ' O ' HG13 ' A' ' 231' ' ' VAL . 65.2 m-20 -34.37 -47.49 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -50.72 -60.77 2.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 248' ' ' VAL . 78.7 p -129.28 133.41 47.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -131.43 137.36 48.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.24 113.55 21.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -89.61 -59.85 2.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 72.1 p -43.18 -40.14 3.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.173 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.588 ' HD2' ' CE2' ' A' ' 312' ' ' TYR . 4.3 tppp? -113.27 80.53 4.45 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.581 0.705 . . . . 0.0 110.87 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.96 -10.94 15.23 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.351 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.588 ' CE2' ' HD2' ' A' ' 310' ' ' LYS . 48.4 p90 -101.14 46.32 0.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.908 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.47 ' HB2' ' CG ' ' A' ' 310' ' ' LYS . 18.8 tp -124.9 130.53 52.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -174.16 -89.52 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.504 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -80.4 45.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.519 ' CD ' ' C ' ' A' ' 316' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 52.9 p -161.52 172.29 16.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 93.7 p -164.27 133.55 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -165.2 55.18 0.26 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.485 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 198' ' ' SER . 12.8 t -84.38 101.5 12.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.87 0.367 . . . . 0.0 110.83 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 197' ' ' SER . 3.3 m -35.42 149.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -152.92 81.53 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.468 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -78.26 120.93 23.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 202' ' ' ILE . 1.6 mpt_? -72.03 83.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.473 ' C ' ' O ' ' A' ' 201' ' ' ARG . 11.2 mt 32.07 53.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 201' ' ' ARG . 44.3 p -100.96 39.16 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.52 155.05 56.98 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.624 0.726 . . . . 0.0 110.899 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -78.31 158.73 29.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.708 2.272 . . . . 0.0 112.302 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -160.86 153.06 23.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.498 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -102.52 131.51 49.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.929 0.395 . . . . 0.0 110.846 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 14.8 t -147.52 152.9 38.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.99 133.98 45.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.828 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.55 143.28 14.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 0.0 110.823 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.462 ' CG ' ' HB2' ' A' ' 215' ' ' ASN . 62.7 Cg_endo -77.78 139.77 17.97 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.62 2.213 . . . . 0.0 112.336 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 211' ' ' PRO . 55.8 p -37.32 120.91 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 39.93 75.28 0.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 55.88 -155.55 11.85 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.484 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.462 ' HB2' ' CG ' ' A' ' 211' ' ' PRO . 64.5 t30 -160.19 147.79 16.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.861 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -68.91 -44.15 73.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.541 HG11 HD21 ' A' ' 296' ' ' LEU . 84.1 t -81.11 142.76 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.415 HD21 ' HB1' ' A' ' 267' ' ' ALA . 20.5 mt -132.2 126.32 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.44 HD11 ' OE1' ' A' ' 256' ' ' GLN . 24.1 tp -82.5 111.92 18.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.568 HD23 HD22 ' A' ' 286' ' ' LEU . 7.7 mp -103.82 130.26 51.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 t -116.1 132.39 56.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.824 HD13 HG22 ' A' ' 255' ' ' ILE . 4.7 mp -92.42 69.02 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.164 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 222' ' ' ILE . 8.2 mm100 -35.73 141.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.53 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 34.4 m-20 44.76 54.22 12.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.646 0.736 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.8 Cg_exo -46.92 93.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.661 2.24 . . . . 0.0 112.331 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.507 HD12 ' HB2' ' A' ' 283' ' ' CYS . 12.3 mt -102.43 -44.62 5.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 228' ' ' PRO . 63.8 m-85 -107.6 130.27 23.06 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.734 0.778 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 227' ' ' TYR . 77.5 Cg_exo -49.47 126.27 15.64 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.7 2.267 . . . . 0.0 112.336 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.806 HD12 HG11 ' A' ' 233' ' ' VAL . 49.6 mm -117.92 118.86 59.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.407 ' HA ' ' CD1' ' A' ' 249' ' ' ILE . 21.5 p -121.75 167.36 13.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.174 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 35.3 m -40.08 -34.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.54 -43.89 96.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.806 HG11 HD12 ' A' ' 229' ' ' ILE . 61.2 t -66.17 -44.39 91.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 25.4 mt -83.19 20.15 1.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -124.81 -26.33 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 86.5 m -85.72 -36.35 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.444 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 13.3 t -89.15 -21.86 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.154 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 83.7 m -84.79 -47.66 10.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.541 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.5 OUTLIER -46.86 -48.1 51.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.708 . . . . 0.0 110.917 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -48.03 -21.05 2.46 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.649 2.232 . . . . 0.0 112.323 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.937 HG11 ' HA ' ' A' ' 270' ' ' ALA . 77.7 t -96.98 -43.06 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.109 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -159.73 -158.52 9.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.98 120.55 39.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.829 0.347 . . . . 0.0 110.87 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 84.4 t -85.67 133.06 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -95.38 -60.55 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -150.58 153.32 35.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.509 HG23 HG22 ' A' ' 259' ' ' VAL . 68.5 mt -132.19 127.33 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.17 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 298' ' ' VAL . 57.3 t -119.92 112.12 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.432 HG12 ' HB2' ' A' ' 257' ' ' ALA . 58.2 mt -100.04 129.91 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.149 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -138.27 163.56 31.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.736 ' HG3' HD13 ' A' ' 255' ' ' ILE . 22.2 ttpt -120.86 86.03 2.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -120.52 88.58 2.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.5 m120 56.14 42.82 27.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 138.25 108.06 0.81 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.497 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.824 HG22 HD13 ' A' ' 222' ' ' ILE . 31.7 mm -39.79 114.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 111.097 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.44 ' OE1' HD11 ' A' ' 219' ' ' LEU . 13.0 mt-30 -139.69 173.58 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 249' ' ' ILE . . . -165.11 120.76 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.09 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.5 mtt -83.93 123.21 29.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.509 HG22 HG23 ' A' ' 247' ' ' ILE . 67.8 t -117.08 127.74 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -97.3 154.29 17.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -127.32 164.33 22.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -43.85 -65.11 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 25.1 p -138.47 169.61 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 265' ' ' LEU . 75.5 t -49.62 -53.83 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.141 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 264' ' ' VAL . 19.5 tp -38.3 -57.88 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 84.8 m -50.43 -44.84 55.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.415 ' HB1' HD21 ' A' ' 218' ' ' LEU . . . -54.11 -38.8 65.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.091 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -57.02 -60.84 2.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -63.71 -54.1 40.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.937 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.63 -48.8 28.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.643 ' HA ' HD13 ' A' ' 288' ' ' ILE . 49.4 tttm -51.19 -52.19 46.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -57.16 -67.32 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.79 -40.0 1.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.581 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.4 mp -84.98 -22.39 29.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 271' ' ' LYS . 41.1 t30 -60.16 100.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.05 19.95 68.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.513 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.477 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -78.32 91.68 4.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.737 0.303 . . . . 0.0 111.117 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.21 123.37 14.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.873 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.465 HD11 HD11 ' A' ' 286' ' ' LEU . 84.9 mt -95.87 -41.55 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.145 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -116.17 173.04 6.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -51.09 102.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.33 61.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . 0.507 ' HB2' HD12 ' A' ' 226' ' ' LEU . 28.2 p -175.06 168.83 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.807 0.337 . . . . 0.0 110.883 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 53.5 m 58.99 47.78 11.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 19.7 m -61.81 145.81 51.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.143 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.568 HD22 HD23 ' A' ' 220' ' ' LEU . 50.0 mt -93.71 95.65 9.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -91.22 97.32 11.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' A' ' 271' ' ' LYS . 21.6 mt -83.86 138.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -143.97 124.87 14.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -51.61 97.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.59 156.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.086 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 1.1 mpt_? -71.45 -60.27 2.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.631 0.729 . . . . 0.0 110.882 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 58.8 Cg_endo -71.78 161.59 44.63 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.7 2.267 . . . . 0.0 112.341 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.6 p -97.31 -34.23 11.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -106.85 163.37 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.541 HD21 HG11 ' A' ' 217' ' ' VAL . 40.8 mt -124.04 -177.24 3.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -144.39 132.62 21.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.546 HG11 ' OD1' ' A' ' 307' ' ' ASP . 75.5 t -122.29 103.01 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.742 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -55.42 -62.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.3 154.47 49.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -84.21 81.38 8.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -124.57 171.76 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -43.0 -47.63 5.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -47.39 -56.74 6.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 82.2 p -137.6 142.12 41.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -136.43 136.85 39.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.546 ' OD1' HG11 ' A' ' 298' ' ' VAL . 0.8 OUTLIER -114.84 110.92 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.97 -49.34 8.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.964 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 31.3 p -38.0 -50.18 1.31 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.174 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.575 ' O ' HD23 ' A' ' 313' ' ' LEU . 27.4 mtmm -122.29 93.71 48.35 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.576 0.703 . . . . 0.0 110.83 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.86 -11.18 16.75 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.358 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.566 ' O ' HD22 ' A' ' 313' ' ' LEU . 11.0 p90 -105.67 94.63 5.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 310' ' ' LYS . 4.4 mm? -128.4 131.63 48.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 169.95 -101.62 0.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -76.78 -35.42 57.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.776 0.322 . . . . 0.0 110.839 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 25.5 mtt85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.6 t -157.87 139.71 14.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 110.866 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.3 t -152.13 155.1 37.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 122.16 89.88 1.01 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.505 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 30.1 t -148.98 140.77 23.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.916 0.389 . . . . 0.0 110.833 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.3 m -147.74 166.81 26.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 159.09 84.93 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -161.27 150.2 16.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 23.3 mmt85 -140.2 106.41 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 202' ' ' ILE . 0.2 OUTLIER -76.29 140.5 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 58.4 p -155.75 127.88 7.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -145.74 142.96 18.57 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.61 0.719 . . . . 0.0 110.858 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.28 153.42 31.47 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.676 2.251 . . . . 0.0 112.316 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -159.65 -89.06 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -67.62 91.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.953 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 32.2 m -135.8 115.93 13.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -145.48 120.19 9.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -128.29 153.71 78.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.7 . . . . 0.0 110.846 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.08 103.28 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.683 2.255 . . . . 0.0 112.341 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 4.8 t -121.03 142.06 50.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.98 96.53 0.88 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -55.25 -164.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -141.06 121.55 14.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 0.0 110.921 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -38.73 -43.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.508 HG13 HD11 ' A' ' 296' ' ' LEU . 76.6 t -82.07 147.8 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 220' ' ' LEU . 15.4 mt -145.3 123.68 12.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.2 tp -78.91 104.52 9.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.44 HD13 HG23 ' A' ' 259' ' ' VAL . 6.9 mp -87.29 126.06 34.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 54.0 m -117.34 112.79 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 1.021 HD13 HG22 ' A' ' 255' ' ' ILE . 2.4 mp -80.85 118.0 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.471 ' C ' ' CG ' ' A' ' 224' ' ' ASN . 17.8 mm100 -85.28 133.28 34.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.932 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.471 ' CG ' ' C ' ' A' ' 223' ' ' GLN . 0.7 OUTLIER 49.39 54.97 16.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.64 0.733 . . . . 0.0 110.897 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 224' ' ' ASN . 59.9 Cg_endo -73.36 99.69 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 0.0 112.328 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 10.2 mt -91.87 -40.31 11.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -88.74 153.47 49.96 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.657 0.742 . . . . 0.0 110.941 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.39 115.93 4.52 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.7 2.266 . . . . 0.0 112.316 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 22.3 mm -97.24 148.17 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 232' ' ' ASP . 16.1 p -148.23 156.13 42.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 303' ' ' ASN . 34.7 m -35.16 -35.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 230' ' ' THR . 6.4 t0 -65.48 -61.58 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 71.6 t -42.02 -46.32 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.437 HD12 HG21 ' A' ' 247' ' ' ILE . 34.8 mt -66.7 -65.6 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.535 ' CD2' ' HB ' ' A' ' 244' ' ' VAL . 5.9 t80 -48.0 -27.44 2.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.428 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 83.6 m -66.01 -47.58 73.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.145 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.441 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 63.5 t -87.42 -15.14 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.428 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 77.3 m -86.13 -46.75 10.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.56 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -47.36 -47.52 57.8 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.626 0.727 . . . . 0.0 110.902 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.8 Cg_exo -47.98 -18.6 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 270' ' ' ALA . 78.6 t -98.6 -42.4 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -162.72 -145.25 4.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.405 ' HD3' ' C ' ' A' ' 243' ' ' LYS . 8.9 tmtm? -116.53 119.21 34.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.535 ' HB ' ' CD2' ' A' ' 235' ' ' TYR . 89.1 t -82.49 141.1 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -96.03 -51.85 4.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.411 ' NE ' ' OE1' ' A' ' 260' ' ' GLU . 22.9 ptt180 -159.89 153.1 21.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.437 HG21 HD12 ' A' ' 234' ' ' LEU . 53.6 mt -131.82 139.26 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 38.1 t -130.45 110.53 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.138 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 52.9 mt -98.55 140.69 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 256' ' ' GLN . 8.2 p90 -146.68 139.98 25.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -98.25 43.19 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -79.55 95.46 5.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 62.76 45.79 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 131.28 -155.56 21.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 1.021 HG22 HD13 ' A' ' 222' ' ' ILE . 32.2 mm -116.04 103.38 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 0.0 111.116 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.569 ' HB2' ' CE2' ' A' ' 250' ' ' PHE . 19.0 mp0 -131.56 157.31 43.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -162.12 118.63 2.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.116 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.8 mtt -82.2 128.81 34.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 220' ' ' LEU . 65.4 t -119.33 127.73 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 24.6 tt0 -104.34 149.43 25.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.903 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.45 ' N ' ' HG2' ' A' ' 260' ' ' GLU . 60.1 m-85 -118.93 166.51 12.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.839 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -45.67 -64.58 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.4 t -130.87 177.81 7.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.54 -54.54 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.16 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 24.4 tp -40.89 -54.49 2.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.919 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 68.6 m -53.57 -43.05 68.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -56.33 -40.21 74.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.085 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -62.49 -63.55 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -55.48 -44.43 76.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.821 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -64.15 -42.28 96.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.695 ' HA ' HD13 ' A' ' 288' ' ' ILE . 42.6 tttm -55.27 -47.65 75.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.62 -62.12 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.102 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -47.13 -37.17 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.097 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.785 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.7 mp -88.38 -22.77 23.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 271' ' ' LYS . 2.0 t30 -60.52 101.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.46 21.44 69.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.506 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -84.55 93.41 8.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.329 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -49.53 143.53 6.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.615 HG22 ' CD1' ' A' ' 280' ' ' TYR . 68.2 mt -102.17 -36.59 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.157 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . 0.615 ' CD1' HG22 ' A' ' 279' ' ' ILE . 62.3 m-85 -139.02 175.88 9.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -39.82 101.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.045 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 29.3 73.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.472 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . 0.464 ' HA ' ' ND2' ' A' ' 224' ' ' ASN . 23.5 p -175.96 173.46 2.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.804 0.335 . . . . 0.0 110.881 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 283' ' ' CYS . 2.0 p 40.25 43.85 1.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 90.2 m -60.76 139.3 57.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.167 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.435 HD22 HD23 ' A' ' 220' ' ' LEU . 31.5 mt -82.42 123.48 29.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.431 ' C ' ' HE3' ' A' ' 287' ' ' LYS . 0.1 OUTLIER -124.35 87.14 2.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.925 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.785 HD11 ' CB ' ' A' ' 274' ' ' LEU . 17.9 mt -71.38 142.58 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -142.51 115.89 9.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -39.71 100.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -52.24 151.85 3.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.138 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 13.0 mmt180 -73.27 -58.05 2.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.594 0.712 . . . . 0.0 110.869 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 60.0 Cg_endo -73.74 159.09 46.12 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.724 2.282 . . . . 0.0 112.344 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 69.5 p -95.65 -34.84 11.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 296' ' ' LEU . 1.4 tmm_? -105.78 152.8 22.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.508 HD11 HG13 ' A' ' 217' ' ' VAL . 74.9 mt -118.54 154.79 31.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.962 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -116.29 127.33 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' A' ' 307' ' ' ASP . 89.3 t -106.27 105.65 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.158 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.703 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.4 mp -59.2 -62.01 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -131.8 170.42 14.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.43 ' ND2' ' OD1' ' A' ' 307' ' ' ASP . 1.8 m-20 -106.56 100.01 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.849 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 303' ' ' ASN . 29.3 t70 -165.58 172.52 11.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.728 ' O ' HG13 ' A' ' 231' ' ' VAL . 1.9 m-80 -34.34 -46.09 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.99 -53.17 28.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 2.9 m -153.48 143.51 22.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.898 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -136.88 149.85 47.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.718 ' HB3' HG21 ' A' ' 298' ' ' VAL . 17.0 p-10 -129.44 95.62 4.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -71.35 -40.46 70.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 21.9 p -40.76 -33.19 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.853 ' HE3' HD13 ' A' ' 313' ' ' LEU . 15.5 mtpp -132.95 88.56 36.79 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.54 0.686 . . . . 0.0 110.868 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.31 -7.84 17.17 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.647 2.232 . . . . 0.0 112.341 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -108.93 40.09 1.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.853 HD13 ' HE3' ' A' ' 310' ' ' LYS . 10.0 tp -109.71 148.97 30.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 132.34 127.37 2.81 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.452 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -39.52 -58.12 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.408 ' C ' ' HD3' ' A' ' 316' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 93.8 p -161.47 135.18 6.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 0.0 110.868 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.9 t -89.36 171.9 9.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.884 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 127.2 178.46 15.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.5 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 51.4 p -160.4 152.54 20.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 110.848 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 20.9 t -63.1 -48.31 79.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.882 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.05 157.73 9.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.489 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -165.49 130.78 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 202' ' ' ILE . 17.3 tpt180 -162.27 149.01 13.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.413 ' N ' ' HG3' ' A' ' 201' ' ' ARG . 32.4 pt -78.33 129.51 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.9 t -174.9 133.18 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -174.59 113.79 0.3 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.601 0.715 . . . . 0.0 110.864 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.72 161.18 33.94 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.638 2.226 . . . . 0.0 112.375 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 133.87 64.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -116.61 132.75 56.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.944 0.402 . . . . 0.0 110.862 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 21.5 p -122.93 90.21 3.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -146.83 130.05 16.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -156.71 154.51 26.88 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.55 12.4 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.288 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 213' ' ' GLY . 48.1 t -132.37 150.2 52.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.649 ' HA3' HG11 ' A' ' 264' ' ' VAL . . . -37.25 155.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.501 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -49.45 -100.53 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.527 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.416 ' ND2' ' HB ' ' A' ' 217' ' ' VAL . 13.4 t30 -160.02 136.75 9.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -59.65 -42.77 93.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.547 HG11 HD21 ' A' ' 296' ' ' LEU . 91.5 t -76.06 138.29 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.402 ' HB3' HG23 ' A' ' 288' ' ' ILE . 12.4 mt -136.44 128.58 29.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 54.5 tp -83.18 113.47 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.514 HD23 HD22 ' A' ' 286' ' ' LEU . 6.9 mp -99.56 125.71 45.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.3 t -115.38 115.37 26.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.573 HD13 HG22 ' A' ' 255' ' ' ILE . 5.4 mp -77.03 122.24 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -80.05 139.09 37.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.543 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 31.6 m-20 43.44 53.82 10.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.666 0.746 . . . . 0.0 110.893 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.6 Cg_exo -47.08 94.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.379 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 13.8 mt -109.91 -44.46 3.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.448 ' CG ' ' CE2' ' A' ' 280' ' ' TYR . 91.6 m-85 -94.66 137.8 22.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.674 0.75 . . . . 0.0 110.912 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.2 132.4 23.41 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.716 2.277 . . . . 0.0 112.341 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.9 mm -122.61 129.9 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.42 ' HA ' ' CD1' ' A' ' 249' ' ' ILE . 21.7 p -144.46 168.58 19.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 33.5 m -42.76 -36.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.2 -44.44 88.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.05 -47.9 88.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.106 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 26.1 mt -84.83 23.68 1.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -130.89 -36.14 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.502 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 26.5 m -79.45 -35.71 39.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.133 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 237' ' ' VAL . 87.6 t -90.62 -14.65 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 76.2 m -87.99 -48.07 8.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.908 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.574 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.8 t-20 -49.78 -46.01 80.01 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.67 0.748 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.0 Cg_exo -47.92 -21.68 2.81 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.68 2.253 . . . . 0.0 112.358 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.482 HG11 ' HB3' ' A' ' 273' ' ' ALA . 21.9 t -99.8 -40.84 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.092 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -152.18 -132.64 1.85 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.46 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -131.8 115.45 15.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.879 HG11 HD11 ' A' ' 247' ' ' ILE . 84.7 t -87.82 137.2 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -109.84 -66.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -120.95 150.2 41.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.879 HD11 HG11 ' A' ' 244' ' ' VAL . 47.7 mt -141.98 121.77 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 66.6 t -119.27 129.45 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 230' ' ' THR . 56.8 mt -120.73 115.39 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -124.32 171.84 9.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -124.78 44.23 2.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.942 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -71.35 96.42 1.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 47.4 43.1 15.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 140.95 137.85 3.49 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.573 HG22 HD13 ' A' ' 222' ' ' ILE . 44.5 mm -58.33 101.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.328 . . . . 0.0 111.104 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -131.91 158.34 41.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -155.89 117.87 4.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 25.9 mtt -83.11 125.09 31.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 247' ' ' ILE . 90.4 t -115.59 124.33 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.17 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -98.43 145.4 26.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.671 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 40.3 m-85 -118.93 158.0 26.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 261' ' ' PHE . 4.4 mm-40 -34.64 -65.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 11.1 t -139.44 166.23 25.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.649 HG11 ' HA3' ' A' ' 213' ' ' GLY . 87.0 t -42.43 -59.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.124 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 264' ' ' VAL . 22.8 tp -35.82 -63.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 81.2 m -42.89 -45.06 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -52.87 -38.14 61.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -55.98 -59.87 4.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -65.49 -55.79 15.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.671 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -47.41 -48.21 26.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.073 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.735 ' HA ' HD13 ' A' ' 288' ' ' ILE . 17.5 tttt -56.51 -45.23 81.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -60.34 -71.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.093 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.704 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -41.38 -39.53 1.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.768 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.5 mp -81.68 -27.35 34.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 272' ' ' ALA . 18.9 t-20 -59.84 100.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 79.2 20.71 69.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.457 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -84.23 94.5 8.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.736 0.303 . . . . 0.0 111.093 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.74 128.42 26.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.561 HD11 HD11 ' A' ' 286' ' ' LEU . 77.4 mt -104.42 -44.05 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . 0.448 ' CE2' ' CG ' ' A' ' 227' ' ' TYR . 33.8 m-85 -112.37 174.35 5.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -53.73 103.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 33.91 56.86 0.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.467 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 27.7 p -175.18 168.19 3.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.338 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 87.0 m 62.63 41.41 9.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 15.3 m -59.54 149.94 28.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.21 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 279' ' ' ILE . 57.5 mt -94.77 105.8 17.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -101.59 80.2 2.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.768 HD11 ' CB ' ' A' ' 274' ' ' LEU . 44.4 mt -69.45 141.54 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.133 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -149.24 109.84 4.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -38.3 106.43 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.75 157.23 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.086 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.471 ' CB ' ' CD ' ' A' ' 293' ' ' PRO . 11.9 mmt180 -73.69 -61.41 1.36 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' A' ' 292' ' ' ARG . 59.0 Cg_endo -71.88 161.21 45.65 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 40.2 p -93.01 -28.14 16.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.144 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.16 160.01 15.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.547 HD21 HG11 ' A' ' 217' ' ' VAL . 66.9 mt -120.95 172.67 7.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . 0.443 ' ND2' HD13 ' A' ' 299' ' ' ILE . 2.1 t30 -119.51 119.71 34.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.27 93.36 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.443 HD13 ' ND2' ' A' ' 297' ' ' ASN . 4.7 mm -46.0 -66.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.36 160.54 43.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -64.88 101.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.83 171.77 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.833 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -46.3 -52.8 11.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.32 -53.87 10.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.7 p -143.39 140.93 30.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.873 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -126.77 145.49 50.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -126.71 92.45 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 309' ' ' THR . 58.6 m-85 -69.44 -50.7 43.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.899 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 308' ' ' TYR . 76.3 p -34.99 -49.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.16 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -112.75 87.08 9.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.551 0.691 . . . . 0.0 110.897 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.54 -1.8 11.92 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.675 2.25 . . . . 0.0 112.301 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -105.79 46.11 0.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 34.4 mt -106.42 41.88 1.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.93 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -75.07 160.6 52.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.446 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -72.22 78.5 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 110.889 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.418 ' C ' ' HD3' ' A' ' 316' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 22.0 m -152.17 131.48 12.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 110.867 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 95.6 p -142.48 162.47 35.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.828 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 162.08 95.38 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.484 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 48.4 p -124.29 98.89 5.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 110.852 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 6.0 t -124.44 155.04 39.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.882 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 119.11 45.77 0.44 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.502 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -73.29 86.1 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.733 0.302 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 19.2 ttm105 -134.93 98.28 3.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.0 pt -41.18 124.45 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.1 m -147.01 105.21 3.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -62.19 155.2 66.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.606 0.717 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.74 -23.97 16.17 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.716 2.277 . . . . 0.0 112.331 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 178.61 81.78 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.45 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -89.12 139.07 30.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.872 0.368 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 77.1 p -71.14 116.34 11.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.06 108.03 15.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.28 112.76 46.21 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.624 0.726 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.5 167.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.71 2.273 . . . . 0.0 112.321 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 4.0 m -97.11 42.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 75.16 118.11 0.1 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.455 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -112.13 -177.88 19.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -149.86 158.98 44.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.908 0.385 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -74.79 -41.3 60.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' A' ' 260' ' ' GLU . 52.6 t -79.24 142.79 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.117 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.555 ' HB3' HG23 ' A' ' 288' ' ' ILE . 19.3 mt -139.81 132.35 28.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.86 111.96 18.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.33 127.3 49.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.3 t -115.33 138.72 50.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.85 131.03 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.136 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -94.7 133.46 38.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.581 ' O ' HD22 ' A' ' 226' ' ' LEU . 0.3 OUTLIER 46.17 53.34 12.79 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.884 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 72.0 Cg_exo -45.09 84.63 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.657 2.238 . . . . 0.0 112.351 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.581 HD22 ' O ' ' A' ' 224' ' ' ASN . 4.0 mm? -58.65 -59.79 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -117.57 146.38 38.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.666 0.746 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.78 114.86 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 0.0 112.336 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.554 HD12 HG11 ' A' ' 233' ' ' VAL . 27.6 mm -87.12 120.13 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.185 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 21.4 p -104.81 161.46 14.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 232' ' ' ASP . 30.4 m -42.37 -40.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 235' ' ' TYR . 7.8 m-20 -55.42 -60.72 3.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.554 HG11 HD12 ' A' ' 229' ' ' ILE . 95.5 t -38.03 -37.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 41.6 mt -88.54 -31.85 18.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.774 ' CD1' ' CE2' ' A' ' 308' ' ' TYR . 37.6 t80 -84.75 23.37 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.502 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 88.3 m -125.21 -38.74 2.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.14 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 237' ' ' VAL . 59.1 t -94.21 -15.4 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.428 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 97.1 m -88.72 -47.46 8.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.571 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 8.6 t-20 -50.58 -45.63 85.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.661 0.743 . . . . 0.0 110.928 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.2 Cg_exo -47.98 -22.97 3.87 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.27 . . . . 0.0 112.354 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' ' 270' ' ' ALA . 91.4 t -96.97 -45.58 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -146.6 -145.18 4.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.508 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.53 112.17 17.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.815 0.341 . . . . 0.0 110.937 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.509 ' HB ' ' CE1' ' A' ' 235' ' ' TYR . 51.4 t -80.73 141.7 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.165 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.465 ' NE2' HG22 ' A' ' 309' ' ' THR . 5.1 mm-40 -101.7 -60.89 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.9 mtm-85 -140.78 156.91 46.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.455 HD11 HG11 ' A' ' 244' ' ' VAL . 74.9 mt -142.56 138.45 28.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.11 134.76 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 87.6 mt -116.07 108.11 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -115.72 164.23 14.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -121.89 43.83 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -94.65 106.99 18.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.6 t30 68.1 44.12 1.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 105.91 151.05 19.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 39.1 mm -56.38 113.4 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -141.24 165.2 28.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -156.76 124.63 5.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 29.6 mtt -88.87 124.04 33.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.413 HG13 HG12 ' A' ' 247' ' ' ILE . 72.9 t -112.08 138.02 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.642 ' HG2' HG22 ' A' ' 217' ' ' VAL . 8.9 tm-20 -114.69 140.96 48.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -114.55 162.67 16.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -41.28 -65.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.897 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.2 m -137.5 176.31 8.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 265' ' ' LEU . 98.2 t -56.43 -56.75 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.158 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 264' ' ' VAL . 20.4 tp -37.51 -54.02 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 6.7 m -52.2 -47.0 65.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.25 -37.47 64.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -55.62 -63.44 1.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -61.34 -58.64 7.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.772 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -46.96 -49.65 20.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.133 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.612 ' HA ' HD13 ' A' ' 288' ' ' ILE . 49.3 tttm -47.82 -54.59 11.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.903 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -53.17 -66.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -42.98 -43.81 4.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.873 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.9 mp -77.52 -22.33 51.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 272' ' ' ALA . 44.4 t-20 -55.94 99.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 78.99 19.72 72.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.498 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -86.31 95.82 9.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 111.103 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.56 155.23 39.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 44.4 mt -113.89 -53.9 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -95.7 172.47 8.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -52.68 107.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.139 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.37 48.18 0.62 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 23.0 m -161.1 177.4 10.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.7 m 49.42 44.26 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 41.1 m -63.51 143.93 57.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.124 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 90.3 mt -94.19 122.99 37.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -116.35 98.74 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.873 HD11 ' CB ' ' A' ' 274' ' ' LEU . 28.3 mt -79.27 139.11 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.178 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -150.23 114.36 5.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.441 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 77.6 m-85 -41.32 103.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.958 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -55.08 159.67 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.121 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.491 ' CB ' ' CD ' ' A' ' 293' ' ' PRO . 47.6 mtt180 -73.94 -62.17 1.14 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.583 0.706 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 292' ' ' ARG . 58.3 Cg_endo -71.8 156.96 56.24 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.673 2.249 . . . . 0.0 112.34 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 64.3 p -93.01 -36.33 12.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -107.28 148.7 28.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.48 HD11 HG13 ' A' ' 217' ' ' VAL . 31.3 mt -117.72 150.28 39.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . 0.442 HD21 ' CD1' ' A' ' 299' ' ' ILE . 16.3 t30 -98.56 120.4 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.63 102.02 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.472 ' N ' HD13 ' A' ' 299' ' ' ILE . 4.6 mm -46.71 -61.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -175.05 162.53 3.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -52.71 94.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 305' ' ' SER . 2.3 m-20 -141.69 172.85 12.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -54.64 -41.83 70.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -56.73 -59.92 4.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 302' ' ' ASP . 3.3 t -130.3 152.52 49.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -134.03 138.54 45.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -122.5 98.86 6.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.844 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . 0.774 ' CE2' ' CD1' ' A' ' 235' ' ' TYR . 99.4 m-85 -76.21 -50.84 13.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.465 HG22 ' NE2' ' A' ' 245' ' ' GLN . 46.1 p -36.72 -43.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.178 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.546 ' HG3' ' CE1' ' A' ' 312' ' ' TYR . 64.4 tttt -111.56 82.07 3.54 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.535 0.683 . . . . 0.0 110.906 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.72 -4.93 15.02 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.681 2.254 . . . . 0.0 112.367 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.546 ' CE1' ' HG3' ' A' ' 310' ' ' LYS . 5.0 p90 -104.73 80.45 1.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 56.8 mt -136.65 118.84 15.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.956 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 124.01 110.01 1.89 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.5 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -99.83 81.65 2.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.793 0.33 . . . . 0.0 110.891 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 75.9 p -163.66 168.85 19.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.371 . . . . 0.0 110.864 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.6 t -156.29 152.01 27.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.833 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -147.9 167.97 28.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.472 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 47.8 t -161.19 138.85 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 110.835 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 56.4 p -138.75 172.08 13.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 148.43 122.78 1.27 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.441 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -134.33 130.53 37.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -145.77 118.97 8.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.8 mt -123.82 110.88 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.9 m -116.46 86.21 2.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -69.75 140.98 89.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.633 0.73 . . . . 0.0 110.835 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.96 84.74 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.302 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -114.24 87.17 0.44 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.479 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -81.66 110.93 17.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.936 0.398 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 41.6 p -97.82 84.42 3.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -127.05 142.05 51.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -40.47 133.49 1.62 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.604 0.716 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.88 -18.77 12.97 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.718 2.279 . . . . 0.0 112.347 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.2 m -97.31 104.61 16.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 107.41 130.0 6.27 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.44 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.84 -109.96 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -154.63 122.87 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.904 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 217' ' ' VAL . 0.1 OUTLIER -52.3 -33.67 43.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.579 HG12 ' CB ' ' A' ' 291' ' ' ALA . 62.0 t -77.77 137.73 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 15.2 mt -134.91 134.37 40.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.453 HD11 ' OE1' ' A' ' 256' ' ' GLN . 22.1 tp -89.94 110.29 21.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.982 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.2 mp -97.51 139.76 32.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -128.81 131.61 47.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.877 HD13 HG22 ' A' ' 255' ' ' ILE . 4.9 mp -91.56 122.02 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.158 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -82.22 143.64 31.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.536 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 15.6 m-20 39.8 54.42 5.83 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.615 0.721 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 74.4 Cg_exo -47.21 92.55 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.738 2.292 . . . . 0.0 112.31 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 11.6 mt -100.78 -48.83 4.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -100.47 137.11 19.86 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.67 0.748 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.51 113.54 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.671 2.248 . . . . 0.0 112.328 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.437 HG13 HG21 ' A' ' 222' ' ' ILE . 47.6 mm -101.11 104.04 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 22.7 p -104.5 159.44 15.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.17 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.462 ' N ' HD11 ' A' ' 249' ' ' ILE . 26.8 m -42.77 -35.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.25 -58.72 7.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 95.2 t -45.15 -45.17 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.093 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 40.1 mt -68.66 -61.89 1.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.46 ' C ' ' CD1' ' A' ' 235' ' ' TYR . 4.8 t80 -49.58 -29.21 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 98.1 m -64.71 -46.98 80.0 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.126 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 237' ' ' VAL . 61.1 t -87.49 -10.07 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.44 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 82.1 m -88.94 -45.17 9.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.909 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.577 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 1.9 t-20 -49.59 -46.11 78.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.626 0.727 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.8 Cg_exo -47.96 -19.92 1.8 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.694 2.262 . . . . 0.0 112.336 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.986 HG11 ' HA ' ' A' ' 270' ' ' ALA . 87.4 t -99.1 -46.92 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -166.42 -170.18 30.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.49 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 244' ' ' VAL . 6.6 tmtm? -82.59 151.14 26.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.368 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.564 HG11 HD11 ' A' ' 247' ' ' ILE . 91.0 t -121.52 128.99 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -80.69 -62.63 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -151.07 155.4 38.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.661 HG12 HG13 ' A' ' 259' ' ' VAL . 77.0 mt -136.85 150.95 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.638 HG22 HG22 ' A' ' 298' ' ' VAL . 94.0 t -136.52 139.91 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 231' ' ' VAL . 88.9 mt -125.38 116.63 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -129.05 158.39 39.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.87 41.84 2.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.402 ' HD3' ' C ' ' A' ' 252' ' ' ARG . 0.0 OUTLIER -67.54 86.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.854 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.2 t30 59.79 42.62 16.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.841 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 137.09 127.89 2.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.53 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.877 HG22 HD13 ' A' ' 222' ' ' ILE . 50.9 mm -48.4 113.11 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.766 0.317 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.453 ' OE1' HD11 ' A' ' 219' ' ' LEU . 37.1 mt-30 -137.67 165.46 26.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.32 127.07 4.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 11.0 mtt -95.67 126.25 40.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.661 HG13 HG12 ' A' ' 247' ' ' ILE . 61.2 t -123.83 127.02 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -105.85 172.74 6.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -142.24 169.78 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -54.27 -68.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 13.8 m -119.35 173.32 7.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 64.6 t -60.43 -52.39 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.139 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 55.2 tp -38.58 -63.48 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 80.7 m -48.03 -46.37 33.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -53.32 -45.57 69.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -63.74 -55.53 22.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.959 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -55.26 -58.27 8.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.986 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -51.24 -46.2 62.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.698 ' HA ' HD13 ' A' ' 288' ' ' ILE . 56.8 tttm -49.03 -52.0 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -56.82 -67.03 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.93 -41.12 2.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.547 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.9 mp -83.6 -22.15 32.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 271' ' ' LYS . 1.2 t30 -57.36 104.7 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.0 22.69 77.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -83.24 90.52 7.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 0.0 111.134 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.76 129.28 19.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.588 HD11 HD21 ' A' ' 286' ' ' LEU . 79.8 mt -99.4 -41.8 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -117.3 173.15 6.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -50.28 103.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.132 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.44 48.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.499 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.2 m -161.42 174.44 13.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.319 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 34.0 m 52.94 42.36 32.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 11.3 m -57.58 152.13 15.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.155 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.588 HD21 HD11 ' A' ' 279' ' ' ILE . 50.9 mt -97.85 125.93 42.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 94.88 4.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.698 HD13 ' HA ' ' A' ' 271' ' ' LYS . 34.0 mt -85.62 145.47 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 290' ' ' TYR . 25.7 mt-10 -155.28 113.82 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 289' ' ' GLU . 68.9 m-85 -34.74 107.27 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.579 ' CB ' HG12 ' A' ' 217' ' ' VAL . . . -50.51 135.95 21.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.084 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.576 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 5.9 ttt180 -64.14 -46.67 79.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.587 0.708 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.5 Cg_endo -79.37 149.81 21.93 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.667 2.245 . . . . 0.0 112.38 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 73.5 p -87.1 -27.52 23.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.11 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -121.22 154.47 36.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 48.1 mt -114.62 179.67 3.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -145.1 133.84 22.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.638 HG22 HG22 ' A' ' 248' ' ' VAL . 96.8 t -131.23 105.69 11.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.576 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.2 mp -63.41 -60.57 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.122 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . 0.47 ' HG3' HG22 ' A' ' 299' ' ' ILE . 88.4 mtt-85 -124.82 166.97 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 302' ' ' ASP . 2.1 m-20 -106.67 95.19 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 303' ' ' ASN . 0.9 OUTLIER -141.19 172.38 12.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 302' ' ' ASP . 0.8 OUTLIER -34.23 -41.69 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -57.4 -63.35 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.4 p -129.57 149.47 51.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -150.9 120.94 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.81 100.66 12.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -84.1 38.51 0.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 67.6 p -119.36 -40.62 2.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.554 ' HB2' HD22 ' A' ' 313' ' ' LEU . 29.6 mttm -129.6 101.31 18.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.561 0.696 . . . . 0.0 110.889 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.52 -50.33 0.11 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.687 2.258 . . . . 0.0 112.3 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.566 ' CG ' ' O ' ' A' ' 312' ' ' TYR . 0.2 OUTLIER -81.0 39.83 0.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.554 HD22 ' HB2' ' A' ' 310' ' ' LYS . 11.6 tp -96.21 123.24 39.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -95.36 -125.5 4.62 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.471 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 316' ' ' ARG . 0.2 OUTLIER -75.27 -38.69 60.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.334 . . . . 0.0 110.865 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.423 ' N ' ' HG3' ' A' ' 315' ' ' ARG . 11.6 mmm180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.3 m -167.28 148.53 5.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 0.0 110.848 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 4.0 m -160.57 159.37 30.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 155.27 134.76 1.92 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 57.4 p -136.79 128.03 28.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.369 . . . . 0.0 110.821 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 8.0 t -112.16 103.22 11.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.64 113.63 0.54 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.536 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -168.8 120.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.791 0.329 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -141.25 128.06 20.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.1 mt -92.98 95.31 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.139 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 81.4 p -154.76 119.34 4.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.095 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 36.6 ttt85 -38.34 133.94 0.95 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.607 0.718 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.82 35.8 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.673 2.249 . . . . 0.0 112.344 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 178.4 63.42 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.58 83.07 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.865 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 44.5 p -132.63 100.22 4.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -88.42 95.12 10.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -88.06 111.06 40.4 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.654 0.74 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.54 160.61 34.96 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.672 2.248 . . . . 0.0 112.336 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.8 m -56.31 98.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -107.96 -176.8 22.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.422 ' HA2' ' CE1' ' A' ' 290' ' ' TYR . . . -165.52 108.53 0.33 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.535 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 291' ' ' ALA . 7.1 p-10 -157.57 139.42 14.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.856 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.494 ' HG2' ' N ' ' A' ' 264' ' ' VAL . 17.3 mtmm -42.99 -45.85 5.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.0 137.64 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.614 ' O ' HD12 ' A' ' 220' ' ' LEU . 19.7 mt -131.99 120.64 22.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.4 HD13 ' HZ ' ' A' ' 250' ' ' PHE . 17.0 tp -76.8 114.52 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.776 HD13 HG23 ' A' ' 259' ' ' VAL . 7.0 mp -102.34 147.95 26.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.0 120.82 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 229' ' ' ILE . 5.2 mp -80.62 123.93 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -81.54 137.57 35.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.561 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 50.4 t30 44.18 53.57 10.83 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.7 Cg_exo -47.3 103.98 0.06 OUTLIER 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.67 2.247 . . . . 0.0 112.38 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 37.8 mt -107.46 -47.65 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.543 ' CD2' ' CD2' ' A' ' 280' ' ' TYR . 94.8 m-85 -97.37 141.11 22.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.689 0.757 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.55 117.33 2.29 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.707 2.271 . . . . 0.0 112.371 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.481 HG21 HD11 ' A' ' 222' ' ' ILE . 30.5 mm -99.61 106.3 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.627 HG22 ' OD1' ' A' ' 303' ' ' ASN . 28.7 p -111.53 165.82 11.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 306' ' ' TRP . 28.9 m -47.38 -40.44 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.147 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 235' ' ' TYR . 9.7 t0 -57.22 -63.89 1.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.854 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 232' ' ' ASP . 90.8 t -35.67 -36.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.17 -37.6 18.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 49.2 t80 -84.11 25.85 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.497 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 89.8 m -130.78 -36.22 1.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.124 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.435 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 25.4 t -98.12 -23.58 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.12 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.446 ' SG ' HD21 ' A' ' 274' ' ' LEU . 98.1 m -86.18 -48.78 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.568 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 11.9 t30 -47.43 -47.04 59.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.592 0.71 . . . . 0.0 110.85 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.8 Cg_exo -48.02 -21.5 2.8 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.643 2.229 . . . . 0.0 112.333 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 273' ' ' ALA . 20.2 t -93.12 -48.64 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.097 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -138.12 -128.02 2.58 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -138.11 114.72 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.759 HG11 HD11 ' A' ' 247' ' ' ILE . 58.9 t -94.84 139.95 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.42 ' NE2' ' OE1' ' A' ' 262' ' ' GLU . 3.3 mm100 -108.09 -67.32 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -116.84 158.19 24.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.759 HD11 HG11 ' A' ' 244' ' ' VAL . 79.6 mt -149.72 108.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.149 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' A' ' 305' ' ' SER . 48.2 t -107.62 143.25 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 257' ' ' ALA . 73.1 mt -126.61 114.89 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.121 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.4 ' HZ ' HD13 ' A' ' 219' ' ' LEU . 15.8 p90 -125.69 146.2 49.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -91.95 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -67.17 89.76 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 12.5 m120 50.58 42.02 26.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 137.32 136.2 3.46 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.506 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 32.7 mm -51.12 97.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.767 0.318 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -127.38 152.74 47.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.564 ' HB2' HG12 ' A' ' 249' ' ' ILE . . . -146.51 124.58 12.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.091 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.496 ' SD ' HD21 ' A' ' 296' ' ' LEU . 25.9 mtt -86.68 118.62 26.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.776 HG23 HD13 ' A' ' 220' ' ' LEU . 57.8 t -102.97 138.06 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -111.26 143.05 42.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -119.07 174.47 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.856 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.42 ' OE1' ' NE2' ' A' ' 245' ' ' GLN . 3.9 mm-40 -56.71 -66.82 0.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.425 ' C ' ' HG2' ' A' ' 216' ' ' LYS . 93.0 p -139.02 165.64 26.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.83 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.494 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 90.7 t -43.15 -54.38 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.116 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 34.7 tp -45.11 -60.8 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 81.7 m -47.91 -39.27 18.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -59.6 -39.29 83.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -57.43 -59.82 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -56.79 -58.75 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.43 ' O ' HD13 ' A' ' 274' ' ' LEU . . . -49.06 -57.45 6.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.692 ' HG3' HG21 ' A' ' 288' ' ' ILE . 55.6 tttm -42.94 -50.26 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -47.5 -71.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.133 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.644 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -47.76 -48.61 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.886 ' HB3' HD11 ' A' ' 288' ' ' ILE . 6.5 mp -64.58 -24.75 67.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 271' ' ' LYS . 50.4 t30 -62.16 102.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 76.27 20.77 76.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.505 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -86.36 94.8 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 0.0 111.12 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.03 162.99 6.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 53.5 mt -121.5 -42.95 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . 0.543 ' CD2' ' CD2' ' A' ' 227' ' ' TYR . 52.4 m-85 -112.74 173.43 6.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -50.77 104.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.101 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.63 58.53 0.71 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.495 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 26.1 p -175.1 160.48 2.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 110.872 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.6 m 63.47 46.67 4.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 286' ' ' LEU . 18.0 m -67.9 155.93 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.404 ' N ' HG22 ' A' ' 285' ' ' THR . 80.3 mt -98.82 125.84 44.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -115.23 98.22 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.886 HD11 ' HB3' ' A' ' 274' ' ' LEU . 74.5 mt -84.05 146.77 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.15 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -159.67 113.32 2.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.422 ' CE1' ' HA2' ' A' ' 214' ' ' GLY . 62.8 m-85 -40.83 102.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -54.95 145.77 19.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.569 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 8.9 ttm180 -61.97 -47.26 91.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.601 0.715 . . . . 0.0 110.826 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 61.3 Cg_endo -78.9 148.89 22.53 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.682 2.255 . . . . 0.0 112.276 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.9 p -90.55 -26.36 19.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -123.81 149.85 45.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.496 HD21 ' SD ' ' A' ' 258' ' ' MET . 78.9 mt -105.37 178.85 4.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.924 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -138.39 110.37 7.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 85.5 t -120.99 110.7 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.8 mp -73.23 -54.03 16.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.18 151.62 51.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.36 97.15 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 303' ' ' ASN . 7.7 p-10 -130.9 166.11 21.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.627 ' OD1' HG22 ' A' ' 230' ' ' THR . 1.1 t30 -36.5 -45.54 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -60.66 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.544 ' HB2' HG22 ' A' ' 248' ' ' VAL . 55.7 p -134.31 128.42 33.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . 0.505 ' HB2' HG11 ' A' ' 231' ' ' VAL . 17.0 t-105 -114.14 149.48 35.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -129.29 106.24 8.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -82.62 -43.37 17.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 58.8 p -44.44 -45.46 9.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -110.59 86.21 5.39 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.544 0.687 . . . . 0.0 110.906 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.68 -11.51 18.48 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.649 2.232 . . . . 0.0 112.34 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -101.04 44.01 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 20.7 mt -94.96 -51.26 4.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 100.02 129.4 6.61 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.468 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -59.98 -44.41 94.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.918 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 52.4 p -112.88 156.31 23.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 110.86 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 9.5 t -106.49 -45.6 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 97.63 52.92 1.37 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 33.1 t -122.35 160.15 25.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.871 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.3 t -77.79 -42.83 32.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.865 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 125.33 165.44 12.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -174.72 116.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.716 0.294 . . . . 0.0 110.856 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.21 155.58 28.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 29.8 pt -77.57 129.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 14.7 t -145.58 146.24 31.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.31 143.57 49.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.584 0.707 . . . . 0.0 110.919 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.06 145.57 24.81 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.708 2.272 . . . . 0.0 112.364 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -113.72 168.53 12.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -142.66 156.71 45.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 110.84 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 87.8 m -134.32 142.2 47.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 28.4 p30 -164.24 170.5 16.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -151.44 121.7 3.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.674 0.749 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -45.94 123.89 6.65 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.709 2.273 . . . . 0.0 112.325 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 92.7 p -44.13 135.22 4.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 81.92 123.55 0.7 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.488 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -56.32 -161.35 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.473 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.774 ' OD1' HG22 ' A' ' 294' ' ' THR . 23.5 t30 -166.77 131.46 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.922 0.391 . . . . 0.0 110.886 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -52.54 -46.06 66.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 90.1 t -81.59 131.11 34.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.128 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.463 HD22 ' HZ2' ' A' ' 271' ' ' LYS . 14.9 mt -123.09 128.17 49.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.658 HD11 ' OE1' ' A' ' 256' ' ' GLN . 29.4 tp -81.97 102.73 11.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.491 HD13 HG23 ' A' ' 259' ' ' VAL . 8.4 mp -89.54 132.78 34.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 m -123.64 118.12 26.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.2 mp -81.2 138.76 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.12 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.438 ' C ' ' HD3' ' A' ' 225' ' ' PRO . 2.1 tp-100 -96.68 141.45 29.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.542 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 48.7 t30 35.5 53.76 1.97 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.62 0.724 . . . . 0.0 110.843 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 77.6 Cg_exo -45.98 106.69 0.1 OUTLIER 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.692 2.261 . . . . 0.0 112.367 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 66.7 mt -101.97 -48.4 4.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -112.49 126.1 28.92 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.675 0.75 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.55 112.25 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.63 HG21 HD21 ' A' ' 234' ' ' LEU . 29.5 mm -88.09 92.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.133 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.684 HG23 ' HB3' ' A' ' 303' ' ' ASN . 2.3 m -70.85 170.3 12.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.577 ' H ' HG22 ' A' ' 230' ' ' THR . 24.5 m -55.63 -41.31 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.408 ' N ' HG23 ' A' ' 231' ' ' VAL . 67.9 m-20 -58.05 -53.33 59.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 86.9 t -44.72 -37.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.63 HD21 HG21 ' A' ' 229' ' ' ILE . 52.6 mt -85.07 -35.65 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 81.8 t80 -82.55 19.95 1.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.412 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 93.0 m -122.78 -36.92 2.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.118 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.426 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 90.0 t -99.75 -18.84 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.441 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 58.5 m -89.07 -46.06 9.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.588 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.7 OUTLIER -50.58 -45.59 85.26 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.583 0.706 . . . . 0.0 110.896 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.4 Cg_exo -47.97 -28.19 9.93 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.681 2.254 . . . . 0.0 112.337 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 29.8 t -86.56 -49.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.097 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.92 -132.55 3.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -133.31 107.53 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.63 HG11 HD11 ' A' ' 247' ' ' ILE . 96.4 t -88.92 119.84 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.457 ' NE2' ' CD ' ' A' ' 262' ' ' GLU . 1.4 mm100 -81.13 -68.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.454 ' NH1' ' O ' ' A' ' 296' ' ' LEU . 7.5 ptp180 -132.97 154.9 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.63 HD11 HG11 ' A' ' 244' ' ' VAL . 70.4 mt -133.43 135.28 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.478 HG13 ' OG ' ' A' ' 305' ' ' SER . 58.7 t -126.98 132.05 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.16 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 23.4 mt -120.61 118.68 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.501 ' CE2' ' HB3' ' A' ' 256' ' ' GLN . 20.2 p90 -126.75 155.18 43.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -110.22 45.22 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -90.05 109.91 20.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 61.51 41.41 12.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 109.04 149.82 13.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.457 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.9 mm -51.37 123.91 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 111.113 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.658 ' OE1' HD11 ' A' ' 219' ' ' LEU . 17.2 tt0 -153.15 163.79 39.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.24 146.18 16.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 35.3 mtt -111.38 124.92 53.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.491 HG23 HD13 ' A' ' 220' ' ' LEU . 65.7 t -111.89 121.64 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.667 ' HB2' HD12 ' A' ' 296' ' ' LEU . 3.9 tp10 -98.36 140.81 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.527 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 42.0 m-85 -116.35 158.21 23.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.457 ' CD ' ' NE2' ' A' ' 245' ' ' GLN . 3.9 mm-40 -41.48 -67.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 10.0 m -130.52 173.84 10.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.856 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 92.1 t -57.02 -56.72 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 264' ' ' VAL . 17.4 tp -38.27 -64.06 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 61.6 m -45.59 -42.15 10.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -55.91 -40.35 72.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -52.04 -62.95 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.877 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -59.77 -59.99 4.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.527 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -42.78 -48.8 5.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.706 ' HG3' HG21 ' A' ' 288' ' ' ILE . 27.2 tttp -56.15 -44.29 79.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.921 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.04 -60.39 3.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.078 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -49.72 -40.45 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.732 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.7 mp -83.99 -22.61 31.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 271' ' ' LYS . 2.7 t30 -62.17 100.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.56 18.0 61.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.451 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.786 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -80.56 154.3 27.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.331 . . . . 0.0 111.135 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -118.24 134.85 54.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.576 HD11 HD21 ' A' ' 286' ' ' LEU . 65.7 mt -101.53 -40.33 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.148 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.2 172.73 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -54.2 105.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.063 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.84 56.89 0.8 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.1 m -167.54 161.1 13.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.8 m 62.3 39.27 12.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.9 m -55.48 143.47 29.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.186 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.786 HD12 ' HB3' ' A' ' 277' ' ' ALA . 67.8 mt -93.41 126.74 38.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.883 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -124.92 84.92 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.732 HD11 ' CB ' ' A' ' 274' ' ' LEU . 27.0 mt -71.27 144.95 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -147.68 120.07 8.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.549 ' CE2' ' HE2' ' A' ' 271' ' ' LYS . 59.0 m-85 -45.84 96.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.8 147.07 15.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.052 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.474 ' HB2' ' HD3' ' A' ' 293' ' ' PRO . 56.8 mtt-85 -65.41 -61.07 6.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.584 0.707 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 292' ' ' ARG . 58.9 Cg_endo -71.37 154.55 60.95 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.654 2.236 . . . . 0.0 112.34 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.774 HG22 ' OD1' ' A' ' 215' ' ' ASN . 37.0 p -116.14 38.54 3.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.475 ' HG2' ' N ' ' A' ' 296' ' ' LEU . 37.4 ttt180 -149.88 151.21 33.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.667 HD12 ' HB2' ' A' ' 260' ' ' GLU . 85.9 mt -141.58 120.91 13.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -106.96 135.05 49.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 92.0 t -120.25 98.34 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.163 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.8 mp -55.49 -62.55 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -119.88 169.65 9.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.424 ' ND2' ' OD1' ' A' ' 307' ' ' ASP . 3.2 m120 -107.49 114.83 29.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.414 ' CG ' ' C ' ' A' ' 301' ' ' ASN . 0.9 OUTLIER -162.56 172.15 15.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.684 ' HB3' HG23 ' A' ' 230' ' ' THR . 20.8 m120 -42.34 -40.28 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.62 -46.31 70.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.478 ' OG ' HG13 ' A' ' 248' ' ' VAL . 8.6 m -158.03 143.89 17.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -134.88 145.19 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.424 ' OD1' ' ND2' ' A' ' 301' ' ' ASN . 2.2 p-10 -119.34 106.65 12.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.836 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.44 -39.67 24.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 37.9 p -48.4 -47.4 37.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.52 ' HE3' HD21 ' A' ' 313' ' ' LEU . 16.3 mmmt -131.18 88.64 44.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.517 0.675 . . . . 0.0 110.885 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.06 -48.99 0.07 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 312' ' ' TYR . 0.1 OUTLIER -75.87 52.67 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.949 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.52 HD21 ' HE3' ' A' ' 310' ' ' LYS . 28.0 mt -89.78 112.35 23.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.93 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 95.25 79.17 1.45 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -87.11 39.58 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.801 0.334 . . . . 0.0 110.855 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 -179.906 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 82.7 p -172.52 136.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 1.1 t -167.88 175.25 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -148.13 73.71 0.29 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 83.7 p -82.53 92.29 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.878 0.371 . . . . 0.0 110.826 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.3 t -165.14 171.11 14.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.866 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 129.91 99.8 0.89 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.472 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -174.2 146.42 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 110.847 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -135.29 120.95 19.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 7.4 pt -48.86 161.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.163 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.1 t -162.05 160.75 27.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.153 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . 0.459 ' CD ' ' HD2' ' A' ' 205' ' ' PRO . 23.9 tpt180 -95.97 136.98 21.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.55 0.691 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.459 ' HD2' ' CD ' ' A' ' 204' ' ' ARG . 72.4 Cg_exo -46.8 165.0 0.09 OUTLIER 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.673 2.249 . . . . 0.0 112.367 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -70.08 71.26 0.59 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.451 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -52.49 147.07 8.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.398 . . . . 0.0 110.873 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 61.8 p -73.04 164.08 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -67.36 145.61 54.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.905 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -71.63 129.91 87.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.34 142.74 12.13 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.667 2.245 . . . . 0.0 112.364 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.4 t -153.92 149.31 27.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -109.47 137.73 14.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.511 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -54.38 168.7 1.66 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.521 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -146.19 127.72 15.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 0.0 110.906 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -51.24 -41.26 60.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.418 HG11 HD21 ' A' ' 296' ' ' LEU . 50.4 t -78.64 147.38 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 10.1 mt -138.52 139.59 38.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.66 109.54 21.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.859 HD23 HD22 ' A' ' 286' ' ' LEU . 7.6 mp -97.87 129.33 44.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -119.77 115.72 24.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.85 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -82.46 134.98 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.161 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.426 ' C ' ' HD3' ' A' ' 225' ' ' PRO . 2.2 tp-100 -100.4 139.06 36.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.552 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 55.8 t30 35.61 54.0 2.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.61 0.719 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.5 Cg_exo -47.18 113.9 0.84 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.358 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 224' ' ' ASN . 3.3 mm? -89.25 -58.82 2.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.24 143.63 26.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.74 0.781 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.16 112.68 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.714 2.276 . . . . 0.0 112.354 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.7 mm -89.32 116.54 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 18.6 p -126.73 169.29 13.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 303' ' ' ASN . 33.0 m -48.81 -20.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.97 -40.96 68.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 79.7 t -70.29 -31.8 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.17 10.48 35.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -121.94 -5.87 9.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.475 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 40.0 m -108.5 -32.51 7.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.134 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 237' ' ' VAL . 59.7 t -97.2 -7.56 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 61.2 m -100.73 -45.36 5.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.588 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 2.6 t-20 -52.04 -45.39 93.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.644 0.735 . . . . 0.0 110.878 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.6 Cg_exo -48.04 -23.78 4.76 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 34.1 t -92.18 -53.65 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.45 -134.89 3.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.525 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.492 ' HE2' ' N ' ' A' ' 244' ' ' VAL . 0.0 OUTLIER -128.49 94.93 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.87 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.634 HG11 HD11 ' A' ' 247' ' ' ILE . 72.9 t -53.11 132.94 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -110.53 -66.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.491 ' NE ' ' OD2' ' A' ' 307' ' ' ASP . 16.3 ttm105 -128.76 143.15 50.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.634 HD11 HG11 ' A' ' 244' ' ' VAL . 43.3 mt -128.63 132.51 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.093 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.49 HG22 HG22 ' A' ' 298' ' ' VAL . 46.8 t -136.55 132.45 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.2 mt -124.06 113.71 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.142 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -120.29 143.6 48.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -113.35 43.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -60.18 -70.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -107.15 48.16 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.58 -120.89 4.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.7 mm -133.81 93.92 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 111.172 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -125.99 167.9 14.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -161.89 124.98 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.129 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.596 ' HB3' HD11 ' A' ' 296' ' ' LEU . 10.7 mtt -93.59 119.23 32.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.78 130.42 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.092 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -104.65 153.92 20.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -125.27 169.43 12.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -37.91 -73.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.9 m -137.57 -175.27 4.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 60.1 t -55.15 -50.9 60.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.085 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 15.9 tp -46.28 -59.41 2.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 3.5 t -55.29 -30.84 60.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -70.26 -36.13 74.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -58.14 -54.4 47.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -68.52 -44.02 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -55.14 -49.57 71.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.677 ' HG3' HG21 ' A' ' 288' ' ' ILE . 27.0 tttm -50.97 -56.55 11.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.23 -59.45 5.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.13 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -47.61 -30.69 3.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.035 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.801 ' CB ' HD11 ' A' ' 288' ' ' ILE . 3.4 mp -98.07 -14.84 20.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 271' ' ' LYS . 8.9 t-20 -58.43 108.18 0.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 68.74 18.93 72.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.488 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -72.48 99.33 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.329 . . . . 0.0 111.14 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.28 113.24 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.824 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 87.0 mt -72.36 -32.76 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.135 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . 0.424 ' O ' ' C ' ' A' ' 281' ' ' ALA . 63.2 m-85 -136.53 150.76 48.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 280' ' ' TYR . . . -35.85 105.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.1 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 39.86 70.87 0.31 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -174.84 150.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 0.0 110.919 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 3.3 m 57.36 51.56 9.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 28.1 m -60.59 109.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.859 HD22 HD23 ' A' ' 220' ' ' LEU . 35.5 mt -68.48 107.29 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -102.23 91.71 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.801 HD11 ' CB ' ' A' ' 274' ' ' LEU . 97.6 mt -79.59 139.58 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.1 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -149.1 125.97 11.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.537 ' CE2' ' HE3' ' A' ' 271' ' ' LYS . 32.4 m-85 -48.69 100.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.987 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 293' ' ' PRO . . . -53.93 142.05 25.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.597 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 0.6 OUTLIER -64.55 -44.79 75.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 60.9 Cg_endo -80.46 147.53 17.92 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.709 2.272 . . . . 0.0 112.339 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 36.8 p -88.57 -14.32 37.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -127.59 164.95 20.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 258' ' ' MET . 42.9 mt -122.0 171.61 8.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.94 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -129.26 98.66 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 307' ' ' ASP . 85.9 t -81.09 101.76 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.123 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.484 HG22 ' HE ' ' A' ' 300' ' ' ARG . 3.2 mm -38.03 -63.24 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . 0.484 ' HE ' HG22 ' A' ' 299' ' ' ILE . 16.1 ptp180 -170.17 142.29 2.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -39.49 100.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -167.63 172.52 9.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.712 ' O ' HG13 ' A' ' 231' ' ' VAL . 12.6 m-80 -47.68 -57.0 6.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.7 -41.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.43 ' OG ' HG13 ' A' ' 248' ' ' VAL . 8.5 m -162.39 136.94 6.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -126.77 129.06 47.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.587 ' HB2' HG21 ' A' ' 298' ' ' VAL . 19.8 t0 -121.8 81.02 1.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.859 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . 0.518 ' CZ ' HG22 ' A' ' 309' ' ' THR . 1.6 p90 -70.72 -37.66 73.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.518 HG22 ' CZ ' ' A' ' 308' ' ' TYR . 30.5 p -62.13 -21.31 64.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 312' ' ' TYR . 32.5 ttpt -127.09 90.16 50.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.57 0.7 . . . . 0.0 110.894 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.98 -3.1 12.95 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.702 2.268 . . . . 0.0 112.332 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.553 ' O ' ' CD2' ' A' ' 312' ' ' TYR . 36.5 p90 -107.44 93.7 4.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -119.78 120.06 35.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 51.66 71.61 0.63 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -71.25 85.4 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 0.0 110.868 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 62.7 m -108.76 160.27 16.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.887 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 3.3 t -69.25 167.45 16.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 98.71 97.2 2.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.526 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 51.3 p -128.6 -45.67 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.839 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 4.7 t -110.98 98.13 7.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -91.29 73.9 1.66 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 201' ' ' ARG . 0.0 OUTLIER -43.7 -26.42 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.781 0.324 . . . . 0.0 110.899 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.4 ' N ' ' HG2' ' A' ' 200' ' ' LYS . 23.5 mtt180 -124.73 162.79 23.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 66.4 mt -122.87 141.15 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.6 m -41.32 -52.95 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -153.23 143.24 15.29 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.32 154.24 31.9 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.38 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -41.87 114.65 0.71 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.494 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -59.73 108.94 0.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.1 m -125.44 89.03 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -112.09 122.42 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.9 143.75 54.19 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.655 0.74 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.01 159.48 34.02 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.74 2.293 . . . . 0.0 112.345 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 6.0 t -122.01 42.7 3.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.9 -68.27 0.76 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 81.23 156.53 15.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -170.92 144.95 2.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.384 . . . . 0.0 110.856 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -43.72 79.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 296' ' ' LEU . 92.8 t -88.13 146.78 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.101 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.3 mt -135.43 124.99 25.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 36.0 tp -81.62 109.03 15.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 7.3 mp -95.84 129.47 43.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 63.1 m -112.73 127.07 56.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.575 HD13 HG22 ' A' ' 255' ' ' ILE . 4.8 mp -89.61 121.74 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.74 138.77 39.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.517 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 1.8 m-20 43.43 53.92 10.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.73 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.5 Cg_exo -45.87 90.24 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.337 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.7 mt -97.04 -42.45 7.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -111.45 153.54 44.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.732 0.777 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.75 115.81 4.28 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.537 HG21 HD21 ' A' ' 234' ' ' LEU . 30.3 mm -99.23 92.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 231' ' ' VAL . 1.6 m -71.81 167.22 20.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.093 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 230' ' ' THR . 21.2 m -54.44 -39.53 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.34 -52.05 67.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 96.0 t -46.05 -40.14 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.537 HD21 HG21 ' A' ' 229' ' ' ILE . 33.7 mt -76.05 -60.5 2.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.964 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -47.31 -34.06 6.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.481 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 87.2 m -63.35 -47.8 80.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.149 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 237' ' ' VAL . 59.6 t -86.94 -10.77 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.128 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.435 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 72.9 m -87.39 -49.2 7.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.571 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 14.3 t30 -48.53 -46.48 70.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.649 0.738 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.3 Cg_exo -47.96 -18.63 1.2 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.667 2.245 . . . . 0.0 112.399 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 37.0 t -104.4 -41.62 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.79 -144.71 4.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -123.16 126.4 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.914 HG11 HD11 ' A' ' 247' ' ' ILE . 85.4 t -96.19 147.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -108.22 -61.89 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 247' ' ' ILE . 21.3 ttm180 -134.6 147.82 50.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.914 HD11 HG11 ' A' ' 244' ' ' VAL . 61.3 mt -140.54 131.0 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.466 HG22 HG22 ' A' ' 298' ' ' VAL . 89.7 t -125.67 135.87 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 304' ' ' ASP . 58.5 mt -120.94 120.82 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -136.1 155.13 50.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -131.76 40.59 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -68.78 -57.26 5.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -119.77 45.77 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 116.69 128.49 4.17 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.443 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.575 HG22 HD13 ' A' ' 222' ' ' ILE . 42.9 mm -43.92 104.41 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -146.3 170.76 16.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -159.54 130.22 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.467 ' SD ' ' CD2' ' A' ' 296' ' ' LEU . 22.4 mtt -87.89 118.0 27.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 87.7 t -107.87 123.43 63.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -103.08 150.3 23.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 262' ' ' GLU . 56.4 m-85 -126.0 161.12 28.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 261' ' ' PHE . 23.4 mt-10 -34.15 -70.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 t -140.39 167.71 21.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 94.8 t -41.04 -57.14 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 264' ' ' VAL . 19.6 tp -37.22 -63.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 30.7 m -47.36 -42.2 21.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -56.33 -38.31 71.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -56.14 -59.44 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -66.32 -50.9 62.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.954 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -49.42 -49.92 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.68 ' HA ' HD13 ' A' ' 288' ' ' ILE . 58.9 tttm -52.57 -46.96 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -60.05 -70.52 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -42.29 -36.8 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.129 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.713 ' CB ' HD11 ' A' ' 288' ' ' ILE . 4.7 mp -85.94 -23.97 26.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 271' ' ' LYS . 14.3 t-20 -58.75 102.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.9 23.07 60.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -93.24 93.71 8.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.32 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.1 148.63 50.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 41.0 mt -104.5 -40.34 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.89 172.93 6.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -57.16 107.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.4 55.68 0.75 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.514 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 6.5 m -164.47 153.67 13.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 4.9 m 62.82 44.53 6.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 39.2 m -59.92 129.22 40.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.439 ' O ' ' NZ ' ' A' ' 287' ' ' LYS . 35.5 mt -78.28 123.31 26.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 286' ' ' LEU . 0.9 OUTLIER -121.83 84.96 2.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.875 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.713 HD11 ' CB ' ' A' ' 274' ' ' LEU . 28.6 mt -65.26 144.02 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.174 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -153.98 111.09 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -38.07 106.26 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -54.62 160.76 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.097 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 14.8 mtt-85 -73.04 -59.37 2.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 0.0 110.901 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 59.7 Cg_endo -73.23 159.09 47.89 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.711 2.274 . . . . 0.0 112.342 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 34.4 p -88.22 -25.1 23.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -173.88 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.606 HD21 HG11 ' A' ' 217' ' ' VAL . 17.8 mt -142.24 168.34 19.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -125.56 114.97 19.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.466 HG22 HG22 ' A' ' 248' ' ' VAL . 84.5 t -106.02 102.86 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.7 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.4 mp -57.25 -51.31 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.03 155.42 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -90.09 85.38 6.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.4 173.16 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -39.39 -51.12 2.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.402 ' O ' HD12 ' A' ' 249' ' ' ILE . 2.1 m-20 -45.46 -59.87 2.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 63.8 p -135.13 138.46 43.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -139.56 127.44 22.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -104.02 98.22 8.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -83.72 40.21 0.73 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 77.3 p -114.68 -39.34 3.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.138 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.46 ' HG2' ' CZ ' ' A' ' 312' ' ' TYR . 24.7 mttp -126.72 89.01 53.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.534 0.683 . . . . 0.0 110.877 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.72 -5.36 15.93 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.707 2.271 . . . . 0.0 112.36 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.46 ' CZ ' ' HG2' ' A' ' 310' ' ' LYS . 8.8 p90 -102.9 45.78 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 20.1 mt -121.61 106.21 11.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.939 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 161.99 46.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.511 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.34 80.27 1.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.813 0.339 . . . . 0.0 110.888 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -179.905 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.8 t -153.95 115.64 4.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.351 . . . . 0.0 110.866 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.3 m -75.21 122.03 23.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 159.19 87.05 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.491 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 66.7 m -119.43 123.62 44.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.888 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 83.8 p -171.32 146.56 2.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.43 -171.26 17.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -82.28 -44.77 15.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -117.56 95.45 4.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 4.5 pt -70.48 70.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.119 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.1 p -140.77 152.78 45.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.175 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -122.71 122.49 27.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.605 0.717 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.87 106.16 2.21 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.743 2.295 . . . . 0.0 112.327 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -129.2 51.12 0.87 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -170.35 157.47 6.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 0.0 110.899 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.7 m -116.78 154.26 30.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -96.87 121.82 39.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -107.98 151.75 41.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.576 0.703 . . . . 0.0 110.912 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.87 122.67 6.42 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.737 2.291 . . . . 0.0 112.371 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 8.4 t 49.96 41.51 23.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -110.13 -149.01 12.26 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.462 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 114.85 -172.1 14.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -156.25 142.31 18.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.859 0.362 . . . . 0.0 110.893 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -58.1 -42.95 86.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.438 ' O ' HD23 ' A' ' 218' ' ' LEU . 59.6 t -73.84 139.27 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.123 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 217' ' ' VAL . 29.5 mt -138.6 126.82 22.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.46 113.48 21.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.489 HD23 HD22 ' A' ' 286' ' ' LEU . 6.9 mp -100.53 132.68 45.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -119.33 137.92 53.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.599 HD13 HG22 ' A' ' 255' ' ' ILE . 5.2 mp -105.28 125.31 60.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -82.57 142.43 31.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.517 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 42.0 t30 40.12 53.49 5.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 110.899 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.3 Cg_exo -44.7 103.61 0.05 OUTLIER 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.697 2.265 . . . . 0.0 112.343 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 55.2 mt -105.08 -46.93 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -100.5 153.61 37.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.709 0.766 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.75 116.34 4.64 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.711 2.274 . . . . 0.0 112.35 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.534 HG21 HD21 ' A' ' 234' ' ' LEU . 43.7 mm -100.22 119.98 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 232' ' ' ASP . 18.2 p -122.57 156.16 34.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 303' ' ' ASN . 34.4 m -33.62 -35.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.2 m-20 -60.96 -65.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 87.3 t -43.62 -51.02 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.16 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.534 HD21 HG21 ' A' ' 229' ' ' ILE . 46.1 mt -60.93 -58.33 8.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.549 ' CE2' ' HB ' ' A' ' 244' ' ' VAL . 3.2 t80 -54.68 -25.86 29.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.422 ' O ' ' CD ' ' A' ' 240' ' ' PRO . 66.6 m -70.19 -45.86 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.171 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.439 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 39.4 t -87.2 -15.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 71.0 m -86.27 -46.12 10.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.556 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -47.11 -47.76 54.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.866 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 66.0 Cg_exo -47.96 -21.07 2.41 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.723 2.282 . . . . 0.0 112.366 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.874 HG11 ' HA ' ' A' ' 270' ' ' ALA . 69.7 t -98.73 -39.09 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.13 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.53 -154.11 7.94 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.457 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.408 ' HB3' ' CD ' ' A' ' 262' ' ' GLU . 2.5 tmtm? -104.23 144.39 31.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.944 HG11 HD11 ' A' ' 247' ' ' ILE . 63.0 t -108.69 141.3 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.42 ' NE2' ' HG3' ' A' ' 262' ' ' GLU . 20.2 mt-30 -110.66 -65.11 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.446 ' HG2' ' N ' ' A' ' 247' ' ' ILE . 17.4 ttm180 -130.9 145.08 51.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.82 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.944 HD11 HG11 ' A' ' 244' ' ' VAL . 71.3 mt -138.34 140.17 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 305' ' ' SER . 17.1 t -131.37 139.98 49.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.418 HG12 ' CB ' ' A' ' 257' ' ' ALA . 77.2 mt -129.02 109.45 18.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -118.96 151.29 38.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 40.88 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -58.48 -63.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -109.19 43.6 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 124.31 -121.96 4.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.495 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.599 HG22 HD13 ' A' ' 222' ' ' ILE . 28.7 mm -129.61 91.21 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 111.102 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -124.83 159.68 30.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.418 ' CB ' HG12 ' A' ' 249' ' ' ILE . . . -155.91 122.93 5.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.464 ' SD ' HD21 ' A' ' 296' ' ' LEU . 19.3 mtt -86.07 125.07 33.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.447 HG23 HD13 ' A' ' 220' ' ' LEU . 95.6 t -111.85 118.86 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -94.31 156.44 16.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -130.67 169.04 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.892 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 262' ' ' GLU . 10.9 mp0 -54.26 -64.2 0.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 73.7 m -128.49 172.53 11.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 91.2 t -61.12 -51.43 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 24.9 tp -40.74 -63.49 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 33.5 m -46.03 -40.59 10.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -58.06 -39.21 77.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -56.75 -57.09 13.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -63.51 -60.35 3.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.874 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -47.62 -50.01 25.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.113 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.555 ' HG3' HG21 ' A' ' 288' ' ' ILE . 49.2 tttm -48.55 -51.67 26.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -59.36 -66.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -41.67 -37.75 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.473 ' CB ' HD11 ' A' ' 288' ' ' ILE . 5.4 mp -87.8 -22.1 24.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 272' ' ' ALA . 7.3 t30 -57.86 104.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.03 23.01 70.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.49 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -79.59 118.37 21.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.25 125.29 28.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 286' ' ' LEU . 78.4 mt -97.8 -41.04 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.146 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -117.77 172.58 7.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -54.38 105.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.12 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 35.63 54.26 1.07 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.497 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 4.3 m -165.45 163.77 19.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.738 0.304 . . . . 0.0 110.882 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.01 41.89 7.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 54.0 m -55.8 118.49 4.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 279' ' ' ILE . 36.3 mt -71.39 127.08 31.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -127.02 95.03 4.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.555 HG21 ' HG3' ' A' ' 271' ' ' LYS . 38.7 mt -77.23 147.36 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -150.38 124.05 9.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -49.64 97.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -47.5 134.75 11.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.116 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.575 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 9.2 ttp180 -60.21 -46.61 97.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 0.0 110.817 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.2 Cg_endo -79.45 149.26 21.38 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.712 2.275 . . . . 0.0 112.349 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 60.6 p -92.66 -25.25 18.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -123.9 139.59 53.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.464 HD21 ' SD ' ' A' ' 258' ' ' MET . 40.0 mt -100.43 176.57 5.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -131.46 115.42 16.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.56 105.66 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.135 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.671 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -65.92 -59.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.136 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -132.9 175.58 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -104.16 105.69 15.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 303' ' ' ASN . 0.9 OUTLIER -149.7 166.74 28.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 231' ' ' VAL . 5.0 p30 -33.71 -39.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.58 -58.24 9.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.416 ' HB2' ' HA ' ' A' ' 248' ' ' VAL . 9.8 t -134.35 153.62 51.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -144.13 134.24 24.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -112.91 108.74 17.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.811 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -79.51 -50.58 10.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.902 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 68.6 p -41.9 -32.56 0.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -135.02 90.42 21.67 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.586 0.708 . . . . 0.0 110.86 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -79.26 -16.63 12.1 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.676 2.25 . . . . 0.0 112.365 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -104.14 69.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 31.4 mt -130.39 112.39 13.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.925 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 315' ' ' ARG . . . 99.78 156.24 28.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 314' ' ' GLY . 22.3 ttp180 -35.09 -53.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.845 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.883 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.8 m -155.73 176.07 13.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.902 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 74.3 m -152.32 170.5 19.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -150.09 176.46 28.73 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.501 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 70.2 m -153.79 116.08 4.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.878 0.371 . . . . 0.0 110.865 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 19.6 m -77.08 174.83 10.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -140.79 129.23 4.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.48 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -147.41 154.97 41.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -144.87 150.91 37.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.3 pt -70.21 166.8 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.158 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.2 t -136.27 151.67 49.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -98.61 154.73 37.36 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.606 0.717 . . . . 0.0 110.93 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.63 149.43 34.19 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.712 2.275 . . . . 0.0 112.312 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -114.39 127.41 7.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.464 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -71.01 165.67 22.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.892 0.377 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 31.4 m -118.29 139.4 51.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.0 168.78 19.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -119.46 133.19 23.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.627 0.727 . . . . 0.0 110.874 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -80.03 27.8 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.707 2.271 . . . . 0.0 112.361 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.7 m -44.45 98.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.839 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 79.62 -163.78 48.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.436 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.478 ' HA2' ' CE1' ' A' ' 290' ' ' TYR . . . 163.22 139.89 2.74 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.485 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.408 ' ND2' ' HB ' ' A' ' 217' ' ' VAL . 51.5 t30 -143.29 147.53 34.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 0.0 110.899 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 264' ' ' VAL . 40.2 mtmt -57.61 -41.91 82.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.674 HG11 HD21 ' A' ' 296' ' ' LEU . 55.8 t -77.59 138.58 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 220' ' ' LEU . 14.0 mt -133.79 119.2 18.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.9 tp -76.25 106.58 7.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.695 HD13 ' CG2' ' A' ' 259' ' ' VAL . 6.9 mp -92.98 123.76 36.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 2.0 m -114.27 118.96 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 5.0 mp -79.55 133.9 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.09 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.43 ' C ' ' HD3' ' A' ' 225' ' ' PRO . 43.8 mt-30 -91.15 141.91 28.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.547 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 62.7 t30 35.11 54.42 1.91 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.632 0.73 . . . . 0.0 110.874 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 75.8 Cg_exo -47.33 115.91 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.326 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 62.6 mt -108.17 -54.86 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -101.08 137.82 19.82 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.67 0.748 . . . . 0.0 110.867 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.77 125.94 13.76 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.673 2.248 . . . . 0.0 112.365 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.442 HD12 HG11 ' A' ' 233' ' ' VAL . 49.9 mm -104.55 126.4 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.107 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.0 p -125.77 163.84 21.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.131 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 235' ' ' TYR . 35.8 m -40.22 -35.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.166 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -55.99 -45.54 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 229' ' ' ILE . 94.7 t -61.9 -52.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 31.4 mt -84.11 24.38 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.455 ' CB ' ' O ' ' A' ' 231' ' ' VAL . 85.2 t80 -130.58 -37.25 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.971 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.499 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 85.2 m -80.58 -34.27 35.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.447 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 11.6 t -87.88 -19.4 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.462 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 73.0 m -84.63 -50.64 7.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.545 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 1.5 t-20 -45.31 -47.39 34.3 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.631 0.729 . . . . 0.0 110.904 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 64.6 Cg_exo -47.98 -30.93 14.76 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.259 . . . . 0.0 112.336 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.01 -39.86 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.168 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.47 -133.24 1.46 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.52 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -121.34 143.7 49.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.896 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.66 128.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.708 ' O ' HG23 ' A' ' 309' ' ' THR . 30.6 mm-40 -92.46 -59.44 2.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -147.27 154.3 40.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 79.5 mt -133.4 134.54 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 298' ' ' VAL . 58.1 t -133.47 116.06 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.5 mt -108.08 106.58 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -118.93 149.19 42.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.512 ' HG3' HD13 ' A' ' 255' ' ' ILE . 2.6 mppt? -118.16 41.45 2.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -54.25 -63.86 1.02 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -109.52 43.26 1.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 123.3 -118.82 3.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.512 HD13 ' HG3' ' A' ' 251' ' ' LYS . 41.8 mm -127.05 95.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 111.132 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -128.83 157.52 41.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -156.32 118.52 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 24.7 mtt -87.53 125.74 34.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.695 ' CG2' HD13 ' A' ' 220' ' ' LEU . 91.7 t -111.58 131.59 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.103 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 261' ' ' PHE . 5.0 tp10 -104.77 152.0 23.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.583 ' CZ ' ' HB1' ' A' ' 270' ' ' ALA . 55.1 m-85 -130.08 157.6 41.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 261' ' ' PHE . 67.3 mt-10 -34.99 -66.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.2 p -143.68 174.54 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.432 ' N ' ' HG2' ' A' ' 216' ' ' LYS . 74.5 t -47.82 -59.87 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 264' ' ' VAL . 18.1 tp -35.98 -60.12 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 85.9 m -53.22 -40.97 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -57.27 -36.88 71.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -58.76 -58.27 9.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -66.13 -53.03 42.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.583 ' HB1' ' CZ ' ' A' ' 261' ' ' PHE . . . -49.38 -47.83 47.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.804 ' HG3' HG21 ' A' ' 288' ' ' ILE . 24.6 tttt -53.38 -55.57 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.847 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 275' ' ' ASN . . . -53.64 -67.27 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.109 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -41.96 -42.29 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.602 ' CB ' HD11 ' A' ' 288' ' ' ILE . 3.6 mp -81.82 -22.0 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 271' ' ' LYS . 65.4 t30 -61.61 101.76 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 77.89 21.46 71.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.629 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -82.1 93.79 7.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.118 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.36 117.08 2.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.587 HD11 HD21 ' A' ' 286' ' ' LEU . 80.3 mt -91.14 -37.43 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.134 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -120.35 173.86 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -56.87 104.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.128 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.49 59.12 0.67 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.423 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 31.2 p -175.12 162.45 3.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.812 0.339 . . . . 0.0 110.908 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 77.2 m 62.48 43.08 8.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 5.9 m -57.24 146.78 27.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.629 HD12 ' HB3' ' A' ' 277' ' ' ALA . 73.6 mt -91.81 119.33 31.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -116.71 79.53 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.804 HG21 ' HG3' ' A' ' 271' ' ' LYS . 47.6 mt -65.41 147.73 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -151.85 113.63 4.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.478 ' CE1' ' HA2' ' A' ' 214' ' ' GLY . 39.1 m-85 -41.12 101.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -50.67 138.9 17.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 293' ' ' PRO . 6.2 ttt180 -66.08 -45.7 62.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.62 0.724 . . . . 0.0 110.889 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 292' ' ' ARG . 61.3 Cg_endo -80.21 148.37 18.98 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.315 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.8 p -82.11 -25.75 34.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.438 ' HD3' ' N ' ' A' ' 296' ' ' LEU . 0.4 OUTLIER -119.21 -174.66 2.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.674 HD21 HG11 ' A' ' 217' ' ' VAL . 52.0 mt -139.17 173.35 11.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.928 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -124.83 117.9 25.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 248' ' ' VAL . 77.9 t -122.35 91.73 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.057 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.714 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.3 mp -50.43 -56.55 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.44 177.23 8.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -99.19 96.47 7.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -136.16 171.55 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -42.11 -45.28 3.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -55.67 -62.3 1.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 97.4 p -129.05 137.15 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -140.98 132.16 26.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -116.21 92.47 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 309' ' ' THR . 53.3 m-85 -69.02 -43.58 74.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 245' ' ' GLN . 47.5 p -37.43 -49.89 1.04 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.136 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.8 102.34 44.77 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.55 0.691 . . . . 0.0 110.884 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.668 ' O ' ' CD1' ' A' ' 312' ' ' TYR . 43.4 Cg_endo -70.71 -159.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 0.0 112.295 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.668 ' CD1' ' O ' ' A' ' 311' ' ' PRO . 0.9 OUTLIER 34.08 55.01 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 313' ' ' LEU . 10.5 mt -123.92 149.28 46.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 315' ' ' ARG . . . 120.38 -60.28 0.53 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.479 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 314' ' ' GLY . 10.4 ttm180 -37.02 -45.35 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.925 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.6 p -152.47 153.08 32.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.858 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 50.0 m -114.62 167.77 10.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -78.79 119.5 5.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.446 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.6 t -118.33 -60.6 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 110.862 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 6.6 t -71.1 -50.88 28.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.821 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 160.48 90.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 201' ' ' ARG . 14.6 pttp -70.5 -44.17 68.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.308 . . . . 0.0 110.893 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.477 ' N ' ' HG3' ' A' ' 200' ' ' LYS . 13.1 tpp85 -146.31 120.02 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 2.3 pp -47.56 150.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 86.6 m -147.01 125.1 12.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.172 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -129.43 113.25 18.1 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.591 0.71 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.53 134.29 13.71 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.67 2.247 . . . . 0.0 112.351 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -169.71 43.06 0.21 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.452 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -141.95 159.18 42.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.913 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 14.8 t -152.98 142.45 21.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.105 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -162.68 134.15 5.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.819 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.48 143.88 98.41 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.563 0.697 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.35 -12.54 17.12 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.315 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 58.6 m 49.77 42.29 23.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.94 88.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -61.63 -144.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.515 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -165.85 125.38 1.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 110.901 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -46.2 -40.22 10.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 49.0 t -77.81 137.23 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.095 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 24.1 mt -136.93 129.98 30.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.03 118.88 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.52 134.7 50.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.8 t -119.63 137.6 53.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.76 HD13 HG22 ' A' ' 255' ' ' ILE . 5.2 mp -99.21 128.83 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -89.75 138.96 31.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.508 ' N ' ' HD3' ' A' ' 225' ' ' PRO . 49.7 t30 39.52 52.7 4.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.624 0.726 . . . . 0.0 110.935 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 224' ' ' ASN . 71.5 Cg_exo -43.7 94.33 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.641 2.228 . . . . 0.0 112.334 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 20.2 mt -95.86 -43.78 7.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -102.71 153.48 38.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.715 0.769 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.29 115.77 4.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.696 2.264 . . . . 0.0 112.274 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 47.8 mm -98.41 110.48 26.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 232' ' ' ASP . 49.6 p -105.99 158.46 16.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.13 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 303' ' ' ASN . 18.3 m -41.49 -26.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.123 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 230' ' ' THR . 1.5 m-20 -68.22 -61.98 1.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 0.477 ' CG1' HD13 ' A' ' 279' ' ' ILE . 78.5 t -39.45 -45.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 31.5 mt -77.74 -37.92 48.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.595 ' O ' ' CD2' ' A' ' 235' ' ' TYR . 76.9 t80 -83.42 20.14 1.4 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.501 ' O ' ' CG ' ' A' ' 240' ' ' PRO . 99.2 m -124.43 -37.19 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.142 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.413 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 89.1 t -98.21 -19.26 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 240' ' ' PRO . 65.3 m -89.75 -45.55 9.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.589 ' N ' ' CD ' ' A' ' 240' ' ' PRO . 4.8 t-20 -51.37 -45.35 89.96 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.728 . . . . 0.0 110.944 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 239' ' ' ASN . 65.1 Cg_exo -47.97 -56.87 2.71 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.711 2.274 . . . . 0.0 112.318 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.3 -47.04 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -142.74 -108.08 0.65 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.507 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.535 ' O ' ' CD2' ' A' ' 261' ' ' PHE . 13.7 tptp -152.33 151.34 30.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.74 HG11 HD11 ' A' ' 247' ' ' ILE . 95.1 t -127.94 122.36 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -82.64 -69.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -137.24 156.91 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.74 HD11 HG11 ' A' ' 244' ' ' VAL . 55.5 mt -137.06 133.47 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.721 HG22 HG22 ' A' ' 298' ' ' VAL . 94.9 t -126.54 110.18 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 257' ' ' ALA . 60.4 mt -94.09 126.14 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.159 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -141.35 135.16 30.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -84.5 41.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -89.59 119.19 29.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.8 m120 51.49 40.95 28.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 109.56 135.71 7.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.463 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.76 HG22 HD13 ' A' ' 222' ' ' ILE . 38.0 mm -46.56 104.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.321 . . . . 0.0 111.152 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -134.1 164.42 27.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.468 ' HB2' HG12 ' A' ' 249' ' ' ILE . . . -152.51 122.03 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.431 ' SD ' HD21 ' A' ' 296' ' ' LEU . 26.4 mtt -83.42 114.68 21.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.517 HG22 HG12 ' A' ' 247' ' ' ILE . 88.7 t -106.8 119.44 56.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 261' ' ' PHE . 11.0 tt0 -91.54 151.01 20.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 243' ' ' LYS . 30.3 m-85 -123.5 163.74 20.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -52.97 -72.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 66.8 m -114.8 -174.95 2.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 267' ' ' ALA . 58.6 t -77.66 -44.54 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 36.6 tp -51.61 -65.8 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 24.3 p -42.44 -38.22 1.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 264' ' ' VAL . . . -60.04 -38.66 83.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -58.68 -59.39 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -56.56 -53.7 54.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.448 ' O ' HD13 ' A' ' 274' ' ' LEU . . . -52.57 -55.04 25.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.074 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.416 ' HA ' HD13 ' A' ' 288' ' ' ILE . 41.5 tttm -43.09 -51.34 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -46.86 -73.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 277' ' ' ALA . . . -45.49 -50.18 12.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.071 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.919 ' HB3' HD11 ' A' ' 288' ' ' ILE . 5.1 mp -61.47 -26.79 68.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 271' ' ' LYS . 33.6 t30 -60.62 105.05 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 74.15 25.66 70.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.459 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 273' ' ' ALA . . . -86.02 93.36 8.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 0.0 111.131 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.69 131.92 45.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.477 HD13 ' CG1' ' A' ' 233' ' ' VAL . 72.6 mt -88.56 -34.34 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -121.61 173.13 7.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.958 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 282' ' ' GLY . . . -55.32 112.55 1.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 281' ' ' ALA . . . 34.17 73.73 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.536 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' CYS . . . . . . . . . . . . . 2.6 t -175.31 177.78 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.313 . . . . 0.0 110.911 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' CYS . . . . . . . . . . . . . 27.8 p 39.44 46.61 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 55.8 m -57.86 90.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -45.72 131.13 9.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -127.8 96.85 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.919 HD11 ' HB3' ' A' ' 274' ' ' LEU . 66.3 mt -80.2 145.94 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -153.01 114.91 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -43.08 98.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -48.15 141.73 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.602 ' N ' ' HD2' ' A' ' 293' ' ' PRO . 0.0 OUTLIER -69.86 -47.43 23.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.56 0.695 . . . . 0.0 110.859 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 292' ' ' ARG . 62.5 Cg_endo -77.57 144.28 22.33 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.676 2.251 . . . . 0.0 112.34 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 81.1 p -83.7 -31.31 26.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -112.8 161.11 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.431 HD21 ' SD ' ' A' ' 258' ' ' MET . 74.6 mt -119.36 -178.28 3.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -143.02 113.53 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.721 HG22 HG22 ' A' ' 248' ' ' VAL . 87.9 t -116.16 106.07 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.515 ' H ' HD12 ' A' ' 299' ' ' ILE . 5.2 mp -66.87 -55.88 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . 0.42 ' CG ' ' OD2' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -133.83 153.13 51.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -90.09 87.19 6.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.42 ' OD2' ' CG ' ' A' ' 300' ' ' ARG . 5.0 p30 -123.18 171.78 9.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.851 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.683 ' O ' HG13 ' A' ' 231' ' ' VAL . 6.5 m120 -39.89 -45.9 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.468 ' O ' ' CG1' ' A' ' 249' ' ' ILE . 25.7 m-20 -57.42 -61.52 2.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.444 ' CB ' ' HA ' ' A' ' 248' ' ' VAL . 97.0 p -123.33 131.79 53.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -144.16 119.11 9.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -97.69 117.65 32.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.88 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -98.61 44.18 1.04 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 76.7 p -116.05 -41.3 3.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.139 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.594 ' HG3' ' CE1' ' A' ' 312' ' ' TYR . 19.3 ttpt -131.29 98.08 19.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.534 0.683 . . . . 0.0 110.875 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.64 -10.15 21.67 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.697 2.265 . . . . 0.0 112.386 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.815 ' O ' HD22 ' A' ' 313' ' ' LEU . 3.1 p90 -110.38 108.65 18.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.949 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.815 HD22 ' O ' ' A' ' 312' ' ' TYR . 4.4 mm? -134.97 44.6 2.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.937 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -83.45 177.08 52.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.504 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.24 -30.36 43.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 0.0 110.871 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.523 ' CD ' ' C ' ' A' ' 316' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.91 -179.913 . . . . . . . . 2 2 . 1 stop_ save_